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ABSTRACT 
 
 
Introduction: 
 
Cupriavidus necator H16 is a chemolithoautotrophic Gram-negative bacterium 
that belongs to the class of b-proteobacteria. In recent years, it has attracted the 
biotechnological attention as a cell factory to produce value-added chemicals. 
Thus, a need for expanding engineering tools for chemical production in C. 
necator H16 has emerged. In order to use C. necator H16 as a cell factory, mainly 
two different engineering strategies are reviewed in this work: rational design 
engineering and evolutionary engineering. 
 
Aim:  
 
The overall aim of the study is to engineer C. necator H16 with rational design 
and evolutionary engineering tools to explore the biotechnological potentials of 
the strain and fine-tune the properties of C. necator H16 for chemical production 
using waste stream as a feedstock. 
 
Thesis content:  
 
In Chapter 1, literature review about C. necator H16 was compiled to understand 
the natural metabolism of the strain and to analyse its different biomanufacturing 
potentials, as well as engineering strategies used for chemical production in C. 
necator H16 and other related microorganisms, afterwards, in Chapter 2 the 
development of an optimised transformation method and a synthetic biology 
toolbox for C. necator H16 was developed to design robust strains of C. necator 
H16. Once the synthetic biology toolbox was tailored for C. necator H16, in 
Chapter 3, the synthetic biology toolbox was tested for the expression of two 
clusters of genes as well as possibly obtain bioproducts from the expression of 
these. Then, in Chapter 4, evolutionary engineering tools were optimised to 
engineer C. necator H16, the evolutionary engineering tool used was directed 
evolution via random mutagenesis, where an optimised protocol for random 
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mutagenesis with a chemical mutagen for C. necator H16 was optimised and used 
to try to understand the biotin biosynthesis pathway of C. necator H16, which 
could furtherly be used for chemical production. In Chapter 5, the knowledge 
and strategies studied in previous chapters and proven to work in C. necator H16 
supported the approaches selected to construct recombinant and evolved strains of 
C. necator H16 for chemical production (bioplastics) using waste stream (crude 
glycerol) as a feedstock. Chapter 6 highlights the general discussions, results, 
future work and perspectives of this PhD work. 
  
CHAPTER 1 
Literature Review: 
Engineering Cupriavidus necator H16 to use it 
as a chassis cell for chemical production 
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Abstract 
 
 
 
 
Cupriavidus necator H16 is a chemolithoautotrophic Gram-negative bacterium 
that belongs to the class of b-proteobacteria. In recent years, C. necator H16 has 
attracted the biotechnological attention as cell factory to produce value-added 
chemicals. Hence, there is a need for expanding engineering tools for chemical 
production in C. necator H16. In order to use C. necator H16 as a cell factory, 
mainly two different strategies are reviewed in this Chapter 1: Rational design 
and Evolutionary engineering, which are the most common engineering tools used 
for chemical production in industry. The current and potential bioproducts that 
can be biosynthesised in C. necator H16 and the different carbon sources - 
including sustainable and cheap feedstock- that this bacterium can utilise are also 
discussed in this Chapter. 
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1 Chapter 1. Literature Review: Engineering Cupriavidus necator H16 to 
use it as a chassis cells for chemical production 
 
 
1.1 Introduction 
 
Fossil hydrocarbons are used as building blocks to produce a wide range of 
organic carbon-based chemical products; nevertheless, it has been vastly 
discussed that we can no longer afford the dependency on fossil hydrocarbons, 
because they are not only finite but also due to environmental concerns. The 
biotechnological community has put more efforts to fine-tune strategies to minor 
environmental burdens. For instance, one of the strategies reinforced during the 
last decades is the production of biodiesel from vegetable or animal fats which 
was proposed as a more environmentally-friendly alternative to conventional 
petroleum diesel production. To make this process entirely environmentally-
friendly, the waste that results from biodiesel production should be reused, as the 
waste stream cannot be disposed of in the environment due to contaminants 
present in it. One of the main byproducts of biodiesel production is crude 
glycerol, which has about 50 % purity once it has emerged from the biodiesel 
process. Although pure glycerol is a value-added chemical for the industry, only a 
small percentage of biodiesel producers have the equipment to refine crude 
glycerol to at least its 80 % purity in order to be sold afterwards to glycerol 
refiners.  Since crude glycerol is contaminated with other components such as 
methanol, free fatty acids, and salts, it cannot be released into the environment; 
therefore, proper disposal strategies must be considered to make the process 
sustainable. As reviewed in Volodina et al. (2016), there are other industrial 
byproducts like residual glycerol that contain high carbon concentrations per 
weight, such is the case for corn, palm, and soybean oils, and other materials rich 
in sugar such as lignocellulose, molasses, and starch. These residues represent the 
most promising sustainable feedstocks, and have been extensively studied. 
 
These sort of waste streams have directed scientists to design engineered cells that 
can function as chemical factories, factories that can contribute to the bio-based 
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economy by employing waste stream as biological feedstock. Some organisms 
can naturally use a wide range of carbon sources and waste stream as biological 
feedstock and convert them into value-added chemicals, although most of the 
times, their native pathways must be engineered, as the natural utilisation of the 
substrates and the bioproductivity yield of wild-type cells does not fulfil the 
expected market demand. Therefore, to design a robust strain capable of targeting 
the general necessities of the biobased economy, this strain must minimise overall 
productions costs and maximise its bioproduction to be economically competitive 
by converting cheap and already available waste stream into a sustainable 
biological feedstock that acts as a building block for chemical production. 
 
As reviewed in Johnson et al., 2015, the organisms that can use waste stream as 
biological feedstock range from plants, mammalian or microbial cells, being 
microbial cells the more widely used platforms due to their simple systems and 
their ability to use biomass feedstock that allows rapid growth and biosynthesis. 
Microbial cells have another advantage, which is their relatively easy genetic 
manipulation since the complete genomic sequence annotation of some bacteria is 
already available, there is also as well, the possibility of regulating the 
fermentation conditions to achieve high product titres. Some of the most well 
studied microbiological systems used worldwide for biomanufacturing are 
Escherichia coli, Bacillus subtilis, Bacillus megaterium, Pseudomonas 
fluorescens, Corynebacterium glutamicum (Witthoff et al., 2015), Saccharomyces 
cerevisiae, Pischia pastoris and in recent years Cupriavidus necator H16 
(reviewed in Johnson et al., 2015). 
 
The work of this PhD study was centred on using C. necator H16 as a cell factory 
for biomanufacturing purposes, where rational design and evolutionary 
engineering strategies were studied and optimised for chemical production. In this 
Chapter 1, the rationales behind of choosing C. necator H16 as a candidate for 
biomanufacturing are given, as well as an overview of rational design and 
evolutionary engineering tools that have been used to engineer this strain. 
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1.2 C. necator H16: A candidate for chemical production 
 
The soil bacterium C. necator H16 (also known as Ralstonia eutropha H16) is a 
Gram-negative bacterium isolated almost 60 years ago in Goettingen, Germany 
(Schlegel et al., 1961a, b; Wilde 1962), it is found in soil and aquatic 
environments under facultative anaerobic conditions. C. necator H16 belongs to 
the class of b-proteobacteria, and it can use either organic compounds 
(heterotrophically) or H2 as sources of energy (autotrophically), it is as well 
capable of growing under mixotrophic conditions depending on the carbon source 
supplied (reviewed in Jajesniak et al., 2014), which is of significant interest for 
biotechnological engineers. The strain can also fix CO2 through the Calvin-
Benson-Bassham (CBB) cycle, where hydrogen is used as the energy source. As 
reviewed in Reinecke et al. (2009), although C. necator H16 can grow either in 
oxygen-limited or anaerobic conditions, it relies primarily on aerobic conditions, 
where it uses oxygen, nitrate or nitrite as terminal electron acceptors. For 
heterotrophic growth, it can metabolise some organic compounds ranging from 
sugars, amino acids, fatty acids and citric acid cycle intermediates. Some of the 
different carbon fixation pathways where C. necator H16 can grow 
autotrophically and heterotrophically are shown in Table 1.1. Apart from its 
natural ability to use a variety this wide range of substrates, when C. necator H16 
is grown under unbalanced nutrient conditions, this microorganism produces and 
accumulates polymers. These characteristics, as well as the possibility of re-
routing the carbon accumulated to produce value-added chemicals, makes this 
strain the perfect candidate for chemical production.  
 
Table 1.1 Carbon fixation pathways of C. necator H16 
Growth Carbon fixation pathway Key fixation reaction 
Autotrophic Calvin-Benson-Bassham cycle CO2 + H2O à 2x 3-Phosphoglycerate 
Heterotrophic ED-pathway C6H12O6 + 6 O2 à 6 CO2 + 6 H2O 
Adapted from Jajesniak et al., 2014. 
 
 
In the absence of organic substrates, C. necator H16 acts as a 
chemolithoautotrophic microorganism, using either H2 or formate as an energy 
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source and fixes CO2 via the CBB cycle. This fact tags C. necator H16 as an 
excellent platform for CO2 assimilation with the subsequent production of value-
added chemicals such as bioplastics, bioalcohols or biodiesel, although it must be 
considered that using CO2 as a carbon substrate implies scientific and 
technological challenges at industrial-scale production. As reviewed in Jajesniak 
et al. (2014), carbon capture utilisation (CCU) using C. necator H16 as a 
biological system is regarded as a green platform, due to it could contribute to the 
reduction of CO2 emissions resulting mainly from petroleum-based refinery 
processes.  
 
Some approaches have been developed to improve the CO2 assimilation in C. 
necator H16; strains 25-1 and HB1 were constructed by the mutation or deletion 
of the can gen, which encodes for one of the four genes for carbonic anhydrases 
β-Can (Ahrens et al., 1972; Kusian et al., 2002; Bowien et al., 2002; Gai et al., 
2014), although still some challenges must be overcome, such as the constraint 
that the RuBisCO has. Even when RuBisCO is the key enzyme of the CBB cycle, 
it is characterised with low catalytic activity, due to it catalyses both 
carboxylation and oxygenation (reviewed in Tcherkez et al., 2006; in Schrag, 
2007; in Chu, 2009). Possible options to solve these issues could include 
leveraging on CO2-capture ability of carbonic anhydrases, introduce and engineer 
RuBisCO with an enhanced catalytic activity and specificity which can be 
achieved with evolutionary engineering, overexpress RuBisCO or apply carbon-
capture enzymes designed computationally with the aid of metabolic engineering 
(Atsumi et al., 2009; reviewed in Ducat et al., 2011; reviewed in Drummond et 
al., 2012; reviewed in Johnson et al., 2015). 
 
Apart from its attractive metabolism, another key milestone that converts C. 
necator H16 a perfect chassis for biomanufacturing purposes is its unravelled 
genome. The genome of C. necator H16 comprises three replicons: chromosome 
1 (4.1Mb), chromosome 2 (2.9 Mb), and the megaplasmid pHG1 (452,156 bp). 
The sequence of the megaplasmid pHG1 was reported in 2003 (Schwartz et al., 
2003), while its whole genome -chromosome 1 and chromosome 2- was published 
in 2006 (Pohlmann et al., 2006). Chromosome 1 has 3,651 coding sequences, 
which comprises essential genes and cell functions, such as DNA replication, 
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transcription, and translation, as well as ribosomal proteins. On the other hand, 
chromosome 2 and the megaplasmid pHG1 contain only a few essential genes. 
Chromosome 1 and 2 encode for 6,116 putative genes, where chromosome 2 is 
responsible for the central steps of the 2-keto-3-deoxy-6-phosphogluconate 
(KDPG) sugar and sugar acid catabolism, and for the utilisation of alternative 
nitrogen sources as well as for the decomposition of aromatic compounds 
(Pohlmann et al., 2006). 
 
Figure 1.1 shows some of the key metabolic pathways of C. necator H16. The 
regulation of some metabolic genes from these pathways has enabled the 
enhancement of the production of different value-added chemicals using C. 
necator H16 as a cell factory when grown under specific environmental 
conditions (Park et al., 2011). For instance, when C. necator H16 is grown under 
chemolithoautotrophic conditions, the Calvin-Benson-Bassham (CBB) cycle 
genes –encoded by the cbb operon- are induced for its expression; the same case 
is observed when plant oils such as oleate are used as substrates, where when used 
as feedstock, the genes of the β-oxidation cycle are up-regulated (Brigham et al., 
2010).
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Figure 1.1 Key metabolic pathways in C. necator H16 under heterotrophic and autotrophic 
conditions. Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCo) converts Ribulose-1,5-
bisphosphate to Glycerol-3-P, which undergoes into the Entner-Duodoroff (ED) pathway for 
Pyruvate production, other carbon substrates such as N-Acetylglucosamine, Fructose and 
Gluconate are also channelled into Pyruvate through the same metabolic pathway. Pyruvate is 
catabolised by the pyruvate dehydrogenase, which converts Pyruvate into Acetyl-CoA, that can be 
converted into poly[(R)-3-hydroxybutyrate] (PHB) or can enter the Tricarboxylic acid cycle 
(TCA). Glyoxylate cycle, a variation of the TCA cycle, has many intermediates in common with the 
TCA cycle, although it differs in the conversion of Isocitrate, where Malonate is synthesised. Fatty 
acids and some organic acids are metabolised via β-oxidation, which also generates Acetyl-CoA. 
C. necator H16 can naturally metabolise glycerol with glycerol kinase (glpK) and glycerol-3-
phosphate dehydrogenase (glpD) (Adapted from Johnson et al., 2015; Volodina et al., 2016). 
 
 
One of the most attractive characteristics of C. necator H16 is its natural ability to 
produce poly[(R)-3-hydroxybutyrate] (PHB), a bio-plastic polymer known for its 
biodegradability. PHB is stored intracellularly when an excess of carbon or energy 
supply is present in the media; this excess is redirected from the central sink for 
accumulation in cellular granules. PHB has gained attention since it is a bioplastic 
that shares mechanical and thermoplastic properties with petroleum-based 
plastics, and it is the building block for the biosynthesis of other value-added 
compounds which converts this compound a key metabolite for the bio-based 
economy. C. necator H16 can accumulate PHB to over 80% (w/w) of its cell dry 
weight (CDW) (reviewed in Reinecke et al., 2009). 
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C. necator H16 represents a strain that covers the requirements as a chassis for 
biomanufacturing due to its characteristics such as 1) the elucidation of its 
complete genome, 2) the in silico analysis of metabolic networks, 3) genome-
scale reconstruction and 4) various demonstrations of its genetic tractability via 
bacterial transformation by electroporation or bacterial conjugation (Park et al., 
2011; reviewed in Johnson et al., 2015; Tee et al., 2017); these characteristics 
have allowed focussing efforts to use this bacterium as a candidate for the 
production of value-added chemicals. 
 
 
1.3 Engineering strategies for chemical production in C. necator H16 
 
To produce value-added chemicals in C. necator H16 and to be able to use a 
specific carbon source such as economical and sustainable biological feedstock, 
the cell requires to be engineered by manipulating its native metabolic pathways. 
Strategies such as rational design engineering (e.g., metabolic engineering aided 
by bioinformatics studies and recombinant strain engineering to regulate 
expression of proteins); and evolutionary engineering with directed and adaptive 
evolution tools, are vital biomolecular strategies for strain engineering (Figure 
1.2). In the bio-based industry, these tools are also coupled with bioprocess 
engineering, this, to achieve cost-effective processes for fermentation and 
chemical production. 
 
 
Figure 1.2 Engineering strategies for production of value-added chemicals in C. necator H16. 
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These strategies complement each other when the chassis cell requires to be 
engineered for chemical production. Engineers will usually choose a rational 
design approach (metabolic and recombinant strain engineering) for the 
development of a biocatalyst when the metabolic pathway of interest has been 
elucidated, because most of the details of the enzymes and genes responsible for 
the biosynthesis of the target value-added chemical and the undesired side 
products are well known, which contributes for an effective optimisation. 
Nevertheless, the cellular metabolism of microorganisms is very complex, and 
due to it is generally highly interdependent, it is difficult to account for all 
possible outcomes when a chassis is engineered with rational design engineering 
strategies. When this scenario is present, and there is no full understanding of the 
pathway or enzymes involved in the study of interest, the other strategies used to 
address this issue are the tools of evolutionary engineering such as directed 
evolution –aided by random mutagenesis- and adaptive evolution.  
 
 
1.3.1 Rational design engineering 
 
Rational design engineering (forward engineering) can be distinguished for 
controlled modifications of specific properties of proteins or genes, which 
deviates from random sequence perturbations, such as the class of optimisation 
techniques used in evolutionary engineering. Hence, this strategy creates 
molecules with new properties based on a known-predicted ability. Some of the 
main strategies used for rational design engineering are recombinant strain 
engineering and metabolic engineering, where metabolic engineering uses the first 
to modify the metabolic pathways of the cell factories. 
 
 
1.3.1.1 Recombinant strain engineering 
 
Recombinant strain engineering is defined as the improvement of cellular activity 
via the manipulation of regulatory, enzymatic and transport functions of the cell 
using recombinant DNA technology (Cakar et al., 2011) where in most cases, 
plasmids are used as the delivery platform of genes to be expressed in bacteria, 
Chapter 1. Literature Review: 
Engineering Cupriavidus necator H16 to use it as a chassis cell for chemical production 
 11 
and the expression of these creates recombinant strains with the desired 
phenotype. Broad-host-range expression systems (e.g., pBBR1-derived plasmids) 
have been reported to be transferable to C. necator H16 (Bi et al., 2013). It has 
been reported that usually plasmids that harbour origins of replication derived 
from broad-host-range plasmids can be replicated in C. necator H16, some 
examples of these plasmids are RSF1010, pSa, RP4 and pBBR1 plasmids (Gruber 
et al., 2014). 
 
As reviewed in Tee et al. (2014) and in Khalil et al. (2010), synthetic biology, 
defined as the engineering of biology, contributes to recombinant strain 
engineering by the re-design and construction of existing systems or the creation 
of novel biological systems with a desired phenotype, which is possible by the 
assembly of standardised and well characterised biological parts. One of the key 
biological bricks of a synthetic biology toolbox is the promoter. Promoters are the 
most critical parts of the synthetic toolbox, as they are in charge of regulating the 
expression of the downstream genes; if a maximised protein expression is desired, 
as it is for biomanufacturing purposes, usually strong promoters are selected for 
gene expression. The expression of the desired genes can be regulated with 
inducible promoters, which are prompt only when an exogenous chemical 
(inducer) or condition is present in the environment, but if a regulation of the 
expression is not required, then constitutive promoters are used. Some of the best 
proven inducible promoter systems for gene expression identified previously to 
work in C. necator H16, are the 1) L-arabinose-inducible PBAD promoter and the 
2) m-toluic acid-inducible promoter (Bi et al., 2013). On the other hand, for 
constitutive gene expression, Gruber et al. (2014) reported bacteriophage T5-
derived promoters to be stronger than other constitutive promoters such as Ptac or 
Plac, which had been previously reported as the strongest constitutive promoter for 
gene expression in C. necator H16 (Gruber et al., 2014). 
 
As reviewed in Johnson et al., 2015 and Johnson et al., 2018, promoter 
engineering has been found as a critical strategy for tuning gene expression, 
which can be achieved through promoter with various strengths. A synthetic 
anhydrotetracycline-controllable gene expression constructed for C. necator H16 
was reported by Li et al. (2015), where a modified rrsC promoter native of C. 
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necator H16 with two copies of integrated tetO1 operators and a tetR regulated by 
a mutated version of phaC1 promoter native of C. necator H16 were part of the 
new biological system. Another example of promoter engineering in C. necator 
H16, are the variants of the Pj5 constitutive promoter; Gruber et al. (2014) 
reported promoters with various strengths which could potentially be used for 
regulation of gene expression in C. necator H16. 
 
Other biological parts also play essential roles in the improvement of gene 
expression, such as the ribosome binding site (RBS). The E. coli consensus RBS 
has proven to be compatible with the C. necator H16 system, the RBS helps to 
improve the translational efficiency. The same scenario has been reported for the 
T7 mRNA stem-loop, which is located upstream to the RBS, this biological part 
has demonstrated to enhance mRNA stability in C. necator H16 (Bi et al., 2013). 
 
 
1.3.1.2 Metabolic engineering 
 
As reviewed in Yadav et al. (2018), metabolic engineering is based on the 
modification of a microorganism to improve its bioproduction by altering 
metabolic pathways to understand better and direct cellular pathways; it is 
motivated by commercial applications for the production of useful metabolites. 
Metabolic engineering of a strain can be achieved with different biomolecular 
tools such as genetic and recombinant strain engineering, as the downregulation 
or overexpression of specific proteins in a metabolic pathway is required; 
metabolic engineering would optimise either existing biochemical pathways or 
introduce new components of non-native pathways to obtain a high-yield 
production of the desired metabolite. In order to do so, an overall analysis of the 
metabolic pathways of the strain must be analysed, whereby the detection of 
metabolic bottlenecks is crucial for the efficient bioproduct synthesis under 
predefined environmental conditions.  
 
As reviewed in Johnson et al., 2015, metabolic engineering will aim to rewire or 
reconstruct metabolic networks that will yield a desired metabolic phenotype 
using a determined substrate convenient for the bioprocess. Most of the metabolic 
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engineering studies focus on the regulation of determined enzymes levels either 
by deletion, addition or amplification of specific pathways (Zha et al., 2009). 
Hence, metabolic engineering changes cell metabolism with the aid of 
recombinant strain engineering in order to improve the productivity during 
fermentation. 
 
 
1.3.2 Evolutionary engineering 
 
As reviewed in Dragosits et al. (2013), evolutionary engineering (reverse 
engineering) under a controlled laboratory setting is another scientific approach 
for generating robust and optimised engineered strains as production systems. 
Evolutionary engineering roots back to Antonie van Leeuwenhoek, Louis Pasteur 
and Charles Darwin days, when the first microorganisms and natural selection for 
biological evolution were discovered. This strategy represents an option to 
overcome the limitations of the rational design engineering (forward engineering), 
limitations such as the lack of extensive knowledge of how the metabolic 
networks work, lack of information on the regulatory factors, enzymes involved 
or kinetics of the metabolic pathway, or in some cases, even the difficulties of 
cloning industrial strains due to genetic complexity (Cakar et al., 2011). 
 
Evolutionary engineering can improve microbial growth on specific relevant 
substrates or develop stress resistance. Usually, selection pressure and genetic 
mutations are used to create a pool of variant strains that have gone through 
natural selection adaptation changing temporarily or permanently the strain 
phenotype. Usually, the strategy consists of improving cellular viability on an 
alternative carbon source, or to develop tolerance on inhibitors, pH, organic 
solvents, or temperature (reviewed in Dragosits et al., 2013). 
 
After the desired phenotype has been found, and the strain mutant or variant has 
been properly isolated, genome or RNA sequencing are the further steps to 
identify the genetics behind -reverse engineering-; these genetic changes can be 
beneficial mutations that combined with rational design -forward engineering- can 
result in further strain improvement. 
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As reviewed in Dragosits et al. (2013), in the past 30 years, an increasing number 
of experiments employing evolutionary engineering in microbial cells such as 
Escherichia coli and Saccharomyces cerevisiae have been reported, but despite 
being a powerful approach, this strategy is still limited in C. necator H16 
(reviewed in Johnson et al., 2015). 
 
 
1.3.2.1 Directed evolution 
 
Directed evolution is the laboratory process where biological systems with desired 
traits are created through iterative rounds of mutation that create genetic 
diversification in order to find a specific phenotype. As reviewed in Cobb et al., 
(2013), a library of mutants is screened, and the best mutant is selected for 
characterisation. This strategy has become one of the most widespread and useful 
tools in bioengineering, as the generation of whole-cell mutants has helped to 
identify new genes and study its properties (Lawrence, 2002). This tool is capable 
of reaching even the most conserved biological processes by the creation of 
variation in a population which is then selected individually – be it an enzyme 
(protein level), operons (pathways) or entire genomes (whole-cell) (reviewed 
Tizei et al., 2016), where genomic mutations are introduced stochastically through 
external mutagenic compounds (reviewed in Tee et al., 2013). 
 
It was in the 90s when the term of directed evolution began to take root, defined 
as an iterative process based on three main steps: 1) the generation of a library of 
mutants of a specific enzyme, pathway or biological system and 2) the screening 
of the library in a high-throughput fashion that identifies the mutants with the 
improved properties, and 3) the subsequent rounds of diversification and selection 
using the best mutant as the basis for the next round of mutagenesis, process that 
is repeated until the desired level of improvement has been achieved (reviewed in 
Cobb et al., 2013). 
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Directed evolution at different biological levels: protein, pathways, genome  
 
As reviewed in Zhao et al. (2007) and in Cobb et al. (2013), directed evolution 
has its roots in classical adaptive evolution and strain engineering, although 
modern directed evolution emerged about 25 years ago with the demonstration of 
iterative rounds of polymerase chain reaction (PCR) for random mutagenesis 
where activity was screened for improved proteins, ever since, different strategies 
have been developed which have enabled not only the evolution of 1) proteins or 
2) pathways, but also it has been able to evolve 3) entire microorganisms in its 
genome level, which helped to create novel functions previously not found in 
nature. As reviewed in Tobin et al. (2000), as an evolutionary engineering tool, it 
has the advantage that there is no need to know the protein structure, metabolic 
pathway or the entire genome of interest, which in some cases is very difficult to 
predict in advance.  
 
Directed evolution of proteins, is a combinatorial approach that can be used to 
improve the functionality of enzymes by using the rational design site-directed 
mutagenesis and random mutagenesis, which allow scientists to produce focused 
libraries, that only concentrate in randomised regions that are expected to be 
richer in beneficial mutations. Other techniques such as error-prone PCR, are used 
for random mutagenesis, this is done in a specific gene sequence, and it creates 
diverse protein libraries of existing scaffolds (reviewed in Cobb et al., 2013; 
Kumar et al., 2013).  
 
As reviewed in Dalby (2011) and Du et al. (2011), on the other hand, directed 
evolution of pathways is focused on enabling cost-effective microbial 
biosynthesis by optimizing the host-cell, as it dodges the limitations of rational 
design due to even simple pathways are not fully understood, as there are gaps in 
the regulation mechanisms and metabolic networks, techniques such as DNA 
shuffling have been used to improve the phenotype of host cells. Crameri et al. 
(1997) engineered an E. coli strain by introducing an evolved arsenate resistance 
operon from Staphylococcus aureus, composed of genes arsR, arsB, and arsC 
which encode for a repressor regulatory protein, an arsenite membrane pump, and 
an arsenate reductase respectively, the operon was evolved by using recursive 
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rounds of DNA shuffling, where after three rounds of mutagenesis, non-
synonymous mutations were identified in arsB and arsC. This recombinant strain 
was able to survive in 0.5 M arsenate, which is 40 times higher than the wild-type 
strain, the use of directed evolution in this pathway allowed to use this strain as a 
candidate for applications in bioremediation arsenate from gold metallurgy. 
 
Directed evolution can cover genome-scale as well. Directed evolution on 
genome-scale has generated new whole cells. The fundamentals of directed 
evolution at genome level is the incorporation of accelerated mutagenesis which 
links phenotype with genotype (Figure 1.3) (Liu et al., 2005; reviewed in Cobb et 
al., 2013), it emerged as well as a solution for the complex cellular metabolism, 
where random mutagenesis of bacterial strains and the use of a selective pressure 
allows having a library of 109 to 1012 mutant strains, which would not be possible 
to achieve otherwise, this procedure goes through iterative cycles until the desired 
phenotype is reached. Nevertheless, a selection pressure (usually inhibitors) for 
the process is highly recommended, as the screening, identification, and analysis 
of mutants can be extremely laborious, hence, a proper planning, choice of strain, 
efficient mutagenesis and screening method are the key elements for directed 
evolution at genome scale (Connor et al., 2010). The drawback of this strategy is 
that in some cases, the selective pressure is not possible for all processes (Connor 
et al., 2010). For these reasons, in some biomanufacturing engineering processes, 
both forward engineering (rational design) and reverse engineering (evolutionary 
engineering) are used to engineer strains.  
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Figure 1.3 Directed evolution of the whole cell (genome level) process via random mutagenesis 
aided by chemical or physical mutagens. Cells are exposed to external mutagens and then selected 
for resistance to an inhibitor in agar plates. Resistant colonies are then screened for growth in 
liquid media usually in 96-well microtitre plates to cover a higher number of mutants under 
selective pressure. The best mutants are then characterised to confirm the desired phenotype, and 
then the best mutant is chosen as the parent strain for the next round of mutagenesis. 
 
 
Connor et al. (2010) used directed evolution with random mutagenesis aided by a 
chemical mutagen to develop a mutant strain of E. coli to produce 3-methyl-1-
butanol (3MB) in combination with rational design engineering by expressing 
heterologous genes from Lactobacillus lactis, S. cerevisiae, and B. subtilis, the 
genes used in this study are involved in the 3MB production, and this 
combinatorial strategy resulted in a mutant E. coli strain capable of producing 4.4 
g/L of 3-methyl butanol. 4-aza-D,L-leucine was used as a selection pressure, 
which acts as an inhibitor to the cell as it is a structural analogue of L-leucine, this 
analogue interferes with the regulation of amino acid synthesis and its 
incorporation into polypeptides. The fundamental of the strategy is that cells can 
adapt to survive in the presence of an inhibitor by developing the ability of 
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producing the natural amino acid in higher enough quantities that will compete 
with the analogue for its incorporation into polypeptides, the mutant that has been 
best adapted is found in the screening selection method, afterwards a verification 
(characterisation) of the desired phenotype is performed before the best mutant is 
subjected to the next round of mutagenesis. Mutants with the desired improved 
phenotype will show an increased growth when grown in the presence of the 
inhibitor. As reviewed in Hall (1998), in directed evolution via random 
mutagenesis, beneficial mutations are typically observed when a population of 
evolved cells is spread onto a media upon which growth cannot occur unless a 
known mutation occurs. Another example is a study published by Sakurai et al. 
(1993), they isolated a mutant strain of Serratia marcescens resistant to 
acidomycin –a biotin analogue- capable of overproducing biotin, where cells were 
first subjected to random mutagenesis with a chemical mutagen and selected in 
agar plates supplemented with the biotin analogue.  
 
On the other hand, this strategy has been used as well to elucidate unknown 
metabolic pathways, as reviewed in Streit et al. (2003), other studies performed in 
different strains such as Corynebacterium glutamicum, Mesorhizobium loti, 
Methylobacillus flagellatum, Kurthia sp., Sinorhizobium meliloti, where cells 
were subjected to detailed analysis for the elucidation of their biotin synthesis 
pathways or for biotin overproduction, aided by engineering tools of random 
mutagenesis and complementation studies, where biotin analogues were used as 
selection pressure. 
 
Chemical and physical mutagens 
As reviewed by Nielsen (1998), random mutagenesis is a common strategy in 
bioengineering as high mutation rates can emerge naturally, but also, as 
mentioned in previous paragraphs, mutations rates can be increased with the aid 
of a chemical or physical mutagen, which contributes to the formation of genetic 
novelty (Sniegowski et al., 1997; Bachmann et al., 2012; reviewed in Tee et al., 
2013).  
 
After increasing the genetic diversity by using external mutagens, the next step is 
the direct selection on solid media of the mutants that have been able to survive 
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under selective pressure, such as high metal concentrations, low or high 
temperatures, high concentrations of inhibitors, etc., although it is important to 
consider that for this reverse engineering method, the major disadvantage is the 
fact that not too many repeated cycles of mutations are recommended as this may 
result in highly improved phenotype but crippled variant strains (Cakar et al., 
2005).  
 
The external mutagens frequently used for the increase in random mutagenesis 
can be divided into two categories: 1) chemical mutagens, and 2) physical 
mutagens. The mutations are known as transitions when interchanges that involve 
nucleotides of similar shape occur, such as two-ring purines (A « G), or one-ring 
pyrimidines (C « T), all four transitions are Ts: AT à GC and GC à AT; and 
transversions when there are interchanges of purine to pyrimidine bases (A « T 
or C; G « T or C), where all eight transversions are Tv: AT à TA, AT àCG, 
GC àCG, and GC à TA (reviewed in Tee et al., 2013). Chemicals mutagens 
induce high frequencies of base-pair substitutions and some lethality depending 
on the concentration used. Some of the most widely used chemical mutagens are 
the alkylating agents N-methyl-N’-nitro-N-nitrosoguanidine (NTG) and ethyl 
methanesulfonate (EMS), which produce transitions at G-C sites. On the other 
hand, one of the most commonly used physical mutagens is ultraviolet light (UV 
light, 254 nm), which has the advantage of producing a more full range of 
substitutions usually in pyrimidines, it includes transitions and transversions; a 
less common physical mutagen are X-rays. Some strategies of directed evolution 
consist of combining both mutagens –chemical and physical- which provide 
outcomes that can satisfy experimental needs. It is important to consider as well 
the optimal dose of the mutagens, since high concentrations may result in a 100 % 
killing; a balance between the competing needs for a high mutation frequency and 
a reasonable survival must be optimised, where usually a 50 % survival rate 
provides the highest proportion of mutants (Lawrence, 2002). 
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1.3.2.2 Adaptive evolution 
 
As reviewed in Hall (1998), adaptive evolution is defined as the spontaneous 
mutations that occur in a microorganism as a consequence of prolonged periods of 
stress. During adaptive evolution, the strain of interest is cultivated under very 
well defined conditions of stress for prolonged periods, which can range from 
weeks to months or even years depending on the target phenotype and the 
condition set; the long cultivation period allows the selection of improved 
phenotypes. Microorganisms have simple nutrient requirements, which makes the 
process feasible, as they can be easily cultivated under controlled conditions in the 
laboratory, and due to cells usually grow very fast, they can be cultivated for 
many generations in a relatively short period (Cakar et al., 2011; reviewed in 
Dragosits et al., 2013). 
 
With adaptive evolution, scientists can know that the phenotype changes are 
associated with the specific growth conditions provided, which can be genotype-
phenotype elucidated with technologies such as whole genome sequencing (WGS) 
and proteomics (Cakar et al., 2011; reviewed in Dragosits et al., 2013). C. necator 
H16 is a perfect candidate for adaptive evolution since it is a ubiquitous inhabitant 
of freshwater and soil that has shown to be well adapted to the constantly 
changing environment (reviewed in Volodina et al., 2016). 
 
The laboratory selection method of adaptive evolution usually consists in batch 
cultivation in shake flasks (although it can be performed in chemostat cultures as 
well) where propagation of the strain of interest is performed through serial 
cultivation (Figure 1.4). An initial population of wild-type cells is cultivated in 
the desired controlled media, and an aliquot of the batch is then withdrawn -
generally daily and at late log or early stationary growth phase (Zambrano et al., 
1993)- and transferred to a new flask for an additional round of growth with fresh 
media either with the same conditions or with variations of the initial conditions. 
Adaptive evolution has the advantage of being a cheap process and that various 
parallel cultures can be performed at the same time, if too many conditions need 
to be analysed or different strains, the cultures can be easily performed in 96-well 
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microtitre plates where hundreds of variations can be analysed in parallel 
(Gonzalez et al., 2013).  
 
 
 
Figure 1.4 Adaptive evolution for biomanufacturing. Generally, the fitness increase tends to slow 
down after the first rounds of adaptive evolution due to inherent properties of biological metabolic 
networks, while the number of mutations increases with the rounds of mutagenesis; adaptive 
evolution can be performed in chemostat or batch cultures (conical flasks or microtitre plates 
when a variety of conditions are analysed). After the process of adaptive evolution, the screening 
and selection of the best variant strain is performed, where the variant can be used directly for the 
desired purpose, or if required, an identification of the genetic basis of the improved phenotype 
can be combined with metabolic engineering or other biomolecular tools to improve further the 
desired phenotype (Adapted from Connor et al., 2010). 
 
 
As observed in Figure 1.4 the improvement of fitness as a function of the rounds 
of mutagenesis tends to be non-linear, the linear increase of adaptation can be 
observed in the first rounds of mutagenesis, but it is considerably slower during 
the last rounds of adaptive evolution (Barrick et al., 2009), therefore, it is essential 
to consider this factor, as a prolonged adaptive evolution will not necessarily lead 
to better phenotypes (Hua et al., 2007). During adaptive evolution, cells can be 
challenged whit changing environmental conditions as selection pressure, which 
can be divided into two main categories: 1) environmental stress and 2) nutrient 
availability; these can be used separately or at the same time (a combinatorial 
approach that may lead to major findings).  
 
As reviewed in Dragosits et al. (2013), various phenotypes will occur at the 
beginning of adaptive evolution, which will compete to dominate over the total 
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population, where only the most stable phenotypes will be accumulated rapidly, 
although the population will not be homogeneous at any point of the evolution 
experiment. Therefore the best variant strains must be identified by screening 
methods and isolated for further characterisation. In some cases, in the 
characterisation experiments of the variant strain, it has been observed that the 
selection of improved phenotype strains in a determined environment sometimes 
may lead to trade-offs when the mutant strain is transferred to another selective or 
stressful condition. Due to these reasons, sometimes, the last step of evolutionary 
engineering is to transfer the identified mutations to the wild-type strain rather 
than using the variant strains directly for bioproduct formation (Cakar et al., 
2011). 
 
A variety of studies on adaptive evolution for improving nutrient availability have 
been performed in different microorganism such as E. coli, T. fusca, and L. lactis, 
where cells have been evolved in glycerol, glucose, lactate media or milk (Ibarra 
et al., 2002; Conrad et al. 2010, Hua et al. 2007, Bachmann et al., 2012). C. 
necator H16 was evolved to grow in glucose by incubating cells in high 
concentrations of the substrate, where glucose-positive phenotype variant strains 
were identified, which showed elevated activities of glucose-6-phosphate 
dehydrogenase (Franz et al., 2012). A similar approach of adaptive evolution for 
glucose assimilation was applied to C. necator H16 strains but with a 
combinatorial approach by using as well a chemical mutagen (NTG) to develop 
mutant strains capable of growing in glucose (Kim et al., 1995). 
 
Even though when we know in advance that DNA replication is a process with 
high fidelity wherein microbial cells it only has a mutation rate of 10-10 per base 
pair per replication, the emergence of mutations occurs during adaptive evolution 
due to large population sizes and different generations of these, which occur 
during adaptive evolution (Drake, 1991).  
 
As reviewed in Dragosits et al. (2013), a variety of mutations have been detected 
in microbial cells after adaptive evolution such as single-nucleotide 
polymorphism (SNPs), small-scale insertions and deletions (Indels), or large 
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amplifications or deletions in genomic regions (Figure 1.5), mutations that may 
contribute to a change in the phenotype of cells. 
 
 
 
Figure 1.5 Mutations that are usually identified in evolutionary engineering. Insertions and 
deletions (Indels), Single nucleotide polymorphisms (SNPs) and larger deletions and insertions, 
which contribute to genetic and sometimes in gene regulatory changes which may impact in the 
phenotype of cells. 
 
 
After identifying the desired phenotype of evolved microbial cells, these can be 
used directly for biomanufacturing purposes, nevertheless, scientist must be aware 
that there are some drawbacks related to this strategy, as mentioned earlier, 
evolved microbial strains are likely to show trade-offs developed during the stress 
exposure, therefore after the isolation of the desired mutant, different analysis 
such as the confirmation of true mutations and the performance of the variants 
under different environment or stress conditions must be considered if the 
biomanufacturing process requires it. For this reason, in many cases, the final step 
of evolutionary engineering is to transfer the identified beneficial mutations to a 
well-defined strain. The integration of evolutionary engineering and metabolic 
engineering offers a variety of tuning possibilities at multiple levels for 
bioengineering; therefore, it is a potential tool to explore in microorganisms such 
as C. necator H16. 
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1.4 Expanding carbon substrate range of C. necator H16 
 
Even though when wild-type C. necator H16 can grow already in a wide range of 
carbon substrates, some carbon substrates that are economically viable for the 
production of value-added chemicals in the industry, are not assimilated or show 
limited growth in C. necator H16, such as glucose, and glycerol. Engineering C. 
necator H16 can expand the carbon substrate range in order to use sustainable and 
economical carbon feedstock, which will always be preferred for industrial scale 
production, fermentation, and for bioprocess development.  
 
 
1.4.1 Glucose 
 
C. necator H16 does not assimilate glucose, xylose, and arabinose (Fukui et al., 
2014), the genomic sequence of C. necator H16 revealed that it lacks the genes 
required for glucose transport, although once it is available intracellularly, it can 
metabolise glucose (Pries et al., 1990; Pohlmann et al., 2006; Sichwart et al., 
2011). Due to glucose is one of the most abundant sugars commonly used as 
carbon substrate for microbial fermentation, and it can be obtained from diverse 
sources, mainly from most carbohydrate crops (Soucaille, 2002; reviewed in Ezeji 
et al., 2007; Linde et al., 2008), diverse strategies have been developed to create 
C. necator H16 strains capable of metabolising glucose.  
 
With the aid of evolutionary engineering, scientists have developed C. necator 
H16 strains capable of utilising glucose as carbon source. One of the first reported 
strategies were C. necator H16 cells mutagenised with UV light for random 
mutagenesis, where Schlegel et al. (1965) achieved one of the first C. necator 
H16 strains capable of assimilating glucose. Kim et al. (1995), on the other hand, 
used a chemical mutagen (NTG) to evolve C. necator H16 glucose-utilising 
strain. Another successful approach that made use of adaptive evolution to obtain 
C. necator H16 glucose-utilising strains was performed by Franz et al. (2012), by 
incubating C. necator H16 strains with high glucose levels of up to 20 g/L for 
about ten days. Studies revealed that most of these mutant glucose-utilising strains 
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had alterations in gene function and expression, such as mutation in the N-
acetylglucosamine phosphotransferase –a transporter that facilitates the diffusion 
of N-acetylglucosamine in the cell- which apparently was altered in its substrate 
specificity, by also accommodating glucose import; an increase in glucose-6-
phosphate dehydrogenase expression was also detected, which is the essential 
enzyme for glucose metabolism via the Entner Duodoroff pathway (Raberg et al., 
2011; Franz et al., 2012). 
 
Some other strategies have been used to construct glucose utilising C. necator 
H16 strains with metabolic engineering, where C. necator H16 expressed 
constitutively the genes that encode for glucose kinase (glk) from E. coli, and the 
gene encoding for the facilitated diffusion protein (glf) from Zymomonas mobile. 
The expression of both genes resulted as well in a glucose-utilising C. necator 
H16 strain, where the glf gene conferred the assimilation of glucose and the glk 
gene helped in the glucose metabolism (Sichwart et al., 2011). 
 
 
1.4.2 Sugars derived from lignocellulosic biomass 
 
As reviewed in Hatti-Kaul et al. (2007), within the lignocellulosic biomass, 
mannose is mostly found, therefore in many microorganisms lignocellulosic 
biomass is considered a candidate as carbon source for biomanufacturing 
purposes, but as it occurs with glucose, C. necator H16 does not assimilate either 
metabolises mannose, therefore, different approaches have been successfully 
carried out to obtain mannose-utilising C. necator H16 strains. A recombinant C. 
necator H16 strain was designed by Sichwart et al. (2011) whereby with the 
heterologous expression of the glf gene (facilitated diffusion protein) and the mak 
and pmi genes (for mannofructokinase and phosphomannose isomerase 
respectively) the mannose-utilizing C. necator H16 was constructed. The glf gene 
conferred the mannose assimilation, whereas the mak and pmi genes conferred the 
mannose metabolism. The engineered strain was capable of assimilating and 
metabolising mannose due to the glf gene enabled mannose assimilation, further 
the mak expressed gene catalysed the reaction to convert mannose to mannose-6-
phosphate, and the pmi expressed gene was in charge of the reversible 
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isomerization of mannose-6-phosphate to fructose-6-phosphate (due to C. necator 
H16 wild-type assimilates fructose) then, the fructose-6-phosphate was 
subsequently metabolised via the Entner-Doudoroff pathway. 
 
 
1.4.3 Glycerol  
 
The importance of reducing the cost of feedstocks to produce value-added 
chemicals is because feedstock represents up to 50 % of the entire production cost 
(Zhu et al., 2010). Sustainable manufacturing has become a trend in the recent 
years, and crude glycerol is an important waste stream which can help to reduce 
the production cost in bioprocess industry owing to its low price and abundance in 
the market; it is desirable carbon substrate as a building block chemical found as a 
byproduct of the transesterification of alcohols and oils (Cameron et al., 1998; 
Ashby et al., 2012). C. necator H16 shows slow growth when glycerol is used as 
the primary carbon source, but it has been previously demonstrated that with the 
aid of metabolic engineering, engineered strains of C. necator H16 have shown to 
enhance glycerol assimilation with the concomitant expression introduction of the 
aquaglyceroporin glpF, which encodes for a transport protein, and with the 
glycerol kinase glpK from E. coli; although it was demonstrated as well that the 
expression of glpK only was capable of enhancing glycerol assimilation (Fukui et 
al., 2014).  
 
 
1.4.3.1 Sources of crude glycerol  
 
As reviewed in Dobson et al. (2012) and in Yang et al. (2012), crude glycerol is a 
candidate to be used as a renewable feedstock due to its availability and meager 
prices; it can be found not only as a byproduct of the biodiesel industries but also 
from oleo-chemical, bioethanol industries and fat splitting processes. In the 
biodiesel production process, glycerol covers approximately 10 % (w/v) of the 
total product; in the bioethanol industry through the fermentation of sugars by 
yeast, glycerol comprises up to 2 % by volume of the liquid fraction in the whole 
stillage (reviewed in Rausch et al., 2006; Kurosawa et al., 2015). 
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Biodiesel is produced from vegetable oils or animal fats by the transesterification 
with alcohol –ethanol or methanol- and catalysed by NaOH or KOH where, as 
mentioned before, glycerol represents about 10 % (w/v) of the ester (Figure 1.6) 
(Paulo da Silva et al., 2009). 
 
 
Figure 1.6 Synthesis of biodiesel. Transesterification reaction of a triglyceride with an alcohol 
(ethanol), using NaOH as a catalyst for biodiesel production (a mixture of fatty acids ethyl esters) 
and glycerol (Adapted from Paulo da Silva et al., 2009). 
 
 
1.4.3.2 Chemical composition of crude glycerol 
 
As reviewed in Dobson et al. (2012), crude glycerol has other components than 
glycerol that must be considered when engineering strains for chemical 
production if crude glycerol is used directly as feedstock, as these could inhibit 
cell growth. These components are usually alcohols (such as methanol), salts, 
heavy metals, free fatty acids, and soaps. The composition of crude glycerol 
depends on the parent feedstock (such as rapeseed, soybean, animal oils or even 
waste cooking oil); the transesterification process used for the biodiesel 
production (for instance if methanol or ethanol were used); the type of catalyst 
(potassium hydroxide or sodium methoxide); the recovery efficiency of the 
biodiesel; among other impurities in the feedstock. In crude glycerol, the content 
salt can vary and go as high as 5 % (w/v), and methanol can go as high as 32 % 
(w/v) (Posada et al., 2010; reviewed in Yang et al., 2012). Therefore, ideally, 
microorganisms which have a certain resistance to these impurities represent the 
perfect chassis for bioconversion with crude glycerol. 
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1.4.3.3 Annual production of crude glycerol and price 
 
The low price of crude glycerol, which can contain from 50 % to up to 85 % 
glycerol, can be obtained in large quantities mainly from the biodiesel industry, 
where for every 100 lb of biodiesel that is produced by transesterification of 
animal fats or vegetable oils, about 10 lb of crude glycerol are produced (Durnin 
et al., 2009; Cavalheiro et al., 2009; Tanadchangsaeng et al., 2012). As reported 
by Oleoline (2018), in The Independent Oleo reporter, the prices of crude glycerol 
in 2018 in the USA ranged from only 0.05 to 0.18/lb. 
 
As reviewed in Dobson et al. (2012), there was a 295 % increase of biodiesel 
production in 2005 with respect to 2001 due to biodiesel was a response of a 
green initiative by the governments, where a global production of 390 million 
litres per year of crude glycerol was produced mainly in Germany, France, Italy 
and USA, only in the USA the annual production of biodiesel in 2012 was 969 
million gallons, which is about 3 times higher than the 343 million gallons 
produced in 2010 (U.S. Energy Information Administration, 2013), and it is 
expected that the biomass-based diesel production reaches up to 36 billion gallons 
by 2022; therefore the surplus production of biodiesel will generate about 3.6 
billion gallons of crude glycerol as a waste by-product by then (reviewed in 
Moser et al., 2011).  
 
The massive production of crude glycerol around the world is an opportunity for 
the biotechnological community for integrating biodiesel production with 
microbial fermentation, as at present, glucose is the most widely used chemical 
feedstock for biomanufacturing, and although the price of glucose is similar to 
crude glycerol (US$ 0.21-0.23/lb), a fluctuation in its price has been observed 
during the last 20 years, where it reached up to US$ 40/lb in 2010 (reviewed in 
Dobson et al., 2012); what is more, waste glycerol is not only a cheaper and 
sustainable substrate compared to glucose, but also it is not considered a suitable 
human source, as is the case for glucose and sucrose (reviewed in Li et al., 2013). 
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1.4.3.4 Purification of crude glycerol 
  
As reviewed in Dobson et al. (2012) and in Min et al. (2011), although crude 
glycerol can be purified, and the refined glycerol can be used in the cosmetics, 
tobacco, and pharmaceutical industries, the industrial purification of glycerol is 
not economically viable for small industries, even in some cases large industries 
do not have much interest in purifying crude glycerol, as, over the last 20 years, 
refined glycerol dropped from US$ 1/lb to US$ 0.34/lb.  
 
When crude glycerol is purified in industry, it is refined by filtration methods, 
fractional vacuum distillation, and chemical additives, and these processes 
produce different commercial pure glycerol grades, nevertheless, the difficulty of 
the process is that these treatments increase the production cost (reviewed in 
Johnson et al., 2007; Prada-Palomo et al., 2012), therefore, high abundance, high 
degree of reduction, and low process make direct use of crude glycerol as an 
attractive feedstock for biomanufacturing purposes, due to the removal of the 
impurities from crude glycerol are cost-intensive, and the potential revenue for 
technical quality refined glycerol, very low (Lindlbauer et al., 2017). 
  
 
1.4.3.5 Bacterial glycerol uptake 
 
A variety of microorganisms can use glycerol as feedstock for microbial 
bioconversion, where value-added chemicals such as 1,3-propanediol, citric acid, 
succinic acid and the well-known PHAs bioplastics (Koutinas et al., 2007) can be 
produced; the advantage of some of these bioproducts is that they will not only be 
produced from renewable feedstock but also these final products can be 
biodegradable, which completes an environmentally friendly cycle strategy. 
 
As reviewed in Dobson et al. (2012), microorganisms uptake glycerol into the cell 
by facilitated diffusion, and they encode metabolic pathways that can convert it 
into different metabolic intermediates, as glycerol is naturally found in different 
forms such as triglycerides. In E. coli, glycerol can cross the membrane by passive 
diffusion when high concentrations of glycerol are present (Truniger et al., 1993), 
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nevertheless when the external concentration of glycerol is low, the glycerol 
facilitator protein (GlpF) transports glycerol by facilitated diffusion, subsequently 
glycerol is converted to glycerol-3-phosphate by glycerol kinase (GlpK), which is 
then further metabolised within the cell as it is no longer a substrate for GlpF 
(Paulo da Silva et al., 2009). A similar utilisation of glycerol is believed to occur 
in C. necator H16, where there are two putative glycerol kinases (GlpK) and two 
putative glycerol-3-phosphate dehydrogenases (glpD) located in both 
chromosomes of C. necator H16 (Table 1.2) 
 
 
Table 1.2 Genes potentially related to glycerol metabolism in C. necator H16. 
Gene ID Chromosome Original annotation Identity to E. coli 
protein (%) 
H16_A3590 1 Glycerol facilitator or related permease glpF (25 %) 
H16_A2507 1 Glycerol kinase glpK (52 %) 
H16_A2508 1 Glycerol-3-phosphate dehydrogenase glpD (29 %) 
H16_B1199 2 Glycerol kinase glpK (28 %) 
H16_A0336 2 Glycerol-3-phosphate dehydrogenase  glpD (39 %) 
Adapted from Fukui et al., 2014. 
 
 
Among the non-pathogenic microorganisms relevant for industry that have been 
reported to date which can use either pure and crude glycerol as feedstock for 
chemical production and obtain very similar tolerance to crude glycerol in 
comparison with pure glycerol are Klebsiella pneumoniae and Clostridium 
butyricum for the production of 1-3 propanediol, which has a great potential to be 
used in the plastic industry as a monomer of polyesters, polyethers, polyurethanes 
and poly(trimethylene) (used for a variety of product such as polymers, food, 
medicines, cosmetics, lubricants and fabrics) (Mu et al., 2006; Oh et al., 2008; 
González-Pajuelo et al., 2004; Moon et al., 2010; Jun et al., 2010); Yarrowia 
lipolytica for citric acid production used in the pharmaceutical and food industry 
due to its low toxicity (Rymowicz et al., 2008); K. pneumoniae for ethanol 
production (Oh et al., 2011); Kluyvera cryocrescens, Escherichia coli, and C. 
butyricum for lactic acid production (Hong et al., 2009; Choi et al., 2011); and E. 
coli (Andreeßen et al., 2009; Fukui et al., 2014) and C. necator H16 for PHA 
production (Fukui et al., 2014; González-Villanueva et al., 2018 (submitted)), 
which has demonstrated that crude glycerol can be used directly as a feedstock for 
chemical production without any pre-treatment.  
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1.5 Bioproduct synthesis in C. necator H16 
 
In order to use C. necator H16 as a cell factory, key points must be considered 
such as 1) sustainable and economically viable feedstock that can produce the 
chemical of interest, 2) native or heterologous metabolic pathways or genes 
required for the production of the chemical of interest, 3) analysis of the product 
of interest, i.e., if it is toxic to the cells or not, and 4) analysis of the carbon flux to 
check if it can be diverted and maintain at the same time sufficient cell viability. 
Some of the bioproducts that have been synthesised in C. necator H16 
considering these key points are bioplastics (PHAs), biofuel, methyl ketones, 
methyl citrates, feluric acid, chyral synthons, among others, where different 
strategies either using forward or reverse engineering have been used to engineer 
the strain. 
 
 
1.5.1 Bioplastics 
 
C. necator H16 is well known for its production of PHA, granules that are 
naturally produced as carbon storage materials. As reviewed in Lenz et al. (2005), 
bioplastics have similar properties to petroleum-based plastics found in the 
market, they are not only biodegradable (which can be biodegraded in most 
biological active environments), but they can also be produced from renewable 
feedstock. The biodegradation of these polymers depends on their chemical 
characteristics, i.e., crystallinity, monomer composition or stereoregularity. 
Considering these factors, some studies have shown that when the biopolymer is 
subjected to degradation under anaerobic sewage, degradation is accomplished in 
about 6 weeks, in soil environments in about 75 weeks and about 350 weeks in 
seawater (reviewed in Kessler et al., 2001; Loo et al., 2007; reviewed in Rehm, 
2010). 
 
PHAs can be produced in different chain lengths, there are short-chain length 
PHAs (scl-PHAs) such as poly-3-hydroxybutyrate (PHB) and poly-3- 
hydroxybutyrate-co-3-hydroxyvalerate [P(3HB-co-3HV)], which are composed of 
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2–5 carbon-chain-length monomer units; medium-chain-length PHAs (mcl-PHAs) 
such as poly-3-hydroxybutyrate-co-3-hydroxyhexanoate [P(3HB-co- 3HHx)] of 
6-14 carbon-chain-length monomer units; and long-chain-length PHAs (lcl-PHAs) 
which are composed of more than 14 carbon-chain-length monomer units.  
 
As reviewed in Brigham et al. (2012), some of the applications suitable for PHAs 
are directed for domestic use such as linings of milk cartons and diapers, and due 
to its biodegradability, PHAs have been also proposed for commercial use in 
garbage bags, so that they can be decomposed together with trash as compost. 
Other applications are fishing nets, as they can be easily degraded when lost in 
seawaters. As reviewed in Kessler et al. (2001), PHAs can be used as well for 
agricultural applications on delivery devices for fertilisers, nutrients, insecticides, 
and herbicides, as biodegradable mulch films and coatings for fertiliser pellets 
(reviewed in Brigham et al., 2012). As reviewed in Jajesniak et al. (2014), PHBs 
have also been used in the food industry for food packaging material due to its 
resistance to UV radiation, O2 impermeability, and water resistance capabilities. 
In the medical field, PHA has been used for meshes and sutures due to its 
flexibility, durability, resorbability and tensile strength. The medical applications 
are still under testing, but expectations are high due to PHA biocompatibility. 
Both PHB and P(3HB-co-3HV) from C. necator H16 origin resulted highly 
compatible at a cell, tissue and macroorganism level, and can also be used in 
contact with blood (reviewed in Brigham et al., 2012).  
 
Among the different chain length PHAs, PHB is one of the most pursued 
biomanufacturing products due to it can be transformed into others value-added 
chemicals such as acetoacetic acid or acetone; at the same time, acetone can be 
used for the synthesis of ketene, methyl methacrylate or diacetone alcohol. As 
reviewed in Yu (2014), propylene is another compound that can be obtained from 
PHB by thermal decarboxylation, which has reached high demands globally with 
a production of approximately 50 million tons per year (Figure 1.7). 
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Figure 1.7 Metabolites derivable from polyhydroxybutyrates (PHB) (Adapted from Johnson et al., 
2015). 
 
 
Due to these potentials, diverse engineering strategies have been developed to 
optimise PHA biosynthesis in C. necator H16 and related species. The three genes 
responsible for PHB synthesis in C. necator H16 are encoded in the phaCAB 
operon, where phaC encodes for PHA synthase, phaA encodes for b-ketothiolase 
and phaB for acetoacetyl-coA reductase, being acetyl-CoA the primary metabolite 
in the metabolic pathway for PHB synthesis. As reviewed in Kessler et al. (2001), 
the phaCAB operon is constitutively expressed, but the PHB synthesis is regulated 
at enzymatic and transcription level. Therefore, strategies such as fed-batch in 
two-stage cultivation are employed to regulate the proportion of precursor 
substrates that enable both cell growth and PHB accumulation. The first stage 
oversees cell growth, which is performed under balanced growth conditions; and 
the second stage is in charge of product accumulation, performed under 
unbalanced growth conditions, usually under nitrogen limitation, which provokes 
the downregulation of TCA enzymes, mainly citrate synthase, as well as the 
reduction of acetyl-CoA flux used for cell growth (reviewed in Byrom, 1987; 
Jung et al., 2000). 
 
As reviewed in Byrom (1987 and 1992), for the synthesis of scl-PHA copolymers, 
propionate has been used as a precursor co-substrate to produce P(3HB-co-3HV), 
due to its structural similarity with 3-hydroxyvalerate (3HV). Although some 
Chapter 1. Literature Review: 
Engineering Cupriavidus necator H16 to use it as a chassis cell for chemical production 
 34 
challenges arise from the use of propionate when high concentrations are used, as 
this compound can be toxic to the cell (Steinbüchel et al., 2003), but at the same 
time regulations such as the fed-batch two-stage strategy can significantly 
decrease the negative impact of propionate toxicity (Lee et al., 1995; Grothe et 
al., 1999). There are some other alternative suitable precursors for 3HV monomer 
production, such as valerate (a direct 3HV precursor), levulinic acid, and some 
fatty acids as heptanoic and nonanoic acids (Steinbüchel et al., 2003). The molar 
fraction of the P(3HB-co-3HV) final product will depend on the choice and 
proportion of the 3HV precursors, along with the cultivation conditions, which 
will impact directly with the physical properties of the bioplastic (Choi et al., 
2003; Albuquerque et al., 2007).  
 
The copolymer P(3HB-co-3HHx) is an mcl-PHA that has been produced in 
engineered strains of C. necator H16 as well; Dennis et al. (1998) co-expressed 
phaC1 and phaB genes from C. necator H16 in a PHA-negative mutant strain of 
C. necator H16, which showed accumulation of this copolymer using chain fatty 
acids as a carbon source. Another approach expressed heterologously the ccr gene 
(crotonyl-CoA reductase) from Streptococcus cinnamonensis and the phaJ and 
phaC genes from Aeromonas caviae (encoding for (R)-specific enoyl-CoA 
hydratase ((R)-ECH) and PHA synthase respectively) in a PHA-negative mutant 
strain of C. necator H16 for the production of P(3HB-co-3HHx) as well, where 
(R)-3HB-CoA is converted to crotonyl-CoA by the expression of the (R)-ECH 
enzyme and subsequently reduced by crotonyl-CoA reductase. PHA synthase then 
catalyses the copolymerization of 3HB-CoA and 3HHx-CoA monomers, ending 
with the P(3HB-co-3HHx) copolymer (Fukui et al., 2002). Different sustainable 
feedstocks such as plant oils (e.g., palm kernel oil, palm oil, soya bean oil) have 
been used for mcl-PHAs production with production of up to 87% (w/w) of the 
CDW (Kahar et al., 2004; Loo et al., 2005; Riedel et al., 2012). In Table 1.3, a 
comparison of the productivity of PHB and P(3HB-co-3HV) using different 
carbon souces is shown, where alternative carbon sources such as glucose, 
glycerol and waste glycerol were used for PHB production with mutant or 
engineered strains of C. necator. 
 
Table 1.3 Production of PHB and P(3HB-co-3HV) from different carbon sources in C. necator. 
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Product Carbon 
sources 
Strain/Cultivation strategy [PHA] 
(g/L) 
Productivity 
(g/L/h) 
Referen-
ces 
PHB CO2 C. necator ATCC 17697T / 
Continuous one-stage 
cultivation with a stirred-tank 
fermenter. 
61.9 1.55 Taga et al., 
1997 
 Glucose C. necator NCIMB  
11599 / Fed-batch cultivation. 
121.0 2.40 Kim et al., 
1994 
  C. necator NCIMB  
11599 / Fed-batch cultivation. 
139.0 3.10 Shang et 
al., 2003 
  C. necator DMS545 / Fed-
batch two-stage cultivation. 
125.0 2.03 Mozumder 
et al., 2014 
 Glycerol C. necator DMS545 / Fed-
batch cultivation. 
51.2 1.52 Cavalheiro 
et al., 2009 
 Waste 
glycerol 
C. necator DMS545 / Fed-
batch cultivation 
65.6 1.36 Cavalheiro 
et al., 2009 
P(3HB-
co-3HV) 
Glucose 
and 
valerate 
C. necator NCIMB  
11599 / Fed-batch two-stage 
cultivation. 
90.4 1.81 Lee et al., 
1995 
 Glucose 
and 
propionic 
acid 
C. necator NCIMB 40529 / 
Alternating feeding of carbon 
substrates in fed-batch 
cultivation. 
65.5 1.60 Madden et 
al., 2000 
  C. necator DMS545 / 
Optimised feeding strategy of 
substrates in a two-stage fed-
batch cultivation. Stepwise 
reduction of propionate to 
glucose ratio to avoid 
propionate inhibition. 
40.8 0.74 Du et al., 
2001 
Adapted from Johnson et al., 2015. 
 
 
1.5.2 Cyanophycin 
 
As reviewed in Reinecke et al. (2009), other biopolymers can be produced in C. 
necator H16. Cyanophycin is a protein-like polyamide that is naturally produced 
in a variety of Synechocystis and Anabaeana spp.; it has been reported to be 
produced as well in recombinant strains of C. necator H16 at high product titters 
with the heterologous expression of cphA and cphA1 that encode for the 
cyanophycin synthetases from Synechocystis and Anabaeana spp. in combination 
with metabolic engineering strategies, where 40% (w/w) of the CDW of 
cyanophycin has been achieved in 30-500 L fermenters (Voss et al., 2006). Due to 
cyanophycins are composed as well of polyaspartate backbone and arginine 
residues, the autotrophic cultivation with 13CO2 and 15NH4Cl in C. necator H16 
has been performed in order to produce 13C/15N-labeled cyanophycin, from which 
13C/15N arginine can be derived, which is a compound demanded for stable 
isotope (SI)-labeled biomolecule for quantitative proteomics (Lüte et al., 2012). 
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1.5.3 Biofuel 
 
As reviewed in Johnson et al., 2015, biofuels represent another vital chemical for 
the bioeconomy industry, therefore, the understanding of the biochemical 
pathways of C. necator H16 is fundamental to the design of the routes that could 
lead to biodiesel production, and that includes the PHA biosynthetic pathway, due 
to acetyl-CoA is the central metabolite for PHA production, which is derived from 
pyruvate decarboxylation. PHA-negative C. necator H16 strains have a pyruvate-
leaky phenotype when they are cultivated under PHA biosynthesis inducing 
conditions (Schlegel et al., 1970), hence, a strategy designed to produce branched-
chain amino acids (such as valine and leucine), and alcohols, is based on the 
diversion of excess pyruvate flux from carbon metabolism to other biosynthetic 
pathways such as α-keto-acids. 
 
Isobutanol, a branched-chain amino acid, is a promising biofuel that has been 
considered as an ethanol substitute in gasoline blends. Isobutanol and 3-methyl-1-
butanol production have been produced with a recombinant strain of C. necator 
H16 by the overexpression of the native branched-chain amino acids leucine and 
valine synthesis genes, which leads to the conversion of pyruvate to α-keto acids; 
along with the overexpression of kivD gene (encoding for ketoisovalerate 
decarboxylase) from Lactococcus lactis, which is in charge of the α-keto acids 
decarboxylation; where the enzyme isobutyraldehyde dehydrogenase diverts the 
carbon flux from pyruvate to the biosynthesis of isobutanol and 3-methyl-1-
butanol. Further optimisation of this approach was developed with the elimination 
of the genes ilvE, bkdAB, and ace, that encode for the three potential carbon sinks 
to reduce product consumption and toxicity (Lu et al., 2012). Another approach 
for production of isobutanol was reported by Li et al. (2012), where C. necator 
H16 was engineered to produce isobutanol and 3-methyl-1-butanol from CO2 in 
an electro-bioreactor that uses only CO2 as carbon source and electricity as the 
energy input. 
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1.5.4 Methyl ketones 
 
Other value-added chemicals that can be obtained from C. necator H16 are 
methyl ketones, which can be used as blending agents for diesel fuels, or are used 
as well as chemical intermediates in the fragrance and flavour industries (Goh et 
al., 2012; Müller et al., 2013). The β-oxidation pathway (or fatty acid degradation 
pathway) is responsible for the breakdown of fatty acids into acetyl-CoA, based 
on this premise Müller et al. (2013) engineered the fatty acid catabolism of C. 
necator H16 to produce fatty-acid derived methyl ketones, by overexpressing 
TesA thioesterase. This approach was achieved with the replacement of the acyl-
CoA dehydrogenase (FadE) from the native β-oxidation pathway of C. necator 
H16 by overexpressing the heterologous acyl-CoA oxidase from Micrococcus 
luteus, and FabB from E. coli, in combination with the deletion of the fadA gene 
in order to overproduce β-ketoacyl-CoAs; followed by the overexpression of 
thioesterase FadM from E. coli, which converts β-ketoacyl-CoAs into β-keto 
acids, from which decarboxylation ends up with methyl ketones. 
 
 
1.5.5 Methyl citrate 
 
2-methyl citrate (2MC) is a building block chemical used for the synthesis of 
various pharmaceuticals. Also, the compound is an essential intermediate for the 
synthesis of polymer plasticisers, and it is involved in the synthesis of citric acid. 
One of the pathways that compete for the propionyl-CoA flux is the 2MC cycle; 
propionyl-CoA is converted to succinate by the 2MMC enzymes, which are 
encoded in a gene cluster in the prp loci. The accumulation of 2MC was achieved 
in C. necator H16 by the inactivation of the acnM gene (encoding for 2-methyl-
cis-aconitic acid dehydratase), which converts 2MC to 2-methyl-cis-aconitic acid, 
and with the insertion of an additional prpC gene, which is in charge of the 
production of 2MC from propionyl-CoA that generates a propionate-negative 
phenotype strain (Ewering et al., 2006).  
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1.5.6 Feluric acid 
 
Vanillin, a compound that is used as a flavour additive in food and beverage 
industries, is synthesised by its precursor feluric acid, which can be produced in 
engineered strains of C. necator H16. A recombinant strain of C. necator H16 for 
industrial-scale production was designed to produce feluric acid, where the genes 
ehyAB, calA, and calB (which encode for eugenol hydroxylase, coniferyl alcohol 
dehydrogenase, and coniferyl aldehyde dehydrogenase, respectively) from 
Pseudomonas sp. strain HR199 -involved in the first reactions of eugenol 
catabolism-, were expressed in C. necator H16. Eugenol is an inexpensive 
compound that provides the biotransformation of feluric acid to vanillin; 
therefore, Overhage et al., (2002) used the recombinant C. necator H16 strain to 
convert eugenol to feluric acid, by the introduction of those three genes. The 
result was that the C. necator H16 recombinant strain (pBBR1-
JO2ehyABcalAcalB) was capable of holding a five-fold-higher eugenol 
concentration than other bacteria, achieving effective biotransformation. 
 
 
1.5.7 Potential bioproducts: pimelic acid for biotin production 
 
 
1.5.7.1 Importance of pimelic acid and biotin 
 
There are other exciting bioproducts such as pimelic acid and biotin that have 
been produced in other microorganisms; these bioproducts could potentially be 
produced as well in C. necator H16, with the advantage of using renewable 
feedstock or cheap substrates which have been used for bioproduction previously 
in this strain. Biotin is added in many foods and feed products, cosmetics for hair, 
skin, and nails, which has created a world market of hundreds of tons per year, 
where 1 kg of biotin costs around US$ 1000 (Finkenwirth et al., 2014). To date, 
most of the biotin is produced by chemical synthesis, previously, it was produced 
following the process developed by Goldberg et al. (1949) were biotin was 
synthesised in more than ten steps using succinic acid or D-mannose as 
precursors, and toxic compounds such as bromide were used for molecular 
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activations; lately, this process has been modified, but still generates considerable 
amounts of chemical waste such as tetrahydrofurane and toluene, ethyl acetate, 
small amounts of phenyl chloroformate, among other toxic compounds; the late 
patented biotin synthesis also needs high energy input, and it takes more than ten 
steps to be synthesised (reviewed in Streit et al., 2003).  
 
For these reasons, and due to the environmental burden because of the 
accumulation of chemical waste, the development of cost-effective biotin-
overproducing microorganisms is desirable. The production of biotin in 
microorganisms should reach production titres of at least 1 g biotin/L and use a 
cheap substrate in order to be cost-effective (reviewed in Streit et al., 2003), 
therefore C. necator H16 represents a good candidate as a biotin-overproducing 
microorganism, as it has been shown that it can use renewable feedstock as well 
as to be a versatile microorganism that can be engineered to obtain high 
production titres of bioproducts. The main strategies that have been used for 
biotin overproduction in different microorganisms to date are: 1) Selection of 
improved biotin-overproducing strains that have been obtained through chemical 
mutagenesis (evolutionary engineering), 2) recombinant strains that are capable of 
overproducing biotin via the expression of extra copies of biotin-biosynthesis 
genes (metabolic engineering) and, 3) the combination of both evolutionary and 
rational design engineering strategies. 
 
One of the strategies used to improve biotin production in bioprocess engineering 
is the addition of pimelic acid in the fermentation process. Pimelic acid is a seven 
carbon a,w-dicarboxylic acid, and it is an essential precursor in the biotin 
biosynthesis, although its synthesis in wild-type strains is low. The use of pimelic 
acid as an additive for biotin production represents a high-cost in the production 
chain; therefore alternatives for biosynthesis of pimelate are a fundamental 
requirement in order to reduce the production cost of biotin. It has been 
demonstrated that the production of dethiobiotin when pimelic acid is added in the 
fermentation, increases by ten-fold than without the addition of pimelate 
(Berkovitch et al., 2004).  
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The early steps of the biotin biosynthesis pathway of C. necator H16 have not 
been investigated yet, the only information available and published to date is the 
existence of the bioFADB operon described by Pohlmann et al. (2006) in the 
genome sequence of the strain, where it was found that C. necator H16 does have 
the standard bioFADB genes clustered in a single operon, these genes are involved 
in the final steps of biotin biosynthesis. On the other hand, there is a predicted 
bioC gene in a different location of the bioFADB operon in C. necator H16 
(Rodionov et al., 2002), although no studies have been performed to date to 
confirm the function of the gene. In order to understand how the pimelate and 
biotin biosynthesis could be improved in C. necator H16, it is important to 
understand the biotin biosynthesis pathways that have been already elucidated in 
other microorganisms.  
 
 
1.5.7.2 Catalytic role of Biotin 
 
Biotin (also known as vitamin H and B7) is a fascinating sulphur-containing 
cofactor which functions when it is covalently attached to crucial metabolic 
enzymes; it is highly involved in the central metabolic pathways of 
gluconeogenesis and fatty acid synthesis of eukaryotic and prokaryotic cells. 
Biotin mediates the transport of CO2 and can be divided into three different 
classes depending on their function: carboxylases (Class I, where CO2 is 
transferred to an acceptor molecule), decarboxylases (Class II, where CO2 is 
released as bicarbonate) or transcarboxylases (Class III, where a reversible 
transfer of a carboxyl group occurs from one compound to another) (reviewed in 
Knowles, 1989; Rodionov et al., 2002; Zhang et al., 2011; Grover et al., 2012). 
The number of biotin-dependent protein ranges from one to five in different 
microorganisms (Cronan et al., 2000) and in most cases, enzymes belong to 
biotin-dependent enzymes catalyse CO2 fixation (Class I) (Grover et al., 2012). 
Without the attachment of biotin, biotin-dependent enzymes are not catalytically 
active, and therefore they cannot fulfil their metabolic roles.  
 
One of the most important biotin-dependent enzymes is acetyl-CoA carboxylase, 
which is in charge of catalysing the first step in the fatty acid biosynthesis 
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pathway; acetyl-CoA carboxylase catalyses the ATP-dependent transfer of a 
carboxyl group from carbonate to acetyl-CoA to produce malonyl-CoA. The fatty 
acid biosynthesis pathway is essential for bacterial cell membrane maintenance 
(Polyak et al., 2012; Soares da Costa et al., 2012), hence, if biotin is inhibited –for 
instance, by biotin analogues-, cell growth could be compromised. Other biotin-
dependent enzymes are pyruvate carboxylase, propionyl-CoA carboxylase, 
methylcrotonyl-CoA carboxylase, geranoyl-CoA carboxylase, oxaloacetate 
decarboxylase, methylmalonyl-CoA decarboxylase, transcarboxylase and urea 
amidolyase, which are found in prokaryotes or eukaryotes (Jitrapakdee et al., 
2003) and participate in different central metabolic pathways as gluconeogenesis, 
amino acid metabolism, lipogenesis and energy transduction (Delli-Bovi et al., 
2003). 
 
The structure of biotin consists of a bicyclic ring that is fused to a valeryl side 
chain; the bicyclic rings are composed of an imidazol (ureido) ring and a sulphur-
containing (tetrahydrothiophene) ring (DeTitta et al., 1976). When biotin is 
active, it is covalently attached to enzymes through an amide bond between the 
carboxyl group of biotin and a specific lysine residue in the ε-amino group of a 
conserved protein domain of about 80 residues (Lane et al., 1964). The valeryl 
side chain helps to extend the bicyclic rings away from the lysine residue, and the 
ureido ring N8 nitrogen is in charge of carrying the CO2 moiety and forming N-
carboxybiotin (reviewed in Knowles, 1989; Attwood et al., 2002).  
 
Biotin-producing systems are limited to microbes, fungi, and plants; mammals are 
not capable of producing biotin, they obtain biotin from the intestinal microflora 
or from the diet. Humans and animals require hundreds of micrograms of biotin 
per day, these amounts of biotin have been provided mainly by chemical synthesis 
(reviewed in Streit et al., 2003; Lin et al., 2010, Cronan et al., 2011; Lin et al., 
2011). Nevertheless, as mentioned before, the chemical synthesis of biotin is 
followed by environmental burden, and it is a lengthy process; hence new 
alternatives for biotin biosynthesis using microorganisms as a cell factory have 
become an attracted strategy for the biotechnological community.  
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1.5.7.3 Biotin biosynthesis in prokaryotes 
 
Although biotin is essential, the knowledge of its biosynthesis remains 
fragmentary in many microorganisms. Comparative genomic analyses have 
indicated that the biotin biosynthesis pathway is largely conserved and can be 
divided into two stages: the first stage is the synthesis of the pimelate moiety -
studies reported to date suggest that in most of the microorganisms the carbon 
atoms of biotin are derived from pimelic acid (Ifuku et al., 1994; Sanyal et al., 
1994)-, and the second stage is the assembly of the bicyclic ring of biotin. The 
biotin biosynthesis pathway is best understood in some prokaryotic 
microorganisms such as E. coli, Bacillus subtilis and Bacillus sphaericus, these 
investigations have been performed using combined genetics, biochemical and 
complementation studies (Otsuka et al., 1978; Gloeckler et al., 1990; Kiyasu et 
al., 2001; Rodionov et al., 2002). As reviewed in Streit et al. (2003), other studies 
have analysed in detail the biotin biosynthesis pathway of other microorganisms 
such as Kurthia sp, Mesorhizobium loti, Methylobacillus flagellatum, 
Corynebacterium glutamicum, and Sinorhizobium meliloti. 
 
The classic models of E. coli and Bacillus spp. show orthodox late steps of biotin 
biosynthesis –those involved in the assembly of the fused rings- which mainly 
differ in the first step of biosynthesis (Figure 1.8), where Bacillus spp. use bioW 
(that encodes for pimeloyl-CoA synthase) and bioX (acyl carrier protein) (Bower 
et al., 1996a; reviewed in Lemoine et al., 1996; Rodionov et al., 2002) to 
incorporate exogenous pimelate to synthesise pimeloyl-CoA, which afterwards 
undergoes to the biotin biosynthesis pathway; in addition, B. subtilis is thought to 
have an alternative route, where it has been proposed to use bioI (which encodes 
for cytochrome P450) to provide de novo synthesis of pimeloyl-ACP by the 
catalysis of oxidative C-C bond cleavage of long-chain acyl-ACPs for pimelic 
acid formation (Stock et al., 2000; Rodionov et al., 2002). In B. subtilis, the genes 
involved in the conversion of pimelic acid to biotin are found within a single 
operon as bioWAFDBI (Perkins et al., 1996).  
 
On the other hand, in E. coli, pimeloyl-CoA is not synthesised from pimelic acid 
but from acetate via acetyl-CoA (Ifuku et al., 1994); recent studies revealed that 
Chapter 1. Literature Review: 
Engineering Cupriavidus necator H16 to use it as a chassis cell for chemical production 
 43 
the products of bioC (annotated as S-adenosyl-L-methionine (SAM) dependent 
methyltransferase) and bioH (which encodes for pimeloyl-ACP methyl ester 
esterase) are required for the synthesis of pimeloyl-CoA. BioC and BioH do not 
catalyse the synthesis of pimelic acid directly, but they provide the means to use 
fatty acid synthesis for the assembly of the pimelate moiety. BioC methylates the 
ω-carboxyl group of malonyl-CoA (or ACP) by transferring a methyl residue 
from SAM, this mimics the methyl ends of regular fatty acyl chains, hence, this 
atypical substrate is recognised by fatty acid enzymes (FabG, FabZ, FabI, FabB, 
FabF); the formed malonyl-CoA methyl ester enters the fatty acid pathway and 
undergoes two reiterations of elongation in the fatty acid synthesis and gives 
pimeloyl-ACP methyl ester, which is then hydrolysed to pimeloyl-ACP by BioH 
to terminate chain elongation and to liberate the ω-carboxyl group of biotin (Lin 
et al., 2010).  
 
After pimelate synthesis, the biosynthesis pathway is similar in E. coli and 
Bacillus spp., with the products of bioF, bioA, bioD, and bioB. In E. coli, the 
biotin genes are not found in a single operon, it has a bioBFCD operon which is 
located divergently with bioA and a single bioH gene in a different location in the 
chromosome; if BioC is overexpressed and active, this will cause the elevated 
levels of malonyl-ACP methylated species, which will block fatty acid synthesis 
due to lack of malonyl-ACP, and that would reduce cell growth (Lin et al., 2012), 
therefore if bioC is overexpressed in a biological system, a proper regulation of its 
expression must be considered. 
 
The bioC gene is widely found in bacteria, while bioH is not found in many bioC-
containing bacteria as it is in E. coli; instead, other genes have been found to 
complement bioH function such as the bioZ gene from Mesorhizobium loti or the 
bioG gene found in some proteobacteria (Sullivan et al., 2001; Rodionov et al., 
2002). In bacteria, biotin is needed only in trace quantities, specifically in E. coli, 
where only few hundred molecules per cell are required for growth 
(concentrations of only a few nanomolar), due to this reason, biotin is expressed at 
shallow levels (Cronan, 2001; Lu et al., 2007). 
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Figure 1.8 The orthodox last steps of the biotin biosynthesis pathway for the assembly of the 
bicyclic rings from studies of E. coli and Bacillus spp. Abbreviations: KAPA, 7-keto-8-
aminoperlargonic acid; DAPA, 7,8-diaminopelargonic acid; DTB, dethiobiotin; SAM, S-adenosyl-
L-methionine. 
 
As reviewed in Cronan (2014), biotin must be covalently attached to metabolic 
enzymes to perform its role in cellular enzymology; free biotin is not physically 
useful, although it plays an indirect regulatory role. In E. coli, the regulation of 
biotin biosynthesis is carried on by the bifunctional protein BirA, which acts as a 
transcriptional repressor of the biotin operon as well as a biotin-protein ligase that 
catalyses the covalent attachment of biotin to biotin-dependent enzymes (Delli-
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Bovi et al., 2010), where the bioH gene that is not located within the bio operon, 
is not regulated by BirA (Barker et al., 1980; Koga et al., 1996; reviewed in 
Cronan, 2014). Predicted BirA-binding sites are well conserved in a variety of 
eubacteria and archaeal genomes. The BirA protein of B. subtilis has a similar 
structure to the BirA of E. coli, it also acts as a repressor of the bioWAFDBI 
operon (Bower et al., 1996a). It has been shown that BirA is the protein most 
widely distributed biotin-related gene among bacteria (Rodionov et al., 2002). 
 
As reviewed in Streit et al. (2003), many investigations have been done to analyse 
the genetics behind the biotin biosynthesis pathway in other microorganisms, 
apart from the more detailed investigations in E. coli, B. subtilis, and B. 
sphaericus, where experimental designs to identify the biotin biosynthesis genes 
included mainly complementation studies, or a combination of complementation 
studies and random mutagenesis to identify the genes related to the biotin 
biosynthesis pathway.  
 
After the studies related to the biotin biosynthesis pathway in different 
microorganisms, it has been observed that the bioFADB operon is universally 
conserved among different prokaryotes, as can be observed in Figure 1.9, while 
the bioFADB operon is conserved in gram-positive, and gram-negative bacteria, 
the genes committed to pimelate synthesis vary among them, where some of the 
species of the gram-negative bacteria appear to have the genes bioC and bioH 
committed to pimelate synthesis (reviewed in Streit et al., 2003). 
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Figure 1.9 Physical organisation of biotin synthesis genes identified and tested for functionality in 
gram-positive and gram-negative microorganisms. In the illustration, different transcriptional 
units are separated by //. Genes linked to the assembly of the fused heterocyclic rings of biotin are 
indicated as orange arrows, the genes most likely involved in pimeloyl-CoA synthesis are 
indicated as green arrows, and the genes not directly linked to biotin biosynthesis are indicated as 
white arrows. Information of the genes involved in the biotin biosynthesis was extracted from 
GenBank (Adapted from Streit et al., 2003). 
 
As mentioned before, one of the most common strategies to either understand the 
biotin biosynthesis pathway or to improve biotin production in a variety of 
microorganisms has been the use of directed evolution via random mutagenesis 
for all cell genome, as this strategy allows to cover the entire genome of the 
strains, as in many cases, the biotin biosynthesis genes of the microorganisms 
have not been predicted or identified.  
 
 
1.5.7.4 Alternative pathways for pimelic acid production 
 
One of the most intriguing biotin biosynthesis pathways is the one encoded by 
two Desulfovibrio spp. Rodionov et al. (2004) studied the metal-reducing genera 
in the δ subgroup of proteobacteria to compare genome sequences of seven 
representatives in order to investigate the regulatory and genetic factors in 
pathways that are involved in the biosynthesis of cofactors and building blocks. 
All δ-proteobacteria studied for the biotin cofactor showed to have the bioFADB 
genes for de novo biosynthesis of biotin, as well as the BirA bifunctional protein, 
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although the initial steps of biotin biosynthesis differed among these species 
(Figure 1.10). The Geobacter species have a bioC-bioH gene pair as E. coli, for 
the synthesis of pimeloyl-CoA, Desulfuromonas species have the same pair but 
also the bioW gene, which represents two different pathways for pimeloyl-CoA 
synthesis, and Desulfotalea psychrophila is predicted to use a bioC-bioG gene 
pair (Rodionov et al., 2002).  
 
 
 
Figure 1.10 Genomic organisation of the biotin biosynthesis genes and regulatory elements of 
metal reducing proteobacteria. Abbreviations: DD, Desulfovibrio desulfuricans; DV, 
Desulfovibrio vulgaris; GS, Geobacter sulfurreducens PCA; GM, Geobacter metallireducens; DA, 
Desulfuromonas spp.; DP, Desulfotalea psychrophila (Adapted from Rodionov et al., 2004). 
 
 
Interestingly, Rodionov et al. (2004) revealed that Desulfovibrio vulgaris (DV) 
and Desulfovibrio desulfuricans (DD) have an extended biotin operon within the 
standard bioFADB with five new genes that are related with the fatty-acid 
biosynthetic pathway (although only one of the genes within the extended biotin 
operon of DD (DD5) is annotated as a hypothetical protein) (Figure 1.11), these 
new genes –which are not present in other δ-proteobacteria-, are homologs of acyl 
carrier protein (ACP), 3-oxoacyl-(ACP) synthase, 3-oxoacyl-(ACP) reductase and 
hydroxymyristol-(ACP) dehydratase, due to this reason, they concluded that these 
genes might be functionally related to the biotin pathway. Hence, they 
hypothesised that these genes could encode a novel pimeloyl-CoA biosynthesis 
pathway, as the known genes for the biotin biosynthesis pathway for δ-
proteobacteria: bioC, bioH, bioG, and bioW are not present in Desulfovibrio spp. 
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Figure 1.11 Biotin biosynthesis genes in Desulfovibrio vulgaris (DV) and Desulfovibrio 
desulfuricans (DD). The genome maps of the genes involved in the biotin biosynthesis pathway of 
both microorganisms were extracted from KEGG. The inset shows the colour codes used by 
KEGG to describe the function of the open reading frames; as can be observed, all the genes 
identified for biotin biosynthesis in pink colour for both microorganisms have been categorised 
under the section of “Metabolism of cofactors and vitamins”, while the genes within the extended 
biotin operons of DV and DD are marked in aqua colour for both microorganisms under the 
section of “Lipid metabolism”. DV1, DV2, DV3, and DV4 correspond to the new genes found 
within the bioFADB extended biotin operon of Desulfovibrio vulgaris (DV); DD1, DD2, DD3, 
DD4 and DD5 correspond to the new genes found within the bioFADB extended biotin operon of 
Desulfovibrio desulfuricans (DD). 
 
 
1.5.7.5 Biotin biosynthesis in C. necator H16  
 
As mentioned earlier, the second stage of biotin biosynthesis in charge of the 
assembly of biotin rings is encoded in the universal bioFADB biotin operon, 
which is found in the chromosome 1 of C. necator H16 (Pohlmann et al., 2006), 
but the early steps of the biotin biosynthesis committed to pimelate synthesis have 
not been elucidated yet (Figure 1.12), therefore, the study of the biotin 
biosynthesis pathway of C. necator H16 represents a great opportunity and 
challenge to scientists to define the genes that are involved in the formation of the 
pimeloyl-CoA moiety, with the subsequent possibility of engineering C. necator 
H16 either to use it as a chassis for pimelate and biotin production. 
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Figure 1.12 Key enzymes of biotin biosynthesis in C. necator H16. A putative bioC gene has been 
predicted in chromosome 1 of C. necator H16, which could be committed to pimelate synthesis. 
 
 
Apart from the information provided after the genome sequencing of C. necator 
H16, Rodionov et al. (2002) predicted by comparative genomics and phylogenetic 
analysis a bioC gene found in chromosome 1of C. necator H16, where the 
sequence identity between the potential bioC in C. necator H16 (originally 
annotated as “Predicted malonyl-CoA O-methyltrasnferase) and the bioC of E. 
coli K-12 MG1655 (originally annotated as SAM-dependent malonyl-CoA O-
methyltrasnferase) is of 30 %, with an overlap of 239 amino acids. This predicted 
bioC gene of C. necator H16 (bioCH16), unlike the bioC of E. coli (bioCEC) is not 
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found within the bioFADB biotin operon of C. necator H16, but in a distinct 
location in the chromosome 1 (about 150,000 bp downstream the bioFADB biotin 
operon), no other open reading frame under the category of “Metabolism of 
cofactors and vitamins” (pink colour arrows in Figure 1.13 for C. necator H16) is 
indicated near the bioFADB biotin operon in C. necator H16.  
 
 
 
Figure 1.13 Biotin biosynthesis genes in E. coli K-12 MG1655 and C. necator H16. The genome 
maps of the genes involved in the biotin biosynthesis pathway of both microorganisms were 
extracted from KEGG. The inset shows the colour codes used by KEGG to describe the function of 
the open reading frames; as can be observed, all the genes identified for biotin biosynthesis in 
pink colour for both microorganisms have been categorised under the section of “Metabolism of 
cofactors and vitamins”, which suggests that BioCH16, could be involved in the biotin biosynthesis 
pathway. 
 
 
Evolutionary engineering could be a possible strategy to use to understand more 
in detail the biotin biosynthesis pathway of C. necator H16. A whole genome 
random mutagenesis would expose the entire genome to mutagenesis and mutant 
strains could be selected after in an agar plate supplemented with a selection 
pressure –such as biotin analogues-, where it would be expected that only the 
mutants capable of growing in those conditions would be the mutants that have 
gone through genetic mutations in regions that could be related to the biotin 
biosynthesis pathway. 
 
Once the best mutant strain had been selected, whole genome sequencing of the 
mutant strain could be carried out to compare the DNA sequences between the 
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mutant and the wild-type, which will help to identify the regions with genetic 
mutations, these regions could be further studied as they could be related to the 
biotin biosynthesis pathway, where perhaps genetic alterations on the predicted 
bioCH16 gene could be found, or in a possible bioHH16 gene (or a similar one such 
as bioZ or bioG) that could be identified in the strain, as it appears that in gram-
negative microbes (as C. necator H16 and E. coli), the bioC and bioH (or a 
similar gene) genes are usually required for the first steps of biotin biosynthesis 
(reviewed in Streit et al., 2003). 
 
 
1.5.7.6 Pimelate and biotin production using rational design and evolutionary 
engineering strategies 
 
As reviewed in Streit et al. (2003), most of the recombinant biotin-overproducing 
bacterial strains reported to date have used forward engineering by employing 
cloning strategies that include the fusion of bio genes with strong promoters. 
Over-producing biotin recombinant strains have been constructed in different 
microorganisms such as E. coli, B. subtilis, and Serratia marcescens (Sakurai et 
al., 1995, Van Arsdell et al., 2005; Zhang et al., 2011), but still the production of 
biotin in these studies have not been able to yield enough biotin cost-effective yet.  
 
Zhang et al., (2011) constructed a recombinant strain of B. subtilis for efficient 
pimelic acid synthesis with a maltose-inducible strong Pg/v promoter inserted into 
the upstream of bioI and created a repeat of the cistron bioI-orf2-orf3 –which are 
the genes involved in the pimelic acid biosynthesis pathway in B. subtilis- in B. 
subtilis chromosome DNA, where high level of production of pimelic acid was 
obtained with 4 times higher production fold compared to the single copy. A 
similar approach could be conducted in C. necator H16 once the genes committed 
to pimelate synthesis have been identified. 
 
Sakurai et al. (1993) engineered Serratia marcescens Sr41 using evolutionary 
engineering by directed evolution via random mutagenesis; they isolated mutants 
of this strain resistant to the biotin analogue acidomycin (ACM, also known as 
actithiazic acid), this biotin analogue reported to inhibit the formation of D-biotin 
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from dethiobiotin by the biotin synthetase (BioB); up to 20 mg/L of biotin was 
produced with the mutant strains. Serratia marcescens Sr41 cells were 
mutagenised with N-methyl-N’-nitro-N-nitrosoguanidine (NTG), and mutated 
cells were grown in minimal medium agar plates supplemented with acidomycin.  
 
On the other hand, Bower et al. (2001) constructed as well biotin analogue 
resistant mutants of B. subtilis that overproduced biotin, where cells were 
mutagenised with ethyl methanesulfonate (EMS) to give a 90 % killing. 5-(2-
thienyl)-valeric acid (TVA) was used as a biotin analogue, which showed to 
inhibit cell growth in B. subtilis wild-type cells, while chemically mutagenised B. 
subtilis cells could grow in the presence of TVA. A different compound was also 
used to screen for biotin-overproducing mutants of B. subtilis: azelaic acid (AZ), 
which is a homologue of pimelic acid thought to be involved in the conversion of 
oleic acid to pimelic acid (Ohsugi et al., 1981). High concentrations of the AZ 
inhibited cell growth of the wild-type, which was reversed by the addition of 
biotin. According to experiments performed by Bower et al. (2001), AZ might act 
at the level of pimelyl-CoA synthetase (bioW) as a competitive inhibitor of 
pimelic acid, Bower et al. (2001) suggested that the mutants screened and selected 
in AZ were likely to have increased their capacity to produce or utilise pimelic 
acid probably with mutations found either in bioI or bioW. The mutant strains of 
B. subtilis selected produced from up to 0.3 mg/L of biotin. 
 
Hoshino et al. (1999) also applied evolutionary engineering to produce biotin in 
high yields by fermentation using microorganism belonging to the genus Kurthia. 
Kurthia spp. mutant strains showed resistance to biotin analogues as ACM, TVA, 
a-methyldethiobiotin, amiclenomycin, bisnorbiotinol, among others, which have 
enabled the cell to accumulate large amounts of d-biotin in the culture broth, that 
can furtherly be recovered in excellent purity. Cells of Kurthia spp. were firstly 
randomly mutagenised with NTG, EMS, acridine orange, UV or X-rays; then 
cells were grown in biotin-free minimal medium supplemented with different 
biotin analogues (ACM, TVA or a-methyldethiobiotin), were mutants resistant to 
the different biotin analogues were obtained. The cultivation of Kurthia spp. takes 
about 2 to 4 days, were after that period of cultivation, biotin could be separated 
Chapter 1. Literature Review: 
Engineering Cupriavidus necator H16 to use it as a chassis cell for chemical production 
 53 
from the culture broth and purified with yields of biotin 5 to 200 higher than the 
yields obtained from Serratia marcescens (Sakurai et al., 1993). 
 
Another notable example was the one developed by Ifuku et al. (1993), where 
ACM and TVA were used as biotin analogues. E. coli cells were mutagenised 
with NTG chemical mutagen and then grown in two different biotin analogues 
TVA and ACM in the same agar plate, among the mutants selected a biotin 
productivity from 0.9 up to 4.5 mg/L was obtained. The mutations points of the 
biotin operon from the biotin-overproducing mutants of E. coli were analysed by 
DNA sequencing. One of the mutations was found in the operator overlapping the 
-10 region of the bioB promoter, and two other mutations were found before and 
after the initiation codon of the bioB gene; the first mutation was considered to 
have disrupted the operator structure, and thus, the promoter activity was 
enhanced, and the second two mutations were thought to have activated the 
translation efficiency. 
 
Other scientists have used the same approach whereby the cells are randomly 
mutated either by chemical or physical mutagens and selected as biotin 
overproducing microorganisms under a biotin analogue pressure, but also, the 
isolated mutants are transformed to express heterologous bio operons mainly from 
E. coli. As reviewed in Streit et al. (2013), it is important to know that in addition 
to strain design, other factors contribute to higher biotin yields such as medium 
components and fermentation conditions. 
 
 
1.6 Future perspectives 
 
With increasing global attention on the environmental burden, approaches in 
biotechnology must consider the development of strategies that are sustainable for 
chemical production in bacteria; this potential can be fully exploited in C. necator 
H16 for biomanufacturing purposes. Understanding the biology of C. necator H16 
is now easier to achieve since its complete genomic sequence annotation is 
already available, and the construction of a synthetic biology toolbox for C. 
necator H16 would allow the regulation and expression of genes that can 
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contribute to bioproduction. Expanding the range of utilisable substrates -mainly 
renewable substrates such as crude glycerol- would decrease production costs and 
make the bioprocess sustainable.  
 
C. necator H16 remains a promising microbial cell factory for value-added 
chemical production. The integration of rational design and evolutionary 
engineering are key strategies to achieve a robust strain of C. necator H16 for 
chemical production. 
 
 
1.7 Overall aim of the study 
 
C. necator H16 has attracted biotechnological interest for the last decades due to 
its versatility and the relatively recent (2006) available genomic sequence, which 
aids to engineer the strain more easily. C. necator H16 is a non-pathogenic 
bacterium that awaits to be used as a cell factory. In this Chapter 1, some of the 
potential strategies and bioproducts that can be synthesised in the strain were 
mentioned and discussed; these strategies served as a basis and theoretical 
fundamental for the studies of this PhD project. 
  
The overall aim of the study is to engineer C. necator H16 with rational design 
and evolutionary engineering tools to explore the biotechnological potentials of 
the strain and fine-tune the properties of C. necator H16 for chemical production 
using waste stream as a feedstock. The specific aims of each Chapter are listed 
below: 
 
Chapter 2 
Recombinant strain engineering: Development of a transformation method 
and a synthetic biology toolbox for metabolic engineering in Cupriavidus 
necator H16 
 
Ø To optimise a transformation method by electroporation for C. necator 
H16. 
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Ø To construct a synthetic biology toolbox with inducible and constitutive 
promoters and other synthetic biology parts for metabolic engineering 
applications  
 
Chapter 3  
Metabolic engineering: Applicability of synthetic biology toolbox by the 
expression of heterologous extended biotin operons in Cupriavidus necator 
H16 
 
Ø To demonstrate the applicability of the synthetic biology toolbox 
constructed in Chapter 2 with the expression of operons driven by a 
single strong promoter (inducible promoter PBAD) in C. necator H16, 
operons that could encode for a modified pathway committed to pimelate 
production. 
 
Chapter 4 
Directed evolution: Development of a directed evolution via random 
mutagenesis tool for Cupriavidus necator H16 to understand its biotin 
biosynthesis pathway 
 
Ø To optimise a random mutagenesis method for C. necator H16 using EMS 
as a chemical mutagen. 
Ø To explore the applicability of evolutionary engineering in C. necator H16 
by using a directed evolution strategy via random chemical mutagenesis to 
generate a library of mutants which could help to understand the biotin 
pathway in C. necator H16. 
 
Chapter 5 
Rational design and Evolutionary engineering: Engineering Cupriavidus 
necator H16 to convert waste stream into useful chemicals by enhancing 
glycerol assimilation 
 
Ø To apply rational design and evolutionary engineering tools explored and 
optimised in this PhD work to engineer C. necator H16 to enhance its 
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glycerol assimilation for chemical production using waste stream (crude 
glycerol) as feedstock. 
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1.8 Organization of this study 
 
The different strategies used in this study to engineer C. necator H16 are 
described in Figure 1.14, which also shows how these may be applied 
synergistically, and how this PhD thesis is organised.  
 
 
Figure 1.14 Expanding engineering tools for Cupriavidus necator H16 to convert waste stream into useful chemicals via 
rational design and evolutionary engineering approaches. In Chapter 1 (Scheme 1), literature review about C. necator 
H16 is compiled to understand its natural metabolism and to analyse the different biomanufacturing potentials of the strain 
as well as some engineering strategies used for chemical production, afterwards, in Chapter 2 (Scheme 2) an optimised 
transformation method and a synthetic biology toolbox for C. necator H16 were developed in order to use the strain as a 
cell factory. Once the synthetic biology toolbox was tailored for C. necator H16, in Chapter 3 (Scheme 3) the synthetic 
biology toolbox was used for the expression of clusters of genes as well as possibly obtain bioproducts from the expression 
of these. Then, in Chapter 4 (Scheme 4), a different strategy to engineer C. necator H16 was studied: directed evolution 
via random mutagenesis, where an optimised protocol for random mutagenesis with a chemical mutagen was developed for 
C. necator H16 to understand its biotin biosynthesis pathway which could furtherly be used for chemical production. In 
Chapter 5 (Scheme 5), the knowledge and strategies studied in previous chapters and proven to work in C. necator H16, 
supported the approaches selected to construct recombinant and evolved strains from C. necator H16 for chemical 
production (bioplastics) using waste stream (crude glycerol) as a feedstock. Chapter 6 (not shown in the illustration) 
analyses the concluding remarks of the PhD study. 
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Abstract 
 
 
 
 
The genome sequence of the Gram-negative lithoautotrophic b-proteobacterium 
Cupriavidus necator H16 is already available, as well as suitable plasmid systems 
that can be used to engineer the strain. In order to expand the biotechnological 
potential of C. necator H16, two different tools of rational design engineering 
were studied in this chapter. The first engineering tool consisted on developing a 
simpler and more robust method of transformation for C. necator H16, since 
transformation methods for C. necator H16 to date are based on bacterial 
conjugation, which requires 4 to 5 days to be accomplished. To overcome this 
challenge, in this Chapter 2, the effects of different parameters were studied to 
design a transformation method by electroporation optimised for C. necator H16. 
The final optimised method of transformation by electroporation consisted of a 
chemical treatment with 50 mM CaCl2, the use of 0.2 M Sucrose, and an 
intermediate electric field strength (11.5 kV/cm), where the transformation 
efficiency was higher than 1 x 105 transformants/µg of DNA. After the 
transformation method was fully optimised, the second tool consisted on the 
construction of a synthetic biology toolbox tailored for C. necator H16, which 
included different biological parts such as different promoters (PBAD for inducible 
expression of genes, and Pj5 for constitutive expression of genes); all the plasmids 
constructed were based on a C. necator H16-compatible broad host range plasmid 
(pBBR1MCS-1). The transformation method and the construction of the synthetic 
biology toolbox are valuable tools for C. necator H16 that will further enable the 
strain to be used as a cell factory to produce value-added chemicals. 
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2 Chapter 2. Recombinant strain engineering: Development of a  
transformation method and a synthetic biology toolbox for metabolic 
engineering in Cupriavidus necator H16 
 
 
2.1 Introduction 
 
 
2.1.1 Transformation method by electroporation for C. necator H16 
 
One of the overall aims of this PhD study is to expand engineering tools for C. 
necator H16 to explore the biotechnological potentials of the strain for chemical 
production, where recombinant strains of C. necator H16 play an important role. 
Low-time consuming, high efficient, and simple transformation methods to 
introduce foreign DNA into the strain are required for this purpose. To date, the 
transformation method by electroporation remained a challenge for C. necator 
H16, as the most common method for introducing plasmids to C. necator H16 
was via bacterial conjugation.  
 
Although bacterial conjugation is a well-studied and established transformation 
method for C. necator H16, it is time-consuming due to it requires two cultivation 
times and two transformations, as it first needs a transformation by employing 
CaCl2 method with a donor strain (usually E. coli S17-1) with the plasmid of 
interest, before the plasmid is transferred to C. necator H16 (the recipient strain) 
by conjugation (Friedrich et al., 1981); this process makes the engineering of the 
strain slow if compared to the one-step method of transformation by 
electroporation in C. necator H16 developed in our laboratory by Tee et al., 2017. 
 
Some publications have reported using both bacterial conjugation and 
electroporation to introduce plasmids in C. necator H16, and some others have 
transformed only by bacterial conjugation as plasmids had not been successfully 
transformed by electroporation into C. necator H16 (Park et al., 1995; Solaiman 
et al., 2010; Sato et al., 2013; Bi et al., 2013). Due to these reasons, the first step 
on this PhD investigation was to study different parameters to evaluate the effects 
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on transformation by electroporation of C. necator H16 in order to optimise the 
method and to achieve a low-time consuming method of transformation by 
electroporation for C. necator H16. 
 
 
2.1.2 Synthetic biology toolbox for C. necator H16 
 
Once having an optimised method for transformation in C. necator H16, it would 
be easier to engineer the strain, where synthetic toolboxes are required to control 
the expression of native or heterologous genes or pathways. In general, protein 
production in fermentation processes relies on a variety of factors such as gene 
dosage and stability of expression construct (Grabherr et al., 2002), promoter 
strength (Wilms et al., 2001) and induction times when inducible systems are 
used (Wu et al., 2001). In prokaryotes, the high-level protein expression is 
achieved by the modulation of gene dosage with the use of medium or high copy 
number plasmids, where usually an increase in plasmid copy number translates to 
an increase in the metabolic burden of the cell (Srinivassan et al., 2013); 
therefore, this must be considered when choosing a plasmid for protein 
expression. In C. necator H16, most of the heterologous expression and metabolic 
engineering studies conducted to date do not show a variety of suitable expression 
systems and neither promoter repertoires, only a few studies have standardised 
expression systems specifically for C. necator H16.  
 
Gruber et al. (2014) designed stable vectors for efficient gene expression in C. 
necator H16 using promoters derived from bacteriophage T5; Bi et al. (2013) on 
the other hand, developed a toolbox with broad-host-range plasmids with a variety 
of origins of replication (including pBBR1), promoters, 5’ mRNA stem-loop 
structures and ribosomal binding sites (an E. coli consensus RBS, a C. necator 
H16 native RBS, and a computationally automated designed RBS); while 
recently, in our laboratory group, Johnson et al. (2018) studied and constructed 
different promoters including the native PphaC1 promoter, a semi-synthetic PrrsC 
promoter, and two coliphage T5 promoters Pj5 and Pg25 which were characterised 
with variable strength for C. necator H16. The promoters were genetically 
modified by either point mutations, length alteration, configuration alteration, or 
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by incorporation of regulatory genetic elements and promoter hybridisation, 
where a library of 42 constitutive promoters was created harbouring promoters 
that are stronger than the Pj5 promoter with a ratio of promoter activities of 137 
between the strongest promoter (derived from Pj5) and the weakest promoter 
(derived from PphaC1). 
 
The most commonly used plasmids for transformation in C. necator H16 are the 
medium-copy-number mobilisable plasmids pBBR1MCS and its derivatives 
(Kovach et al., 1994). In order to develop a highly stable plasmid expression 
system in C. necator H16, new plasmids derived from either pBBR1, RSF1010, 
RP4 and pSa have to be constructed, where pBBR1 plasmids have exhibited the 
less plasmid loss (Srinivasan et al., 2003; Voss et al., 2006). For this reason, 
pBBR1MCS-1 was used as plasmid backbone for the construction of the synthetic 
biology toolbox, as it is important to maintain a high rate of plasmid stability, as 
the decrease in productivity is often related to plasmid instability due to the lack 
of recombinant high-level protein expression (Voss et al., 2006).  
 
The versatility of the promoter systems must be considered as well, as this will 
expand the range of regulated expression; promoters derived from bacteriophage 
T5, such as Pj5, have been characterised as one of the strongest constitutive 
promoters in C. necator H16 (Gruber et al., 2014), other native constitutive 
promoters derived from PHB biosynthesis (PphaC), pyruvate metabolism (PpdhE), 
and acetoin metabolism (PacoD, PacoX, PacoE) have been used for expression studies 
in C. necator H16, but these promoters showed comparatively weak activity 
(Delamarre et al., 2006). For inducible systems, Bi et al. (2013) demonstrated that 
the PBAD and Pxyls/PM inducible promoters provided the highest red fluorescence 
protein (rfp) expression upon induction in C. necator H16, hence, the promoters 
chosen for the synthetic biology toolbox constructed in this chapter were the Pj5 
and PBAD promoters for constitutive and inducible protein expression respectively.  
 
On the other hand, the inclusion of other biological parts to improve further 
protein expression have been reported and considered to be included in our 
synthetic toolbox; Bi et al. (2013) demonstrated that the insertion of a T7 stem-
loop structure upstream the RBS and downstream the promoter, resulted in an 
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increase in RFP expression by approximately 2-fold compared to an identical 
plasmid without the T7 stem-loop biological part.  
 
Regarding the RBS studied to date for C. necator H16, the results obtained by Bi 
et al. (2013) from three different RBS sites tested were that the E. coli consensus 
RBS sequence was the one that showed the highest RFP expression, followed by 
the computationally automated RBS; the RBS that showed the weakest RFP 
expression was a native RBS sequence from C. necator H16 (nrdD RBS). 
 
The systems created by Bi et al. (2013) were used to produce hydrocarbon in C. 
necator H16, where results showed that the promoter with the highest 
hydrocarbon titres was the PBAD promoter. On the other hand, the same plasmid 
with the PBAD promoter was constructed with and without the T7 5’ mRNA stem-
loop structure, and both plasmids showed similar production titres; the E. coli 
consensus RBS achieved the highest hydrocarbon titres, as it had been observed in 
RFP expression.  
 
Based on this studies performed previously in C. necator H16, the construction of 
a synthetic biology toolbox was the second step in the investigation of this PhD, 
since this would serve to expand the metabolic capabilities of C. necator H16. 
The optimised transformation method by electroporation developed in the 
laboratory was used to transfer the plasmids to C. necator H16.  
 
 
2.2 Aim  
 
The aims of Chapter 2 are: 
 
Ø To optimise a transformation method by electroporation for C. necator 
H16. 
Ø To construct a synthetic biology toolbox with inducible and constitutive 
promoters and other synthetic biology parts for metabolic engineering 
applications. 
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2.3 Materials and methods 
 
 
2.3.1 Materials 
 
List of detailed information on the materials used (reagents, kits, equipment, 
software, media preparation and miscellaneous) can be found in Appendix 1 - 6. 
 
 
2.3.2 Strains, plasmids and primers 
 
All strains, plasmids and primers that were used in this Chapter 2 are shown in 
Table 2.1. 
 
Table 2.1 Strains, plasmids and primers used in this study. 
Strains, plasmids or 
primers 
Description References or 
source 
Strains   
E. coli DH5a Standard cloning strain Lab collection 
C. necator H16 Wild-type Genr DSM 428 
Plasmid backbones  
pBHR1 Broad-host-range plasmid, Camr, Kanr, pBBR1 
Rep, pBBR1oriV, mob 
MoBiTec GmbH, 
Germany 
pBBR1MCS-1 Broad-host-range plasmid, Camr, pBBR1 Rep, 
pBBR1oriV, mob 
Kovach et al., 
1994 
pBbA8k-RFP Kanr, araC, PBAD, RBS, rfp Lee et al., 2011 
pEGFP Ampr, Plac, egfp Clontech 
Plasmids constructed  
pBADk.rbs-RFP Kanr, pBBR1 Rep, pBBR1 oriV, mob, araC, 
PBAD, RBS, rfp  
This work 
pBADc.rbs-RFP Camr, pBBR1 Rep, pBBR1 oriV, mob, araC, 
PBAD, RBS, rfp 
This work 
pPj5c.T7rbs-RFP Camr, pBBR1 Rep, pBBR1 oriV, mob, Pj5, T7 5’ 
mRNA stem-loop, RBS, rfp  
This work 
pPj5c.T7rbs-eGFP Camr, pBBR1 Rep, pBBR1 oriV, mob, Pj5, T7 5’ 
mRNA stem-loop, RBS, egfp 
This work 
Primers (5’ à 3’)   
AvrII-pBBR1MCS1 GATCCCTAGGGAAGACGAAAGGGCCTCG
TGATACG 
This work 
pBBR1MCS1-SacI GATCGAGCTCAAATTGTAAGCGTTAATAT
TTTGTTAAAATTCGCGTTAAATTTTTG 
This work 
AvrII-Cam-pBBR1 GATCCCTAGGATTGTTATCCGCTCACAAT
TCCACACAACATAC 
This work 
pBBR1MCS1-PstI GATCCTGCAGAAATTGTAAGCGTTAATAT
TTTGTTAAAATTCGCGTTAAATTTTTG 
This work 
T7-RBS-RFP-fwd GAATTCAAAAGATCTGGGAGACCACAA This work 
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CGGTTTCCCTCTAGAAATAATTTTGGA
ATTCAAAAGATCTTTTAAGAAGGAGATA
TACATATGGCGAGTAGCGAAGACGT 
Pj5-T7-fwd GATCCTGCAGAGCGGATATAAAAACCG
TTATTGACACAGGTGGAAATTTAGAAT
ATACTGTTAGTAAACCTAATGGATCGA
CCTTGAATTCAAAAGATCTGGGAGACC 
This work 
RFP-rev GATCCTCGAGTTAAGCACCGGTGGAGTG
ACGACCT 
This work 
NdeI-eGFP-fwd GATCCATATGGTGAGCAAGGGCGAGGAG This work 
eGFP-XhoI-rev GATCCTCGAGTTACTTGTACAGCTCGTCC
ATGCCG 
This work 
All the RBS noted in all the plasmids in the list correspond to the sequence encoding for the E. 
coli consensus RBS. Nucleotide sequences highlighted in purple encode for T7 5’ mRNA stem-
loop, nucleotide sequences in blue encode for E. coli consensus RBS, and the nucleotide sequence 
highlighted in orange encodes for the Pj5 promoter. Restriction enzyme sequences of primers are 
underlined. Abbreviations: Genr, gentamicin resistance; Camr, chloramphenicol resistance; Kanr, 
kanamycin resistance; Ampr, ampicillin resistance; RBS, ribosome binding site; rfp; red 
fluorescence protein gene; egfp, enhanced green fluorescence protein.  
 
 
2.3.3 Cultivation of E. coli DH5a and C. necator H16 
 
E. coli DH5a cells were cultivated at 37 ºC on 2x YT medium and 250 rpm, and 
when required with chloramphenicol [25 µg/mL] or kanamycin [50 µg/mL] 
according to the application, the strain was used for all molecular cloning, 
plasmid propagation, and maintenance. C. necator H16 cells were cultivated at 30 
ºC using nutrient broth (NB) and 250 rpm always supplemented with gentamicin 
[10 µg/mL] and when needed with chloramphenicol [25 µg/mL] or kanamycin 
[250 µg/mL]. The optical density was measured at 600 nm with a BioPhotometer.  
 
 
2.3.4 Bacterial transformation of E. coli DH5a and C. necator H16 
 
E. coli DH5a cells were transformed using a standard chemical transformation 
method. E. coli DH5a was used for circularization and propagation of ligation 
mixtures of all plasmids constructed. C. necator H16 cells were transformed by 
the electroporation method optimised in our laboratory group.  
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2.3.4.1 Transformation using CaCl2 heat-shock method for E. coli DH5a 
 
A pre-culture of E. coli DH5a  was cultivated in 5 mL of 2x YT for 16 h at 37 ºC; 
for competent cell preparation, a fresh 2x YT falcon tube was inoculated with the 
pre-culture at a 1:100 dilution and cultivated at 37 ºC, when cells reached an 
optical density at 600 nm (OD600) of 0.5, 1 mL of cells were transferred to a sterile 
1.5 mL microcentrifuge tube. Cells were centrifuged at maximum speed (17,000 x 
g) for 30 s, and the supernatant was removed by pipetting. The pellet was washed 
once with 500 µL of pre-chilled 50 mM CaCl2. Then, the cell pellet was 
resuspended carefully in 500 µL of pre-chilled 50 mM CaCl2 and incubated in ice 
for 30 min (for transforming intact plasmid, a 10 min incubation was sufficient). 
Plasmid DNA was added to a concentration of 1 µg or 5 µL of ligation mixture 
and mixed gently. A second 30 min incubation step was performed after the 
addition of the plasmid (for transforming intact plasmid, a 10 min incubation was 
sufficient). After the second incubation, the cells were heat-shocked at 42 ºC for 1 
min and further incubated in ice for 2 min. After heat shock and ice incubation 
time, 800 µL of 2x YT was added, and cells were left to grow for a 1 h outgrowth 
at 37 ºC. After the outgrowth, cells were centrifuged at maximum speed for 30 s 
and most of the media removed, the remaining 200 – 300 µL media was used to 
resuspend the cells gently before plating them on TYE agar plates with the 
required antibiotic, and incubated overnight at 37 ºC. 
 
 
2.3.4.2 Transformation by electroporation method for C. necator H16 
 
Unless specified otherwise, the following transformation by electroporation 
method was used. A pre-culture of C. necator H16 was cultivated in 5 mL of NB 
with gentamicin for 40 – 44 h at 30 ºC; for electrocompetent cell preparation, a 
fresh NB supplemented with gentamicin falcon tube was inoculated with the pre-
culture at a 1:50 dilution and cultivated at 30 ºC, when cells reached an OD600 of 
0.5 – 0.7, cells were transferred to ice and chilled for 5 min. Two millilitres of the 
cells were then transferred to a sterile 2 mL microcentrifuge tube. Cells were 
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centrifuged at maximum speed (17,000 x g) for 30 s, and the supernatant was 
removed by pipetting followed by three cell washes. For experiments with 
chemical treatment (100 mM EDTA or 20 mM MgCl2) the pellet was first washed 
once by resuspending cells in 1 mL of the chemical and incubated for 30 min in 
ice. Then, the cell pellet was washed twice by resuspension in 1 mL of pre-chilled 
transformation buffer (10 % (v/v) Glycerol or 0.3 M Sucrose), after the last 
washing step, the supernatant was removed by pipetting. When chemical 
treatments were not used, the first cell wash was replaced by resuspending the cell 
pellet with the transformation buffer instead of the chemical agent. After the final 
wash, the cell pellet was resuspended in 100 µL of pre-chilled transformation 
buffer. Plasmid DNA was added to a concentration of 0.5 µg to the resuspended 
cells and mixed gently. The resuspension was then transferred into a pre-chilled 2 
mm electroporation cuvette and electroporated at 2.5 kV. After electroporation, 1 
mL of NB was added immediately directly to the electroporation cuvette, then, 
cells were transferred to a new 2 mL microcentrifuge tube for a 2 h outgrowth at 
30 ºC. After the outgrowth, cells were centrifuged at maximum speed for 30 s, 
and 950 µL of the supernatant was removed to resuspend all cells in the remaining 
150 µL supernatant. Then, cells were plated in NB with gentamicin and 
chloramphenicol agar plates and incubated at 30 ºC for 40 – 48 h (Adapted from 
Tee et al., 2017). 
 
 
2.3.5 DNA preparation  
 
Standard procedures were used for isolation of plasmids, restriction enzyme 
digestions, polymerase chain reaction (PCR) with Pfu Turbo and Ultra DNA 
polymerase, DpnI digestions, DNA gel extraction, PCR purification, and T4 DNA 
ligation (Sambrook et al., 2011) and recommendations by the manufacturers. All 
primers were synthesised by Eurofins Genomics. 
 
Chapter 2. Recombinant strain engineering:  
Development of a transformation method and a synthetic  
biology toolbox for metabolic engineering in Cupriavidus necator H16 
 69 
 
2.3.6 DNA Gel electrophoresis 
 
An agarose gel electrophoresis was prepared to analyse DNA; 0.7 % or 1.0 % 
(w/v) agarose gels were prepared in 1x TBE buffer (prepared from a 5x TBE 
buffer composed of 54.0 g of Tris base, 27.5 g of Boric acid, and 20 mL of 0.5 M 
EDTA per 1 L, pH 8.3) by dissolving 0.35 g or 0.50 g of agarose respectively in 
50 mL buffer. The percentage of gel used was dependent on the purpose of the 
gel, if only an analysis of the DNA was required, then 1.0 % (w/v) gels were used, 
but if gel extraction was required, then 0.7 % (w/v) agarose gels were used to 
excise the DNA band from the gel. To ensure that the agarose is fully dissolved in 
the buffer, the solution was microwaved until all the agarose was dissolved, then, 
when the gel had cooled down, 2 µL of ethidium bromide was added and the gel 
was cast using a gel caster, then the comb was inserted and the gel was left to 
room temperature until it solidified. 6 µL of DNA Ladder 1 kb and appropriate 
volume of DNA samples were loaded into the gel. The electrophoresis was run at 
a constant voltage of 100 V for 60 min. The gel image was captured with a gel 
documentation system. 
 
 
2.3.7 Plasmid construction 
 
All plasmid constructed in this Chapter 2 were based on the plasmid backbones 
pBBR1MCS-1 and pBbA8k-RFP plasmids for the construction of the synthetic 
biology toolbox. The plasmid backbones are illustrated in Figure 2.4 and Figure 
2.5 respectively. The chloramphenicol resistance (Camr) cassette (containing Pcat 
and Camr), pBBR1 Rep, pBBR1 oriV origin of replication, and mob gene were 
amplified from pBBR1MCS-1; the rfp gene, E. coli consensus RBS, L-arabinose-
inducible system (containing araC and PBAD), and the kanamycin resistance (Kanr) 
cassette (containing PNEOKAN and Kanr) were amplified from pBbA8k-RFP; and 
the egfp gene was amplified from pEGFP. The primers and in silico analyses of 
plasmid construction were generated using the SnapGene software tool. Correct 
construction of all plasmids was confirmed by restriction enzyme analysis (ReA). 
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2.3.7.1 Construction of plasmid pBADk.rbs-RFP 
 
pBADk.rbs-RFP was constructed by amplifying the mob gene, pBBR1 oriV, and 
pBBR1 Rep from pBBR1MCS-1 plasmid with AvrII-pBBR1MCS1 (forward 
primer) and pBBR1MCS1-SacI (reverse primer) primers. Subsequently, the 
amplified fragment was subjected to DpnI digestion, PCR purification and 
restriction enzyme digestion with AvrII and SacI, followed by a further PCR 
purification for ligation with T4 DNA ligase with the AvrII and SacI digested and 
gel extracted fragment containing Kanr cassette, the L-arabinose-inducible system 
(araC and PBAD), E. coli consensus RBS, and rfp gene from pBbA8k-RFP; 
resulting in the 6.3 kb plasmid pBADk.rbs-RFP. After transformation of E. coli 
DH5a, a single colony of the resulting plasmid pBADk.rbs-RFP was isolated and 
analysed by restriction enzyme analysis to confirm the right inserts before it was 
transformed into C. necator H16 by electroporation. 
 
 
2.3.7.2 Construction of plasmid pBADc.rbs-RFP 
 
pBADc.rbs-RFP was constructed by amplifying the Camr cassette, mob gene, 
pBBR1 oriV, and pBBR1 Rep from pBBR1MCS-1 plasmid with AvrII-Cam-
pBBR1 (forward primer) and pBBR1MCS1-PstI (reverse primer) primers. 
Subsequently, the amplified fragment was subjected to DpnI digestion, PCR 
purification and restriction enzyme digestion with AvrII and PstI, followed by a 
further PCR purification for ligation with T4 DNA ligase with the AvrII and PstI 
digested and gel extracted fragment containing the L-arabinose-inducible system 
(araC and PBAD), E. coli consensus RBS, and rfp gene from pBbA8k-RFP; 
resulting in the 6.7 kb plasmid pBADc.rbs-RFP. After transformation of E. coli 
DH5a, a single colony of the resulting plasmid pBADc.rbs-RFP was isolated and 
analysed by restriction enzyme analysis to confirm the right inserts before it was 
transformed into C. necator H16 by electroporation. 
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2.3.7.3 Construction of plasmid pPj5c.T7rbs-RFP 
 
pPj5c.T7rbs-RFP was constructed by amplifying the rfp gene from pBbA8k-RFP 
plasmid with T7-RBS-RFP-fwd (forward primer) and RFP-rev (reverse primer) 
primers; the T7 stem-loop and E. coli consensus RBS sequences were contained 
within the T7-RBS-RFP-fwd (forward primer), resulting in an amplified fragment 
with a T7 stem-loop and E. coli consensus RBS upstream the rfp gene amplified 
from pBbA8k-RFP. Subsequently, the amplified fragment was subjected to DpnI 
digestion and PCR purification before a second PCR reaction was carried out with 
Pj5-T7-fwd (forward primer) and RFP-rev (reverse primer) primers to insert the 
Pj5 promoter sequence upstream the T7 stem-loop. This fragment was then 
subjected to restriction enzyme digestion with PstI and XhoI, followed by a 
further PCR purification for ligation with T4 DNA ligase with PstI and XhoI 
digested and gel extracted fragment containing the Camr cassette, mob gene, 
pBBR1 oriV origin of replication and pBBR1 Rep from pBADc.rbs-RFP; 
resulting in the 5.3 kb plasmid pPj5c.T7rbs-RFP plasmid. After transformation of 
E. coli DH5a, a single colony of the resulting plasmid pPj5c.T7rbs-RFP was 
isolated and analysed by restriction enzyme analysis to confirm the right inserts 
before it was transformed into C. necator H16 by electroporation. 
 
 
2.3.7.4 Construction of plasmid pPj5c.T7rbs-eGFP 
 
pPj5c.T7rbs-eGFP was constructed by amplifying the egfp gene from pEGFP 
plasmid with NdeI-eGFP-fwd (forward primer) and eGFP-XhoI-rev (reverse 
primer) primers. Subsequently, the amplified fragment was subjected to DpnI 
digestion, PCR purification and restriction enzyme digestion with NdeI and XhoI, 
followed by a further PCR purification for ligation with T4 DNA ligase with the 
NdeI and XhoI digested and gel extracted fragment containing the Camr cassette, 
mob gene, pBBR1 oriV origin of replication, pBBR1 Rep, Pj5 promoter, T7 stem-
loop, and E. coli consensus RBS from pPj5c.T7rbs-RFP; resulting in the 5.3 kb 
plasmid pPj5c.T7rbs-eGFP. After transformation of E. coli DH5a, a single colony 
of the resulting plasmid pPj5c.T7rbs-eGFP was isolated and analysed by 
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restriction enzyme analysis to confirm the right inserts before it was transformed 
into C. necator H16 by electroporation. 
 
  
2.4 Results and discussion  
 
 
2.4.1 Optimisation of C. necator H16 transformation by electroporation 
 
One of the first experiments performed during the PhD was a collaboration with 
the laboratory group for the optimisation of the transformation by electroporation 
method for C. necator H16. Electroporation is a physical method of cell 
transformation that applies an electric field to the cell membrane of cells, which 
aids to open pores in the cell wall that permits the entry of external DNA or other 
molecules (RNA, proteins, etc.), where the electroporator generates an 
electromagnetic field in the cell solution. The advantages of electroporation are 
that it is not limited by plasmid size and that the DNA uptake is immediate as the 
electroporation does not require incubation. 
 
In order to optimise this method, common factors responsible for the 
transformation efficiency by electroporation were studied, such as the choice of 
chemical agents and electroporation buffers, which are responsible for the 
increase in cell wall permeability. Other factors considered as well were heat-
shock treatment and different gap sizes of electroporation cuvettes. 
 
In this part of the study, C. necator H16 cells were cultivated in NB and 
transformants were selected on NB agar plates with gentamicin, and when 
required with chloramphenicol at 30 ºC. Plasmids used in this work were the 
broad-host-range mobilisable plasmids pBBR1MCS-1 (4.7 kb), pBHR1 (5.3 kb) 
and pBADc.rbs-RFP (6.7 kb). A negative control sample ((-)ve) using cells of C. 
necator H16 washed with 10 % (v/v) glycerol transformation buffer was always 
included in all parameters studied to check for any contamination that could occur 
during the process and interfere with the analysis of data. The transformation 
method followed for this (-)ve control sample was the same as described in 
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Section 2.3.4.2, with the only difference in that no plasmid was added for these 
samples. 
 
 
2.4.1.1 Electroporation cuvettes: 1 mm and 2 mm 
 
In the early steps of the optimisation for transforming C. necator H16 by 
electroporation, 10 % (v/v) glycerol was used as standard transformation buffer to 
make C. necator H16 cells competent. This buffer was initially used as a constant 
in the optimisation process. Then the first parameter analysed was the gap size of 
the electroporation cuvettes.  
 
Two different gap size cuvettes can be used for the electroporation step in 
transformation by electroporation for bacteria, the 1 mm cuvette and the 2 mm 
cuvette. Electroporation cuvettes (Figure 2.1) have aluminium electrodes and are 
available in three different sizes of gap widths of 1 mm (for up to 100 µL 
volume), 2 mm (for up to 400 µL volume), and 4 mm (for up to 800 µL volume). 
Usually, 1 mm cuvettes are used for electroporation of bacteria, 2 mm cuvettes are 
used for electroporation of yeast, and 4 mm cuvettes for electroporation of 
mammalian cells, although 2 mm cuvettes have been used for bacteria 
electroporation as well. The gap size is the distance between the electrodes, and it 
is one of the first optimisations to be considered for electroporation experiments, 
as the gap size is used for the determination of the field strength (kV) by the 
formula of voltage divided by gap size (mm) (Dower et al., 1988). Hence, the 1 
mm cuvette is used for the highest field strength, the 2 mm cuvette is for 
intermediate requirements, and the 4 mm cuvette has the lowest field strength. 
Generally, the voltage used for 1 mm cuvettes is around 1.7 kV, while the voltage 
used for 2 mm cuvettes is around 2.5 kV. 
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Figure 2.1 Electroporator cuvette components. Gap sizes can be 1 mm, 2 mm or 4 mm. 
 
The method followed for transformation by electroporation for C. necator H16 to 
study the effects of using different gap sizes is described in Section 2.3.4.2, 
whereby 10 % (v/v) glycerol was used as transformation buffer for the three cells 
washes as no chemical treatment was performed. Plasmid DNA (pBBR1MCS-1) 
was added to a concentration of 0.5 µg and cells were electroporated at 1.7 kV 
when 1 mm cuvettes were used and at 2.5 kV when 2 mm cuvettes were used. 
After the 2 h outgrowth, all cells were plated in NB agar plates supplemented with 
gentamicin and chloramphenicol and incubated at 30 ºC for 40 – 48 h. The results 
of these experiments are shown in Table 2.2 and Figure 2.2. 
 
Table 2.2 Parameter studied for transformation by electroporation: Gap size of electroporation 
cuvettes. 
  Transformation efficiency 
Cell density at start of transformation  
OD600 0.676  
DNA used  
pBBR1MCS-1 0.5 µg  
Other information  
Electroporation cuvette 1 mm, 2 mm  
Colony count 10 % (v/v) Gly  
 1 mm: 78 colonies 1.56 x 102 transformants/µg DNA 
 2 mm: 697 colonies 1.39 x 103 transformants/µg DNA 
Abbreviations: Gly, glycerol. 
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Figure 2.2 Transformation by electroporation in C. necator H16 with pBBR1MCS-1 using 1 mm 
and 2 mm electroporation cuvettes. 
 
From this first parameter studied, it was clear that the 2 mm gap electroporation 
cuvette provided the best transformation efficiency, this might be due to the 1 mm 
gap electroporator cuvette that provided a higher field strength, killed a higher 
population of cells during electroporation, while the 2 mm gap electroporation 
cuvette provided and intermediate field strength allowing a higher number of cells 
to survive after electroporation. From this point onwards, only 2 mm 
electroporation cuvettes were used for the analysis of the rest of the experiments 
as they provided a higher transformation efficiency. 
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2.4.1.2 Physical treatment: Electroporation and heat shock 
 
Another experiment was designed in order to improve the transformation 
efficiency based on the principle used for bacterial transformation of the CaCl2 
heat shock method. The principle behind the transformation by CaCl2 heat shock 
method is that the cells are manipulated with positively charged calcium ions (a 
divalent cation, Ca2+) followed by a temperature imbalance that helps to uptake 
the plasmid DNA. It has been reported that the naked plasmid DNA is bound to 
the lipopolysaccharide (LPS) receptor molecules of the bacterial cell wall, then 
the divalent cations of calcium chloride bind both to the negatively charged LPS 
in the bacterial cell wall and the negatively charged plasmid DNA; after the CaCl2 
treatment, is the heat-shock step that ferries the plasmid DNA into the bacterial 
cell due to pores are formed in the cell membrane once cells are chilled in ice after 
being heated at 42 ºC for a short time. The heat shock at 42 ºC depolarises the cell 
wall of the already chemically treated competent cells lowering its negativity 
potential, and the subsequent cold shock makes the cell membrane to raise its 
membrane potential and recover its original value. Hence, this experiment was 
designed to observe the effect of the heat shock treatment and observe if this 
could improve further the cell wall permeability and therefore increase the 
transformation efficiency.  
 
The transformation by electroporation method followed for this part of the study 
is described in Section 2.3.4.2, whereby 10 % (v/v) glycerol was used as 
transformation buffer for the three cell washes and as no chemical treatment was 
performed. Plasmid DNA (pBADc.rbs-RFP and pBHR1) was added to a 
concentration of 0.5 µg, after adding the plasmid DNA, cells were incubated for 
10 min in ice, followed by heat shock at 42 ºC for 1 min and a further incubation 
in ice for 2 min, then cells were electroporated at 2.5 kV in 2 mm cuvettes. After 
the 2 h outgrowth, all cells were plated in NB agar plates supplemented with 
gentamicin and chloramphenicol and incubated at 30 ºC for 40 – 48 h. The results 
of these experiments are shown in Table 2.3. 
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Table 2.3 Parameter studied for transformation by electroporation: Physical treatment with heat 
shock. 
  Transformation efficiency 
Cell density at start of transformation  
OD600 0.604  
DNA used  
pBADc.rbs-RFP 0.5 µg  
pBHR1 0.5 µg  
Other information  
Electroporation cuvette 2 mm  
Colony count 10 % (v/v) Gly   
 pBADc.rbs-RFP: 658 colonies 1.32 x 103 transformants/µg DNA 
 pBHR1: 5 colonies 1.00 x 101 transformants/µg DNA 
 Heat shock & 10 % (v/v) Gly  
 pBADc.rbs-RFP: 3 colonies 6.00 x 100 transformants/µg DNA 
 pBHR1: 1 colony 2.00 x 100 transformants/µg DNA 
 Abbreviations: Gly, glycerol. 
 
 
This strategy yielded very few transformants after heat shock and electroporation 
treatment, this might be due to bacteria are not stable when they have a large 
number of pores on the cell wall, and this might lead to death easily; therefore, it 
is possible that the application of the two physical methods to the cells surpassed 
the limit of destabilisation that cells can stand and that could have lead to a 
decrease in cell’s viability. 
 
 
2.4.1.3 Chemical treatment: 100 mM EDTA 
 
It has been reported that Ethylenediaminetetraacetic acid (EDTA) chemical 
treatment helps to increase the permeability of the cell membrane of gram-
negative bacteria, where presumably, the external cell membrane loses its barrier 
function in relation to DNA after the EDTA treatment; it was also reported that 
EDTA treatment without a subsequent electric treatment was not successful in E. 
coli strains (Cymbalyuk et al., 1988). Considering what has been reported in 
literature, the design of this experiment was performed using EDTA as a chemical 
treatment for cell-weakening in combination with electroporation, using 10 % 
(v/v) glycerol and 0.3 M sucrose as transformation buffers. 
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The transformation by electroporation method followed for this part of the study 
is described in Section 2.3.4.2, whereby the chemical treatment was performed 
with 1 mL of 100 mM EDTA and an incubation of 30 min in ice in the first cell 
wash. Then, the cell pellet was washed twice by resuspension in 1 mL of pre-
chilled transformation buffer of 10 % (v/v) glycerol or 0.3 M sucrose. Plasmid 
DNA (pBADc.rbs-RFP and pBHR1) was added to a concentration of 0.5 µg, and 
cells were electroporated at 2.5 kV in 2 mm electroporation cuvettes. After the 2 h 
outgrowth, all cells were plated in NB agar plates supplemented with gentamicin 
and chloramphenicol and incubated at 30 ºC for 40 – 48 h. The results of the 
experiments are shown in Table 2.4. 
 
 
Table 2.4 Parameter studied for transformation by electroporation: Chemical treatment with 100 
mM EDTA. 
  Transformation efficiency 
Cell density at start of transformation  
OD600   
DNA used  
pBADc.rbs-RFP 0.5 µg  
pBHR1 0.5 µg  
Other information  
Electroporation cuvette 2 mm  
Colony count 10 % (v/v) Gly   
 pBADc.rbs-RFP:  467 colonies 9.34 x 102 transformants/µg DNA 
 pBHR1: 9 colonies 1.80 x 101 transformants/µg DNA 
 100 mM EDTA & 10 % (v/v) Gly 
 pBADc.rbs-RFP: 3 colonies 6.00 x 100 transformants/µg DNA 
 pBHR1: 0 colonies 0 transformants/µg DNA 
 100 mM EDTA & 0.3 M Suc   
 pBADc.rbs-RFP: 1 colony 2.00 x 100 transformants/µg DNA 
 pBHR1: 2 colonies 4.00 x 100 transformants/µg DNA 
Abbreviations: Gly, glycerol; EDTA, ethylenediaminetetraacetic acid; Suc, sucrose. 
 
 
The treatment with EDTA not only did not improve transformation efficiency but 
it decreased the transformation efficiency significantly compared to the one 
obtained when only 10 % (v/v) glycerol was used as transformation buffer for 
pBADc.rbs-RFP. The same low transformation efficiency values were obtained 
when EDTA was used in combination with 0.3 M sucrose as transformation 
buffer. Even though it has been reported in literature that EDTA improved 
transformation efficiency in E. coli strains, it is well known that the 
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transformation efficiency can be different among different microorganims, as they 
have different cell membrane structures. 
 
 
2.4.1.4 Chemical treatment: 20 mM MgCl2 
 
Other chemicals have been reported to improve transformation efficiency, such as 
combinations of calcium and magnesium (Taketo, 1974: Wensink et al., 1974) at 
prolonged incubations in ice (reviewed in Asif et al., 2017). In general, all 
divalent cation such as Ca2+ and Mg2+ enhance the transformation process. It has 
been reported that magnesium increases the transformation efficiency in bacteria 
by 15 to 20-fold compared with transformations performed with no magnesium 
treatment (Hanahan, 1983), where incubation of 30 min in ice enhanced further 
bacterial transformation (reviwed in Asif et al., 2017). 
 
The transformation by electroporation method followed for this part of the study 
is described in Section 2.3.4.2, whereby the chemical treatment was performed 
with 1 mL of 20 mM MgCl2 and an incubation of 30 min in ice in the first cell 
wash. Then, the cell pellet was washed twice by resuspension in 1 mL of pre-
chilled transformation buffer of 0.3 M sucrose. Plasmid DNA (pBADc.rbs-RFP 
and pBHR1) was added to a concentration of 0.5 µg, and cells were electroporated 
at 2.5 kV in 2 mm electroporation cuvettes. After the 2 h outgrowth, all cells were 
plated in NB agar plates supplemented with gentamicin and chloramphenicol and 
incubated at 30 ºC for 40 – 48 h. The results of these experiments are shown in 
Table 2.5. 
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Table 2.5 Parameter studied for transformation by electroporation: Chemical treatment with 20 
mM MgCl2. 
  Transformation efficiency 
Cell density at start of transformation  
OD600   
DNA used  
pBADc.rbs-RFP 0.5 µg  
pBHR1 0.5 µg  
Other information  
Electroporation cuvette 2 mm  
Colony count 10 % (v/v) Gly   
 pBADc.rbs-RFP: 751 colonies 1.50 x 103 transformants/µg DNA 
 pBHR1: 12 colonies 2.40 x 101 transformants/µg DNA 
 20 mM MgCl2 & 0.3 M Suc   
 pBADc.rbs-RFP: 683 colonies 1.37 x 103 transformants/µg DNA 
 pBHR1: 380 colonies 7.60 x 102 transformants/µg DNA 
Abbreviations: Gly, glycerol; MgCl2, magnesium chloride; Suc, sucrose. 
 
Although these results did not show an enhancement in transformation efficiency 
with the pBADc.rbs-RFP plasmid compared to only using 10 % (v/v) glycerol as 
transformation buffer, it did show an improvement of transformation efficiency 
with the pBBHR1 plasmid compared to previous results obtained with all 
different buffers and chemicals studied before. From this point onwards, the 
investigation of the transformation buffer of 0.3 M sucrose was focused on testing 
whether the enhancement in transformation efficiency for pBHR1 transformation 
was due to MgCl2 chemical treatment or due to the use of 0.3 M sucrose as 
transformation buffer, or if it was required to combine both to achieve this 
transformation efficiency. 
 
 
2.4.1.5 Transformation buffer: 0.3 M sucrose 
 
In order to have high efficient electroporation, a medium with low conductivity 
has to be used, for this end, cell washes are essential in electroporation as they 
remove the ions present in the growth media (Dower et al., 1998). Some of the 
most common transformation buffers used in microorganisms are double-distilled 
water, 10 % (v/v) glycerol, 0.3 M sucrose, 10 % (w/v) fructose, and 0.3 M 
glucose. The first one was used in the first set of experiments, and the second one 
had been used in combination with chemical treatments before this section. 
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In this section, the study of combining the transformation buffer 0.3 M sucrose 
with 10 % (v/v) glycerol was also investigated (a single buffer solution containing 
both glycerol and sucrose transformation buffers was prepared). The 
transformation by electroporation method followed for this investigation is 
described in Section 2.3.4.2, whereby the only difference is that the buffers of 0.3 
M sucrose or 10 % (v/v) glycerol and 0.3 M sucrose were used as transformation 
buffers for the three cell washing steps. Plasmid DNA (pBADc.rbs-RFP and 
pBHR1) was added to a concentration of 0.5 µg and cells were electroporated at 
2.5 kV in 2 mm electroporation cuvettes. After the 2 h outgrowth, all cells were 
plated in NB agar plates supplemented with gentamicin and chloramphenicol and 
incubated at 30 ºC for 40 – 48 h. The results of these experiments are shown in 
Table 2.6. 
 
 
Table 2.6 Parameter studied for transformation by electroporation: Transformation buffer 0.3 M 
sucrose. 
  Transformation efficiency 
Cell density at start of transformation  
OD600 0.631  
DNA used  
pBADc.rbs-RFP 0.5 µg  
pBHR1 0.5 µg  
Other information  
Electroporation cuvette 2 mm  
Colony count 10 % (v/v) Gly   
 pBADc.rbs-RFP: 483 colonies 9.66 x 102 transformants/µg DNA 
 pBHR1: 10 colonies 2.00 x 101 transformants/µg DNA 
 0.3 M Suc  
 pBADc.rbs-RFP: 1796 3.59 x 103 transformants/µg DNA 
 pBHR1: 240 colonies 4.80 x 102 transformants/µg DNA 
 10 % (v/v) Gly & 0.3 M Suc   
 pBADc.rbs-RFP: 2 colonies 4.00 x 100 transformants/µg DNA 
 pBHR1: 1 colony 2.00 x 100 transformants/µg DNA 
Abbreviations: Gly, glycerol; Suc, sucrose. 
 
The buffer 0.3 M sucrose showed the best transformation efficiency obtained for 
both plasmids, and the combination of sucrose with glycerol transformation 
buffers resulted in poorer transformation efficiency for both plasmids 
transformed, so at this point of the investigation, the 0.3 M sucrose buffer showed 
the highest transformation efficiency. 
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2.4.1.6 Other chemical and transformation buffers studied 
 
The results of the parameters shown and discussed in the previous sections 
developed in the first stages of my PhD served as a basis to plan further 
experiments that were performed by other members of our laboratory group to 
fine-tune and finalise the optimisation of the transformation method by 
electroporation for C. necator H16, which can be found more detailed in Tee et 
al., 2017. These studies were performed with the pBHR1 plasmid. Figure 2.3 
shows the replicates of the control samples (C. necator H16 electroporation using 
10 % (v/v) glycerol as transformation buffer) from all the parameters studied, 
which show the reproducibility of the transformation by electroporation method 
when using 10 % (v/v) glycerol as transformation buffer. 
 
 
 
Figure 2.3 Replicates of control samples included in each study of transformation by 
electroporation for C. necator H16. A) Control sample harbouring pBADc.rbs-RFP plasmid. B) 
Control sample harbouring pBHR1 plasmid. Error bars are ± SEM of four independent 
determinations. 
 
From all the parameters studied, the experiment that used 0.3 M sucrose as a 
transformation buffer resulted with the highest transformation efficiency, hence, 
further experiments were performed in the laboratory to find the optimal sucrose 
concentration, which was tested from 0.1 to 0.6 M sucrose, where 0.2 M sucrose 
resulted in the optimum concentration with the highest transformation efficiency. 
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Additionally, different chemical treatments were analysed, 50 mM CaCl2, and 
TSS buffer, which showed to improve further transformation efficiency. Once the 
optimum transformation buffer -0.2 M sucrose- and the optimum chemical 
treatment -50 mM CaCl2- were set, further investigations were performed to 
investigate the time dependency of 50 mM CaCl2. Chemical treatments with 50 
mM CaCl2 ranged from 0 to 60 min, where it was found that the highest 
transformation efficiency was obtained after 15 min incubation, with a 5-fold 
increase in transformation efficiency compared to the sample without chemical 
treatment. 
 
The optimum electroporation voltage was also investigated; voltages from 2.1 to 
2.5 kV were tested, being 2.3 kV (11.5 kV/cm) the one that showed the highest 
transformation efficiency for 2 mm cuvettes. Also, different DNA concentrations 
were investigated, and very similar transformation efficiencies were obtained with 
DNA concentrations ranging from 0.25 to 1.00 µg DNA. 
 
Hence, the final optimised method for an efficient transformation by 
electroporation for C. necator H16 consisted on cultivate cells in NB to an OD600 
of 0.6, followed by the chemical treatment with 50 mM CaCl2 for 15 min in ice 
and two further cell washes with 0.2 M sucrose before the cells were 
electroporated with 2.3 kV in 2 mm cuvettes, where a maximum transformation 
efficiency of 3.86 x 105 transformants/µg DNA was achieved. 
 
The main advantage of optimising this protocol is that it represents a tool for 
constructing recombinant strains is a shorter time, as the transformation can be 
accomplished only after 40 h, while transformation by bacterial conjugation 
requires from 4 to 5 days to be achieved. 
 
 
2.4.2 Synthetic biology toolbox construction 
 
As mentioned in Section 2.1.2, the design of the synthetic biology toolbox was 
based on previous synthetic biology parts reported to function efficiently in C. 
necator H16, where four plasmids were constructed pursuing to develop 
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metabolic capabilities in future experiments; the plasmids were transferred to C. 
necator H16 using the transformation by electroporation method optimised in our 
laboratory. 
 
All plasmid designs were based on the premise that C. necator H16 has shown 
preference and replicability with broad-host-range plasmids, being pBBR1 
derived plasmids one of the plasmids most commonly used for C. necator H16. 
The pBBR1MCS-1 (4.7 kb) plasmid (Figure 2.4) was chosen as a plasmid 
backbone to create a synthetic toolbox for C. necator H16, as it has proven to be 
replicable in the strain due to its pBBR1 oriV origin of replication (Gruber et al., 
2014), as the origin of replication has to be compatible with the replication 
machinery of the host cell to be able to regulate gene expression (Li et al., 2015). 
 
 
 
Figure 2.4 Illustration of pBBR1MCS-1 map (4.7 kb). The plasmid encodes for pBBR1 Rep, 
pBBR1 oriV origin of replication, mob gene (mob) for plasmid mobilisation, CAT promoter, and 
chloramphenicol resistance (CamR). 
 
The promoters chosen for the versatile construction of plasmids for C. necator 
H16 were the inducible promoter PBAD, which relies on the induction with L-
arabinose; and the constitutive promoter Pj5. The inducible PBAD promoter was 
cloned from the pBbA8k-RFP plasmid (3.9 kb) (Figure 2.5), this plasmid was not 
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used directly for gene expression in C. necator H16 due to it is a narrow range 
plasmid (Lee et al., 2011). The constitutive promoter was constructed by two 
subsequent PCR amplifications with the Pj5 sequence contained within the 
primers. For this part of the study, RFP and enhanced green fluorescent protein 
(eGFP) proteins were used as fluorescence protein reporters to be expressed in the 
different constructed plasmids systems in C. necator H16 to demonstrate the 
successful replicability of all the plasmids constructed. 
 
 
 
Figure 2.5 Illustration of pBbA8k-RFP map (3.9 kb). The plasmid encodes for the NEOKAN 
promoter, kanamycin resistance (KanR), araC and PBAD promoter, and rfp protein. 
 
 
The structure of the synthetic toolbox of the four plasmids constructed 
(pBADk.rbs-RFP, pBADc.rbs-RFP, pPj5c.T7rbs-RFP, and pPj5c.T7rbs-eGFP) 
with the different biological parts considered for the versatility of the toolbox –
promoters, 5’ mRNA stem-loop, RBS, terminators- is shown in Figure 2.6, where 
two different antibiotic resistance markers (chloramphenicol and kanamycin) and 
fluorescence reporters (RFP and eGFP) were included in the synthetic toolbox. 
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Figure 2.6 Synthetic biology toolbox for C. necator H16 for inducible and constitutive protein 
expression. All plasmids constructed harbour the pBBR1 oriV origin of replication, the pBBR1 
Rep and mob genes. 
 
2.4.2.1 Construction of inducible synthetic biology toolbox for protein 
expression 
 
The construction of the arabinose-inducible pBADk.rbs-RFP plasmid was 
successfully achieved with the amplification of the pBBR1 Rep, pBBR1 oriV and 
mob gene from pBBR1MCS-1, which was inserted into the AvrII and SacI sites of 
pBbA8k-RFP harbouring the Kanr cassette, L-arabinose-inducible system (araC 
and PBAD), E. coli consensus RBS, and rfp gene. The RBS included in the 
synthetic biology toolbox was the E. coli consensus RBS taken from the digested 
pBbA8k-RFP plasmid, due to this synthetic RBS has been reported to provide the 
highest expression of RFP in C. necator H16 (Bi et al., 2013). 
 
The PCR amplified fragment harbouring the pBBR1 Rep, pBBR1 oriV and mob 
gene from pBBR1MCS-1 was analysed to confirm the size of the insert, which 
was a 3.3 kb DNA band as expected (Figure 2.7A). Then, once the construction 
of the pBADk.rbs-RFP plasmid was successfully ligated and transformed into E. 
coli DH5a, a restriction enzyme analysis (ReA) was performed, where DNA 
bands of 3.3 kb and 3.0 kb confirmed the right sizes expected for the digested 
pBADk.rbs-RFP plasmid (Figure 2.7B). After E. coli DH5a transformation, 
protein expression of RFP with 0.1 % (w/v) L-arabinose at the early log phase 
was performed (Figure 2.7C). Then, the constructed plasmid was isolated from E. 
coli DH5a and used to transform C. necator H16 cells, followed by the induction 
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with 0.1 % (w/v) L-arabinose at the early log phase for RFP protein expression 
(Figure 2.7D), where the cell pellets of both cultures from L-arabinose-induced 
expression in E. coli DH5a and C. necator H16 were indeed red. 
 
 
 
Figure 2.7 Analysis of the construction and RFP protein expression of pBADk.rbs-RFP in E. coli 
DH5a and C. necator H16. A) Analysis of the PCR amplified insert from pBBR1MCS-1, B) 
Restriction enzyme analysis (ReA) with AvrII and SacI of the constructed pBADk.rbs-RFP, C) E. 
coli DH5a RFP protein expression after induction with 0.1 % (w/v) L-arabinose, left tube sample 
(-)ve control corresponds to a non-induced sample, right tube sample corresponds to an induced 
sample. D) C. necator H16 RFP protein expression after induction with 0.1 % (w/v) L-arabinose, 
left tube sample (-)ve control corresponds to a non-induced sample, right tube sample corresponds 
to an induced sample. Abbreviations: (-)ve, negative control; ReA, Restriction enzyme analysis. 
 
 
On the other hand, the construction of the other arabinose-inducible pBADc.rbs-
RFP system with a chloramphenicol resistance cassette was successfully achieved 
as well with the amplification of the pBBR1 Rep, pBBR1 oriV, mob gene, and 
Camr cassette from pBBR1MCS-1, which was inserted into the AvrII and PstI 
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sites of pBbA8k-RFP harbouring the L-arabinose-inducible system (araC and 
PBAD), E. coli consensus RBS, and rfp gene.  
 
The PCR amplified fragment harbouring the pBBR1 Rep, pBBR1 oriV, mob 
gene, and Camr cassette from pBBR1MCS-1 was analysed to confirm the size of 
the insert, which was a 4.3 kb DNA band as expected (Figure 2.8A). Then, once 
the construction of the pBADc.rbs-RFP plasmid was successfully ligated and 
transformed into E. coli DH5a, a restriction enzyme analysis (ReA) was 
performed, where DNA bands of 4.3 kb and 2.4 kb confirmed the right sizes 
expected for the digested pBADc.rbs-RFP plasmid (Figure 2.8B). After E. coli 
DH5a transformation, protein expression of RFP with 0.1 % (w/v) L-arabinose at 
the early log phase was performed (Figure 2.8C). Then, the constructed plasmid 
was isolated from E. coli DH5a and used to transform C. necator H16 cells, 
followed by the induction with 0.1 % (w/v) L-arabinose at early log phase for 
RFP protein expression (Figure 2.8D), where the cell pellets of both cultures 
from L-arabinose-induced expression in E. coli DH5a and C. necator H16 were 
indeed red. 
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Figure 2.8 Analysis of the construction and RFP protein expression of pBADc.rbs-RFP in E. coli 
DH5a and C. necator H16. A) Analysis of the PCR amplified insert from pBBR1MCS-1, B) 
Restriction enzyme analysis (ReA) with AvrII and PstI of the constructed pBADc.rbs-RFP, C) E. 
coli DH5a RFP protein expression after induction with 0.1 % (w/v) L-arabinose, left tube sample 
(-)ve control corresponds to a non-induced sample, right tube sample corresponds to an induced 
sample. D) C. necator H16 RFP protein expression after induction with 0.1 % (w/v) L-arabinose, 
left tube sample (-)ve control corresponds to a non-induced sample, right tube sample corresponds 
to an induced sample. Abbreviations: (-)ve, negative control; ReA, Restriction enzyme analysis. 
 
Both successful RFP expressions in E. coli DH5a and in C. necator H16 for the 
inducible synthetic biology toolbox constructed demonstrated that 1) the plasmids 
harboured the insert RFP, 2) that the transformation method optimised for C. 
necator H16 described in this Chapter 2 allowed high transformation efficiencies 
with all plasmids transformed with transformation efficiencies higher than 1 x 105 
transformants/µg of DNA, and that 3) the PBAD promoter is compatible with C. 
necator H16 for protein expression. 
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2.4.2.2 Construction of constitutive synthetic biology toolbox for protein 
expression  
 
For the construction of the synthetic biology toolbox for constitutive expression of 
proteins, the synthetic biology part T7 5’ mRNA stem-loop structure was inserted 
upstream of the RBS for the rfp gene in both plasmids designed in order to 
increase further the RFP expression, as this biological part has been reported to 
enhance mRNA stability in C. necator H16 (Bi et al. 2013). The RBS included in 
this synthetic biology toolbox was the E. coli consensus RBS sequence as well, 
due to as mentioned before, this RBS has been reported to provide the highest 
expression of RFP in C. necator H16 (Bi et al., 2013). 
 
The construction of the constitutive pPj5c.T7rbs-RFP plasmid was successfully 
achieved with the restriction enzyme digestion (ReD) of the pBADc.rbs-RFP 
plasmid previously constructed harbouring the pBBR1 Rep, pBBR1 oriV, mob 
gene, and Camr cassette; and from the insertion of the PCR amplified rfp gene 
from pBbA8k-RFP. The first PCR that amplified the rfp gene from pBbA8k-RFP 
was used to insert as well the E. coli consensus RBS and the T7 stem-loop 
sequences, which DNA sequences were contained within the T7-RBS-RFP-fwd 
primer, subsequently, after the purification of the first amplicon, a second round 
of PCR was carried out to insert the Pj5 promoter sequence, which DNA sequence 
was contained within the Pj5-T7-fwd primer. The amplicon harbouring the Pj5, T7 
stem-loop, E. coli consensus RBS, and the rfp gene was analysed in a gel to 
confirm its right size, which was a 0.9 kb DNA band as expected (Figure 2.9A). 
Then, once the construction of the pPj5c.T7rbs-RFP plasmid was successfully 
ligated and transformed into E. coli DH5a, a PCR amplification of the insert 
within the newly constructed plasmid was performed, as this short insert (0.9 kb) 
was not visible in the gel after restriction enzyme analysis (ReA); also a ReA was 
performed to confirm the 4.5 kb DNA band corresponding to the vector of the 
constructed pPj5c.T7rbs-RFP plasmid (Figure 2.9B). After E. coli DH5a 
transformation, constitutive protein expression of RFP was performed (Figure 
2.9C). Then, the constructed plasmid was isolated from E. coli DH5a and used to 
transform C. necator H16 cells, followed by the constitutive RFP protein 
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expression (Figure 2.9D), where the cell pellets of both cultures in E. coli DH5a 
and C. necator H16 were indeed red. 
 
 
 
Figure 2.9 Analysis of the construction and RFP protein expression of pPj5c.T7rbs-RFP in E. coli 
DH5a and C. necator H16. A) Analysis of the PCR amplified insert from pBbA8k-RFP, B) PCR of 
the amplified insert from pPj5c.T7rbs-RFP and restriction enzyme analysis (ReA) with PstI and 
XhoI of the constructed pPj5c.T7rbs-RFP, C) E. coli DH5a constitutive RFP protein expression. 
D) C. necator H16 constitutive RFP protein expression. Abbreviations: ReA, Restriction enzyme 
analysis. 
 
 
Then, the construction of the other constitutive pPj5c.T7rbs-eGFP plasmid with 
chloramphenicol resistance as well was successfully achieved using the 
previously constructed plasmid pPj5c.T7rbs-RFP as plasmid backbone, which 
was digested with NdeI and XhoI to replace the rfp gene for the egfp gene from 
pEGP plasmid. Thus, the pPj5c.T7rbs-eGFP is a constitutive system that harbours 
a Pj5 promoter, T7 stem-loop, and E. coli consensus RBS. 
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The amplicon harbouring the Pj5, T7 stem-loop, E. coli consensus RBS, and the 
egfp gene was analysed in a gel to confirm its right size, which was a 0.9 kb DNA 
band as expected (Figure 2.10A). Then, once the construction of the pPj5c.T7rbs-
eGFP plasmid was successfully ligated and transformed into E. coli DH5a, a PCR 
amplification of the insert within the newly constructed plasmid was performed, 
as this short insert (0.9 kb) was not visible in the gel after restriction enzyme 
analysis (ReA) as observed previously with the insert of pPj5c.T7rbs-RFP; also a 
ReA was performed to confirm the 4.6 kb DNA band corresponding to the vector 
of the constructed pPj5c.T7rbs-eGFP plasmid (Figure 2.10B). After E. coli DH5a 
transformation, constitutive protein expression of eGFP was performed (Figure 
2.10C). Then, the constructed plasmid was isolated from E. coli DH5a and used 
to transform C. necator H16 cells, followed by the constitutive eGFP protein 
expression (Figure 2.10D), where the cell pellets of both cultures in E. coli DH5a 
and C. necator H16 were indeed green. 
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Figure 2.10 Analysis of the construction and eGFP protein expression of pPj5c.T7rbs-eGFP in E. 
coli DH5a and C. necator H16. A) Analysis of the PCR amplified insert from pPj5c.T7rbs-RFP, 
B) PCR of the amplified insert from pPj5c.T7rbs-eGFP and restriction enzyme analysis (ReA) 
with NdeI and XhoI of the constructed pPj5c.T7rbs-eGFP, C) E. coli DH5a constitutive eGFP 
protein expression. D) C. necator H16 constitutive eGFP protein expression. Abbreviations: ReA, 
Restriction enzyme analysis. 
 
 
Both successful RFP and eGFP expressions in E. coli DH5a and in C. necator 
H16 for the constitutive synthetic biology toolbox constructed demonstrated that 
1) the plasmids harboured the RFP and eGFP inserts, and 2) that the 
transformation method optimised for C. necator H16 described in this Chapter 2 
allowed high transformation efficiencies with all plasmids transformed with 
transformation efficiencies higher than 1 x 105 transformants/µg of DNA. 
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2.5 Conclusions 
 
A contribution to optimise the transformation method of C. necator H16 by 
electroporation was developed in this part of the study. The final optimised 
method consisted of a chemical treatment (50 mM CaCl2), the use of an efficient 
transformation buffer (0.2 M sucrose) and an intermediate electric field strength 
(11.5 kV/cm), which were key factors in the process, where a transformation 
efficiency higher than 1 x 105 transformants/µg of DNA was achieved. The 
development of this method was used to efficiently transform C. necator H16 
with the versatile synthetic biology toolbox reported in this Chapter 2. The 
optimisation of the transformation method for C. necator H16 represents a 
significant milestone for genetic manipulation, which would help to develop 
metabolic engineering strategies. 
 
The synthetic biology toolbox is a potential system for metabolic engineering 
applications in C. necator H16, as metabolic engineering and synthetic biology 
usually focus on a narrow set of microbial host, such as E. coli and 
Saccharomyces cerevisiae, due to the ease of genetic manipulation and the 
heterologous gene expression tools already available for these microorganisms, 
although these strains might have limitations for diverse industrial applications. C. 
necator H16 is a microbial host with both metabolic capabilities and growth 
conditions that are promising for industrial applications as it is a microorganism 
that can function as a chemolithoautotroph, therefore the construction of the 
synthetic toolbox explicitly created for C. necator H16 is required for chemical 
production.  
 
In this study, plasmids with two different promoters were successfully 
transformed by electroporation in C. necator H16, with inducible and constitutive 
systems that have responded to the expression of RFP and eGFP as models 
proteins. The design of both systems will be useful for metabolic engineering 
approaches. 
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Abstract 
 
 
In Chapter 3, the synthetic biology toolbox with the inducible system previously 
constructed in this work was used to test the heterologous expression of two 
clusters of genes in Cupriavidus necator H16. The cluster of genes encoded for 
extended biotin operons from Desulfovibrio vulgaris (four genes) and 
Desulfovibrio desulfuricans (five genes) respectively. The function of the genes of 
the extended biotin operons remains unknown to date, although it is believed that 
these genes could be related to pimelic acid synthesis. The extended biotin 
operons were expressed in E. coli BW25113, E. coli BW25113 DbioC, and in C. 
necator H16. The protein expression after the induction of the PBAD promoter 
showed the target proteins of most of the genes of the extended biotin operons of 
Desulfovibrio spp. in the SDS-PAGE in all host cells, although there was no full 
evidence that all the four and five genes of the extended biotin operons had been 
expressed simultaneously, and hence the function of these genes could not be 
determined.  
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3 Chapter 3. Metabolic engineering: Applicability of the synthetic biology 
toolbox by the expression of heterologous extended biotin operons in 
Cupriavidus necator H16 
 
 
3.1 Introduction 
 
The applicability of the synthetic biology toolbox described in Chapter 2 
was tested for metabolic engineering in C. necator H16 for the expression of a 
cluster of genes corresponding to extended biotin operons of Desulfovibrio 
vulgaris and Desulfovibrio desulfuricans. As mentioned in Section 1.5.7 and 
1.5.7.4, an interesting bioproduct that could be produced in C. necator H16 is 
pimelic acid, which at the same time can be used to overproduce biotin in 
microorganisms, as it is an important precursor compound for biotin biosynthesis. 
The importance of applying metabolic engineering to microbial strains for 
overproduction of pimelic acid is because natural pimelate biosynthesis is low in 
wild-type strains, as biotin is required at very low concentrations in 
microorganisms. 
 
The synthesis of biotin is widely conserved among microorganisms, and as 
mentioned in Section 1.5.7.3, it can be divided into two stages: 1) the synthesis of 
the pimelic acid moiety, which carbon atoms serve for biotin biosynthesis, and 2) 
the assembly of the bicyclic ring of biotin. The genes for the second stage of the 
biotin biosynthesis are encoded in the bioFADB operon in many microorganisms, 
while the first stage usually varies among different species, although 
microorganisms such as E. coli, and Bacillus spp., among other bacteria, have 
shown to use BioC and BioH, or BioX and BioI to synthesise the pimelate moiety 
(Figure 1.8).  
 
As mentioned in Section 1.5.7.4, Rodionov et al. (2004) studied the regulatory 
and genetic factors in pathways that are involved in the biosynthesis of cofactors 
of the metal-reducing genera in the d subgroup of proteobacteria, and they found 
that Desulfovibrio vulgaris (DV) and Desulfovibrio desulfuricans (DD) had an 
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extended biotin operon within the standard bioFADB with four and five new 
genes (respectively), and no bioC, bioH or similar genes were found in their biotin 
operon, while the rest of the d-proteobacteria showed to have the standard 
bioFADB for the ring assembly of biotin and also bioC and bioH, bioW or bioC 
and bioG pairs known for its function for pimelic acid synthesis (Figure 1.10 and 
Figure 1.11). This fact suggested that the new genes found within the bioFADB 
biotin operon of Desulfovibrio spp could be related to pimelic acid production. 
Among the genes found within the bioFADB operon of DV and DD, there are 
homologs of acyl carrier protein (ACP), 3-oxoacyl-ACP synthase, 3-oxoacyl-ACP 
reductase and hydroxymyristol-ACP dehydratase (Table 3.1). Due to the four 
(DV) and five (DD) new genes of the extended biotin operon might be related 
with the fatty-acid biosynthesis, this suggests that they could have similar 
functions as the bioC and bioH genes in E. coli, which are the genes that provide 
the means to use fatty acid synthesis for the assembly of pimelate.  
 
 
Table 3.1 New genes found within the bioFADB operon of Desulfovibrio vulgaris and 
Desulfovibrio desulfuricans. 
Genes Locus tag  
(Old locus tag) 
Original annotationa Position 
Desulfovibrio vulgaris (DV)  
birA DVU2557 birA bifunctional protein 2668667..2669659 
bioB DVU2558 biotin synthase 2669895..2670827 
bioA DVU2559 adenosylmethionine-8-amino-7-
oxononanoate transaminase 
2670824..2672452 
DV1 DVU2560 3-hydroxyacyl-[acyl carrier protein] 
dehydratase 
2672449..2672835 
DV2 DVU2561 3-oxoacyl-[acyl carrier protein] reductase 2672832..2673860 
DV3 DVU2562 acyl carrier protein 2673960..2674367 
DV4 DVU2563 3-oxoacyl-[acyl carrier protein] synthase 
II  
2674645..2676093 
bioF DVU2564 8-amino-7-oxononanoate synthase 2676659..2677933 
bioD DVU2565 dethiobiotin synthetase 2677915..2678655 
Desulfovibrio desulfuricans (DD)  
birA DDE_RS12230 
(Dde_2654) 
bifunctional protein 2667956..2668987 
bioB DDE_RS12235 
(Dde_2655) 
biotin synthase 2669096..2670070 
bioA DDE_RS12240 
(Dde_2656) 
adenosylmethionine-8-amino-7-
oxononanoate aminotransferase 
2670067..2671446 
DD1 DDE_RS17745 
(Dde_2657) 
3-hydroxyacyl-ACP dehydratase 2671439..2671894 
DD2 DDE_RS12250 
(Dde_2658) 
short-chain dehydrogenase/reductase SDR 
(3-oxoacyl-[acyl-carrier protein] 
reductase) 
2671885..2672640 
DD3 DDE_RS12255 phosphopantetheine-binding protein 2672655..2673077 
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(Dde_2659) 
DD4 DDE_RS12260 
(Dde_2660) 
3-ketoacyl-ACP synthase 2673067..2674377 
DD5 DDE_RS12265 
(Dde_2661) 
hypothetical protein 2674374..2674883 
bioF DDE_RS12270 
(Dde_2662) 
8-amino-7-oxononanoate synthase 2674865..2676022 
bioD DDE_RS12275 
(Dde_2663) 
dethiobiotin synthase 2676019..2676735 
DV1, DV2, DV3, and DV4 correspond to the four new genes found within the bioFADB biotin 
operon of Desulfovibrio vulgaris (DV); DD1, DD2, DD3, DD4 and DD5 correspond to the five 
new genes found within the bioFADB biotin operon of Desulfovibrio desulfuricans (DD). Data of 
locus tag and original annotation was obtained from KEGG. 
 
 
In order to explore the genes of unknown function of the extended biotin operons 
of DV and DD, the first stages of the experiments in this chapter were designed to 
express the extended biotin operons initially in E. coli BW25113 and nutrient-rich 
media to corroborate the expression of all the genes found within the biotin 
operons, then, the second stage was designed to express the extended biotin 
operons in an E. coli BW25113 DbioC strain -a mutant deficient in bioC 
synthesis, thus, the mutant strain is not capable of growing in media where biotin 
is not supplemented- in biotin-free media, this would verify if the extended biotin 
operons of DV and DD had a similar function to the bioC or bioH genes and were 
effectively related or not with pimelic acid synthesis. Moreover, if the extended 
biotin operons resulted to be related with pimelic acid biosynthesis, these could be 
transformed into C. necator H16 and be used for pimelate production.  
 
The use of a single promoter for the expression of the extended biotin operon 
from DV and DD was based on the premise that in prokaryotic cells, proteins with 
related functions are usually clustered in an operon and are transcribed together 
with a single promoter, where the regulation of the transcription of all the genes 
that encode for proteins that catalyse a single biochemical pathway are controlled 
all at once, due to the cluster of genes are all required, or none of them needed.  
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3.2 Aim  
 
The aim of this Chapter 3 is:  
 
Ø To demonstrate the applicability of the synthetic biology toolbox 
constructed in Chapter 2 with the expression of operons driven by a 
single strong promoter (inducible promoter PBAD) in C. necator H16, 
operons that could encode for a modified pathway committed to pimelate 
production. 
 
 
3.3 Materials and methods 
 
 
3.3.1 Materials 
 
List of detailed information on the materials used (reagents, kits, equipment, 
software, media preparation and miscellaneous) can be found in Appendix 1 – 7.  
 
3.3.2 Strains, plasmids, and primers 
 
All strains, plasmids and primers that were used in this Chapter 3 are shown in 
Table 3.2. The four genes of the extended biotin operon of DV are indicated as 
bioDV1-4, and the five genes of the extended biotin operon of DD are indicated as 
bioDD1-5 in all the experiments and data shown in this Chapter 3. 
 
 
Table 3.2 Strains, plasmids, and primers used in this study. 
Strains, plasmids or 
primers 
Description References or 
source 
Strains   
E. coli BW25113 Wild-type Kanr Datsenko et al., 
2000  
E. coli BW25113 DbioC Kanr, mutant deficient in bioC synthesis  Lab collection 
E. coli DH5a Standard cloning strain Lab collection 
C. necator H16 Wild-type Genr DSM 428 
Plasmid backbones  
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pBADc.rbs-RFP Camr, pBBR1 Rep, pBBR1 oriV, mob, araC, 
PBAD, RBS, rfp 
This work 
pUC57-bioDV1-4 Plasmid carrying the bioDV1-4 biotin 
synthetic operon codon optimised for E. coli 
BW25113 with four genes and restriction 
enzymes between the genes: NdeI and SpeI 
for DV1; SpeI and SacI for DV2; SacI and 
ClaI for DV3, and ClaI and BamHI and XhoI 
for DV4. 
GenScript 
pUC57-bioDD1-5 Plasmid carrying the bioDD1-5 biotin 
synthetic operon codon optimised for E. coli 
BW25113 with five genes and restriction 
enzymes between the genes: NdeI and SpeI 
for DD1; SpeI and SacI for DD2; SacI and 
ClaI for DD3, and ClaI and SalI for DD4, 
SalI and BamHI and XhoI for DD5. 
GenScript 
Plasmids constructed  
pBADc.rbs-bioC Camr, pBBR1 Rep, pBBR1 oriV, mob, araC, 
PBAD, RBS, bioC 
This work 
pBADc.rbs-bioDV1-4 Camr, pBBR1 Rep, pBBR1 oriV, mob, araC, 
PBAD, RBS, bioDV1-4 biotin operon 
This work 
pBADc.rbs-bioDD1-5 Camr, pBBR1 Rep, pBBR1 oriV, mob, araC, 
PBAD, RBS, bioDD1-5 biotin operon 
This work 
Primers (5’ à 3’)   
bioC-fwd GATCCATATGGCAACGGTTAATAAACA
AGCCATTG 
This work 
bioC-rev GATCCTCGAGTAACGTTTACTCACGAG
CAATCACTC 
This work 
All the RBS noted in all the plasmids in the list correspond to the sequence encoding for the E. 
coli consensus RBS. DV1, DV2, DV3, and DV4 correspond to the new genes found within the 
bioFADB extended biotin operon of Desulfovibrio vulgaris (DV); DD1, DD2, DD3, DD4 and 
DD5 correspond to the new genes found within the bioFADB extended biotin operon of 
Desulfovibrio desulfuricans (DD). Restriction enzyme sequences of primers are underlined. 
Abbreviations: Kanr, kanamycin resistance; Genr, gentamicin resistance; Camr, chloramphenicol 
resistance; RBS, ribosome binding site; rfp; red fluorescence protein gene. 
 
 
3.3.3 Cultivation of E. coli DH5a, E. coli BW25113, E. coli BW25113 DbioC, 
and C. necator H16 
 
E. coli DH5a cells were cultivated at 37 ºC on 2x YT medium and 250 rpm, and 
when required with chloramphenicol [25 µg/mL] according to the application, the 
strain was used for all molecular cloning, plasmid propagation, and maintenance. 
E. coli BW25113 and E. coli BW25113 DbioC cells were cultivated at 37 ºC on 
2x YT medium, M9 minimal biotin-free medium, or M9 minimal medium 
supplemented with biotin at 250 rpm and with kanamycin [50 µg/mL] and when 
needed with chloramphenicol [25 µg/mL] according to the application. The E. coli 
BW25113 DbioC was used for complementation studies. C. necator H16 cells 
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were cultivated at 30 ºC using nutrient broth (NB) and 250 rpm always 
supplemented with gentamicin [10 µg/mL] and when needed with 
chloramphenicol [25 µg/mL]. The optical density was measured at 600 nm with a 
BioPhotometer.  
 
 
3.3.4 Bacterial transformation of E. coli DH5a and C. necator H16 
 
E. coli DH5a cells were transformed using a standard chemical transformation 
method. E. coli DH5a was used for circularization and propagation of ligation 
mixtures of all plasmids constructed. C. necator H16 cells were transformed by 
the electroporation method optimised in our laboratory group and described in 
Chapter 2. 
 
 
3.3.4.1 Transformation using CaCl2 heat-shock method for E. coli DH5a 
 
A pre-culture of E. coli DH5a  was cultivated in 5 mL of 2x YT for 16 h at 37 ºC; 
for competent cell preparation, a fresh 2x YT falcon tube was inoculated with the 
pre-culture at a 1:100 dilution and cultivated at 37 ºC, when cells reached an 
optical density at 600 nm (OD600) of 0.5, 1 mL of cells were transferred to a sterile 
1.5 mL microcentrifuge tube. Cells were centrifuged at maximum speed (17,000 x 
g) for 30 s, and the supernatant was removed by pipetting. The pellet was washed 
once with 500 µL of pre-chilled 50 mM CaCl2. Then, the cell pellet was 
resuspended carefully in 500 µL of pre-chilled 50 mM CaCl2 and incubated in ice 
for 30 min (for transforming intact plasmid, a 10 min incubation was sufficient). 
Plasmid DNA was added to a concentration of 1 µg or 5 µL of ligation mixture 
and mixed gently. A second 30 min incubation step was performed after the 
addition of the plasmid (for transforming intact plasmid, a 10 min incubation was 
sufficient). After the second incubation, the cells were heat-shocked at 42 ºC for 1 
min and further incubated in ice for 2 min. After heat shock and ice incubation 
time, 800 µL of 2x YT was added, and cells were left to grow for a 1 h outgrowth 
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at 37 ºC. After the outgrowth, cells were centrifuged at maximum speed for 30 s 
and most of the media removed, the remaining 200 – 300 µL media was used to 
resuspend the cells gently before plating them on TYE agar plates with the 
required antibiotic, and incubated overnight at 37 ºC. 
 
 
3.3.4.2 Transformation by electroporation method for C. necator H16 
 
A pre-culture of C. necator H16 was cultivated in 5 mL of NB with gentamicin 
for 40 – 44 h at 30 ºC; for electrocompetent cell preparation, a fresh NB 
supplemented with gentamicin falcon tube was inoculated with the pre-culture at a 
1:50 dilution and cultivated at 30 ºC, when cells reached an OD600 of 0.5 – 0.7, 
cells were transferred to ice and chilled for 5 min. Two millilitres of the cells were 
then transferred to a sterile 2 mL microcentrifuge tube. Cells were centrifuged at 
maximum speed (17,000 x g) for 30 s and the supernatant was removed. Then, the 
cell pellet was washed once with 1 mL of pre-chilled 50 mM CaCl2 and incubated 
for 15 min in ice. Then the cell pellet was centrifuged at maximum speed for 30 s 
followed by two washes by resuspension in 1 mL of pre-chilled 0.2 M Sucrose. 
After the final wash, the cell pellet was resuspended in 100 µL of pre-chilled 0.2 
M Sucrose. Plasmid DNA was added to a concentration of 0.5 µg to the 
resuspended cells and mixed gently. The resuspension was then transferred into a 
pre-chilled 2 mm electroporation cuvette and electroporated at 2.3 kV. After 
electroporation, 1 mL of NB was added immediately directly to the 
electroporation cuvette, then, cells were transferred to a new 2 mL 
microcentrifuge tube for a 2 h outgrowth at 30 ºC. After the outgrowth, typically 
about 10 % (v/v) cells were plated in NB with gentamicin and chloramphenicol 
agar plates and incubated at 30 ºC for 40 – 48 h. 
 
 
3.3.5 DNA preparation 
 
Standard procedures were used for genomic DNA isolation, isolation of plasmids, 
restriction enzyme digestions, polymerase chain reaction (PCR) with Q5 DNA 
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polymerase, DpnI digestions, DNA gel extraction, PCR purification, and T4 DNA 
ligation (Sambrook et al., 2011) and recommendations by the manufacturers. All 
primers were synthesised by Eurofins Genomics, bioDV1-4 and bioDD1-5 
extended biotin operons were synthesised by GenScript (Piscataway, USA). 
 
 
3.3.6 DNA Gel electrophoresis 
 
An agarose gel electrophoresis was prepared to analyse DNA; 0.7 % or 1.0 % 
(w/v) agarose gels were prepared in 1x TBE buffer (prepared from a 5x TBE 
buffer composed of 54.0 g of Tris base, 27.5 g of Boric acid, and 20 mL of 0.5 M 
EDTA per 1 L, pH 8.3) by dissolving 0.35 g or 0.50 g of agarose respectively in 
50 mL buffer. The percentage of gel used was dependent on the purpose of the 
gel, if only an analysis of the DNA was required, then 1.0 % (w/v) gels were used, 
but if gel extraction was required, then 0.7 % (w/v) agarose gels were used to 
excise the DNA band from the gel. To ensure that the agarose is fully dissolved in 
the buffer, the solution was microwaved until all the agarose was dissolved, then, 
when the gel had cooled down, 2 µL of ethidium bromide was added and the gel 
was cast using a gel caster, then the comb was inserted and the gel was left to 
room temperature until it solidified. 6 µL of DNA Ladder 1 kb and appropriate 
volume of DNA samples were loaded into the gel. The electrophoresis was run at 
a constant voltage of 100 V for 60 min. The gel image was captured with a gel 
documentation system. 
 
 
3.3.7 Plasmid construction 
 
 
All plasmid constructed in this Chapter 3 were based on the plasmid backbone 
pBADc.rbs-RFP plasmid from the synthetic biology toolbox described in 
Chapter 2 and illustrated in Figure 3.1. The pBADc.rbs-RFP plasmid was 
digested with NdeI and XhoI to harbour the pBBR1 Rep, pBBR1 oriV origin of 
replication, mob gene, chloramphenicol resistance (Camr) cassette (containing Pcat 
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and Camr), L-arabinose-inducible system (containing araC and PBAD), and E. coli 
consensus RBS; the rfp gene was replaced with either bioC, bioDV1-4 extended 
biotin operon or bioDD1-5 extended biotin operon. The synthetic codon optimised 
bioDV1-4 and bioDD1-5 extended biotin operons DNA sequences for E. coli 
BW25113 can be found in Appendix 7. The primers and in silico analyses of 
plasmid construction were generated using the SnapGene software tool. Correct 
construction of all plasmids was confirmed by restriction enzyme analysis (ReA). 
 
 
3.3.7.1 Construction of plasmid pBADc.rbs-bioC 
 
pBADc.rbs-bioC was constructed by first extracting total genomic DNA from E. 
coli BW25113, where the bioC gene was amplified from genomic DNA by PCR 
with bioC-fwd (forward primer) and bioC-rev (reverse primer) primers. 
Subsequently, the amplified fragment was subjected to DpnI digestion, PCR 
purification and restriction enzyme digestion with NdeI and XhoI, followed by a 
further PCR purification for ligation with T4 DNA ligase with the NdeI and XhoI 
digested and gel extracted fragment containing the pBBR1 Rep, pBBR1 oriV 
origin of replication, mob gene, Camr cassette, L-arabinose-inducible system 
(containing araC and PBAD), and E. coli consensus RBS from pBADc.rbs-RFP 
resulting in the 6.8 kb plasmid pBADc.rbs-bioC. After transformation of E. coli 
DH5a, a single colony of the resulting plasmid pBADc.rbs-bioC was isolated and 
analysed by restriction enzyme analysis to confirm the right inserts before it was 
transformed into E. coli BW25113, E. coli BW25113 DbioC and C. necator H16. 
 
 
3.3.7.2 Construction of plasmid pBADc.rbs-bioDV1-4 
 
The synthetic bioDV1-4 extended biotin operon was synthesised by GenScript, 
where the entire operon (bioDV1-4) harboured the four new genes from the 
extended biotin operon of DV, the genes were codon optimised for E. coli 
BW25113 and specific restriction enzymes and spacers were inserted in between 
the genes. pBADc.rbs-bioDV1-4 was constructed by digesting with NdeI and 
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XhoI the bioDV1-4 operon from the pUC57-bioDV1-4 plasmid (plasmid obtained 
from GenScript). The digested bioDV1-4 operon was then used for ligation with 
T4 DNA ligase with the NdeI and XhoI digested and gel extracted fragment 
containing the pBBR1 Rep, pBBR1 oriV origin of replication, mob gene, Camr 
cassette, L-arabinose-inducible system (containing araC and PBAD), and E. coli 
consensus RBS from pBADc.rbs-RFP; resulting in the 9.5 kb plasmid 
pBADc.rbs-bioDV1-4. After transformation of E. coli DH5a, a single colony of 
the resulting plasmid pBADc.rbs-bioDV1-4 was isolated and analysed by 
restriction enzyme analysis to confirm the right inserts before it was transformed 
into E. coli BW25113, E. coli BW25113 DbioC and C. necator H16. 
 
 
3.3.7.3 Construction of plasmid pBADc.rbs-bioDD1-5 
 
The synthetic bioDD1-5 extended biotin operon was synthesised by GenScript, 
where the entire operon (bioDD1-5) harboured the five new genes from the 
extended biotin operon DD, the genes were codon optimised for E. coli BW25113 
and specific restriction enzymes and spacers were inserted in between the genes. 
pBADc.rbs-bioDD1-5 was constructed by digesting with NdeI and XhoI the 
bioDD1-5 operon from the pUC57-bioDD1-5 plasmid (plasmid obtained from 
GenScript). The digested bioDD1-5 operon was then used for ligation with T4 
DNA ligase with the NdeI and XhoI digested and gel extracted fragment 
containing the pBBR1 Rep, pBBR1 oriV origin of replication, mob gene, Camr 
cassette, L-arabinose-inducible system (containing araC and PBAD), and E. coli 
consensus RBS from pBADc.rbs-RFP; resulting in the 9.7 kb plasmid 
pBADc.rbs-bioDD1-5. After transformation of E. coli DH5a, a single colony of 
the resulting plasmid pBADc.rbs-bioDD1-5 was isolated and analysed by 
restriction enzyme analysis to confirm the right inserts before it was transformed 
into E. coli BW25113, E. coli BW25113 DbioC and C. necator H16. 
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3.3.8 Depletion of biotin for corroboration of E. coli BW25113 DbioC 
phenotype 
 
For depletion of biotin to corroborate the E. coli BW25113 DbioC phenotype, a 
pre-culture of the cells was cultivated in 5 mL of 2x YT for 16 h at 37 ºC, for 
depletion of biotin present in the spent media and biotin within the cells, a fresh 5 
mL 2x YT falcon tube was inoculated with the pre-culture at a 1:100 dilution and 
cultivated at 37 ºC, when cells reached an OD600 of 0.8, 1 mL of cells was 
transferred to a sterile 1.5 mL tube. Cells were centrifuged at 2,800 rpm for 2 min, 
and the supernatant was removed by pipetting. The pellet was washed thrice with 
500 µL of M9 biotin-free medium. Then, the cell pellet was resuspended carefully 
in 150 µL of M9 biotin-free medium and inoculated at a 1:100 dilution in a fresh 
falcon tube with 5 mL of 1) M9 biotin-free medium or 2) M9 supplemented with 
biotin and grown for 16 h at 37ºC (first generation of cultivation). Then, the first 
generation was used to inoculate the second generation at a 1:1000 dilution in a 
fresh falcon tube with 5 mL of 1) M9 biotin-free medium or 2) M9 supplemented 
with biotin; the second generation was grown for up to 21 h.  
 
 
3.3.9 Protein expression 
 
For protein expression, freshly transformed cells with the desired plasmid were 
prepared, and a single colony was picked and grown overnight (E. coli strains for 
16 h, and C. necator H16 for 40 h) in 5 mL of rich medium (E. coli strains in 2x 
YT, and C. necator H16 in NB) supplemented with antibiotics, then a fresh falcon 
tube with 5 mL of new rich medium supplemented with chloramphenicol was 
inoculated with the pre-culture at a 1:200 dilution and cultivated at 37 ºC (E. coli 
strains) or 30 ºC  (C. necator H16); samples were induced at the early log phase 
when cells reached an OD600 of ~0.6 with 0.1 % or 0.5 % (w/v) L-arabinose. Cells 
were grown for 5 h, or overnight before 1 mL of cells was harvested by 
centrifugation at maximum speed (17,000 x g) and 4 ºC for 15 min, the 
supernatant was removed by pipetting, and the cell pellet was stored at -20 ºC for 
further use. 
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3.3.10 Preparation of protein gel 
 
For analysis of protein expression, a 15 % SDS-PAGE gel was prepared. In order 
to prepare the 15 % SDS-PAGE gel, two different steps are required, the first one 
is the preparation of the resolving gel (lower part), and the second step is the 
preparation of the stacking gel (upper part). The composition of resolving gel was 
1.20 mL of DDI H2O, 2.5 mL of 30 % Acrylamide/Bis, 1.25 mL of 1.5 M Tris-
HCl (pH 8.8), 0.05 mL of 10 % (w/v) SDS, 2.5 µL of TEMED, and 25 µL of 
APS. The composition of the stacking gel was 2.05 mL of DDI H2O, 1.65 mL of 
30 % Acrylamide/Bis, 1.25 mL of 0.5 M Tris-HCl (pH 6.8), 0.05 mL of 10 % 
(w/v) SDS, 5 µL of TEMED, and 25 µL of APS. After the addition of the 
polymerisation initiators, the gel was allowed to solidify and then 5 µL of the 
PageRuler Broad Range Unstained Protein Ladder, and 10 µL of the samples were 
loaded in each of the wells. The electrophoresis was run at a constant voltage at 
200 V for 70 min. Protein gel was stained with coomassie brilliant blue staining 
dye for 20 min, then rinsed three times with water before destaining the gel with a 
destaining solution (500 mL of methanol to a final concentration of 50 % (v/v), 
100 mL Acetic acid to a final concentration of 10 % (v/v), and 400 mL DDI water 
to a final concentration of 40 % (v/v)). The gel image was captured with a gel 
documentation system. 
 
 
3.3.10.1 Analysis of protein expression for total protein content 
 
The gel for total protein content analysis was prepared as described in Section 
3.3.10. The cell pellet (after protein expression) from a 1 mL culture was 
resuspended in 100 µL of 50 mM phosphate buffer (470 µL of 1 M KH2PO4, and 
2.03 mL of 1 M K2HPO4, top-up to 50 mL at pH 7.5) by vortexing, then 100 µL 
of SDS reducing buffer (2x SDS reducing buffer supplemented with b-
mercaptoethanol; 2x SDS buffer was composed of 5.25 mL of DDI H2O, 6.25 mL 
of 0.5 M Tris-HCl pH 6.8, 25 mL of 50 % (v/v) Glycerol, 10 mL of 10 % (w/v) 
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SDS, and 1 mL of 0.5 % (w/v) Bromophenol blue, where 50 µL b-
mercaptoethanol was added to 950 µL of 2x SDS reducing buffer prior to use) 
was added before the cells were incubated at 94 ºC using a block heater for 10 
min, cells were then centrifuged at maximum speed (17,000 x g) for 5 min before 
10 µL sample was loaded into the SDS-PAGE gel. 
 
 
3.3.10.2 Analysis of protein expression for the soluble and insoluble 
fraction of proteins 
 
The gel for the soluble and insoluble fraction of protein analysis was prepared as 
described in Section 3.3.10. The cell pellet (after protein expression) from a 1 mL 
culture was resuspended in 100 µL of lysomix (1,900 µL of 50 mM phosphate 
buffer, and 100 µL of 10 mg/mL lysozyme (lysozyme was dissolved in 50 mM 
phosphate buffer) by vortexing, then, cells were centrifuged at maximum speed 
(17,000 x g) for 10 min. Afterwards, the supernatant (soluble fraction) was 
removed from the pellet (insoluble fraction) by pipetting and transferred to a new 
microcentrifuge tube. To 1 part of the soluble fraction sample, 1 part of SDS 
reducing buffer (2x SDS reducing buffer supplemented with b-mercaptoethanol; 
2x SDS buffer was composed of 5.25 mL of DDI H2O, 6.25 mL of 0.5 M Tris-
HCl pH 6.8, 25 mL of 50 % (v/v) Glycerol, 10 mL of 10 % (w/v) SDS, and 1 mL 
of 0.5 % (w/v) Bromophenol blue, where 50 µL b-mercaptoethanol were added to 
950 µL of 2x SDS reducing buffer prior to use) was added and mixed by 
vortexing before the cells were incubated at 94 ºC using a block heater for 5 min, 
cells were then centrifuged at maximum speed (17,000 x g) for 2 min before 10 
µL sample was loaded into the SDS-PAGE gel. For the insoluble fraction, the cell 
pellet was resuspended in 100 µL SDS reducing buffer (1x SDS reducing buffer 
supplemented with b-mercaptoethanol; 1x SDS reducing buffer was composed of 
1 mL 2x SDS reducing buffer, and 1 mL of 50 mM Phosphate buffer) by 
vortexing and boiled at 94 ºC for 5 min, then, cells were centrifuged at maximum 
speed for 2 min, before 10 µL sample was loaded into the SDS-PAGE gel.  
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3.4 Results and discussion 
 
 
3.4.1 Construction of inducible plasmid systems for biotin related genes 
expression 
 
The plasmid pBADc.rbs-bioC was constructed as a positive control. All plasmids 
described in this Chapter 3 used pBADc.rbs-RFP plasmid from the synthetic 
biology toolbox described in Chapter 2 as plasmid backbone. The pBADc.rbs-
RFP is illustrated in Figure 3.1, where the digested fragment of pBADc.rbs-RFP 
harboured the pBBR1 Rep, pBBR1 oriV origin of replication, mob gene, 
chloramphenicol resistance (Camr) cassette (containing Pcat and Camr), L-
arabinose-inducible system (containing araC and PBAD), and E. coli consensus 
RBS; the rfp gene was replaced with either bioC, bioDV1-4 extended biotin 
operon or bioDD1-5 extended biotin operon. The synthetic extended biotin 
operons of DV and DD were codon optimised by GenScript for E. coli BW25113 
to improve the expression of recombinant proteins. 
 
 
 
Figure 3.1 Illustration of pBADc.rbs-RFP map (6.7 kb). The plasmid encodes for pBBR1 Rep, 
pBBR1 oriV origin of replication, mobilisation sequence mob, CAT promoter, chloramphenicol 
resistance (Camr), araC and PBAD promoter, and rfp gene. 
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3.4.1.1 Construction of plasmid pBADc.rbs-bioC 
 
The construction of the arabinose-inducible pBADc.rbs-bioC plasmid was 
successfully achieved by replacing the rfp gene from pBADc.rbs-RFP with the 
bioC gene from E. coli BW25113. The pBADc.rbs-bioC plasmid was constructed 
to be used as a positive control for further experiments. 
 
The PCR amplified bioC from E. coli BW25113 genomic DNA was analysed to 
confirm the size of the insert, which was a 0.8 kb DNA band as expected (Figure 
3.2A). Then, once the construction of the pBADc.rbs-bioC plasmid was 
successfully ligated and transformed into E. coli DH5a, a PCR amplification of 
the insert within the newly constructed plasmid was performed, as this short insert 
(0.8 kb) was not visible in the gel after restriction enzyme analysis (ReA) as 
observed previously with other DNA bands of a similar size after ReA; also a 
ReA was performed, where DNA bands of 4.5 kb and 2.3 kb confirmed the right 
sizes expected for the digested pBADc.rbs-bioC plasmid (Figure 3.2B). After E. 
coli DH5a transformation, the constructed plasmid was isolated from E. coli 
DH5a and used to transform E. coli BW25113, E. coli BW25113 DbioC and C. 
necator H16 cells. 
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Figure 3.2 Analysis of the construction of pBADc.rbs-bioC. A) Analysis of the PCR amplified 
insert from genomic DNA of E. coli BW25113, B) PCR of the amplified insert from E. coli 
BW25113 and restriction enzyme analysis (ReA) with PstI and XhoI of the constructed pBADc.rbs-
bioC. Abbreviations: ReA, Restriction enzyme analysis. 
 
3.4.1.2 Construction of plasmid pBADc.rbs-bioDV1-4 and pBADc.rbs-
bioDD1-5 
 
The construction of the arabinose-inducible pBADc.rbs-bioDV1-4 and 
pBADc.rbs-bioDD1-5 plasmids was successfully achieved by replacing the rfp 
gene from pBADc.rbs-RFP with the synthetic operon bioDV1-4 from pUC57-
bioDV1-4 or the synthetic operon bioDD1-5 from pUC57-bioDD1-5. 
 
The synthetic operons were digested by restriction enzyme digestion (ReD) with 
NdeI and XhoI from pUC57-bioDV1-4 or pUC57-bioDD1-5 plasmids, which 
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yielded a DNA band of 3.4 kb corresponding to the bioDV1-4 operon or a 3.6 kb 
DNA band for the bioDD1-5 operon, and a DNA band of 2.5 kb corresponding to 
the pUC57 vector (Figure 3.3A). Then, once the construction of the pBADc.rbs-
bioDV1-4 and pBADc.rbs-bioDD1-5 plasmids was successfully ligated and 
transformed into E. coli DH5a, a restriction enzyme analysis (ReA) was 
performed, where DNA bands of 3.4 kb confirmed the right size of the bioDV1-4 
operon or a 3.6 kb DNA band for the bioDD1-5 operon, and a 6 kb DNA band 
expected for the vector (Figure 3.3B). After E. coli DH5a transformation, the 
constructed plasmids were isolated from E. coli DH5a and used to transform E. 
coli BW25113, E. coli BW25113 DbioC and C. necator H16 cells. 
 
 
 
Figure 3.3 Analysis of the construction of pBADc.rbs-bioDV1-4 and pBADc.rbs-bioDD1-5. A) 
Restriction enzyme digestion (ReD) with NdeI and XhoI of inserts bioDV1-4 from pUC57-bioDV1-
4 (lane labelled as ReD1) and bioDD1-5 from pUC57-bioDD1-5 (lane labelled as ReD2). B) 
Restriction enzyme analysis (ReA) with NdeI and XhoI of the constructed pBADc.rbs-bioDV1-4 
(lane labelled as ReA1) and pBADc.rbs-bioDD1-5 (lane labelled as ReA2). Abbreviations: ReD, 
Restriction enzyme digestion; ReA, Restriction enzyme analysis. 
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3.4.2 Corroboration of E. coli BW25113 DbioC phenotype 
 
E. coli BW25113 DbioC is a mutant deficient in bioC synthesis, the bioC gene is 
one of the essential genes in charge of the synthesis of pimelic acid; hence, this 
mutant strain is not capable of growing in biotin-free medium due to pimelate is a 
precursor for biotin synthesis. Critical metabolic enzymes of central metabolic 
pathways such as gluconeogenesis and fatty acid synthesis that mediate the 
transport of CO2 cannot be active if biotin is not synthesised. In order to 
corroborate that the bioC gene had been knocked-out from E. coli BW25113 
DbioC mutant strain, the mutant was subjected to grow in a biotin-free medium. 
This experiment was useful to confirm how many generations of cultivations were 
required to deplete biotin entailed from previous pre-cultures in rich media before 
cells could be able to grow in a biotin-free medium. 
 
Thus, the first experiment performed in this set of experiments was to corroborate 
the phenotype of E. coli BW25113 DbioC, as this confirmation was a critical step 
in understanding the function of the bioDV1-4 and bioDD1-5 biotin operons of 
Desulfovibrio spp in further experiments. Once the phenotype of E. coli 
BW25113 DbioC was confirmed, it could be furtherly determined that if there 
were cell growth in E. coli BW25113 DbioC recombinant strains expressing 
bioDV1-4 and bioDD1-5 in biotin-free media, it would potentially be due the 
expression of the extended biotin operons was related to pimelate synthesis and 
not due to E. coli BW25113 DbioC could grow in biotin-free media. 
 
In order to corroborate the phenotype of E. coli BW25113 DbioC, an overnight 
culture of the strain was first grown in 2x YT medium, then, an aliquot of the pre-
culture was used to grow cells in fresh 2x YT medium to an OD600 of 0.8, once 
cells reached the specified OD600, the spent media was removed before cells were 
washed in M9 biotin-free medium, this was the first step designed to remove any 
biotin left in the spent 2x YT medium. Then, the cell pellet was inoculated in two 
different media: 1) M9 biotin-free and 2) M9 supplemented with biotin, the 
second medium served as a control, where cell growth was always expected 
through all generations of cultivation. The two different media previously 
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mentioned correspond to the first generation of cultivation, where the pre-culture 
came from a rich medium (2x YT), therefore, growth in the M9 biotin-free 
medium was expected in the first generation of cultivation, as cells would carry 
some minimal but essential amounts of biotin within the cells to survive, and it is 
well known that in bacteria, biotin is needed only in trace quantities, specifically 
in E. coli, where only a few hundred molecules per cell are required for growth 
(nanomolar concentrations). The first generation was cultivated for 16 h, where 
effectively, there was cell growth of E. coli BW25113 DbioC in both conditions 
(biotin-free medium and medium supplemented with biotin); an aliquot of the first 
generation was then transferred to the second generation of cultivation. 
 
In the second generation of cultivation, only the sample of E. coli BW25113 
DbioC in M9 supplemented with biotin showed growth after 21 h of incubation 
(Figure 3.4). This experiment confirmed 1) the expected phenotype of E. coli 
BW25113 DbioC where there should be no growth when cells are cultivated in 
biotin-free medium, and 2) the number of generations of cultivation required to 
remove the trace quantities of biotin entailed from pre-cultures and biotin that 
could be generated within the cells.  
 
 
 
Figure 3.4 Growth of E. coli BW25113 DbioC cells from the second generation of cultivation in 
M9 biotin-free media (- biotin) and M9 supplemented with biotin (+ biotin). 
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3.4.3 Analysis of protein expression of bioC, bioDV1-4 and bioDD1-5  
 
Analysis of protein expression after induction of bioC, bioDV1-4 and bioDD1-5 
operons in E. coli BW25113 was carried out in order to corroborate the 
expression of all the genes of the extended biotin operons before analysing the 
function of the extended biotin operons. Recombinant strains of E. coli BW25113 
harbouring bioC, bioDV1-4 and bioDD1-5 were grown in 5 mL of 2x YT medium 
supplemented with chloramphenicol, where 0.1 % or 0.5 % (w/v) L-arabinose was 
used to induce the PBAD promoter when cells reached early log phase to an OD600 
of ~0.6. Different concentrations of L-arabinose in separate cultures were tested, 
this was done in order to obtain the highest protein expression yield at an inducer 
concentration that would not compromise cell growth. 
 
After induction with L-arabinose, an aliquot of the samples was withdrawn from 
the cultures after 5 h and after 20 h of induction. Protein analysis samples were 
taken after 5 hours of expression as a longer expression time could sometimes 
potentially lead to protein degradation, hence compromising protein detection via 
SDS-PAGE. Protein analysis samples were also taken after 20 h of expression on 
the premise that longer expression time might enable better detection assuming 
the proteins are not degraded. Non-induced control samples were always included. 
The optical density at 600 nm was measured for all samples after the induction, as 
this could help to check whether the induction influenced or not in cell growth 
and thus, confirm if the induction was successfully achieved (Table 3.3). 
 
Table 3.3 OD600 of samples of E. coli BW25113 expressing bioC, bioDV1-4 and bioDD1-5 after 
induction at the early log phase with 0.1 % and 0.5 % (w/v) L-arabinose in 2x YT medium. 
Genes and operons OD600 
BioC 0 h 5 h 20 h 
Non-induced 0.298 6.680 11.300 
Induced 0.5 % (w/v) L-arab 0.254 2.680 2.280 
Induced 1.0 % (w/v) L-arab 0.234 2.710 2.820 
BioDV1-4   
Non-induced 0.224 7.070 13.360 
Induced 0.5 % (w/v) L-arab 0.200 4.750 4.750 
Induced 1.0 % (w/v) L-arab 0.212 8.620 10.160 
BioDD1-5    
Non-induced 0.267 5.720 12.340 
Induced 0.5 % (w/v) L-arab 0.289 3.810 4.410 
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Induced 1.0 % (w/v) L-arab 0.256 6.150 9.490 
Abbreviations: L-arab, L-arabinose. 
 
As observed in Table 3.3, the induction of the PBAD promoter for the expression of 
the BioC, BioDV1-4 and BioDD1-5 resulted in significant cell growth decrease (» 
77 % cell growth decrease when BioC was expressed at both different 
concentrations of the inducer, » 64 % cell growth decrease when BioDV1-4 or 
BioDD1-5 were induced with 0.1 % (w/v) L-arabinose, and » 24 % cell growth 
decrease when BioDV1-4 or BioDD1-5 were induced by 0.5 % (w/v) L-arabinose 
after 20 h of cultivation). This cell growth decrease might be attributed to 
metabolic burden ensuing from the diversion of energy resources and vital cellular 
building blocks towards the expression of the BioC and BioDV1-4 proteins. 
Expression of heterologous genes or pathways is generally known to lead to a 
hijacking of resources vital for cell viability, which have been known to unleash 
energetic inefficiency on the cell (Wu et al., 2006). 
 
Overall, the observed cell growth decrease was more marked with the expression 
of BioC than with expression of BioDV1-4 and BioDV1-5, this could be due to 
the expression of BioC not only causes metabolic burden but also it is toxic to the 
cells. The toxicity of BioC to the cells might be due to as described by Lin et al. 
(2012), the bioC gene oversees the methylation of the ω-carboxyl group of 
malonyl-CoA (or malonyl-ACP), which mimics the methyl ends of regular fatty 
acyl chains, where this substrate is recognised by the fatty acid enzymes, entering 
thus to elongation in the fatty acid synthesis, which gives pimeloyl-ACP methyl 
ester. Henceforth, the overexpression of BioC could have caused elevated levels 
of malonyl-ACP methylated substrates, which could lead to the blockage of the 
fatty acid synthesis due to the lack of malonyl-ACP, thereby causing the decrease 
in cell growth.  
 
In regard to the different concentrations of L-arabinose tested, it could be 
appreciated that for the extended biotin operons when a higher concentration of L-
arabinose (0.5 % (w/v) L-arabinose) was used, there was less cell growth decrease 
compared to when a lower concentration of L-arabinose was used (0.1 % (w/v) L-
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arabinose), meaning possibly that the genes were more highly expressed when 0.1 
% (w/v) L-arabinose was used to induce than when 0.5 % (w/v) L-arabinose was 
used to induce protein expression. For further experiments, only 0.1 % (w/v) L-
arabinose was used for induction to ensure the protein expression of the operons. 
The samples were withdrawn after 5 h and 20 h of cultivation after induction and 
analysed in an SDS-PAGE (Figure 3.5). 
 
 
 
Figure 3.5 15 % SDS-PAGE showing the total protein content of bioC, bioDV1-4 and bioDD1-5 
expression in E. coli BW25113 in 2x YT medium based on the induction of the PBAD promoter with 
0.1 % and 0.5 % (w/v) L-arabinose. Samples were withdrawn from the culture after 5 h of 
induction. The following plasmids were carried for protein expression: Lane 1: PageRuler Broad 
Range Unstained Protein Ladder, Lane 2: pBADc.rbs-bioC non-induced, Lane 3: pBADc.rbs-bioC 
induced with 0.1 % L-arabinose, Lane 4: pBADc.rbs-bioC induced with 0.5 % L-arabinose, Lane 
5: pBADc.rbs-bioDV1-4 non-induced, Lane 6: pBADc.rbs-bioDV1-4 induced with 0.1 % L-
arabinose, Lane 7: pBADc.rbs-bioDV1-4 induced with 0.5 % L-arabinose; Lane 8: pBADc.rbs-
bioDD1-5 non-induced, Lane 9: pBADc.rbs-bioDD1-5 induced with 0.1 % L-arabinose, Lane 10: 
pBADc.rbs-bioDD1-5 induced with 0.5 % L-arabinose. The arrows show the protein bands of the 
different plasmids, where only the arrows of identified proteins are shown in the illustration. 
Abbreviations: (-)ve, negative control; L-arab, L-arabinose. 
 
 
From the SDS-PAGE shown in Figure 3.5, which corresponds to the samples 
withdrawn after 5 h of induction, it could be appreciated that only three out of the 
four proteins from the bioDV1-4 extended biotin operon could be identified in the 
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gel; where the target protein corresponding to the expression of the DV3 gene 
seemed to have migrated slightly slower than expected, which appears to have a 
higher molecular weight of about 1 to 2 kDa higher, although this is not unusual 
as sometimes proteins migrate differently in the gels, due to in some occasions the 
abundance of a specific amino acid can affect protein migration, such as a high 
content of acid or basic amino acids (Guan et al., 2015).  
 
On the other hand, the expression of the bioDD1-5 biotin operon showed similar 
results compared to the bioDV1-4, where only three out of the five proteins of the 
extended biotin operon could be identified in the gel. Both extended biotin 
operons did not show their first protein of the operon in the gel corresponding to 
the DV1 and DD1 genes; therefore, the SDS-PAGE gel of the samples withdrawn 
after 20 h of induction (Figure 3.6) was performed as well to check if the proteins 
corresponding to DV1 and DD1 could be identified in the gel, as well as the DD2 
from the bioDD1-5 extended biotin operon.  
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Figure 3.6 15 % SDS-PAGE showing the total protein content of bioC, bioDV1-4 and bioDD1-5 
expression in E. coli BW25113 in 2x YT medium based on the induction of the PBAD promoter with 
0.1 % and 0.5 % (w/v) L-arabinose. Samples were withdrawn from the culture after 20 h of 
induction. The following plasmids were carried for protein expression: Lane 1: PageRuler Broad 
Range Unstained Protein Ladder, Lane 2: pBADc.rbs-bioC non-induced, Lane 3: pBADc.rbs-bioC 
induced with 0.1 % L-arabinose, Lane 4: pBADc.rbs-bioC induced with 0.5 % L-arabinose, Lane 
5: pBADc.rbs-bioDV1-4 non-induced, Lane 6: pBADc.rbs-bioDV1-4 induced with 0.1 % L-
arabinose, Lane 7: pBADc.rbs-bioDV1-4 induced with 0.5 % L-arabinose; Lane 8: pBADc.rbs-
bioDD1-5 non-induced, Lane 9: pBADc.rbs-bioDD1-5 induced with 0.1 % L-arabinose, Lane 10: 
pBADc.rbs-bioDD1-5 induced with 0.5 % L-arabinose. The arrows show the protein bands of the 
different plasmids, where only the arrows of identified proteins are shown in the illustration. 
Abbreviations: (-)ve, negative control; L-arab, L-arabinose. 
 
 
From the analysis of proteins of samples withdrawn after 20 h of induction 
(Figure 3.6), the same results of the previous gel of samples withdrawn after 5 h 
(Figure 3.5) were observed, whereby none of the first genes from the extended 
biotin operons could be appreciated in the gel (DD1, 13.73 kDa and DV1, 15.75 
kDa) and neither the protein band for the second gene of the bioDD1-5 biotin 
operon (DD2, 25.90 kDa). The fact that these proteins were not overexpressed 
migh indicate that these proteins could be toxic to the cells, and therefore, they are 
not highly expressed. 
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Due to not all the target proteins were detected in the SDS-PAGE analysis of total 
protein content after 5 h or 20 h of induction, a repeat of the experiment, 
alongside with a growth curve to observe clearer the impact in cell growth after 
induction of the PBAD promoter was performed again for the expression of bioC, 
bioDV1-4, and bioDD1-5, but this time in E. coli BW25113 DbioC, and in C. 
necator H16, as ultimately, the synthetic biology toolbox with the inducible 
system was tailored for optimised protein expression in C. necator H16. In C. 
necator H16, only one of the extended biotin operons (BioDD1-5) was 
transformed into the cell to analyse protein expression. 
 
In this set of experiments, the pBADc.rbs-RFP plasmid, used as a plasmid 
backbone for the construction of the plasmids described in this chapter, was also 
included in the samples as an external control. All samples were induced at the 
early log phase to an OD600 of 0.5 with 0.1 % (w/v) L-arabinose, and samples for 
protein analysis were withdrawn after 5 h of induction. The growth curve of E. 
coli BW25113 DbioC and its recombinant strains is shown in Figure 3.7A and 
Figure 3.7B, and the growth curve of C. necator H16 and its recombinant strains 
is shown in Figure 3.7C and Figure 3.7D. 
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Figure 3.7 Cell growth study of E. coli BW25113 DbioC (shown as DbioC) and C. necator H16 
(shown as H16) in nutrient-rich media. A) Cell growth curve of non-induced samples of E. coli 
BW25113 DbioC (no plasmid) (diamonds, black dotted line), DbioC_bioDV1-4 (square, blue line), 
and DbioC_bioDD1-5 (triangle, green line); and its induced samples with 0.1 % (w/v) L-arabinose 
DbioC_bioDV1-4 (open square, blue line), and DbioC_bioDD1-5 (open triangle, green line) in 2x 
YT medium. B) Cell growth curve of non-induced samples of E. coli BW25113 DbioC (no plasmid) 
(diamonds, black dotted line), DbioC_bioC (circle, orange line), and DbioC_rfp (inverted triangle, 
red line); and its induced samples with 0.1 % (w/v) L-arabinose DbioC_bioC (open circle, orange 
line), and DbioC_rfp (open inverted triangle, red line) in 2x YT medium. C) Cell growth curve of 
non-induced samples of C. necator H16 (no plasmid) (diamonds, black dotted line), and 
H16_bioDD1-5 (triangle, green line); and its induced samples with 0.1 % (w/v) L-arabinose 
H16_bioDD1-5 (open triangle, green line) in NB medium. D) Cell growth curve of non-induced 
samples of C. necator H16 (no plasmid) (diamonds, black dotted line), H16_bioC (circle, orange 
line), and H16_rfp (inverted triangle, red line); and its induced samples with 0.1 % (w/v) L-
arabinose H16_bioC (open circle, orange line), and H16_rfp (open inverted triangle, red line) in 
NB medium. The graphs show the results of single determinations per sample. 
 
 
From the growth curve shown in Figure 3.7A and Figure 3.7B corresponding to 
the cell growth study of E. coli BW25113 DbioC and its recombinant strains, it 
was observed that the induced samples depicted in Figure 3.7A of bioDV1-4 
(open square, blue line) and bioDD1-5 (open triangle, green line) were expressed 
after the induction with 0.1 % (w/v) L-arabinose, as the decrease in cell growth 
was evident with a 49 % cell growth decrease when BioDV1-4 was expressed, 
and 39 % cell growth decrease when BioDD1-5 was expressed after 25 h of 
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cultivation. On the other hand, in Figure 3.7B the decrease in cell growth when 
BioC was expressed was again significantly higher compared to its non-induced 
sample, showing a 65 % cell growth decrease when BioC was expressed after 25 
h of cultivation. The impact in cell growth decrease for the expression of these 
proteins was similar to what was previously observed with the impact in cell 
growth decrease of the E. coli BW25113 recombinant strains. The expression of 
RFP did not impact in cell growth significantly (only a 15 % cell growth decrease 
was observed when RFP was expressed by 0.1 % (w/v) L-arabinose after 25 h of 
cultivation) compared to the impact in cell growth decrease when BioC, BioDV1-
4 and BioDD1-5 were expressed, although a slight decrease in cell growth was 
noticeable; this negligible impact in cell growth decrease when RFP was 
expressed might be due to the expression of RFP does not affect the natural 
metabolism of the host cell, since this protein might not interfere with any of its 
native pathways, as it is not the case for BioC, which does interfere with the 
natural metabolism of the cell.  
 
On the other hand, the growth curves shown in Figure 3.7C and Figure 3.7D 
demonstrate the impact in cell growth of C. necator H16 and its recombinant 
strains. In Figure 3.7C, the impact in cell growth was not significant after the 
expression of BioDD1-5 (open triangle, green line), contrary to what was 
observed with protein expression of the extended biotin operons of E. coli 
BW25113 DbioC and E. coli BW25113 recombinant strains. In the case of the 
expression of BioC in Figure 3.7D, the same results than the ones observed for E. 
coli BW25113, and E. coli BW25113 DbioC were obtained, although the impact 
in cell growth decrease was lower (26 % cell growth decrease was observed when 
BioC expression was induced by 0.1 % (w/v) L-arabinose after 25 h of cultivation 
in H16_bioC). The cell growth decrease after BioC expression was expected as 
we know that the overexpression of BioC might block the fatty acid synthesis 
which can directly impact in cell growth. Also, as observed in E. coli BW25113 
DbioC cell growth curve, the expression of RFP did not decrease cell growth of 
H16_rfp, which might be attributed to the fact that the expression of this protein 
does not interfere with the natural metabolism of the cell. The fact that the impact 
in cell growth decrease of H16_bioDD1-5 was lower compared to E. coli 
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recombinant strains harbouring the same extended biotin operon, might be due to 
the same concentration of L-arabinose was used to induce the samples of both 
microorganisms (E. coli and C. necator H16), where 0.1 % (w/v) L-arabinose 
might be an optimum L-arabinose concentration for protein expression in E. coli, 
but not for C. necator H16; recent publications mention that the generally the 
PBAD promoter reaches expression maxima at 0.2 % (w/v) L-arabinose in C. 
necator H16 (Johnson et al., 2018). 
 
An aliquot of all samples shown in Figure 3.7 was withdrawn after 5 h of 
cultivation after induction and was analysed in an SDS-PAGE. Although for this 
analysis, the soluble and insoluble fractions of the proteins were analysed (Figure 
3.8, and Figure 3.9). 
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Figure 3.8 15 % SDS-PAGE showing the soluble and insoluble fractions of proteins of bioDV1-4, 
bioDD1-5, rfp and bioC in E. coli BW25113 DbioC in 2x YT medium. Protein expression was 
based on the induction of the PBAD promoter with 0.1 % (w/v) L-arabinose. Samples were 
withdrawn from the culture after 5 h of induction and treated to analyse the soluble (A) and 
insoluble (B) fractions of proteins. The following plasmids were carried for protein expression for 
both protein gels: Lanes 1: PageRuler Broad Range Unstained Protein Ladder, Lanes 2: 
pBADc.rbs-bioDV1-4 non-induced, Lanes 3: pBADc.rbs-bioDV1-4 induced with 0.1 % (w/v) L-
arabinose, Lanes 4: pBADc.rbs-bioDD1-5 non-induced, Lanes 5: pBADc.rbs-bioDD1-5 induced 
with 0.1 % (w/v) L-arabinose, Lanes 6: pBADc.rbs-RFP non-induced, Lanes 7: pBADc.rbs-RFP 
induced with 0.1 % (w/v) L-arabinose; Lanes 8: pBADc.rbs-bioC non-induced, Lanes 9: 
pBADc.rbs-bioC induced with 0.1 % (w/v) L-arabinose, Lanes 10: E. coli BW25113 DbioC. The 
arrows show the protein bands of the different plasmids, where only the arrows of identified 
proteins are shown in the illustration. Abbreviations: (-)ve, negative control; L-arab, L-arabinose. 
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The previous gel (Figure 3.8) corresponds to the soluble and insoluble fractions 
of proteins expressed in E. coli BW25113 DbioC, where a target protein that had 
not been observed in the SDS-PAGE analysis of total protein content of E. coli 
BW25113 samples (Figure 3.5 and Figure 3.6) could be observed this time in the 
soluble fraction, which corresponded to the DD2 gene (red arrow in Lane 5). 
Although once more, no target protein bands could be observed for the first genes 
of the extended biotin operons of either DD or DV and neither the DD4 protein 
band that had been observed in previous gels, while the RFP protein was highly 
expressed in both soluble and insoluble fractions.  
 
On the other hand, the BioC protein band could be appreciated in the insoluble 
fraction gel, while BioC was not observed in the soluble fraction gel; this fact is 
understandable since usually, a high level of expression of recombinant proteins 
in bacteria leads to the formation of inclusion bodies, which are the insoluble 
fractions of proteins; inclusion bodies are highly aggregated proteins that are 
generally formed in the cytoplasm, and can be observed in the SDS-PAGE after 
lysing the cells. After the analysis of the soluble and insoluble fraction of proteins 
in E. coli BW25113 DbioC, the same SDS-PAGE was carried out for C. necator 
H16 samples.  
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Figure 3.9 15 % SDS-PAGE showing the soluble and insoluble fractions of proteins of bioDV1-4, 
bioDD1-5, bioC, and rfp expression in C. necator H16 in NB medium. Protein expression was 
based on the induction of the PBAD promoter with 0.1 % (w/v) L-arabinose. Samples were 
withdrawn from the culture after 5 h of induction and treated to analyse the soluble (A) and 
insoluble (B) fractions of proteins. The following plasmids were carried for protein expression for 
both protein gels: Lanes 1: PageRuler Broad Range Unstained Protein Ladder, Lanes 2: 
pBADc.rbs-bioDD1-5 non-induced, Lanes 3: pBADc.rbs-bioDD1-5 induced with 0.1 % (w/v) L-
arabinose, Lanes 4: pBADc.rbs-bioC non-induced, Lanes 5: pBADc.rbs-bioC induced with 0.1 % 
(w/v) L-arabinose; Lanes 6: pBADc.rbs-RFP non-induced, Lanes 7: pBADc.rbs-RFP induced with 
0.1 % (w/v) L-arabinose, Lane 8: C. necator H16. The arrows of different colours show the 
protein target bands of the different plasmids, where only the arrows of identified proteins are 
shown in the illustration. Abbreviations: (-)ve, negative control; L-arab, L-arabinose. 
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The soluble and insoluble fractions of the proteins of the extended biotin operon 
expressed in C. necator H16 (Figure 3.9) did not show the DD1 protein either as 
observed previously in E. coli recombinant strains. On the other side, the 
expression of the rest of the proteins of the BioDD1-5 operon could be observed 
in the SDS-PAGE analysis in both soluble and insoluble fractions. The RFP 
protein was highly expressed in both soluble and insoluble fractions (mainly in 
the soluble fraction as observed for E. coli BW25113 DbioC samples); and the 
BioC protein band could be appreciated in the insoluble fraction gel, as it occurred 
with the E. coli BW25113 DbioC.  
 
The summary of the genes observed in the total protein content and soluble and 
insoluble fractions of the SDS-PAGE protein gels are shown in Table 3.4.  
 
 
Table 3.4 Target protein bands observed in SDS-PAGE after 5 h and 20 h of induction of bioDV1-
4, bioDD1-5, bioC and rfp in E. coli BW25113, E. coli BW25113 DbioC and C. necator H16. 
Operon and 
genes 
5 h of 
induction 
E. coli 
BW25113 
20 h of 
induction 
E. coli 
BW25113 
5 h of  
induction 
E. coli  
BW25113DbioC 
5 h of  
induction 
C. necator H16 
bioDV1-4 Total pt Total pt Soluble 
pt 
Insoluble 
pt 
Soluble 
pt 
Insoluble 
pt 
DV1 (13.73 kDa) - - - - NA NA 
DV2 (35.31 kDa) + + - + NA NA 
DV3 (15.01 kDa) + + + + NA NA 
DV4 (49.22 kDa) + + + + NA NA 
bioDD1-5      
DD1 (15.75 kDa) - - - - - - 
DD2 (25.90 kDa) - - + - + + 
DD3 (15.27 kDa) + + + - + - 
DD4 (45.24 kDa) + + - - + + 
DD5 (18.44 kDa) + + + + + + 
BioC       
BioC (28.30 kDa) + + - + - + 
RFP       
RFP (28.80 kDa) NA NA + + + + 
The signs + and – denote the existence or absence of the target protein bands in the SDS-PAGE. 
Abbreviations: Pt, protein; NA, not applicable. 
 
 
As depicted in Table 3.4, not all the proteins of bioDV1-4 and bioDD1-5 
extended biotin operons could be observed in the protein gels in any of the strains, 
although all proteins were observed throughout the different samples, unless for 
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DV1 and DD1. The lack of ability to visualise protein bands of the DV1 and DD1 
genes is not conclusive in terms of determining the expression of the proteins. 
Alternative approaches could be performed to corroborate the expression of these 
proteins, which could include proteomic analysis by mass spectrometry (MS) 
(Washburn et al., 2001). 
 
Proteomic analysis can be performed using a so called ‘shotgun’ bottom-up 
approach for protein identification, by analysis at the peptide level, where proteins 
are proteolytically digested, typically using trypsin. The resulting peptides are 
analysed by LC-MS/MS analysis, which couples peptide separation by reversed-
phase high performance liquid chromatography (LC) with accurate mass 
measurement by tandem MS (MS/MS). Peptide masses are measured together 
with their fragments obtained by collision-induced dissociation. The resulting 
MS/MS spectra lead to peptide sequence information and thus protein 
identification by in silico matching against protein sequence database(s) (Perkins 
et al., 1999).  The approach is applicable to proteins in-solution or post separation 
by SDS-PAGE. The advantage of using SDS-PAGE is that it provides a one-step 
sample clean up with high protein resolution.  GeLC-MS/MS, uses entire gel 
lanes from SDS-PAGE (Lundby et al., 2011). In this procedure, entire gel lanes 
are excised as a series of gel slices, followed by in-gel digestion, typically using 
trypsin as the proteolytic enzyme of choice.  
 
If after the above-mentioned analysis to corroborate the expression of DV1 and 
DD1 proteins the outcome shows that the proteins have not been expressed, it 
could be possible that the fact that DV1 and DD1 were not overexpressed in any 
of the different microorganisms tested indicate that these proteins are potentially 
toxic to the cells, and therefore, they are not highly expressed.  
 
 
3.5 Conclusions 
 
The plasmids constructed and described in this Chapter 3 used the synthetic 
biology toolbox with the inducible system described in Chapter 2, which were 
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successfully transformed into C. necator H16 by electroporation with the 
optimised protocol method described in Chapter 2, although the expression of the 
cluster of genes of the extended biotin operons could not be confirmed, the 
inducible system demonstrated to be able to express other functional single genes 
apart from the reporter gene rfp. The bioC gene was successfully expressed in C. 
necator H16, and in E. coli BW25113 strains. 
 
The protein expression after induction of the PBAD promoter showed the target 
proteins of most of the genes of the extended biotin operons of Desulfovibrio spp. 
in the SDS-PAGE protein gels in the E. coli BW25113, E. coli BW25113 DbioC 
and C. necator H16 host cells, although there was no full evidence that all 4 and 5 
genes of the extended biotin operons had been expressed simultaneously. If 
alternative analysis (e.g., MS) of protein expression would not show either the 
successful expression of DV1 and DD1, the possible reason why the DV1 and 
DD1 proteins are not being expressed could be due to these genes might cause an 
imbalance in the cells due to toxicity, and hence these proteins can not be highly 
expressed. 
 
In the SDS-PAGE protein gels, both E. coli BW25113 DbioC and C. necator H16 
showed high expression of the positive controls RFP and BioC proteins, this 
indicated that the PBAD promoter was successfully induced for protein expression. 
Due to the expression of the entire extended biotin operons was not proven in the 
experiments described in this Chapter 3, it could not be investigated if the 
extended biotin operons are committed to pimelate synthesis. Further studies 
should be performed to analyse the function of the extended biotin operons of 
Desulfovibrio spp., which might include studying different dose-responses of the 
L-arabinose inducer, as well as different points of L-arabinose induction; also, 
other inducible promoters could be integrated into the synthetic biology toolbox, 
which could allow a better expression of these cluster of genes. 
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Abstract 
 
 
 
 
In Chapter 4, evolutionary engineering tools were optimised to engineer C. 
necator H16, the evolutionary engineering tool used was directed evolution via 
random mutagenesis, where an optimised protocol for random mutagenesis with 
the chemical mutagen EMS for C. necator H16 was optimised. The EMS random 
mutagenesis method provided a survival rate % of 50 to 85 % using different 
concentrations of EMS from 0.3 to 1.0 % (v/v) EMS. The method was used to try 
to understand the biotin biosynthesis pathway of C. necator H16, where TVA (a 
biotin analogue) was used as selection pressure to identify beneficial mutants. A 
total of 696 TVA-resistant mutants were isolated and screened, from which 8 
mutants were further characterised. Biotin quantitation was performed for the 
mutants characterised in order to compare the biotin production with C. necator 
H16. The biotin studies showed no improvement in biotin production compared to 
C. necator H16. The development of the EMS random mutagenesis method for C. 
necator H16 is a potential engineering tool for the strain, as it can be used for 
engineering C. necator H16 for a wide variety of other bioindustry purposes. 
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4 Chapter 4. Directed evolution: Development of a directed evolution via 
random mutagenesis tool for Cupriavidus necator H16 to understand its 
biotin biosynthesis pathway. 
 
 
4.1 Introduction  
 
In previous Chapters 2 and 3, rational design engineering approaches in C. 
necator H16 were used for the expression of heterologous genes using a synthetic 
biology toolbox for protein expression in C. necator H16. In this Chapter 4, a 
different engineering strategy is described, a tool of evolutionary engineering –
directed evolution via random mutagenesis- was studied in order to expand the 
engineering methods useful for chemical production in C. necator H16, as this 
powerful approach remains limited for C. necator H16. 
 
As mentioned in Section 1.3, rational design engineering (e.g., recombinant strain 
engineering, metabolic engineering) and evolutionary engineering (e.g., directed 
evolution, adaptive evolution) are the most common strategies used for chemical 
production in microorganisms. As reviewed by Nannemann et al. (2011), the 
second strategy is often used when there is no full understanding of the pathways, 
proteins or genes of interest of the host cell. Evolutionary engineering is a reverse 
engineering method that generates random mutations and then analyses the impact 
of the mutations to link phenotype with genotype. Mutants generated by 
evolutionary engineering sometimes can be used directly as cell factories, and 
they have an advantage versus plasmid-borne recombinant strains in that these 
have permanent cellular phenotypes and are not dependent on the stability of the 
plasmid vector expressing the protein of interest. On the other hand, if mutants 
generated are not suitable to be used directly for chemical production, whole 
genome sequencing of the mutant of interest can be performed to understand the 
changes occurred in their genome, where genome sequences of the wild-type and 
the mutant strain are compared to find mutations in their DNA sequence. Once 
beneficial mutations are identified, these can be replicated in wild-type strains by 
recombinant strain engineering for chemical production. 
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4.1.1 Directed evolution via random mutagenesis tool for C. necator H16 to 
understand its biotin biosynthesis pathway 
 
As reviewed in Kim et al. (2005), one of the main tools of evolutionary 
engineering is directed evolution; it is a powerful approach useful to understand 
the biological function of genes by producing mutants with altered phenotypes; in 
this post-genomic era, the use of reverse engineering to understand the function of 
genes has become widespread. Directed evolution is a term that encompasses a 
wide variety of methods that are used to improve or alter the functions of genes, 
enzymes, or pathways. Random mutagenesis is one of the main strategies used in 
directed evolution experiments to generate a library of mutants; where at the same 
time different random mutagenesis methods can be used such as epPCR, and 
chemical or physical mutagenesis. Chemical and physical mutagens can be used 
for modifying template DNA to foster mutations. Some of the chemical mutagens 
used for mutation of bacterial strains are ethyl methanesulfonate (EMS), nitrous 
acid, hydrazine, or formic acid, which generate chemical changes in nucleotide 
bases; also, physical mutagens such as UV irradiation can be used to generate 
whole-cell mutations (reviewed by Nannemann et al., 2011). The rationale behind 
directed evolution via random mutagenesis is the incorporation of accelerated 
random mutagenesis that can create random mutations for instance, in bacterial 
genomes; the procedure goes through iterative cycles until the desired phenotype 
is obtained, and a selection pressure is used for the screening of the mutant strains 
to check for phenotype improvement. 
 
Evolutionary engineering is often used when there is a lack of extensive 
knowledge on how genes or entire metabolic pathways work, thus, it represented 
a potential approach to be optimised for C. necator H16, which could be used to 
study one of its unknown metabolic pathways. One of the most intriguing 
metabolic pathways in many microorganisms to date is biotin biosynthesis, as 
even when the bioFADB biotin operon – which is in charge of the assembly of the 
fused heterocyclic rings of biotin- is a universal operon in many prokaryote 
systems, the origin of pimelic acid in bacteria lacking the E. coli biotin 
biosynthesis pathway, remains a mystery (Manandhar et al., 2017). This is the 
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case for C. necator H16, where, as mentioned in Section 1.5.7.5, the biotin 
operon in charge of the assembly of the biotin rings in C. necator H16 (bioFADB 
biotin operon) has been identified in its genome (Pohlmann et al. 2006), although 
the synthesis of pimelic acid in the strain remains unknown, where only a bioC 
gene has been predicted (Rodionov et al., 2002; Pohlmann et al., 2006), albeit no 
studies have been reported to date to confirm the function of that or other genes 
committed to pimelic acid in C. necator H16. The understanding of the biotin 
biosynthesis pathway in C. necator H16 could be further used for chemical 
production in the strain, such as bioproduction of pimelate (which is used as a 
building block for the synthesis of Nylon 7,7 (Cartman et al., 2018)). 
 
Thus, an optimised directed evolution via random chemical mutagenesis method 
for C. necator H16 was developed in this chapter, where different chemical or 
physical mutagens were investigated to choose the mutagen that could be optimal 
for the strain; also, a biotin analogue was chosen to be used as selection pressure 
for the identification of rare mutants with an improved phenotype. 
 
 
4.1.2 EMS random mutagenesis 
 
As mentioned in Section 1.3.2.1, directed evolution via random mutagenesis is a 
common strategy in bioengineering where mutations rates can be increased with 
the aid of a chemical or physical mutagen. Chemical mutagens induce high 
frequencies of base-pair substitutions and some lethality depending on the 
concentration used. Some of the most widely used chemical mutagens are the 
alkylating agents N-methyl-N’-nitro-N-nitrosoguanidine (NTG) and ethyl 
methanesulfonate (EMS), which produce transitions at G(guanine)-C(cytosine) 
sites (Lawrence, 2002). On the other hand, one of the most commonly used 
physical mutagens is ultraviolet light (UV light, 254 nm). Some strategies of 
directed evolution consist of combining both mutagens –chemical and physical- 
which provide outcomes that can satisfy experimental needs.  
 
The external mutagens mentioned in the previous paragraph have been used for 
random mutagenesis in different experimental approaches of biotin-
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overproduction in microorganisms, where all mutagens proved to have induced 
beneficial mutations, some publications have mentioned that one of the most 
potent chemical mutagens to induce genetic variability is EMS as it induces high 
frequencies of base-pair substitutions and little lethality (Coulondre et al., 1977; 
Lawrence, 2002; reviewed in Shahnawaz et al., 2014), it has also been described 
to be even more effective than physical mutagens (Lawrence, 2002; Bhat et al., 
2005). 
 
As reviewed in Sega (1984), EMS is an alkylating agent that typically produces 
only point mutations in nucleotides, it owes its biological reactivity to its ethyl 
group, where G-rich regions are preferred, reacting to form a variety of modified 
G residues (reviewed in Shahnawaz et al., 2014), which results in mispairing and 
base changes. The strongly biased alkylation G residues forms O6-ethylguanine, 
which subsequently can pair only with thymine (T) but not with cytosine (C), 
then, after DNA repair, the original G/C pair can be substituted by an adenine 
(A)/thymine (AT pair) (Greene et al., 2003). Most of genetic data obtained using 
microorganisms suggest that mutations induced by EMS will be C-to-T changes 
(99 %), which result in a G/C to A/T substitution as shown in Error! Reference 
source not found. (Krieg, 1963; Todd et al., 1981; reviewed in Sega, 1984; 
Cupples et al., 1989; Kovalchuk et al., 2000; Lawrence, 2002; Greene et al., 
2003), although at low frequency other mutations can be generated by EMS such 
as G/C to C/G transversions due to hydrolysis by 7-ethilguanine (Krieg, 1963; 
reviewed in Kim et al., 2005), as reviewed in Sega (1984), there is also some 
evidence that EMS can induce base-pair deletions or insertions. 
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Figure 4.1 EMS mechanism of action as a chemical mutagen. EMS is an alkylating agent that 
induces predominately GC to AT transitions by alkylating guanine residues to form O6-
ethylguanine which subsequently can only pair with T but not C. Abbreviations: EMS, ethyl 
methanesulfonate; G, guanine; C, cytosine; A, adenine; T, thymine. 
 
C. necator H16 is a GC-rich microorganism, its two chromosomes have almost 
identical GC content with > 60 % G + C content (Pohlman et al., 2006), and due 
to EMS has been reported as one of the best external mutagens that prefers G rich 
regions it is the indicated chemical mutagen to start with for random mutagenesis 
of its entire genome. 
 
Apart from selecting the external mutagen for random mutagenesis of C. necator 
H16, it is essential to consider in the experimental design the optimal dose of the 
mutagen, since high concentrations may result in a 100 % killing; a balance 
between the competing needs for a high mutation frequency and a reasonable 
survival must be optimised, where usually a 50 % survival rate provides the 
highest proportion of mutants, it is desirable to avoid doses that would kill more 
than 95 % of cells (Lawrence, 2002); and, after mutagen treatment, plating 
dilutions on solid media to select colonies for screening is desirable, as it has the 
advantage that each specimen of mutation identified is of independent origin 
(Lawrence, 2002). 
 
The different methodologies used for EMS random mutagenesis in other 
microorganisms such as E. coli, Bacillus borniphilus, S. typhimurium, and S. 
cerevisiae are described in Table 4.1. 
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Table 4.1 EMS random mutagenesis in microorganisms. 
Strain,  
Cell growth phase 
previous to mutagenesis 
EMS % (v/v),  
Incubation time,  
Survival rate % 
Cell washes References 
E. coli,  
early log phase 
1.40 % EMS, 30 min, 56 % KH2PO4 buffer Foster, 1991 
E. coli,  
stationary phase 
0.15 % EMS, 90 min, 70 % 
0.25 % EMS, 90 min, 40 % 
0.30 % EMS, 90 min, 32 % 
0.35 % EMS, 90 min, 26 % 
0.40 % EMS, 90 min, 22 % 
Minimal media Todd et al., 
1981 
E. coli,  
stationary phase 
1.40 % EMS, 15 min, 71 % 
1.40 % EMS, 30 min, 56 % 
1.40 % EMS, 60 min, 36 % 
KH2PO4 buffer Cupples et 
al., 1989 
E. coli, 
stationary phase 
1.00 % EMS, 15 min, 20 % 
2.00 % EMS, 10 min, 70 % 
Minimal media Loveless, 
1959 
B. boroniphilus,  
early log phase 
50.0 % EMS, 60 min, 10 % KH2PO4 buffer Sen et al., 
2011 
S. typhimurium, 
stationary phase 
4.00 % EMS, 15 min, 30 % KH2PO4 buffer Loveless, 
1959 
S. cerevisiae, 
stationary phase 
0.30 % EMS, 30 min, 10 – 50 % KH2PO4 buffer Lawrence, 
2002 
S. cerevisiae,  
early log phase 
0.30 % EMS, 40 min, 5 – 30 % PBS buffer Sonderegger 
et al., 2003 
S. cerevisiae, 
early log phase 
0.30 % EMS, 30 min, 10 % KH2PO4 buffer Cakar et al., 
2009 
Abbreviations: E. coli, Escherichia coli; B. boroniphilus, Bacillus boroniphilus; S. typhimurium, 
Salmonella typhimurium; S. cerevisiae, Saccharomyces cerevisiae; EMS, ethyl methanesulfonate. 
 
 
The Survival rate % will depend on either the concentration of the mutagen or the 
time exposure of cells with the mutagen (Foster, 1991), on the other hand, in some 
other methodologies for random mutagenesis, it is suggested that cells should be 
mutagenised at the exponential growing log-phase, as according to literature, this 
greatly enhances the reproducibility of mutagenesis experiments (reviewed in 
Sega, 1984; Foster, 1991; Sonderegger et al., 2003), due to mainly bases in DNA 
and not in the nucleotide pool are modified (Grzesiuk et al., 1993), although some 
other experiments also mutagenised cells at the stationary phase (Todd et al., 
1981; Lawrence, 2002). 
 
 
4.1.3 Biotin analogues  
 
There is a variety of biotin analogues reported in literature that can interfere with 
the biotin biosynthesis in different microorganisms, such as actithiazic acid 
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(ACM), a-dehydrobiotin, a-methylbiotin, a-methyldethiobiotin, and 
amiclenomycin, although some of them are difficult to synthesise at considerable 
amounts because they are antibiotics, which are produced only in small amounts 
by actinomycetes (Izumi et al., 1977), some others synthetic biotin analogues 
such as norbiotin, homobiotin, 2-oxo-4-imidazolidinecaproic acid, synthetic 
amiclenomycin are not commercially available or their synthesis is complicated 
(Izumi et al., 1977; Mann et al., 2002; Shi et al., 2012); among the synthetic 
biotin analogues that are easily synthesised or commercially available is 5-(2-
thienyl)-valeric acid (TVA). TVA is chemically synthesised from thiophene and 
glutaric anhydride (Izumi et al., 1978). 
 
TVA inhibited the growth of Rhodotorula glutinis (fungi), Bacillus sphaericus 
(gram-positive bacteria), and other microorganisms including yeast 
(Saccharomyces rouxii, Pichia farinose, Candida utilis), bacteria (Aerobacter 
spp., Agrobaterium radiobacter, Bacterium cadaveris), moulds (Mucor spp., 
Aspergillus niger, Monascus anka, Neurospora crassa), and actinomycetes 
(Streptomyces lidicus) (Izumi et al., 1977 and 1978; Yamada et al., 1983), where 
the addition of biotin, dethiobiotin (DTB), and 7,8-diaminopelargonic acid 
(DAPA) reversed the inhibition of growth in Rhodotorula glutinis, while the 
addition of 7-keto-8-aminopelargonic acid (KAPA) and pimelic acid did not show 
a recovering effect (Izumi et al., 1977), the same effects of cell growth recovery 
were observed for B. sphaericus (Izumi et al., 1978); hence Izumi et al. (1978) 
concluded with enzymatic investigations that TVA inhibited the DAPA 
aminotransferase reaction, which is responsible for DAPA synthesis from KAPA 
(Figure 4.2). These findings suggested that TVA might act as a biotin analogue 
for a wide variety of microorganisms, which might be linked to the fact that TVA 
has the same side chain as biotin. 
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Figure 4.2 Mode of action proposed for the biotin analogue TVA in the orthodox last steps of the 
biotin biosynthesis pathway. TVA is thought to inhibit BioA, as, after the addition of biotin, DTB, 
and DAPA, a cell growth recovery has been observed, whereas when KAPA or pimelic acid are 
added into the media, there is no cell growth recovery. TVA has shown to inhibit cell growth in 
different microorganisms from yeast, bacteria, moulds, and actinomycetes; the inset shows the 
chemical structure of TVA. Biotin pathway shown in the illustration corresponds to the biotin 
synthesis in E. coli and Bacillus spp. Abbreviations: KAPA, 7-keto-8-aminoperlargonic acid; 
DAPA, 7,8-diaminopelargonic acid; DTB, dethiobiotin; TVA, 5-(2-thienyl)-valeric acid. 
 
A compilation of the biotin analogues that have been used for mutant biotin-
overproducing strains is shown in Table 4.2, as well as the different 
microorganisms that have shown cell growth inhibition by the action of these.  
 
Table 4.2 Biotin analogues previously used for biotin studies in different microorganisms and its 
mechanisms of action. 
Biotin analogue Strains  Description Comm. 
avai-
lable? 
Reference 
Acidomycin E. coli  
S. marcescens,  
Other names:  
ACM, Actithiazic Acid, 6-
(4-oxo-1,3-thiazolidin-2-
yl)hexanoic acid 
Yes Kanzaki et 
al., 2001; 
Sakurai et 
al., 1993 
  Mechanism of action:  
Cell growth recovery after 
the addition of biotin. ACM 
might prevent the formation 
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of D-biotin from 
dethiobiotin (bioB level) 
Amiclenomycin  Mechanism of action:  
The target of 
aminoclenomycin is DAPA 
aminotransferase 
No Mann et 
al., 2002; 
Izumi et 
al., 1977 
Azelaic acid B. subtilis Mechanism of action:  
It might act at the level of 
pimelyl-CoA synthetase 
(bioW) as a competitive 
inhibitor of pimelic acid 
Yes Bower et 
al., 2001 
Norbiotin S. cerevisiae 
139 
Other names:  
1H-Thieno[3,4-d]imidazole-
4-butanoicacid, hexahydro-
2-oxo-, (3aS,4S,6aR) 
Mechanism of action:  
Not investigated 
Yes Izumi et 
al., 1977; 
Sakurai et 
al., 1993 
a-Dehydrobiotin B. subtilis  
E. coli  
 
Mechanism of action:  
Cell growth recovery after 
the addition of biotin. It 
might act like biotin, 
presumably as a false 
corepressor for the biotin 
operon. 
No Eisenberg, 
1975; 
Sakurai et 
al., 1993. 
a-methylbiotin B. subtilis 
B. cereus, 
Mycobacterium 
avium 
Mycobacterium 
phlei 
Other names:  
cis-tetrahydro-a-methyl-2-
oxo-thieno[3,4-
d]imidazoline-4-valeric acid. 
Mechanism of action:  
Not investigated 
No Hanka et 
al., 1972; 
Izumi et 
al., 1977; 
Sakurai et 
al., 1993 
a-
methyldethiobiotin 
B. subtilis 
E. coli 
Mycobacterium 
avium 
Other names:  
5-dimethyl-2-oxo-4-
imidazolidinehexanoic acid 
No Hanka et 
al., 1972 
  Mechanism of action:  
Not investigated. 
  
5-(2-thienyl)-
valeric acid 
B. sphaericus  
B. subtilis 
E. coli 
Rhodotorula 
glutinis  
S. marcescens 
Other names:  
TVA, 5-(2-thienyl)pentanoic 
acid 
Mechanism of action: TVA 
inhibited the DAPA 
aminotransferase reaction, 
which is responsible for 
DAPA synthesis from 
KAPA (BioA level). 
 
Yes Bower et 
al., 2001; 
Izumi et 
al., 1977; 
Kanzaki et 
al., 2001; 
Ifuku et 
al., 1993; 
Sakurai et 
al., 1993 
Abbreviations: Comm. available, commercially available; ACM, acidomycin; DAPA, 7,8-
diaminopelargonic acid; TVA, 5-(2-thienyl)-valeric acid; KAPA, 7-keto-8-aminoperlargonic acid. 
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4.2 Aim 
 
The aims of Chapter 4 are: 
 
Ø To optimise a random mutagenesis method for C. necator H16 using EMS 
as a chemical mutagen. 
Ø To explore the applicability of evolutionary engineering in C. necator H16 
by using a directed evolution strategy via random chemical mutagenesis to 
generate a library of mutants which could help to understand the biotin 
pathway in C. necator H16. 
 
  
4.3 Materials and methods 
 
 
4.3.1 Materials 
 
List of detailed information on the materials used (reagents, kits, equipment, 
software, media preparation and miscellaneous) can be found in Appendix 1 - 6. 
 
 
4.3.2 Wild-type and mutant strains 
 
All strains that were used in this Chapter 4 are shown in Table 4.3. 
 
 
Table 4.3 Strains used in this study. 
WT and mutant 
strains 
Description References 
or source 
C. necator H16 Wild-type, Genr DSM 428 
m1D9  Mutant strain from first Rd mutagenesis with 0.3 % (v/v) 
EMS, parent strain C. necator H16 WT, Genr 
This work 
m1F2 Mutant strain from first Rd mutagenesis with 0.3 % (v/v) 
EMS, parent strain C. necator H16 WT, Genr 
This work 
m1F5 Mutant strain from first Rd mutagenesis with 0.3 % (v/v) 
EMS, parent strain C. necator H16 WT, Genr 
This work 
m1G6 Mutant strain from first Rd mutagenesis with 0.3 % (v/v) This work 
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EMS, parent strain C. necator H16 WT, Genr 
m1C3 Mutant strain from first Rd mutagenesis with 0.5 % (v/v) 
EMS, parent strain C. necator H16 WT, Genr 
This work 
m1G9 Mutant strain from first Rd mutagenesis with 1.0 % (v/v) 
EMS, parent strain C. necator H16 WT, Genr 
This work 
m2C2 Mutant strain from second Rd mutagenesis with 0.3 % 
(v/v) EMS, parent strain m1F5, Genr 
This work 
m2C4 Mutant strain from second Rd mutagenesis with 0.3 % 
(v/v) EMS, parent strain m1F5, Genr 
This work 
Abbreviations: Genr, gentamicin resistance; Rd, round; WT, wild-type. 
 
 
4.3.3 Cultivation of C. necator H16  
 
C. necator H16 wild-type (WT) and mutant strains were cultivated at 30 ºC using 
5 mL of nutrient broth (NB) or mineral salts medium (MSM), and 250 rpm always 
supplemented with gentamicin [10 µg/mL] when cells were cultivated in falcon 
tubes. C. necator H16 WT and mutant cells were cultivated at 30 ºC using 150 µL 
of NB or MSM and 1050 rpm always supplemented with gentamicin [10 µg/mL] 
when cells were cultivated in 96-well microtitre plates. The optical density of all 
types of cultivation (falcon tubes or microtitre plates) was measured at 595 nm 
with a microplate reader or at 600 nm with a BioPhotometer.  
 
 
4.3.4 EMS random mutagenesis for C. necator H16 
 
Unless specified otherwise, a pre-culture of C. necator H16 was cultivated in 5 
mL of MSM with gentamicin for 40 – 44 h at 30 ºC; for random mutagenesis cell 
preparation, a fresh falcon tube with MSM supplemented with gentamicin was 
inoculated with the pre-culture at a 1:50 dilution and cultivated at 30 ºC, when 
cells reached an OD600 of 0.9 – 1.0, four millilitres of the cells were then 
transferred to a sterile 2 mL microcentrifuge tube using two rounds of 
centrifugation at maximum speed (17,000 x g) for 30 s, the supernatant was 
removed by pipetting and the cell pellet was resuspended in 1 mL MSM. For 
chemical mutagen treatment with EMS, three different EMS stock solutions were 
prepared at different concentrations (0.6 % (v/v), 1.0 % (v/v), and 2.0 % (v/v)), 
then four different microcentrifuge tubes were prepared with 250 µL of MSM for 
the control sample (0 % (v/v) EMS), 250 µL of 0.6 % (v/v) EMS stock for a final 
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concentration of 0.3 % (v/v) EMS, 250 µL of 1.0 % (v/v) EMS stock for a final 
concentration of 0.5 % (v/v) EMS, and 250 µL of 2.0 % (v/v) EMS stock for a 
final concentration of 1.0 % (v/v) EMS before 250 µL of the concentrated cells 
were transferred to each of the four sample tubes to achieve 0 %, 0.3 %,  0.5 % 
and 1.0 % (v/v) EMS. After exposure to the chemical mutagen for 60 min, cells 
were centrifuged at maximum speed for 2 min, and the supernatant was removed 
by pipetting, then, cells were washed thrice by resuspending the cell pellet in 0.5 
mL of MSM, after the last washing step, supernatant was removed by pipetting 
and cell pellet was resuspended in 1 mL of MSM and further diluted into a 2 x 104 
fold. Then, 100 µL of the diluted cells were plated in MSM with gentamicin agar 
plates and incubated at 30 ºC for 40 – 48 h. The neat EMS solution was always 
used in a fume cupboard, and it was always prepared before use. The EMS stock 
solutions were diluted with 50 mM KH2PO4 buffer and then sterilised with a 0.2 
µm filter unit. The remaining EMS stock solution and the used EMS waste 
solution were always treated before discarding with 10 % (w/v) of sodium 
thiosulphate and 1 M NaOH. 
 
 
4.3.5 Screening of C. necator H16 mutants in TVA 
 
Unless specified otherwise, after EMS mutagenesis of C. necator H16, single 
colonies of mutant strains were picked from MSM agar plates supplemented with 
gentamicin, and pre-cultured in a 96-well microtitre plate with MSM 
supplemented with gentamicin; the pre-culture was grown for 24 h or until all 
cells had reached saturation. Then, cells were transferred with a pin replicator to a 
fresh microtitre plate with MSM supplemented with different concentrations of 
TVA and gentamicin for mutant screening, OD595 was measured to check for cell 
growth in the presence of TVA with a microtitre plate reader. Once the microtitre 
plate of the pre-culture had been used to inoculate the microtitre plate of the 
outgrowth culture, 50 µL of 50 % (v/v) Glycerol were added to the microtitre 
plate of the pre-culture and cells were stored at -80 ºC. The screening of mutants 
was carried out by monitoring cell growth to select the best mutants, cell growth 
of mutants was always compared against cell growth of the WT and parent strain. 
After the best mutant of the first round of mutagenesis was characterised and its 
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phenotype resistant to TVA had been confirmed, the selected mutant was used for 
the next round of EMS random mutagenesis. 
 
 
4.3.6 Characterisation of C. necator H16 mutants in TVA 
 
A pre-culture of C. necator H16 mutant strains was cultivated in 5 mL of MSM 
with gentamicin for 40 – 44 h at 30 ºC, then, the characterisation of mutants of C. 
necator H16 was performed in 5 mL of MSM supplemented with TVA in falcon 
tubes with a 1:50 dilution. The growth of the mutant strains was monitored until 
cells reached stationary phase, optical density was measured at 600 nm in a 
BioPhotometer. The inoculum of the mutants was always adjusted to an initial 
OD600 of 0.5 using the following formulae: 
 
Mutant inoculum (µL) =    OD600 WT     ´  100 µL 
                  OD600 mutant 
 
 
4.3.7 Determination of biotin content in C. necator H16 and mutant strains 
 
A pre-culture of C. necator H16 WT and mutant strains was cultivated in 5 mL of 
MSM with gentamicin for 40 h at 30 ºC for biotin quantitation. Standard 
procedures described in the Biotin Quantitation Assay Kit were followed for 
determination of biotin content of cells; briefly, the fundamentals of the assay are 
based on a Biotective Green reagent that consists of avidin labelled with a 
fluorescent dye and quencher dye ligands, the quencher dye ligands occupy the 
biotin binding sites, and it is through fluorescence resonance energy transfer 
(FRET) that the ligand quenches the fluorescence, thus when biotin displaces the 
quencher dye from the Biotective Green reagent, it yields fluorescence, which is 
proportional to the amount of biotin. The assay has a sensitivity of 4 to 80 pmol of 
biotin in a sample. For biotin content determination, a standard curve using 
biocytin (biotinylated lysine) was performed as described by the manufacturers, 
and used as a standard for the assay, in the same experiment, 50 µL of the samples 
were taken directly from the pre-cultures and placed into separate empty wells in 
a fluorescence microtitre plate, each sample was assayed in triplicates, then, 50 
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µL of 2x Biotective Green reagent were added to each microtitre well containing 
either a sample or a standard. The fluorescence microtitre plate was left at room 
temperature for 5 minutes in the dark before the fluorescence was measured in a 
fluoroskan microplate reader, where the excitation/emission used for 
determination of the biotin content was set at 485/538 nm. 
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4.4 Results and Discussion 
 
 
4.4.1 Development of EMS random mutagenesis method for C. necator H16 
 
Due to a method of EMS random mutagenesis for C. necator H16 has not been 
reported to date, different methodologies used for EMS random mutagenesis in 
other microorganisms were analysed to design the random mutagenesis method 
for C. necator H16 based on publications described for other microorganisms 
such as E. coli, Bacillus borniphilus, S. typhimurium, and S. cerevisiae (Table 
4.1). 
 
Hence, after analysing the data shown in Table 4.1 on how EMS random 
mutagenesis methods have been developed in other microorganisms, the 
following variables were taken into consideration for the proposed EMS random 
mutagenesis method developed for C. necator H16 in order to optimise the 
method: 1) Survival rate %: the target survival rate was set to be within the 50 % 
survival rate range; 2) Cell growth phase previous to mutagenesis: the cells for 
chemical mutagenesis was set to be both at the early log-phase and stationary 
phase; 3) Incubation time of EMS treatment: from the ranges used in different 
EMS methods shown in Table 4.1, it was decided to test mutagenesis with an 
incubation time of 60 min; 4) Cell wash: before and after mutagenesis treatment, 
three different buffers were tested, a) sodium thiosulphate, b) buffer solution 
(KH2PO4), and c) MSM; 5) Outgrowth after mutagenesis treatment: two different 
cell cultivations for the outgrowth can be performed, a) an overnight culture of 
mutagenised cells before plating treated cells in solid medium, and b) plate 
mutagenised cells directly in solid medium after mutagen treatment. The first 
option is recommended to allow cells to stabilise before they are subjected to 
selective conditions, which can help to enhance the production and expression of 
mutations (Lawrence, 2002), while the second option is suggested to avoid that 
the progeny of a small number of mutants could dominant the resultant population 
which occurs during the overnight culture, as this would give a large proportion of 
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siblings and could make the process of screening more laborious (Foster, 1991); 
both strategies were considered to be tested in the experimental design. 
 
Once the variables of the experimental design for random mutagenesis in C. 
necator H16 were defined, the different variables were tested in order to optimise 
the EMS random mutagenesis method for C. necator H16; the first method served 
as a basis to design the second, and so forth depending on the results obtained, 
where all the variables specified in the previous paragraph were tested. The 
experimental designs performed are shown in Table 4.4.  
 
Table 4.4 Variables tested for optimisation of EMS random mutagenesis for C. necator H16. 
Cell cultivation, 
Vol. of cells, 
Cell washes before 
mutagenesis 
EMS % (v/v), Incubationt Cell washes 
after 
mutagenesis 
Cell outgrowth 
Method 1    
Early-log phase, 
0.5 mL cells, 
KH2PO4 wash (2x) 
0 % EMS, 60 min, (-)ve 
0.30 % EMS, 60 min 
0.50 % EMS, 60 min 
0.75 % EMS, 60 min 
1.00 % EMS, 60 min 
Na2S2O3 (2x) 
MSM (2x) 
Plate immediately 
Method 2    
Stationary phase, 
0.5 mL cells, 
KH2PO4 wash (2x) 
0 % EMS, 60 min, (-)ve 
0.50 % EMS, 60 min 
1.00 % EMS, 60 min 
KH2PO4 (2x) Plate immediately 
Method 3 (a and b)*    
Stationary phase, 
0.5 mL cells, 
KH2PO4 wash (2x) 
0 % EMS, 60 min, (-)ve 
1.00 % EMS, 60 min 
2.00 % EMS, 60 min 
KH2PO4 (2x) Plate immediately 
(Method 3a)* 
Plate after O.N. 
cultivation 
(Method 3b)* 
Method 4    
Early-log phase, 
1.0 mL cells, 
0 % EMS, 60 min, (-)ve 
0.30 % EMS, 60 min 
0.50 % EMS, 60 min 
1.00 % EMS, 60 min 
MSM (3x) Plate immediately 
Notes: Main variables changed between one experiment an another are shown in green; 50 mM 
KH2PO4, pH 7.0; and 10 % (w/v) Na2S2O3 concentrations were used for cell washes. 
Abbreviations: Vol., volume; Incubationt, incubation time; KH2PO4, potassium phosphate 
monobasic; (-)ve, negative control; Na2S2O3, sodium thiosulphate; O.N., overnight. 
 
 
The results of the protocols tested out for EMS random mutagenesis in C. necator 
H16 described in Table 4.4 are shown in Figure 4.3, where the survival rate % 
was calculated using the formulae below: 
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Survival rate % = # of EMS treated survivors (MSM) ´ 100 %  
                               # of EMS control survivors (MSM) 
 
 
 
Figure 4.3 Survival rate % of the different EMS random mutagenesis methods tested for C. 
necator H16. Method 1 (grey line): cells at early-log phase, buffers KH2PO4, Na2S203, and MSM, 
no overnight cultivation after mutagenesis; Method 2 (green line): cells at stationary phase, buffer 
KH2PO4, no overnight cultivation after mutagenesis; Method 3a (orange line): cells at stationary 
phase, buffer KH2PO4, no overnight cultivation after mutagenesis; Method 3b (blue line): cells at 
stationary phase, buffer KH2PO4, overnight cultivation after mutagenesis; Method 4 (red line): 
cells at early log phase, buffer MSM, no overnight cultivation after mutagenesis. Error bars are ± 
SEM of three independent determinations. Abbreviations: EMS, ethyl methanesulfonate. 
 
 
From Figure 4.3, it was observed that the Method 1 (grey line) effectively 
provided a survival rate % decrease as the concentration of EMS increased, where 
there was > 100 % survival when 0.3 % (v/v) EMS was used to mutagenise cells, 
while there was 0 % survival when 1.0 % was used. Method 2 (green line), on the 
other hand, showed a higher survival rate when 0.5 % and 1.0 % (v/v) EMS were 
used compared to Method 1 (grey line), this due to the fact that the same volume 
of cells was taken but at different growth phases in both methods, where in 
Method 2, cells were withdrawn from the culture at the stationary phase and not at 
the early-log phase as in Method 1 (grey line), hence, cell concentration was 
higher in Method 2 than in Method 1; From Method 1 and Method 2, it was 
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observed that all the different buffers used for cell washes worked well for the 
mutagenesis process. In Method 2, it was observed as well that the different EMS 
concentrations used (0.5 % and 1.0 % (v/v) EMS) did not provide a survival rate 
close to 50 %, thus in Method 3a and 3b (orange and blue lines respectively), the 
EMS concentration was increased.  
 
Methods 3a and 3b have the same experimental design, the only difference was 
the condition of the outgrowth, whereby in Method 3a (orange line) cells were 
plated right after EMS mutagenesis and in Method 3b (blue line) cells were plated 
after overnight culture. For both methods, a higher concentration of EMS (2.0 % 
(v/v)) was tried out, since previous observations in Method 2, showed no 
significant survival rate % decrease when they were mutagenised with up to 1.0 % 
(v/v) EMS. Effectively, doubling the EMS concentration provided a lower 
survival rate % of ~ 50 % for both methods. Another observation noted from 
Method 3a and 3b, was that the conditions of cell outgrowth after mutagenesis 
provided similar results in terms of survival rate %, hence, for the next 
experimental design only the cell growth condition of Method 3a (cells plated 
right after mutagenesis) was considered, since this could help to avoid to have a 
large population of siblings during the screening process.  
 
The last Method 4 (red line) was designed based on previous results obtained in 
Method 1, 2, 3a and 3b, where the variables with the best outcomes were 
considered to design the Method 4. The variables considered were: 1) mutagenise 
cells at the early-log phase due to from literature it is known that this greatly 
enhances the reproducibility of mutagenesis experiments, 2) increase the volume 
of cells in order to have a higher concentration of cells (in the early-log phase), 3) 
use MSM as buffer for cell washes, which could help to make the process more 
straightforward, and 4) for the cell outgrowth conditions, cells would be plated 
immediately after EMS mutagenesis (i.e., no overnight culture before plating the 
cells). Thus, Method 4 (red line), was performed with the previous variables 
mentioned, where it was observed that compared to Method 1 (grey line) (which 
also was tried out with cells in the early-log phase but with a lower concentration 
of cells), a higher survival rate % when 0.5 % and 1.0 % of EMS was used was 
observed, this might be due to the cell concentration was higher in the samples of 
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Method 4. Method 4 provided the best results concerning reproducibility, where 
the standard error of mean (SEM) (error bars shown in Figure 4.3) was within the 
10 % range. The survival rates of Method 4 were: 87 % survival rate when cells 
were mutagenised with 0.3 % (v/v) EMS, 43 % survival rate when cells were 
mutagenised with 1.0 % (v/v) EMS, and 75 % survival rate when 0.5 % EMS was 
used to mutagenise cells. Once the EMS random mutagenesis method for C. 
necator H16 was optimised (Method 4) for a ~50 % survival rate, the selection 
pressure to be used was analysed. 
 
 
4.4.2 Selection pressure to understand C. necator H16 biotin biosynthesis 
pathway 
 
In Section 1.5.7.6, some examples of biotin-overproducing bacterial mutants are 
mentioned, whereby when directed evolution via random mutagenesis was used to 
mutagenise whole-cells, a selection pressure (biotin analogue) was used in order 
to select mutants with an improved phenotype. The biotin analogues previously 
used for biotin studies in different microorganisms and its mechanisms of action 
is shown in Table 4.2. Thus, after C. necator H16 strains have been subjected to 
mutagen treatment these can be screened in the presence of a biotin analogue, 
where it would be expected that only the mutants capable of growing under those 
conditions would be the mutants that have gone through genetic mutations in 
regions that could be related to the biotin biosynthesis pathway. 
 
Due to the characteristics in terms of 1) commercial availability, 2) 
microorganisms which have a similar pathway to C. necator H16 (i.e., bioC, bioH 
genes involved in the biotin synthesis such as E. coli) for biotin synthesis, and 3) 
the mechanism of inhibition of biotin biosynthesis studied in more detail (i.e., that 
it is known how the biotin analogue inhibits the synthesis of biotin), TVA biotin 
analogue was chosen to be used as a selection pressure for the study of the biotin 
biosynthesis pathway in C. necator H16. 
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4.4.2.1 MIC of TVA biotin analogue for C. necator H16 
 
The first experiment after selecting the biotin analogue as a selection pressure for 
C. necator H16 mutants was to prove cell growth inhibition of the C. necator H16 
WT in the presence of TVA in synthetic medium (MSM). In order to do so, a 
growth inhibition curve was performed, where the minimum inhibitory 
concentration (MIC) of TVA for C. necator H16 was the lowest concentration of 
TVA at which no growth was visible after 24 h. The growth inhibition curve is 
shown in Figure 4.4. 
 
 
 
Figure 4.4 Growth inhibition of C. necator H16 by the biotin analogue TVA. C. necator H16 was 
cultivated at 30 ºC for 24 h in 5 mL MSM for Falcon tube experiments and 150 µL MSM for 
Microtitre plate experiments containing the indicated concentrations of TVA. Error bars are ± 
SEM of three independent determinations. Abbreviations: c.g.d. %, cell growth decrease %; TVA, 
5-(2-thienyl)-valeric acid. 
 
From Figure 4.4 it was observed that TVA effectively inhibits cell growth of C. 
necator H16, as reported in literature for other microorganisms such as E. coli and 
B. subtilis, this suggests that TVA might act as a biotin analogue as well for C. 
necator H16. On the other hand, the growth inhibition of C. necator H16 by TVA 
was tested in two different conditions, falcon tubes (5 mL medium) and microtitre 
plates (150 µL medium), since these were the two conditions where all further 
experiments would be carried out. In these sets of experiments both optical 
densities were measured with the same microplate reader at 595 nm (OD595). 
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The MIC of C. necator H16 when cells were cultivated in falcon tubes, was 
observed when TVA had concentrations > 4.5 g/L, while the MIC of C. necator 
H16 when cells were cultivated in microtitre plates was observed when TVA had 
concentrations > 5.5 g/L, as there was no further growth even after 48 h 
cultivation at these concentrations. From the results obtained of both cultivation 
conditions (falcon tubes and microtitre plates), it was noticeable that the cell 
growth decrease % (c.g.d. %) was higher when the TVA concentration was 
increased in both cultivation conditions, although it was observed as well that at 
the same concentrations of TVA, different c.g.d. % resulted among the different 
cultivation conditions, e.g., when 2.5 g/L of TVA was added into the medium, an 
80 % c.g.d. was observed when cells were grown in falcon tubes, while a 49 % 
c.g.d. was observed when cells were grown in microtitre plates at the same TVA 
concentration; the impact of cell growth inhibition was always higher in falcon 
tubes than in microtitre plates. The fact that this was reproducible confirms the 
that cells grow differently in different reactor cultivation conditions, and hence, 
the effect of TVA inhibition was also different depedending on the reactor used. 
The difference in the impact of cell growth decrease in the presence of TVA was 
constantly observed in screening and characterisation studies when different 
reactors were used. 
 
The reason behind the difference in bacterial cell growth using different reactors 
(i.e., falcon tubes or microtitre plates in these set of experiments) is the different 
conditions provided in each of them, such as the shaking, since this parameter not 
only serves to ensure that cells are uniformly suspended before each OD 
measurement but also to provide aeration by providing adequate oxygen for cell 
growth (reviewed in Hall et al., 2013). The type of culture vessel used to cultivate 
cells affects cell growth at different cell growth phases, where one of the main 
factors that contribute to the cell growth in different reactors is oxygenation 
provided by the headspace of the vessel (Kram et al., 2014). Kram et al. (2014) 
hypothesize that exposure to oxygen allow more efficient respiration. Due to in 
the bioindustry usually large culture reactors are used to scale up experiments, it is 
important to consider the fact that the physiology of the bacterial cells is quite 
different in various types of reactors, the reactors could impact directly in growth, 
gene expression, protein production, resistance to stress, etc. 
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4.4.3 Genetic variation of C. necator H16 obtained after EMS random 
mutagenesis – First Round 
 
Once the EMS random mutagenesis method for C. necator H16 was developed, 
the selection pressure determined, and the c.g.d. % at different concentrations of 
the biotin analogue TVA analysed, the first round of random mutagenesis 
consisted on mutating C. necator H16 WT cells with different concentrations of 
EMS (0.3 %, 0.5 %, and 1.0 % (v/v) EMS). The procedure followed for the 
generation and selection of mutants is shown in Figure 4.5. 
 
 
 
Figure 4.5 Diagram of directed evolution via random mutagenesis: screening, and 
characterisation scheme for C. necator H16 WT cells. C. necator H16 WT cells (parent strain) 
were exposed to random mutagenesis with 0.3 %, 0.5 %, and 1.0 % (v/v) EMS. Mutant colonies 
were then screened in MSM supplemented with different concentrations of TVA in microtitre 
plates to cover a higher number of mutants. The best mutants were then characterised in falcon 
tubes to confirm the desired phenotype, and then the best mutant was chosen as the parent strain 
for the next round of mutagenesis. Abbreviations: EMS, ethyl methanesulfonate; m, mutants; TVA, 
5-(2-thienyl)-valeric acid; Rd, round. 
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The survival rate % of the first round of mutagenesis with 0.3 % (v/v) EMS was 
84 % survival rate, with 0.5 % (v/v) EMS was 72 % survival rate, and with 1.0 % 
(v/v) EMS was 46 % survival rate as observed previously in the development of 
the EMS random mutagenesis for C. necator H16 method. A total of 360 mutant 
strains from the first round of mutagenesis mutated with different concentrations 
of EMS were screened throughout the entire study in MSM supplemented with 
gentamicin and different concentrations of TVA. Each microtitre plate contained 
control samples to compare cell growth and find beneficial mutants, control 
samples were the parent strain C. necator H16 WT in MSM, and C. necator H16 
in MSM supplemented with TVA, which were always included in triplicates in all 
experiments. The best mutant strains for each of the experiments performed for 
the first round of random mutagenesis were chosen as follows: for each OD595 
measurement taken during the cell growth curve, the two highest OD595 values 
corresponding to mutant strains were selected to be followed through the entire 
cell growth study, then, all the mutants selected were compared against each other 
and against the parent strain to identify the mutant strains with the best cell 
growth performance in the presence of TVA. The mutant strains were named as 
“m” for mutant, followed by a “number” from 1 to 2, which corresponds to the 
round of random mutagenesis, and a “letter + number” corresponding to the well 
of the microtitre plate where the mutant strain was grown.  
 
Screening analysis was performed in microtitre plates with 150 µL of MSM with 
or without TVA and OD was measured at 595 nm, while the characterisation 
analysis was performed in 5 mL of MSM with or without TVA and OD was 
measured at 600 nm. Through all the experiments performed in this Chapter 4, 
the OD readings of samples measured with cuvettes appear to reach higher ODs 
(e.g. cells in MSM without TVA, cells could reach a max OD600 » 14) than the 
samples measured with microtitre plates (e.g. cells in MSM without TVA, cells 
could reach a max OD595 » 2), this is due to the method of photometry differs 
between a standard spectrophotometer and a microtitre plate reader. The OD 
readings of the samples measured in a cuvette is determined by the light sent 
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through the sample in a horizontal manner, while the OD readings of the samples 
measured with the microtitre plate is determined by the light sent through the 
sample in a vertical manner. With the cuvette, the path length is usually 1 cm, 
while the path length in a microtitre plate reader depends on the volume of the 
sample. Due to according to Beer’s Law (A = eBC), the concentration of a 
solution (C) depends on its absorbance (A), path length (b), and molar 
absorptivity (e), an identical sample that is measured in a standard 
spectrophotometer and in a microtitre plate reader will provide different values 
due to the difference in path length. 
 
 
4.4.3.1 Analysis of mutant strains of C. necator H16 obtained from EMS 
random mutagenesis with 0.3 % (v/v) EMS – First Round 
 
When C. necator H16 WT cells were mutagenised with 0.3 % (v/v) EMS, the 
screening of the mutants was performed in two different microtitre plates with 
different concentrations of TVA. A total of 180 mutant strains were screened in 
two different 96-well microtitre plates with MSM supplemented with gentamicin 
and TVA; one microtitre plate was set with 1.0 g/L of TVA and the other one with 
3.5 g/L of TVA, these two different concentrations of TVA were used as it was 
unknown how would mutants grow in the presence of the biotin analogue, hence a 
low concentration (1.0 g/L TVA) was used in case mutants were not capable of 
growing at high concentrations of TVA, while a higher concentration (3.5 g/L 
TVA) was used in case the lower concentrations would not allow detecting a 
difference in growth performance between the WT and the mutant strains (Figure 
4.6). 
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Figure 4.6 Screening of mutant strains mutagenised with 0.3 % (v/v) EMS. Screening analysis was 
performed in microtitre plates with 150 µL of MSM with or without TVA. A) C. necator H16 WT in 
MSM (circle, green line), and C. necator H16 WT in MSM supplemented with 1.0 g/L TVA (circle, 
red line); m1A6 in MSM supplemented with 1.0 g/L TVA (triangle, blue line), m1B11 in MSM 
supplemented with 1.0 g/L TVA (inverted triangle, pink line), m1D9 in MSM supplemented with 
1.0 g/L TVA (diamond, orange line), and m1F2 in MSM supplemented with 1.0 g/L TVA (square, 
grey line). B) C. necator H16 WT in MSM (circle, green line), and C. necator H16 WT in MSM 
supplemented with 3.5 g/L TVA (circle, red line); m1D9 in MSM supplemented with 3.5 g/L TVA 
(triangle, blue line), m1F5 in MSM supplemented with 3.5 g/L TVA (inverted triangle, pink line), 
m1G6 in MSM supplemented with 3.5 g/L TVA (diamond, orange line), and m1G7 in MSM 
supplemented with 3.5 g/L TVA (square, grey line). Error bars are ± SEM of three independent 
determinations. Abbreviations: TVA, 5-(2-thienyl)-valeric acid; m, mutant. 
 
 
The screening of this first round of random mutagenesis showed mutants with an 
improved phenotype in cell growth in the presence of the TVA biotin analogue. 
All the best mutants shown in Figure 4.6 of both microtitre plates showed less 
cell growth decrease in the presence of TVA than the WT parent strain. C. necator 
H16 showed an 11 % c.g.d.  when grown in 1.0 g/L of TVA, and a 72 % c.g.d. 
when grown in 3.5 g/L of TVA after 24 h cultivation as observed in previous MIC 
studies. Although all mutants grew very similarly in both microtitre plates, the 
two mutants of each microtitre plate with the highest fold in growth compared to 
the WT were chosen as the best mutants; the fold comparison was analysed at 24 
h of cultivation. The best mutants were the m1D9 and m1F2 from the 1.0 g/L of 
TVA microtitre plate, where growth was 1.1-fold faster compared to the WT in 
TVA for both mutants, and m1F5 and m1G6 from the 3.5 g/L of TVA microtitre 
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plate, where growth was 2.5 and 2.4-fold faster compared to the WT in TVA 
respectively. 
 
After selecting the best mutants from both microtitre plates, the characterisation of 
all four mutants was performed in 5 mL of MSM supplemented with TVA in 
falcon tubes, a higher concentration of TVA was used to analyse the performance 
of the mutant strains. The cell growth curve for the characterisation of mutant 
strains is shown in Figure 4.7, where 4.5 g/L of TVA was used to confirm their 
phenotype. Mutant strains were also grown in MSM without TVA to check if 
mutant strains could still grow like the WT in sodium gluconate. 
 
 
 
Figure 4.7 Characterisation of mutant strains mutagenised with 0.3 % (v/v) EMS. 
Characterisation analysis was performed in falcon tubes with 5 ml of MSM with or without TVA. 
C. necator H16 WT in MSM (circle, green line), and C. necator H16 WT in MSM supplemented 
with 4.5 g/L TVA (circle, red line); m1D9 mutant strain in MSM (triangle, green line), m1F2 
mutant strain in MSM (inverted triangle, green line), m1F5 mutant strain in MSM (diamond, 
green line), and m1G6 mutant strain in MSM (square, green line); m1D9 mutant strain in MSM 
supplemented with 4.5 g/L TVA (triangle, blue line), m1F2 mutant strain in MSM supplemented 
with 4.5 g/L TVA (inverted triangle, pink line), m1F5 mutant strain in MSM supplemented with 4.5 
g/L TVA (diamond, orange line), and m1G6 mutant strain in MSM supplemented with 4.5 g/L TVA 
(square, grey line). The inset shows the magnified cell growth curve of C. necator H16 WT and 
mutant strains in 4.5 g/L TVA. Abbreviations: TVA, 5-(2-thienyl)-valeric acid; m, mutant. 
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From Figure 4.7 it was confirmed that the cell growth of the mutant strains 
screened in the presence of 1.0 g/L of TVA (m1D9 and m1F2), and the mutants 
screened in the presence of 3.5 g/L of TVA (m1F5 and m1G6) was effectively 
improved compared the cell growth of C. necator H16 WT in TVA. On the other 
hand, it was observed as well that mutant strains were also capable of growing in 
MSM as the WT strain. C. necator H16 showed a 96 % c.g.d. when grown in 4.5 
g/L of TVA after 24 h cultivation as observed in previous MIC studies.  
 
The best mutant from the characterisation studies was selected by analysing the 
performance in cell growth of all mutants in the presence of TVA, where the 
highest fold in growth compared to the WT was chosen as the best mutant, the 
fold comparison was analysed at 24 h of cultivation. The best mutant from the 
screening was the m1F5 mutant (diamond, orange line), which showed to be 5.8-
fold faster than the WT strain in the presence of TVA, followed by the m1G6 
mutant (square, grey line), which showed to be 4.1-fold faster than the WT strain, 
and then by the m1F2 (inverted triangle, pink line) and m1D9 (triangle, blue line) 
mutants; which showed to be 2.6 and 2.0-fold faster than the WT strain 
respectively when cells were grown at 4.5 g/L of TVA.  
 
 
4.4.3.2 Analysis of mutant strains of C. necator H16 obtained from EMS 
random mutagenesis with 0.5 % (v/v) EMS – First Round 
 
When C. necator H16 WT cells were mutagenised with 0.5 % (v/v) EMS, the 
screening of the mutants was set in a microtitre plate with 4.5 g/L of TVA for this 
first round of mutagenesis, where a total of 90 mutant strains were screened 
(Figure 4.8). 
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Figure 4.8 Screening of mutant strains mutagenised with 0.5 % (v/v) EMS. Screening analysis was 
performed in microtitre plates with 150 µL of MSM with or without TVA. C. necator H16 WT in 
MSM (circle, green line), and C. necator H16 WT in MSM supplemented with 4.5 g/L TVA (circle, 
red line); m1B8 in MSM supplemented with 4.5 g/L TVA (triangle, blue line), m1C3 in MSM 
supplemented with 4.5 g/L TVA (inverted triangle, pink line), m1C4 in MSM supplemented with 
4.5 g/L TVA (diamond, orange line), and m1G7 in MSM supplemented with 4.5 g/L TVA (square, 
grey line). Error bars are ± SEM of three independent determinations. Abbreviations: TVA, 5-(2-
thienyl)-valeric acid; m, mutant. 
 
 
The screening of this first round of random mutagenesis showed mutants with an 
improved phenotype in cell growth in the presence of the TVA biotin analogue. 
All the best mutants shown in Figure 4.8 showed less cell growth decrease in the 
presence of TVA than the WT parent strain. C. necator H16 showed an 85 % 
c.g.d.  when grown in 4.5 g/L of TVA after 24 h cultivation as observed in 
previous MIC studies. The mutant with the highest fold in growth compared to the 
WT was chosen as the best mutant, the fold comparison was analysed at 24 h of 
cultivation. The best mutant was the m1C3, where growth was 1.4-fold faster 
compared to the WT in TVA. 
 
After selecting the best mutant, the characterisation of m1C3 was performed in 5 
mL of MSM supplemented with TVA in falcon tubes. The cell growth curve for 
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the characterisation of the mutant strain is shown in Figure 4.9, where 4.5 g/L of 
TVA was used to confirm its phenotype. The mutant strain was also grown in 
MSM without TVA to check if it could still grow like the WT in sodium 
gluconate. 
 
 
 
Figure 4.9 Characterisation of mutant strains mutagenised with 0.5 % (v/v) EMS. 
Characterisation analysis was performed in falcon tubes with 5 ml of MSM with or without TVA. 
C. necator H16 WT in MSM (circle, green line), and C. necator H16 WT in MSM supplemented 
with 4.5 g/L TVA (circle, red line); m1C3 mutant strain in MSM (triangle, green line), and m1C3 
mutant strain in MSM supplemented with 4.5 g/L TVA (triangle, blue line). The inset shows the 
magnified cell growth curve of C. necator H16 WT and m1C3 in 4.5 g/L TVA. Abbreviations: TVA, 
5-(2-thienyl)-valeric acid; m, mutant. 
 
 
From Figure 4.9 it was confirmed that the cell growth of the mutant strain 
screened in the presence of 4.5 g/L of TVA (m1C3) was effectively improved 
compared the cell growth of C. necator H16 WT in TVA. On the other hand, it 
was observed as well that the mutant strain was also capable of growing in MSM 
as the WT. C. necator H16 showed a 94 % c.g.d. when grown in 4.5 g/L of TVA 
after 24 h cultivation as observed in previous MIC studies. The performance in 
cell growth of the mutant strain in the presence of TVA was analysed at 24 h of 
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cultivation. The m1C3 mutant (triangle, blue line) showed to be 3.0-fold faster 
than the WT strain in the presence of 4.5 g/L of TVA. 
 
4.4.3.3 Analysis of mutant strains of C. necator H16 obtained from EMS 
random mutagenesis with 1.0 % (v/v) EMS – First Round 
 
When C. necator H16 WT cells were mutagenised with 1.0 % (v/v) EMS, the 
screening of the mutants was set in a microtitre plate with 4.5 g/L of TVA, where 
a total of 90 mutant strains were screened (Figure 4.10). 
 
 
 
Figure 4.10 Screening of mutant strains mutagenised with 1.0 % (v/v) EMS. Screening analysis 
was performed in microtitre plates with 150 µL of MSM with or without TVA. C. necator H16 WT 
in MSM (circle, green line), and C. necator H16 WT in MSM supplemented with 4.5 g/L TVA 
(circle, red line); m1B11 in MSM supplemented with 4.5 g/L TVA (triangle, blue line), m1G9 in 
MSM supplemented with 4.5 g/L TVA (inverted triangle, pink line), m1H3 in MSM supplemented 
with 4.5 g/L TVA (diamond, orange line), and m1H7 in MSM supplemented with 4.5 g/L TVA 
(square, grey line). Error bars are ± SEM of three independent determinations. Abbreviations: 
TVA, 5-(2-thienyl)-valeric acid; m, mutant. 
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The screening of this first round of random mutagenesis showed mutants with an 
improved phenotype in cell growth in the presence of the TVA biotin analogue. 
All the best mutants shown in Figure 4.10 showed less cell growth decrease in the 
presence of TVA than the WT parent strain. C. necator H16 showed an 84 % 
c.g.d.  when grown in 4.5 g/L of TVA after 24 h cultivation as observed in 
previous MIC studies. The mutant with the highest fold in growth compared to the 
WT was chosen as the best mutant, the fold comparison was analysed at 24 h of 
cultivation. The best mutant was the m1G9, where growth was 1.8-fold faster 
compared to the WT in TVA. 
 
After selecting the best mutant, the characterisation of m1G9 was performed in 5 
mL of MSM supplemented with TVA in falcon tubes. The cell growth curve for 
the characterisation of the mutant strain is shown in Figure 4.11, where 4.5 g/L of 
TVA was used to confirm its phenotype. The mutant strain was also grown in 
MSM without TVA to check if it could still grow like the WT in sodium 
gluconate. 
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Figure 4.11 Characterisation of mutant strains mutagenised with 1.0 % (v/v) EMS. 
Characterisation analysis was performed in falcon tubes with 5 ml of MSM with or without TVA. 
C. necator H16 WT in MSM (circle, green line), and C. necator H16 WT in MSM supplemented 
with 4.5 g/L TVA (circle, red line); m1G9 mutant strain in MSM (triangle, green line), and m1G9 
mutant strain in MSM supplemented with 4.5 g/L TVA (inverted triangle, pink line). The inset 
shows the magnified cell growth curve of C. necator H16 WT and m1G9 in 4.5 g/L TVA. 
Abbreviations: TVA, 5-(2-thienyl)-valeric acid; m, mutant. 
 
From Figure 4.11 it was confirmed that the cell growth of the mutant strain 
screened in the presence of 4.5 g/L of TVA (m1G9) was effectively improved 
compared the cell growth of C. necator H16 WT in TVA. On the other hand, it 
was observed as well that the mutant strain was also capable of growing in MSM 
as the WT. C. necator H16 showed a 94 % c.g.d.  when grown in 4.5 g/L of TVA 
after 24 h cultivation as observed in previous MIC studies. The performance in 
cell growth of the mutant strain in the presence of TVA was analysed at 24 h of 
cultivation. The m1G9 mutant (inverted triangle, pink line) showed to be 3.7-fold 
faster than the WT strain in the presence of 4.5 g/L of TVA. 
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4.4.3.4 C. necator H16 mutant library from the first round of mutagenesis 
 
A total of 360 mutant strains were screened after the first round of EMS random 
mutagenesis with different EMS concentrations, where all the mutants 
characterised showed to have a better cell growth performance in the presence of 
the biotin analogue TVA than its parent strain C. necator H16, this could mean 
that these mutants have gone through mutations in specific regions that could be 
related to the biotin biosynthesis pathway, and these mutations allowed the mutant 
strains to survive under different concentrations of TVA better than the WT. 
Table 4.5 shows the different concentrations of EMS used to mutagenise C. 
necator H16 WT cells, and the survival rates % obtained after mutagenesis, the 
c.g.d. % obtained from C. necator H16 WT in screening and characterisation 
analyses, and the mutant strains generated from the WT with its corresponding 
growth fold compared to the WT at 24 h cultivation in characterisation analyses.  
 
 
Table 4.5 Library of mutants of the first round of mutagenesis. 
Parent strain EMS % (v/v), 
Survival rate % 
Screening/Characterisa-
tion in [TVA] and c.g.d. %  
of WT 
Mutant 
strains 
Fold in 
characteri-
sation 
C. necator H16 0.3 % EMS, 84 % Screening in Mp:  
[1.0 g/L] TVA, 11 % 
[3.5 g/L] TVA, 72 % 
Characterisation in Ft: 
[4.5 g/L] TVA, 96 %  
m1F2 
m1D9 
m1F5 
m1G6 
2.6 
2.0 
5.8 
4.1 
C. necator H16 0.5 % EMS, 72 % Screening in Mp: 
[4.5 g/L] TVA, 85 %  
Characterisation in Ft: 
[4.5 g/L] TVA, 94 % 
m1C3 3.0 
C. necator H16 1.0 % EMS, 46 % Screening in Mp:  
[4.5 g/L] TVA, 84 % 
Characterisation in Ft:  
[4.5 g/L] TVA, 94 % 
m1G9 3.7 
Abbreviations: EMS, ethyl methanesulfonate; m, mutants; TVA, 5-(2-thienyl)-valeric acid; c.g.d. 
%, cell growth decrease %; Mp, microtitre plates; Ft, falcon tubes. 
 
 
After analysing the results obtained from the first round or mutagenesis, the best 
mutants were used to proceed with the second round of mutagenesis with the two 
mutant strains with the highest fold in growth from different EMS concentrations 
used, hence, the m1F5 and m1G9 mutant strains were selected for the second 
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round of mutagenesis. These new parent strains were mutagenised in the second 
round of mutagenesis with 0.3 % (v/v) EMS and 1.0 % (v/v) EMS respectively, as 
it was done in the first round of mutagenesis. 
 
 
4.4.4 Genetic variation of m1F5 and m1G9 mutant strains obtained after 
EMS mutagenesis – Second Round 
 
Once the best mutants from the first round of mutagenesis were selected, the 
second round of mutagenesis was performed using m1F5 and m1G9 mutants as 
parent strains. In the second round of mutagenesis 0.3 % (v/v) EMS was used to 
mutagenise m1F5 cells, while 1.0 % (v/v) EMS was used to mutagenise m1G9 
cells. The procedure followed for the generation and selection of mutants was the 
same followed for the first round of mutagenesis (Figure 4.5), although this time 
the parent strains were m1F5 and m1G9 and not C. necator H16 WT. 
 
The survival rate % of the second round of mutagenesis with 0.3 % (v/v) EMS for 
m1F5 mutant was 83 % survival rate, and with 1.0 % (v/v) EMS for m1G9 mutant 
was 48 % survival rate as observed previously in the development of the EMS 
random mutagenesis method. A total of 336 mutant strains from the second round 
of mutagenesis mutated with different concentrations of EMS were screened 
throughout the entire study in MSM supplemented with gentamicin and different 
concentrations of TVA. Each microtitre plate contained control samples to 
compare cell growth and find beneficial mutants, control samples were C. necator 
H16 WT in MSM, and C. necator H16 in MSM supplemented with TVA, and the 
parent strains m1F5 and m1G9 with and without TVA as well, which were always 
included in triplicates in all experiments. The best mutant strains for each of the 
experiments performed for the second round of random mutagenesis were chosen 
as follows: for each OD595 measurement taken during the cell growth curve, the 
two highest OD595 values corresponding to mutant strains were selected to be 
followed through the entire cell growth study, then, all the mutants selected were 
compared against each other and against the parent strain to identify the mutant 
strains with the best cell growth performance in the presence of TVA. The mutant 
strains were named as “m” for mutant, followed by a “number” from 1 to 2, which 
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corresponds to the round of random mutagenesis, and a “letter + number” 
corresponding to the well of the microtitre plate where the mutant strain was 
grown. 
 
 
4.4.4.1 Analysis of mutant strains of m1F5 obtained from EMS random 
mutagenesis with 0.3 % (v/v) EMS – Second Round 
 
When m1F5 cells were mutagenised with 0.3 % (v/v) EMS, the screening of the 
mutants was set in a microtitre plate with 4.5 g/L of TVA, where a total of 84 
mutant strains were screened (Figure 4.12). 
 
 
 
Figure 4.12 Screening of mutant strains mutagenised with 0.3 % (v/v) EMS. Screening analysis 
was performed in microtitre plates with 150 µL of MSM with or without TVA. C. necator H16 WT 
in MSM (circle, green line), m1F5 in MSM (open square, green line), C. necator H16 WT in MSM 
supplemented with 4.5 g/L TVA (circle, red dotted line), and m1F5 in MSM supplemented with 4.5 
g/L TVA (open square, red line); m2C2 in MSM supplemented with 4.5 g/L TVA (triangle, blue 
line), m2C4 in MSM supplemented with 4.5 g/L TVA (inverted triangle, pink line), m2C8 in MSM 
supplemented with 4.5 g/L TVA (diamond, orange line), and m2H5 in MSM supplemented with 4.5 
g/L TVA (square, grey line). Error bars are ± SEM of three independent determinations. 
Abbreviations: TVA, 5-(2-thienyl)-valeric acid; m, mutant. 
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The screening of this second round of random mutagenesis showed mutants with 
an improved phenotype in cell growth in the presence of the TVA biotin 
analogue. Although all the best mutants shown in Figure 4.12 showed less cell 
growth decrease in the presence of TVA than the WT strain (circle, red dotted 
line), its improvement in cell growth was not better than its parent strain m1F5 
(open square, red line), unless for the mutant m2C4 (inverted triangle, pink line), 
which showed to have an slight better cell growth performance than the parent 
strain m1F5 in the presence of TVA. C. necator H16 showed an 86 % c.g.d. when 
grown in 4.5 g/L of TVA after 24 h cultivation as observed in previous MIC 
studies.  
 
Since at least one of the mutants (m2C4) showed to have a slightly better cell 
growth performance in the presence of TVA than the parent strain m1F5, the 
characterisation of the best two mutants with the highest fold in growth compared 
to the WT was performed. The best mutants were the m2C2 and m2C4, where 
growth was 2.0 and 2.3-fold faster compared to the WT in TVA, and only 1.1-fold 
faster than the parent strain m1F5 for the mutant m2C4; the fold comparison was 
analysed at 24 h of cultivation. 
 
After selecting the best mutants, the characterisation of m2C2 and m2C4 was 
performed in 5 mL of MSM supplemented with TVA in falcon tubes to confirm if 
effectively m2C4 showed a better performance in cell growth than m2C2, or if 
they grew similarly in the presence of TVA, and to confirm also if they had a 
better cell growth performance than its parent strains m1F5. The cell growth curve 
for the characterisation of mutant strains is shown in Figure 4.13, where 4.5 g/L 
of TVA was used to confirm the phenotype of the mutant strains. The mutant 
strains were also grown in MSM without TVA to check if they could still grow 
like the WT in sodium gluconate. 
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Figure 4.13 Characterisation of mutant strains mutagenised with 0.3 % (v/v) EMS. 
Characterisation analysis was performed in falcon tubes with 5 ml of MSM with or without TVA. 
C. necator H16 WT in MSM (circle, green line), m1F5 in MSM (open square, green line), C. 
necator H16 WT in MSM supplemented with 4.5 g/L TVA (circle, red dotted line), and m1F5 in 
MSM supplemented with 4.5 g/L TVA (open square, red line); m2C2 in MSM (triangle, green 
line), and m2C4 in MSM (inverted triangle, green line); m2C2 mutant strain in MSM 
supplemented with 4.5 g/L TVA (triangle, blue line), and m2C4 mutant strain in MSM 
supplemented with 4.5 g/L TVA (inverted triangle, pink line). The inset shows the magnified cell 
growth curve of C. necator H16 WT and mutant strains in 4.5 g/L TVA. Error bars are ± SEM of 
three independent determinations. Abbreviations: TVA, 5-(2-thienyl)-valeric acid; m, mutant. 
 
 
From Figure 4.13 it was confirmed that the cell growth of the mutant strains 
screened in the presence of 4.5 g/L of TVA (m2C2, and m2C4) was effectively 
improved compared the cell growth of C. necator H16 WT in TVA. On the other 
hand, it was observed as well that the mutant strains were also capable of growing 
in MSM as the WT strain. C. necator H16 showed a 95 % c.g.d. when grown in 
4.5 g/L of TVA after 24 h cultivation as observed in previous MIC studies. The 
performance in cell growth of the mutant strains in the presence of TVA was 
analysed at 24 h of cultivation. The m2C2 (triangle, blue line) and m2C4 (inverted 
triangle, pink line) mutants showed to be 2.4 and 1.7-fold faster than the WT 
strain in the presence of TVA respectively, and only 1.1-fold faster than the parent 
strain m1F5 for the mutant m2C2. Thus, the mutants obtained from this second 
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round of mutagenesis did not improve significantly compared to its parent strain 
m1F5; nevertheless, m2C2 was chosen as the best mutant strain of this round for 
further experiments. 
 
 
4.4.4.2 Analysis of mutant strains of m1G9 obtained from EMS random 
mutagenesis with 1.0 % (v/v) EMS – Second Round 
 
When m1G9 cells were mutagenised with 1.0 % (v/v) EMS, the screening of the 
mutants was set in a microtitre plate with 4.5 g/L of TVA for this second round of 
mutagenesis, where a total of 84 mutant strains were screened (Figure 4.14). 
 
 
Figure 4.14 Screening of mutant strains mutagenised with 1.0 % (v/v) EMS. Screening analysis 
was performed in microtitre plates with 150 µL of MSM with or without TVA. C. necator H16 WT 
in MSM (circle, green line), m1G9 in MSM (open square, green line), C. necator H16 WT in MSM 
supplemented with 4.5 g/L TVA (circle, red dotted line), and m1G9 in MSM supplemented with 4.5 
g/L TVA (open square, red line); m2C7 in MSM supplemented with 4.5 g/L TVA (triangle, blue 
line), m2E6 in MSM supplemented with 4.5 g/L TVA (inverted triangle, pink line), m2E9 in MSM 
supplemented with 4.5 g/L TVA (diamond, orange line), and m2G7 in MSM supplemented with 4.5 
g/L TVA (square, grey line). Error bars are ± SEM of three independent determinations. 
Abbreviations: TVA, 5-(2-thienyl)-valeric acid; m, mutant. 
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The screening of this second round of random mutagenesis showed mutants with 
an improved phenotype in cell growth in the presence of the TVA biotin 
analogue. Although all the best mutants shown in Figure 4.14 showed less cell 
growth decrease in the presence of TVA than the WT strain (circle, red dotted 
line), its improvement in cell growth was not better than its parent strain m1G9 
(open square, red line) as observed previously with m1F5 derived mutants. C. 
necator H16 showed an 84 % c.g.d. when grown in 4.5 g/L of TVA after 24 h 
cultivation as observed in previous MIC studies.  
 
Due to no mutants were found to be better than the parent strain m1G9, no 
characterisation was performed for this experiment, instead, a separate trial of 
second round of mutagenesis of m1G9 with 1.0 % (v/v) EMS was performed, but 
the same results were found, whereby there were mutants with an improvement in 
cell growth in the presence of TVA compared to C. necator H16 WT (data not 
shown) but the cell growth improvement was not better than the m1G9 parent 
strain; another trial was performed by modifying the selection system, which 
consisted on increasing throughput for higher probability of identifying rare 
mutants by plating mutated cells in MSM agar plates supplemented with different 
concentrations of TVA rather than plating mutated cells in MSM agar plates 
without the selection pressure. The incubation of agar plates was left for 24 h 
more than when cells had been plated in agar plates without TVA (where only 48 
h was sufficient to observe growth of colonies in agar plates) (Figure 4.15), but 
again, no better mutants than m1G9 were found after screening analyses even at 
longer incubation times. 
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Figure 4.15 Diagram of improvements in the selection system to find rare mutants. The diagram 
highlights in red the main differences in the selection system on how mutants were plated after 
EMS mutagenesis in the first and the second round of mutagenesis. In order to select mutants with 
a better cell growth performance in TVA than m1G9, the mutagenised m1G9 was plated in MSM 
agar plates supplemented with 2.0 g/L and 2.5 g/L of TVA after EMS treatment in order to 
increase throughput for a  higher probability of identifying rare mutants. Abbreviations: TVA, 5-
(2-thienyl)-valeric acid; m, mutant. 
 
 
4.4.4.3 C. necator H16 mutant library from the second round of mutagenesis 
 
A total of 336 mutant strains were screened after the second round of EMS 
random mutagenesis with different EMS concentrations, where not all the mutants 
characterised showed to have a better cell growth performance in the presence of 
the biotin analogue TVA than its parent strains isolated from the first round of 
mutagenesis, even when improvements in the selection system shown in Figure 
4.15 were performed. Table 4.6 shows the different concentrations of EMS used 
to mutagenise m1F5 and m1G9 mutant strains, and the survival rates % obtained 
after mutagenesis, the c.g.d. % obtained from C. necator H16 WT in screening 
and characterisation analyses, and the mutant strains of the second round of 
mutagenesis with its corresponding growth fold compared to the WT at 24 h 
cultivation in characterisation analyses.  
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Table 4.6 Library of mutants of the second round of mutagenesis. 
Parent strain EMS % (v/v), 
Survival rate % 
Screening/Characterisation 
in [TVA] and c.g.d. %  
of WT 
Mutant 
strains 
Fold in 
characteri-
sation 
m1F5 0.3 % EMS, 83 % Screening in Mp:  
[4.5 g/L] TVA, 83 % 
Characterisation in Ft: 
[4.5 g/L] TVA, 95 %  
m2C2 
m2C4 
2.4 
1.7 
 
m1G9  1.0 % EMS, 48 % Screening in Mp: 
[ 4.5 g/L] TVA, 84 %  
NA NA 
Abbreviations: EMS, ethyl methanesulfonate; m, mutants; TVA, 5-(2-thienyl)-valeric acid; c.g.d. 
%, cell growth decrease %; Mp, microtitre plates; Ft, falcon tubes; NA, not applicable. 
 
 
4.4.5 Determination of biotin content in C. necator H16 and mutant strains 
 
In order to corroborate if effectively the improvement in cell growth in the 
presence of the TVA biotin analogue was due to an overproduction of biotin by 
the mutant strains, the biotin produced in C. necator H16 WT strain was 
compared to the biotin produced in some of the mutant strains previously isolated 
from the first and second round of mutagenesis, where it was expected that mutant 
strains would produce higher quantities of biotin since they had been able to grow 
better than the WT in the presence of the biotin analogue. The mutants isolated 
from previous rounds of EMS random mutagenesis are shown in Figure 4.16. 
 
 
 
Figure 4.16 Library of mutants generated by directed evolution via EMS random mutagenesis 
from the first and second round of mutagenesis.  
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The determination of the biotin content was performed with a FluoReporter Biotin 
Quantitation Assay Kit, which is a sensitive fluorometric assay for biotin 
quantitation. A biocytin (biotinylated lysine) standard curve was generated in 
order to be able to determine the biotin content of cells. Triplicates of each of the 
samples for the standard curve as well as for cell samples were set in order to 
determine the biotin content. Once the standard curve was generated, only the 
mutants with the highest fold in growth compared to the WT were chosen to 
determine their biotin content: m1F5, m1C3, m1G9, and m2C2.  
 
Initially, the biotin content of C. necator H16 and mutant strains was quantified 
when cells were grown only in MSM (Figure 4.17A), where cells were cultivated 
in MSM for 40 h before an aliquot of the culture was withdrawn for biotin 
quantitation assays. After analysing biotin content, from Figure 4.17A, it could be 
observed that the difference in biotin production between the WT and the mutants 
was not very significant, where the biotin production was only 1.1-fold higher for 
m1C3 and m1G9 compared to the biotin production of the WT strain; due to the 
biotin production among the WT and the mutant strains was not as high as 
expected, a further experiment was designed, where the determination of biotin 
content was analysed when cells were grown in MSM and the selection pressure 
(MSM supplemented with 2.5 g/L of TVA) (Figure 4.17B), the rationale behind 
this experimental design was that probably the mutant strains would only produce 
higher amounts of biotin when they were grown under the selection pressure. 
Nevertheless, the results of the determination of the biotin content when cells 
were grown in MSM supplemented with TVA were very similar to the results 
obtained when cells were grown only in MSM, whereby the biotin production was 
very similar among all samples (WT and mutants), where the highest fold 
obtained was 1.1 for the m2C2 compared to the WT. 
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Figure 4.17 Determination of biotin content in C. necator H16 and mutant strains. A) Biotin 
quantitation of samples grown only in MSM, where control samples were MSM medium (no cells) 
(black column), and C. necator H16 WT strain in MSM (green column). B) Biotin quantitation of 
samples grown in MSM supplemented with 2.5 g/L TVA, where control samples were MSM 
medium supplemented with 2.5 g/L TVA (no cells) (black column), and C. necator H16 WT strain 
in MSM supplemented with 2.5 g/L TVA (green column). Error bars are ± SEM of three 
independent determinations. Abbreviations: TVA, 5-(2-thienyl)-valeric acid; m, mutant. 
 
 
As observed in Figure 4.17B, the concentration of biotin was higher by »10-fold 
when cells were grown in the presence of TVA than when cells were grown only 
in MSM, this might be due to TVA generates a high background, as can be 
observed with the control sample which only contained MSM medium 
supplemented with TVA (no cells) (black column). Nevertheless, the outcome 
was the same than the one obtained in cells grown without TVA, where no 
significant difference in biotin production among the WT and the mutant strains 
was found. 
 
The fact that the biotin quantitation results demonstrated that the biotin production 
was about the same in the WT strain and the mutant strains raise the question on 
whether TVA is leading to find mutants that are related with the biotin 
biosynthesis pathway of C. necator H16 or not. It is possible that TVA might not 
be leading to finding mutants that are related with the genes of the biotin 
biosynthesis but to find mutants that have mutations in other non-biotin related 
genes, and hence the mutants do not show a higher biotin production. 
 
Chapter 4. Directed evolution:  
Development of a directed evolution via random mutagenesis tool for  
Cupriavidus necator H16 to understand its biotin biosynthesis pathway 
 176 
Also, it could be possible that there is no significant increase in biotin production 
in the mutant strains compared to the WT due to the difference in cell growth in 
the presence of TVA between the WT and the mutant strains isolated from the 
first and second round of mutagenesis is still not significant enough to show a 
higher biotin production. Further studies would be required to find mutants with a 
higher fold in growth in TVA compared to the WT, to confirm if a higher fold in 
growth in the presence of TVA would provide a significant increase in biotin 
content between the mutants and the WT strain. On the other hand, a different 
selection pressure, such as the biotin analogues described in Error! Reference 
source not found., could be tested also to find rare mutants. 
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4.5 Conclusions 
 
A method of EMS random mutagenesis for C. necator H16 was developed and 
optimised in this Chapter 4, which provided a survival rate % from ~ 50 to 85 %. 
This method represents a powerful tool for C. necator H16, since no EMS random 
mutagenesis method has been reported to date for the strain. This tool can be used 
for engineering C. necator H16 for a wide variety of purposes, as along with other 
combinatorial approaches, directed evolution via random mutagenesis is 
becoming increasingly important for metabolic engineering of complex 
phenotypes. 
 
In order to explore the applicability of directed evolution via random mutagenesis 
for C. necator H16, a library of mutants was generated to try to understand the 
biotin pathway in C. necator H16. The chemical mutagen EMS was used for 
random mutagenesis; the mutagen was used to speed up the selection process of 
C. necator H16 mutants that were expected to overproduce biotin in the presence 
of the biotin analogue TVA. A total of 696 TVA-resistant mutants of C. necator 
H16 were isolated and screened, from which 8 mutants were further characterised 
at different concentrations of TVA. All these 8 mutants showed an improved 
performance in cell growth in the presence of TVA, these mutants were obtained 
either in the first or the second round of EMS random mutagenesis, being m1F5 
(from the first round of mutagenesis, mutated with 0.3 % (v/v) EMS) the mutant 
that showed the highest cell growth fold compared to the WT (5.8-fold faster than 
the WT after 24 h cultivation). Nevertheless, when the mutants isolated from the 
first and second round of mutagenesis were analysed for biotin quantitation, 
studies showed no improvement in biotin production compared to C. necator H16 
WT. 
 
The results of the determination of biotin content could suggest that a higher fold 
in cell growth must be achieved (e.g., a mutant that grows at least 10-fold faster 
than the WT strain) in order to observe a higher difference in biotin production 
between the WT and the mutant strains. Nevertheless, the optimisation of the 
EMS random mutagenesis method developed in this study for C. necator H16 
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proved to be a useful tool, as mutants with an improved phenotype to grow in the 
presence of TVA were obtained after directed evolution via random mutagenesis. 
This method is a potential tool that could be used for exploring other unknown 
metabolic pathways of C. necator H16, or to continue exploring the biotin 
biosynthesis pathway of C. necator H16 with a different biotin analogue. 
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Abstract 
 
 
 
 
Cupriavidus necator H16 has a versatile metabolism that can utilise a wide-range 
range of carbon sources, including renewable carbon sources that can be used for 
chemical production. Glycerol (crude glycerol) is a by-product mainly obtained 
from biodiesel production and fat splitting processes, and, although C. necator 
H16 can utilise glycerol to produce different bioproducts such as PHB, the growth 
of the wild-type strain of C. necator H16 in glycerol is very slow compared to 
other preferable carbon sources such as gluconate, this fact limits the use of 
glycerol as a feedstock for chemical production. In this Chapter 5, the knowledge 
and strategies studied in previous chapters and proven to work in C. necator H16 
supported the approaches selected to construct recombinant and evolved strains of 
C. necator H16 for chemical production (bioplastics) using waste stream (crude 
glycerol) as a feedstock. This chapter compares rational design and evolutionary 
engineering approaches for unlocking the glycerol. Specifically, expression of 
glycerol utilisation enzymes native to C. necator H16 or from E. coli, and 
adaptive evolution were investigated. Both strategies were successful and the best 
C. necator H16 variant showed a 8-fold improvement in growth compared to the 
wild type strain, where the best variant was derived from adaptive evolution. 
Worthy of note, this best variant also demonstrated superior growth in crude 
glycerol (sweetwater) obtained from an industrial fat splitting process.  
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5 Chapter 5. Rational design and Evolutionary engineering: Engineering 
Cupriavidus necator H16 to convert waste stream into useful chemicals 
by enhancing glycerol assimilation 
 
 
5.1 Introduction 
 
The exploration and optimisation of rational design and evolutionary 
engineering tools for C. necator H16 investigated in previous chapters are useful 
tools that can be used to engineer the strain by introducing and tuning metabolic 
pathways for industrial purposes. The work presented in this Chapter 5 aims to 
prove the previous statement by using C. necator H16 as cell factory to convert 
waste stream into useful chemicals such as polyhydorxybutyrate (PHB), which is 
valuable plastic that has been widely produced in C. necator H16 as the strain is a 
natural PHB producer. 
 
As mentioned in Section 1.4.3, crude glycerol –a by-product of the biodiesel 
industry- is sometimes even considered a waste stream. This waste stream could 
be used as feedstock and be converted into a valuable co-product for the biodiesel 
supply chain. In this work, C. necator H16 was used as a cell factory to convert 
this waste stream into a value-added product (PHB, bioplastics). As reviewed in 
He et al. (2017), there are different value-added products such as PHB, 1,3-
propanediol, short-chain organic acids, alcohols, among others that are very 
promising bioproducts that can be obtained from microbial fermentation with 
crude glycerol. 
 
C. necator H16 can naturally utilise glycerol as a carbon source, and the 
engineering tools required to tune its metabolic pathway have been optimised in 
previous chapters of this thesis, and are available to engineer the strain to improve 
its glycerol utilisation. 
 
The engineering of C. necator H16 WT to improve glycerol assimilation is 
essential, since the WT strain grows slower in glycerol than in other preferred 
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carbon substrates such as gluconate, hence, in this work, two parallel strategies -
rational design and evolutionary engineering- studied and described in previous 
chapters were used to improve the productivity levels of C. necator H16 for a 
large-scale production using glycerol as its carbon feedstock. The first strategy 
consisted of expressing native glycerol utilisation enzymes, and the second 
strategy consisted of evolving C. necator H16 wild-type cells in glycerol via 
adaptive evolution. The rational design strategy was used based on the 
improvement of glycerol utilisation by increasing the intracellular levels of 
glycerol kinase (GlpK) and glycerol dehydrogenase (GlpD) - both native of the 
strain-, since these proteins were postulated to participate in C. necator H16 
glycerol metabolism (Fukui et al., 2014); while the adaptive evolution strategy 
was used due to the underlying reason of slow growth of C. necator H16 is not 
fully understood, and this strategy circumvents this problem by exploiting the 
linkage between carbon (glycerol) utilisation and survival (growth). 
 
Initially, the studies for the enhancement of glycerol assimilation in C. necator 
H16 were performed in laboratory-grade glycerol (pure glycerol), and once the 
improvements in pure glycerol assimilation were achieved in recombinant strains 
of C. necator H16 -from the rational design engineering strategy-, and variants 
strains of C. necator H16 -from the evolutionary engineering strategy-, the 
performance of the above-mentioned strains was verified in crude glycerol (also 
referred to as sweetwater), which was sourced from a fat splitting process.  
 
 
5.2 Aim 
 
The aim of Chapter 5 is:  
 
Ø To apply rational design and evolutionary engineering tools explored and 
optimised in this PhD work to engineer C. necator H16 to enhance its 
glycerol assimilation for chemical production using waste stream (crude 
glycerol) as feedstock. 
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5.3 Materials and methods 
 
 
5.3.1 Materials 
 
List of detailed information on the materials used (reagents, kits, equipment, 
software, media preparation and miscellaneous) can be found in Appendix 1 – 6. 
 
5.3.2 Strains, plasmids and primers 
 
All strains, plasmids and primers that were used in this Chapter 5 are shown in 
Table 5.1. 
 
Table 5.1 Strains, plasmids and primers used in this study. 
Strains, plasmids or 
primers 
Description References 
or source 
Strains   
E. coli DH5a Standard cloning strain Lab 
collection 
E. coli BW25113 Wild-type Kanr Datsenko et 
al., 2000 
C. necator H16 Wild-type Genr DSM 428 
v6C6 Variant of C. necator H16 from Rd 6 of adaptive 
evolution 
This work 
Plasmid backbones  
pPj5c.rbs-RFP Camr, pBBR1 Rep, pBBR1 oriV, mob, Pj5, RBS, rfp  This work 
pBADc.rbs-RFP Camr, pBBR1 Rep, pBBR1 oriV, mob, araC, PBAD, 
RBS, rfp 
This work 
Plasmids constructed  
pPj5’c.rbs- glpKH16 Camr, pBBR1 Rep, pBBR1 oriV, mob, Pj5, RBS, 
glpKH16 
This work 
pPj5’c.rbs- glpKEc Camr, pBBR1 Rep, pBBR1 oriV, mob, Pj5, RBS, 
glpKEc 
 
pPj5’c.rbs- glpDH16 Camr, pBBR1 Rep, pBBR1 oriV, mob, Pj5, RBS, 
glpDH16 
This work 
pPj5’c.rbs1- glpKDH16 Camr, pBBR1 Rep, pBBR1 oriV, mob, Pj5, RBS, 
glpKDH16, native glpDH16 RBS preceding glpDH16 
This work 
pPj5’c.rbs2- glpKDH16 Camr, pBBR1 Rep, pBBR1 oriV, mob, Pj5, RBS, 
glpKDH16, synthetic RBS preceding glpDH16 
This work 
pBADc.rbs-glpKH16 Camr, pBBR1 Rep, pBBR1 oriV, mob, araC, PBAD, 
RBS, glpKH16 
This work 
Primers (5’ à 3’)   
NdeI-H16-A2507-fwd GGAATTCCATATGAACCAGCCAGCCGCGCAG This work 
XhoI-H16-A2507-rev AACGCTCGAGTTATCAGGCGTGGCTGCCGCTG This work 
BW25113_glpk-fwd GCTCCATATGACTGAAAAAAAATATATCG This work 
BW25113_glpk-rev TATAATCCTCGAGTTATTCGTCGTGTTC This work 
NdeI-glpD-fwd GGAATTCATATGCAGAGAGTCTCC This work 
XhoI-glpD-rev TTAACTCGAGTTATCAGCCGAGCATGTA This work 
NdeI-glpK-fwd GGAATTCCATATGAACCAGCCAGCC This work 
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RBS-glpD-fwd AGATCTTTTAAGAAGGAGATATACATATGCAG
AGAGTCTC 
 
HiFi-fwd TACATGCTCGGCTGATAACTCGAGTAAGGAT This work 
Hifi-rev CTTCTTAAAAGATCTTCAGGCGTGGCTGCC This work 
All the RBS noted in all the plasmids in the list correspond to the sequence encoding for the E. 
coli consensus RBS. Restriction enzyme sequences of primers are underlined. Abbreviations: 
Kanr, kanamycin resistance; Genr, gentamicin resistance; Rd, round; Camr, chloramphenicol 
resistance; RBS, ribosome binding site; rfp; red fluorescence protein gene; glpKH16, glycerol 
kinase from C. necator H16; glpKEc, glycerol kinase from E. coli BW25113; glpDH16, glycerol 
dehydrogenase from C. necator H16. 
 
 
5.3.3 Cultivation of E. coli DH5a and C. necator H16  
 
E. coli DH5a and E. coli BW25113 cells were cultivated at 37 ºC on 2x YT 
medium and 250 rpm and when required with chloramphenicol [25 µg/mL] or 
kanamycin [50 µg/mL] according to the application. E. coli DH5a was used for 
all molecular cloning, plasmid propagation, and maintenance; and E. coli 
BW25113 was used for genomic DNA extraction. C. necator H16 WT and C. 
necator H16 recombinant and variant strains cells were cultivated at 30 ºC using 
nutrient broth (NB), or mineral salts medium (MSM) with different carbon 
sources depending on the experiment performed: MSM with 1.00 % or 0.59 % 
(w/v) sodium gluconate (for practical purposes, sodium gluconate will be referred 
to as gluconate from this point onwards), 0.50 % (w/v) laboratory-grade glycerol 
with purity over 99 % (for practical purposes, laboratory-grade glycerol will be 
referred to as glycerol from this point onwards), or 4.00 % (v/v) crude glycerol, 
and 250 rpm supplemented always with gentamicin [10 µg/mL] and when needed 
with chloramphenicol [25 µg/mL]. Crude glycerol (sweetwater) sample (batch 
8/1/18), was obtained from a high-pressure fat splitting process, kindly provided 
by Croda (Hull). The optical density was measured at 600 nm with a 
BioPhotometer or at 595 nm with a microtitre plate reader. 
 
For growth comparison, a pre-culture of C. necator H16 WT strain, recombinant 
strain or variant strain, was prepared from a single colony in an agar plate of 
MSM with 1.00 % (w/v) gluconate, which was further inoculated in 5 mL of 
MSM with either gluconate, glycerol or crude glycerol at different concentrations, 
always with a starting OD600 of 0.1 using the pre-culture. Cells were cultivated at 
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30°C, and their optical density monitored at 600 nm with a BioPhotometer or at 
595 nm with a microtitre plate reader. Specific growth rate was calculated by 
fitting the exponential growth to the exponential growth equation (𝑋 = 𝑋#𝑒µ%) 
provided in GraphPad Prism, where X is the number or mass of cells 
(mass/volume), X0 the initial number or mass of cells, t is time, and µ is the 
specific growth rate constant (1/time).  
 
 
 
5.3.4 Bacterial transformation of E. coli DH5a and C. necator H16 
 
E. coli DH5a cells were transformed using a standard chemical transformation 
method. E. coli DH5a was used for circularization and propagation of ligation 
mixtures of all plasmids constructed. C. necator H16 cells were transformed by 
the electroporation method optimised in our laboratory group and described in 
Chapter 2. 
 
 
5.3.4.1 Transformation using CaCl2 heat-shock method for E. coli DH5a 
 
A pre-culture of E. coli DH5a  was cultivated in 5 mL of 2x YT for 16 h at 37 ºC; 
for competent cell preparation, a fresh 2x YT falcon tube was inoculated with the 
pre-culture at a 1:100 dilution and cultivated at 37 ºC, when cells reached an 
optical density at 600 nm (OD600) of 0.5, 1 mL of cells were transferred to a sterile 
1.5 mL microcentrifuge tube. Cells were centrifuged at maximum speed (17,000 x 
g) for 30 s, and the supernatant was removed by pipetting. The pellet was washed 
once with 500 µL of pre-chilled 50 mM CaCl2. Then, the cell pellet was 
resuspended carefully in 500 µL of pre-chilled 50 mM CaCl2 and incubated in ice 
for 30 min (for transforming intact plasmid, a 10 min incubation was sufficient). 
Plasmid DNA was added to a concentration of 1 µg or 5 µL of ligation mixture 
and mixed gently. A second 30 min incubation step was performed after the 
addition of the plasmid (for transforming intact plasmid, a 10 min incubation was 
sufficient). After the second incubation, the cells were heat-shocked at 42 ºC for 1 
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min and further incubated in ice for 2 min. After heat shock and ice incubation 
time, 800 µL of 2x YT was added, and cells were left to grow for a 1 h outgrowth 
at 37 ºC. After the outgrowth, cells were centrifuged at maximum speed for 30 s 
and most of the media removed, the remaining 200 – 300 µL media was used to 
resuspend the cells gently before plating them on TYE agar plates with the 
required antibiotic, and incubated overnight at 37 ºC. 
 
 
5.3.4.2 Transformation by electroporation method for C. necator H16 
 
A pre-culture of C. necator H16 was cultivated in 5 mL of NB with gentamicin 
for 40 – 44 h at 30 ºC; for electrocompetent cell preparation, a fresh NB 
supplemented with gentamicin falcon tube was inoculated with the pre-culture at a 
1:50 dilution and cultivated at 30 ºC, when cells reached an OD600 of 0.5 – 0.7, 
cells were transferred to ice and chilled for 5 min. Two millilitres of the cells were 
then transferred to a sterile 2 mL microcentrifuge tube. Cells were centrifuged at 
maximum speed (17,000 x g) for 30 s and the supernatant was removed. Then, the 
cell pellet was washed once with 1 mL of pre-chilled 50 mM CaCl2 and incubated 
for 15 min in ice. Then the cell pellet was centrifuged at maximum speed for 30 s 
followed by two washes by resuspension in 1 mL of pre-chilled 0.2 M sucrose. 
After the final wash, the cell pellet was resuspended in 100 µL of pre-chilled 0.2 
M sucrose. Plasmid DNA was added to a concentration of 0.5 µg to the 
resuspended cells and mixed gently. The resuspension was then transferred into a 
pre-chilled 2 mm electroporation cuvette and electroporated at 2.3 kV. After 
electroporation, 1 mL of NB was added immediately directly to the 
electroporation cuvette, then, cells were transferred to a new 2 mL 
microcentrifuge tube for a 2 h outgrowth at 30 ºC. After the outgrowth, typically 
about 10 % (v/v) cells were plated in NB with gentamicin and chloramphenicol 
agar plates and incubated at 30 ºC for 40 – 48 h. 
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5.3.5 Colony PCR verification of transformants in C. necator H16 
 
All plasmids constructed and transformed into C. necator H16 were verified by 
colony PCR using Q5 polymerase according to the manufacturer’s protocol. 
Colonies were picked from NB agar plates with a pipette tip and then were 
swirled vigorously in 20 µL of nuclease-free water in 1.5 mL microcentrifuge 
tubes. The liquid suspension was used as DNA template for colony PCR. Primers 
specific to the insert present in the plasmids constructed were used for colony 
PCR verification. The PCR product was then analysed using a 1.0 % (w/v) 
agarose gel electrophoresis. 
 
 
5.3.6 DNA preparation 
 
Standard procedures were used for isolation of plasmids, restriction enzyme 
digestions, polymerase chain reaction (PCR) with Q5 DNA polymerase, DpnI 
digestions, DNA gel extraction, PCR purification, and T4 DNA ligation 
(Sambrook et al., 2011) and recommendations by the manufacturers. All primers 
were synthesised by Eurofins Genomics. 
 
 
5.3.7 DNA Gel electrophoresis 
 
An agarose gel electrophoresis was prepared to analyse DNA; 0.7 % or 1.0 % 
(w/v) agarose gels were prepared in 1x TBE buffer (prepared from a 5x TBE 
buffer composed of 54.0 g of Tris base, 27.5 g of Boric acid, and 20 mL of 0.5 M 
EDTA per 1 L, pH 8.3) by dissolving 0.35 g or 0.50 g of agarose respectively in 
50 mL buffer. The percentage of gel used was dependent on the purpose of the 
gel, if only an analysis of the DNA was required, then 1.0 % (w/v) gels were used, 
but if gel extraction was required, then 0.7 % (w/v) agarose gels were used to 
excise the DNA band from the gel. To ensure that the agarose is fully dissolved in 
the buffer, the solution was microwaved until all the agarose was dissolved, then, 
when the gel had cooled down, 2 µL of ethidium bromide was added and the gel 
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was cast using a gel caster, then the comb was inserted and the gel was left to 
room temperature until it solidified. 6 µL of DNA Ladder 1 kb and appropriate 
volume of DNA samples were loaded into the gel. The electrophoresis was run at 
a constant voltage of 100 V for 60 min. The gel image was captured with a gel 
documentation system.  
 
5.3.8 Plasmid construction 
 
All plasmid constructed in this Chapter 5 were based on the plasmid backbones 
pBADc.rbs-RFP and pPj5c.rbs-RFP plasmids. The plasmid backbones are 
illustrated in Figure 3.1 and Figure 5.3 respectively. The primers and in silico 
analyses of plasmid construction were generated using the SnapGene software 
tool. Correct construction of all plasmids was confirmed by restriction enzyme 
analysis (ReA) and DNA gene sequencing by Eurofins Genomics. 
 
 
5.3.8.1 Construction of plasmids with a constitutive promoter 
 
The constitutive plasmids driven by the Pj5 promoter were constructed by first 
extracting total genomic DNA from E. coli BW25113 and C. necator H16, where 
the glpKEc, glpKH16, glpDH16, and glpKDH16 genes were amplified from their 
respective genomic DNA (where “Ec” stands for E. coli BW25113, and “H16” for 
C. necator H16) by PCR with the primers BW25113_glpk-fwd and 
BW25113_glpk-rev for plasmid pPj5c.rbs-glpKEc, NdeI-H16-A2507-fwd and 
XhoI-H16-A2507-rev for plasmid pPj5c.rbs-glpKH16, NdeI-glpD-fwd and XhoI-
glpD-rev for plasmid pPj5c.rbs-glpDH16, and NdeI-glpK-fwd and XhoI-glpD-rev 
for plasmid pPj5c.rbs1-glpKDH16. Subsequently, the amplified fragments were 
subjected to DpnI digestion, PCR purification and restriction enzyme digestion 
with NdeI and XhoI, followed by a further PCR purification for ligation with T4 
DNA ligase with the NdeI and XhoI digested and gel extracted fragment 
containing the pBBR1 Rep, pBBR1 oriV origin of replication, mob gene, Camr 
cassette, Pj5 promoter, and E. coli consensus RBS from pPj5c.rbs-RFP. The 
plasmid pPj5c.rbs-RFP was constructed based on the pPj5c.T7rbs-RFP from the 
synthetic biology toolbox described in Chapter 2, where the T7 mRNA stem-
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loop was removed from pPj5c.T7rbs-RFP by site-directed mutagenesis using the 
NEBaseChanger protocol. 
 
The standard restrictive digestion and ligation were used for all plasmids unless 
for pPj5c.rbs2-glpKDH16, which was constructed using the HiFi DNA Assembly 
cloning method with primers RBS-glpD-fwd, HiFi-fwd and HiFi-rev. After DNA 
sequencing, mutations in the Pj5 promoter region of pPj5c.rbs-glpKH16 were 
found, for this reason, all genes were subsequently re-cloned to have the same 
mutated Pj5’ promoter for a fair comparison (Table 5.2), resulting in the plasmids 
pPj5’c.rbs-glpKEc, pPj5’c.rbs-glpKH16, pPj5’c.rbs-glpDH16, pPj5’c.rbs1-glpKDH16, 
and pPj5’c.rbs2-glpKDH16. After transformation of E. coli DH5a, a single colony 
of the resulting plasmids was isolated and analysed by restriction enzyme analysis 
and DNA sequencing to confirm the construct before they were transformed into 
C. necator H16. 
 
 
Table 5.2 Comparison of Pj5 and Pj5’ promoter sequences. 
Promoter Sequence (5’ à 3’) 
Pj5  agcggatataaaaaccgttattgacacaggtggaaatttagaatatactgttagtaaacctaatggatcgacctt 
Pj5’ agcggatataaaaaccgttattgacacaggtggaaatttagaatatacggttagtaaacctaatggatcgacct 
Note: The nucleotides in red, highlight the differences between the 2 promoters. 
 
 
5.3.8.2 Construction of plasmid with an inducible promoter 
 
The inducible pBADc.rbs-glpKH16 was constructed by first extracting total 
genomic DNA from C. necator H16, where the glpK gene was amplified from 
genomic DNA by PCR with NdeI-H16-A2507-fwd (forward primer) and XhoI-
H16-A2507-rev (reverse primer) primers. Subsequently, the amplified fragment 
was subjected to DpnI digestion, PCR purification and restriction enzyme 
digestion with NdeI and XhoI, followed by a further PCR purification for ligation 
with T4 DNA ligase with the NdeI and XhoI digested and gel extracted fragment 
containing the pBBR1 Rep, pBBR1 oriV origin of replication, mob gene, Camr 
cassette, L-arabinose-inducible system (containing araC and PBAD), and E. coli 
consensus RBS from pBADc.rbs-RFP resulting in the 7.6 kb plasmid pBADc.rbs-
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glpKH16. After transformation of E. coli DH5a, a single colony of the resulting 
plasmid was isolated and analysed by restriction enzyme analysis and DNA 
sequencing to confirm the construct before it was transformed into C. necator 
H16. 
 
 
5.3.8.3 Gene Sequencing Analysis  
 
Eurofins Genomics sequencing service was used to check the sequence quality of 
the plasmids and GlpK proteins of C. necator H16 WT and C. necator H16 
variant strains (v6C6, v6F8, and v6G7) from the Round 6 of adaptive evolution. 
The DNA fragments of GlpK and its 500-bp upstream element were amplified by 
PCR with Q5 polymerase from genomic DNA of their corresponding strain in 
order to check for gene modifications in that region. The DNA sequences were 
then analysed using the SnapGene software tool. 
 
 
5.3.9 Adaptive evolution of C. necator H16  
 
Adaptive evolution of C. necator H16 was performed by serial cultivation in 5 
mL of MSM with 0.50 % (w/v) glycerol as a sole carbon source in falcon tubes 
for six rounds of adaptive evolution. In each round, cells were grown to their early 
stationary phase before using them to inoculate the subsequent round with a 1:100 
dilution. Serial cultivation was continued until there was no significant 
improvement in glycerol assimilation (sixth round). An aliquot of 0.5 mL was 
withdrawn from each round of adaptive evolution and stored as glycerol stock of 
the cell population of each round at -80°C for further analysis.  
 
 
5.3.10 Screening of C. necator H16 variant strains 
 
After six rounds of adaptive evolution, the population of variants of C. necator 
H16 from the last three rounds of adaptive evolution were screened for isolation 
of single variants from the population. The population of the last three rounds was 
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grown in 5 mL of MSM with 0.50 % (w/v) glycerol and gentamicin [10 µg/mL] to 
an OD600 of 1.0 before cells were plated on MSM agar plate with the same 
glycerol and gentamicin concentrations. Agar plates were incubated at 30°C for 
48 h before 90 single colonies from each round were transferred to 96-well 
microtitre plates and screened in 150 µL of MSM with 0.50 % (w/v) glycerol. The 
growth of the variant strains was monitored until cells reached stationary phase at 
optical density was measured at 595 nm with a microtitre plate reader. 
 
 
5.3.11 Characterisation of C. necator H16 variants in glycerol 
 
A pre-culture of C. necator H16 variant strains was cultivated in 5 mL of MSM 
with gentamicin for 40 – 44 h at 30 ºC, then, the characterisation of variants of C. 
necator H16 was performed in 150 µL of MSM with 0.50 %, 1.00 % and 2.00 % 
(w/v) glycerol in microtitre plates with a 1:100 dilution. The growth of the variant 
strains was monitored until cells reached stationary phase at optical density was 
measured at 595 nm with a microtitre plate reader. The inoculum of the variants 
was always adjusted to an initial OD600 of 0.1. 
 
 
5.3.12 Confirmation of improved glycerol-utilising phenotype 
 
Improved glycerol-utilising phenotype in the identified variants was further 
verified by five rounds of cultivation in the absence of glycerol, in either MSM 
with 1.00 % (w/v) gluconate or NB. In each of these rounds, cells were cultivated 
for 48 h at 30°C. Cells from the fifth round were re-transferred into MSM with 
0.50 % (w/v) glycerol and gentamicin [10 µg/mL]. True variants were expected to 
grow as quickly as when they were first isolated, in contrast to those that 
exhibited transient adaptation. 
 
 
5.3.13 Protein model of GlpK of C. necator H16 and v6C6 
 
The protein models of GlpK of C. necator H16 WT and v6C6 variant strain were 
generated using SWISS-MODEL (Biasini et al., 2014), where the GlpKEc from E. 
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coli (PDB code 1BOT) was used as a template protein. The graphics were 
generated using PyMOL software. 
 
 
5.3.14 Analysis of PHB content using Nile red assay 
 
A pre-culture of C. necator H16 WT and v6C6 variant was cultivated in 5 mL of 
MSM with 1.00 % (w/v) gluconate supplemented with gentamicin [10 µg/mL] at 
30 ºC for 40 h. This preculture was then used to inoculate fresh 300 mL 
Erlenmeyer flasks (in a 1:100 dilution) with 50 mL of four different media: 1) 
MSM with 0.59 % (w/v) gluconate and 0.10 % (w/v) NH4Cl (for nutrient-
balanced conditions), 2) MSM with 0.59 % (w/v) gluconate and 0.05 % (w/v) 
NH4Cl (for nitrogen-limiting conditions), 3) MSM with 0.50 % (w/v) glycerol and 
0.10 % (w/v) NH4Cl (for nutrient-balanced nitrogen conditions), and 4) MSM 
with 0.50 % (w/v) glycerol and 0.05 % (w/v) NH4Cl (for nitrogen-limiting 
conditions), all four media were supplemented also with gentamicin [10 µg/mL] 
and grown at 30 ºC and 250 rpm. The growth of samples was monitored by 
measuring the optical density at 600 nm with a BioPhotometer. A 1 mL aliquot of 
all samples was harvested at the exponential, early stationary, and late-stationary 
phases for PHB quantitation. When the aliquot of the samples had an OD600 > 2, 
the cell samples were diluted to an OD600 ≤ 2 with MSM in order to keep the 
fluorescence detection within the linear range. Subsequently, the aliquots of the 
samples were centrifuged, and the spent media was removed by pipetting, and the 
pellet was stored at -20ºC until all samples of all growth phases had been 
collected. For the determination of PHB content with Nile Red, all samples were 
thawed and resuspended in 0.5 mL of 50 % (v/v) ethanol, then 50 µL of cell 
suspension of each of the samples was mixed with 50 µL of 10 µg/mL of Nile 
Red in a microtitre plate, and the fluorescence was measured (Ex 552 nm, Em 600 
nm; bottom read) in a microtiter plate/cuvette reader for 1 h at 10 min intervals, 
where the fluorescence values were stable after 1 h for all samples, hence, 
comparisons between samples were made at this time point. The comparison of 
PHB production among samples was based on the fluorescence per 100 µL of cell 
culture. 
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5.3.15 Fluorescence microscopy of PHB stained with Nile Red 
 
A pre-culture of C. necator H16 WT and v6C6 variant was cultivated in 5 mL of 
MSM with 0.59 % (w/v) gluconate or 0.50 % (w/v) glycerol under nitrogen-
limiting conditions supplemented with gentamicin [10 µg/mL] at 30 ºC for 40 h. 
This preculture was then used to inoculate fresh 50 mL falcon tube (in a 1:100 
dilution) with 5 mL of two different media: 1) MSM supplemented with 0.59 % 
(w/v) gluconate and 0.05 % (w/v) NH4Cl (for nitrogen-limiting conditions), and 
2) MSM supplemented with 0.50 % (w/v) glycerol and 0.05 % (w/v) NH4Cl (for 
nitrogen-limiting conditions), all media were supplemented also with gentamicin 
[10 µg/mL] and grown at 30 ºC and 250 rpm until cells reached early stationary 
phase. Then, samples were adjusted to an OD600 of 7.0 before 200 µL of the 
samples were centrifuged and the spent media removed. The cell pellet was then 
resuspended in 50 µL of PBS buffer and used for fluorescence microscopy; cells 
were visualised using the filter G-1 ((Ex 560 nm, Em 645 nm). 
 
 
5.4 Results and discussion 
 
 
5.4.1 Glycerol assimiliation in C. necator H16 
 
As reviewed in Volodina et al. (2016), C. necator H16 can grow in a wide variety 
of carbon sources that ranges from carbohydrates, organic acids, and glycerol 
among other carbon sources. In order to improve the specific growth rate and 
hence the PHB productivity of C. necator H16 from glycerol, the first experiment 
designed was the study of the natural cell growth of the strain at different 
concentrations of glycerol, which were compared to cell growth of the strain in a 
preferred carbon source (gluconate). Glycerol was added as a carbon source in 
MSM at 0.50 %, 1.00 % and 2.00 % (w/v) of glycerol, and the reference sample 
was inoculated in MSM with 0.59 % (w/v) of gluconate. The concentrations of 
glycerol and gluconate at 0.50 % (w/v) and 0.59 % (w/v) respectively, were 
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chosen to maintain the same carbon molarity (0.16 M) among those two carbon 
sources. As depicted in Figure 5.1, the specific growth rate is significantly slower 
when cells are grown in glycerol than in gluconate. 
 
 
 
Figure 5.1 Cell growth study of C. necator H16 WT in gluconate and glycerol. C. necator H16 in 
MSM with 0.59 % (w/v) gluconate (circle, green line), C. necator H16 in MSM with 0.50 % (w/v) 
glycerol (circle, red line), C. necator H16 in MSM with 1.00 % (w/v) glycerol (circle, blue line), 
C. necator H16 in MSM with 2.00 % (w/v) gluconate (circle, orange line). Error bars are ± SEM 
of two independent determinations. 
 
From Figure 5.1, it could be observed that effectively, C. necator H16 cell 
growth in 0.50 % (w/v) glycerol and in 0.59 % (w/v) gluconate showed a similar 
final OD600 of 6.0 to 7.0 as expected, since both have the same carbon 
concentration. The cell growth of C. necator H16 in glycerol was characterised by 
a long lag-phase which took 110 h to reach an OD600 of 1.0, while C. necator H16 
in gluconate reached the same OD600 after only 9 h. The specific growth rate of C. 
necator H16 in 0.50 % (w/v) glycerol was 0.024 h-1, while the specific growth 
rate of C. necator H16 in 0.59 % (w/v) gluconate was 0.290 h-1, which is 12-fold 
faster compared to the specific growth rate of C. necator H16 in glycerol. On the 
other hand, the specific growth rate of C. necator H16 in the three different 
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glycerol concentrations shown in Figure 5.1 were similar, which ranged from 
0.024 to 0.027 h-1 (Table 5.3), although the final OD600 was different among the 
glycerol samples, this fact corroborated a positive correlation with the increasing 
glycerol concentrations used. The highest concentrations of glycerol used did not 
inhibit C. necator H16 cell growth, which suggests that the slow growth of the 
strain might be attributed to slow metabolism of glycerol in C. necator H16. 
 
 
Table 5.3 Specific growth rate of C. necator H16 in gluconate and glycerol. 
Strain Carbon source Specific growth rate [h-1] 
H16_WT 0.59 % (w/v) gluconate 0.290 
H16_WT 0.50 % (w/v) glycerol 0.024 
H16_WT 1.00 % (w/v) glycerol 0.024 
H16_WT 2.00 % (w/v) glycerol 0.027 
 
 
5.4.2 Rational design strategy for improvement of glycerol assimilation in 
C. necator H16 
 
As mentioned in Section 1.4.3.5, the genome of C. necator H16 has two pairs of 
putative glycerol genes: glycerol kinase and glycerol-3-phosphate dehydrogenase. 
The first pair has the gene loci of H16_A2507 (which encodes for the glycerol 
kinase gene), and H16_A2508 (which encodes for the glycerol-3-phosphate 
dehydrogenase); and the second pair has the gene loci of H16_B1198 (which 
encodes for the glycerol-3-phosphate dehydrogenase gene), and H16_B1199 
(which encodes for the glycerol kinase gene) (Figure 5.2). The glycerol kinase 
(GlpK) phosphorylates glycerol by ATP, which yields ADP and glycerol-3-
phosphate, then, glycerol-3-phosphate dehydrogenase (GlpD) is in charge of the 
oxidation of glycerol-3-phosphate to dihydroxyacetone phosphate (Figure 1.1). 
As shown in Table 1.2, the gene H16_A2507 has the highest protein sequence 
identity compared to the known GlpKEc of E. coli with a protein sequence identity 
of 52 %; also previous work by Shimizu et al. (2013) showed that the first pair of 
genes had a higher transcriptional level. Hence, based on this information 
available about glycerol metabolism for C. necator H16 glycerol-related proteins, 
the GlpKH16 and GlpDH16 from the pair of genes H16_A2507 and H16_A2508 
were chosen to be studied and cloned for protein expression in C. necator H16 
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using the previously constructed synthetic biology toolbox tailored for C. necator 
H16 described in Chapter 2. 
 
 
 
Figure 5.2 Two pairs of putative genes of glycerol metabolism in C. necator H16 (glycerol kinase 
and glycerol-3-phosphate dehydrogenase). The genes encoding glycerol kinase and glycerol 
dehydrogenase are boxed in red. The inset shows the colour codes used by KEGG to describe the 
function of the open reading frames. A) The first pair has the gene loci of H16_2507 and 
H16_A2508. B) The second pair has the gene loci H16_B1198 and H16_B1199. 
 
 
5.4.2.1 Construction of plasmids  
 
The plasmids with a constitutive promoter pPj5’c.rbs-glpKH16, pPj5’c.rbs-glpKEc, 
pPj5’c.rbs-glpDH16, pPj5’c.rbs1-glpKDH16, and pPj5’c.rbs2-glpKDH16 were 
constructed using pPj5c.rbs-RFP plasmid as plasmid backbone. The pPj5c.rbs-
RFP is illustrated in Figure 5.3, the digested fragment of pPj5c.rbs-RFP 
harboured the pBBR1 Rep, pBBR1 oriV origin of replication, mob gene, 
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chloramphenicol resistance (Camr) cassette (containing Pcat and Camr), Pj5 
promoter, and the E. coli consensus RBS. The construction of all plasmids with 
the Pj5’ constitutive promoter was successfully achieved by replacing the rfp gene 
from pPj5c.rbs-RFP with the PCR amplified glycerol-related protein genes either 
from C. necator H16 or E. coli BW25113.   
 
 
 
Figure 5.3 Illustration of pPj5c.rbs-RFP map (5.2 kb). The plasmid encodes for pBBR1 Rep, 
pBBR1 oriV origin of replication, mobilisation sequence mob, CAT promoter, chloramphenicol 
resistance (Camr), Pj5 promoter, E. coli consensus RBS, and rfp gene. 
 
The plasmid with an inducible promoter pBADc.rbs-glpKH16 was constructed 
using pBADc.rbs-RFP plasmid as plasmid backbone from the synthetic biology 
toolbox described in Chapter 2. The pBADc.rbs-RFP is illustrated in Figure 3.1, 
the digested fragment of pBADc.rbs-RFP harboured the pBBR1 Rep, pBBR1 
oriV origin of replication, mob gene, chloramphenicol resistance (Camr) cassette 
(containing Pcat and Camr), L-arabinose-inducible system (containing araC and 
PBAD), and the E. coli consensus RBS. The construction of the arabinose-inducible 
pBADc.rbs-glpKH16 plasmid was successfully achieved by replacing the rfp gene 
from pBADc.rbs-RFP with the PCR amplified glpKH16 gene from C. necator H16.   
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The structure of the plasmids constructs used in this work is shown in Figure 5.4. 
The construction of the plasmids with the inducible and constitutive promoters 
was designed in order to study the effects of the glycerol-related proteins either 
individually or in combination, where all plasmids were pBBR1-based plasmids 
(Figure 5.4A). The plasmids pPj5’c.rbs1-glpKDH16 and pPj5’c.rbs2-glpKDH16 
which harbour glpKH16 and glpDH16 genes in combination, differed in the 
ribosome binding site (RBS) preceding the glpDH16 gene, while pPj5’c.rbs1-
glpKDH16 used the native glpDH16 RBS (RBS in light blue in Figure 5.4B), 
pPj5’c.rbs2-glpKDH16 was constructed with the same synthetic RBS (RBS in dark 
blue in Figure 5.4B) preceding both glpKH16 and glpDH16 genes. 
 
 
 
Figure 5.4 Schematic drawing of the recombinant plasmids used in this work for engineering C. 
necator H16. A) Overall plasmid construct. B) Various promoter and gene combinations 
 
 
5.4.2.2 Cell growth studies of glycerol metabolic pathway expression in C. 
necator H16 
 
Once all the plasmids were successfully constructed and transformed into C. 
necator H16, cell growth studies were performed in order to see the effects on 
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glycerol assimilation of the expression of the glycerol-related proteins. The 
specific growth rate of C. necator H16 carrying all plasmids was compared to C. 
necator H16 WT to check for improvement in glycerol assimilation (Figure 5.5). 
 
 
Figure 5.5 Cell growth curve of C. necator H16 harbouring glpKH16, glpKEc, glpDH16, and 
glpKDH16 plasmids cultivated in 0.50 % (w/v) glycerol. Cell growth study of H16_WT (circle, 
green line) in MSM with 0.59 % (w/v) gluconate, and H16_WT (circle, red line) in MSM with 0.50 
% (w/v) glycerol; H16_glpKH16 (square, dark blue line) in MSM with 0.50 % (w/v) glycerol, 
H16_glpKEc (open square, light blue line) in MSM with 0.50 % (w/v) glycerol, H16_rbs1.glpKDH16 
(triangle, dark pink line) in MSM with 0.50 % (w/v) glycerol, H16_rbs2.glpKDH16 (open triangle, 
light pink line) in MSM with 0.50 % (w/v) glycerol, and H16_glpDH16 (diamond, orange line) in 
MSM with 0.50 % (w/v) glycerol. The inset shows the magnified cell growth curve of H16_WT in 
gluconate and H16 recombinant strains harbouring glpKH16, glpKEc, and glpKDH16 in glycerol. 
Error bars are ± SEM of three independent determinations. 
 
 
From Figure 5.5, it could be observed that most of the recombinant strains 
harbouring the glycerol-related proteins (glpKH16, glpKEc, and glpKDH16) showed a 
significant specific growth rate improvement compared to C. necator H16 WT, 
unless for H16_glpDH16. The recombinant strains H16_rbs1.glpKDH16, which was 
constructed with a native RBS, and H16_rbs2.glpKDH16 constructed with a 
synthetic RBS, showed also similar cell growth among them, these two 
recombinant strains showed the best cell growth performance in glycerol 
compared to the other recombinant strains. The specific growth rate in glycerol 
improved from 0.024 h-1 for C. necator H16 WT to 0.120 - 0.140 h-1 for 
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recombinant strains (Table 5.4). This suggests that glpKH16 might be more critical 
compared to glpDH16 for improving glycerol assimilation in C. necator H16.  
 
Table 5.4 Specific growth rate of C. necator H16 in glycerol. 
Strain Carbon source Specific growth rate [h-1] 
H16_WT 0.59 % (w/v) gluconate 0.290 
H16_WT 0.50 % (w/v) glycerol 0.024 
H16_glpKH16 0.50 % (w/v) glycerol 0.120 
H16_glpKEc 0.50 % (w/v) glycerol 0.130 
H16_glpDH16 0.50 % (w/v) glycerol - 
H16_rbs1.glpKDH16 0.50 % (w/v) glycerol 0.130 
H16_rbs2.glpKDH16 0.50 % (w/v) glycerol 0.140 
 
 
On the other hand, as observed in Figure 5.5, the recombinant strain 
H16_glpDH16 (diamond, orange line) not only did not improve glycerol 
assimilation, but it was not able to grow in glycerol, even though the presence of 
plasmid-borne glpDH16 gene in the transformed cells of C. necator H16 was 
confirmed by colony PCR. As reviewed in Allaman et al. (2015), the possible 
reason of the growth inhibition when GlpDH16 was expressed in C. necator H16 
might be that the increase of GlpDH16 could lead to dihydroxyacetone phosphate 
accumulation, which in turn might be converted into methylglyoxal by the 
methylglyoxal synthase (MgsA), which is encoded by H16_A0932 in C. necator 
H16; methylglyoxal, is a highly reactive dicarbonyl compound, and it is one of the 
most potent glycating agents, readily reacting with nucleic acids, proteins and 
lipids, that could lead to cellular damage. 
 
Once that GlpK was identified as a key enzyme for improving glycerol 
assimilation in C. necator H16, the construction of the pBADc.rbs-glpKH16 was 
performed in order to increase the expression level of the enzyme by the L-
arabinose-inducible PBAD promoter, although despite three independent attempts to 
improve specific growth rate using the pBADc.rbs-glpKH16 plasmid, variable 
results were obtained (data not shown). In contrast to the improvement in glycerol 
assimilation observed with the recombinant strain H16_glpKH16 driven by the 
constitutive promoter Pj5’, the recombinant strain H16_glpKH16 driven by the 
inducible promoter PBAD showed either similar or slower growth in glycerol 
compared to the C. necator H16 WT. This variability observed, could be due to 
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protein expression is sensitive to the point of L-arabinose induction, or due to 
plasmid instability during cultivation. A recent publication by Aboulnaga et al. 
(2018) also reported that the constitutive expression of glpKEc was more 
successful than the inducible expression of the same gene. 
 
Apart from that, it is worth to note that the integration of glpKEc into C. necator 
H16 chromosome was previously reported by Fukui et al. (2014) to improve 
glycerol assimilation with some success, but the effects of glpKH16 and glpDH16 
genes native of the C. necator H16 strain were not investigated. Fukui et al. 
(2014) showed that the plasmid harbouring the glpKEC gene was not successfully 
transformed into C. necator H16, likely due to spontaneous deletion of the gene 
by C. necator H16. In order to understand better the differences between glpKH16 
and glpKEc, the plasmid pPj5’c.rbs-glpKEc was constructed; after the analysis of 
the cell growth study shown in Figure 5.5, the specific growth rate of 
H16_glpKEc (open square, light blue line) was 0.130 h-1, which was similar to the 
specific growth rate of H16_glpKH16 (square, dark blue line) (0.120 h-1). Thus, it 
is possible that the difference observed for plasmid-based glpKEc might be 
attributed to the use of different promoters that could cause variability in plasmid 
stability and expression level in C. necator H16, which has been reported in other 
publications (Johnson et al., 2018; Aboulnaga et al., 2018). 
 
From these experiments performed in the rational design approach, it could be 
observed that the specific growth rate of the recombinant strains (» 0.130 h-1) in 
0.50 % (w/v) glycerol was significantly improved compared to the specific 
growth rate of C. necator H16 (0.024 h-1) in 0.50 % (w/v) glycerol, which was 
5.4-fold faster compared to the specific growth rate of C. necator H16, and only 
2.2-fold slower compared to the specific growth rate of C. necator H16 in 0.59 % 
(w/v) gluconate. 
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5.4.3 Evolutionary engineering strategy for improvement of glycerol 
assimilation in C. necator H16 
 
A parallel strategy to improve glycerol assimilation in C. necator H16 apart from 
rational design was performed, which was based on evolutionary engineering via 
adaptive evolution since the underlying reason of the slow growth of C. necator 
H16 growth in glycerol is not fully understood. In Chapter 4, directed evolution 
via random mutagenesis of the entire genome of C. necator H16 was used to 
evolve the strain, where a population of C. necator H16 cells was subjected to 
chemical mutagenesis in order to create unknown random mutations which were 
furtherly screened in a defined medium with a selection pressure to select only the 
mutated cells with the desired improved phenotype. A similar approach of 
evolutionary engineering was used to evolve C. necator H16 cells to enhance its 
glycerol utilisation, although the conditions of the experiment allowed to evolve a 
population of C. necator H16 WT cells in a defined habitat –glycerol- which 
would allow to generate unknown mutations but in specific DNA regions related 
to glycerol assimilation, thus linking phenotype with genotype. 
 
As reviewed in Porcar (2010), adaptive evolution, is a process whereby a 
microorganism can become better to live in a defined habitat by improving its 
genetic circuits; the experimental design is straightforward, it involves 
maintaining cells in the exponential growth or early stationary phase by daily 
passage of cultures into a fresh medium under a selection pressure, in this case, 
glycerol. This strategy can be a simpler and faster tool for the selection of desired 
phenotypes compared to the previous evolutionary engineering tool studied in 
Chapter 4, although it is not always feasible for all studies (as it was the case of 
the studies of Chapter 4). Thus, adaptive evolution was used as a strategy to 
improve the phenotype of C. necator H16 cells for enhancement of glycerol 
assimilation, where C. necator H16 WT cells were evolved by serial cultivation in 
MSM with 0.50 % (w/v) glycerol. 
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5.4.3.1 Genetic variation of C. necator H16 obtained after adaptive evolution 
 
The initial selective condition in adaptive evolution was MSM with 0.50 % (w/v) 
glycerol. Serial cultivation was followed for up to six rounds of adaptive 
evolution, where cells were transferred from one culture to the next one at the 
early-stationary phase (Figure 5.6). The number of rounds performed for this 
experiment of adaptive evolution was accumulated until no further improvement 
in glycerol assimilation was found. A significant improvement in glycerol 
assimilation by the new population of C. necator H16 was observed from the 
second round of adaptive evolution (open circle, grey line).  
 
Figure 5.6 Cell growth curve of C. necator H16 in the six serial cultivations of adaptive evolution 
in MSM with 0.50 % (w/v) glycerol. Round 1 (circle, red line), Round 2 (open circle, grey line), 
Round 3 (open triangle, orange line), Round 4 (inverted open triangle, blue line), Round 5 (open 
diamond, pink line), and Round 6 (open square, green line). The inset shows the magnified cell 
growth curve of the last four rounds of adaptive evolution in glycerol. Abbreviations: Rd, round. 
 
 
From Figure 5.6 it could be noted that the cell population adapted quickly, where 
cells were able to reach their maximum optical density from 9 days in Round 1 to 
only 4 days in Round 2, and to 2 days in Round 3. The time required to reach 
maximum optical density did not change significantly from Round 3 to Round 6, 
although the lag phase (inset Figure 5.6) in these rounds seemed to be different. It 
is perhaps unsurprising that C. necator H16 WT was capable of adapting quickly 
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to improve its growth in glycerol, as this kind of adaptation has been previously 
observed when C. necator H16 was adapted to grow in glucose (Franz et al., 
2012). After the six rounds of adaptive evolution, the population of variants from 
Round 4, Round 5, and Round 6 was selected for screening analysis.  
 
 
5.4.3.2 Analysis of variant strains of C. necator H16 obtained after adaptive 
evolution from Round 4 to 6. 
 
The screening of the population of C. necator H16 variant strains was performed 
in three different microtitre plates in MSM with 0.50 % (w/v) glycerol 
supplemented with gentamicin (one microtitre plate for each of the rounds of 
adaptive evolution), where a total of 270 variant strains were screened (Figure 
5.7). Each microtitre plate contained control samples to compare cell growth and 
find the variants with an improved phenotype; the control samples were the parent 
strain C. necator H16 WT in MSM with 0.59 % (w/v) gluconate and C. necator 
H16 in MSM with 0.50 % (w/v) glycerol, which were always included in 
triplicates in all experiments. The best variant strains for each of the rounds of 
adaptive evolution were chosen as follows: for each OD595 measurement taken 
during the cell growth curve, the two highest OD595 values corresponding to 
variant strains were selected to be followed through the entire cell growth study, 
then, all the variants selected were compared against each other and against the 
parent strain to identify the variant strains with the best cell growth performance 
in glycerol. The variant strains were named as “v” for variant, followed by a 
“number” from 4 to 6, which corresponds to the round of adaptive evolution, and 
a “letter + number” corresponding to the well of the microtitre plate where the 
variant strain was grown. 
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Figure 5.7 Screening of variant strains adapted in 0.50 % (w/v) glycerol from Round 4, Round 5 
and Round 6. Screening analysis was performed in microtitre plates with 150 µL of MSM with 
0.50 % (w/v) glycerol. C. necator H16 WT in MSM with 0.59 % (w/v) gluconate (circle, green 
line), and C. necator H16 WT in MSM with 0.50 % (w/v) glycerol (circle, red line); v4C2 in MSM 
with 0.50 % (w/v) glycerol (triangle, orange line), v4D1 in MSM with 0.50 % (w/v) glycerol (open 
triangle, orange line), v5A4 in MSM with 0.50 % (w/v) glycerol (diamond, pink line), v5E8 in 
MSM with 0.50 % (w/v) glycerol (open diamond, pink line), v6C6 in MSM with 0.50 % (w/v) 
glycerol (square, blue line), v6F8 in MSM with 0.50 % (w/v) glycerol (open square, blue line), and 
v6G7 in MSM with 0.50 % (w/v) glycerol (open crossed square, blue line). Error bars are ± SEM 
of three independent determinations. Abbreviations: v, variant. 
 
 
The screening of the last three rounds of adaptive evolution showed variants with 
an improved phenotype in glycerol assimilation compared to their parent strain C. 
necator H16 WT. While the parent strain did not show any growth even after 52 h 
of cultivation, all the best variants depicted in Figure 5.7 reached the maximum 
optical density in less than 42 h of cultivation. Although all variants from the 
three microtitre plates grew similarly, and all of them showed a significant 
improvement in glycerol assimilation compared to the WT parent strain, two of 
the variants from the Round 6 of adaptive evolution v6C6 (square, blue line) and 
v6G7 (open square, blue line) in the screening analysis showed a slightly better 
cell growth performance in glycerol than the rest of the variants of Round 5 and 
Round 4 of adaptive evolution.  
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After screening analysis, the characterisation of the three variants from the Round 
6 of adaptive evolution (v6C6, v6F8, and v6G7), and only one variant from Round 
5 (v5A4) and one from Round 4 (v4C2) was performed in 150 µL of MSM with 
0.50 %, 1.00 % and 2.00 % (w/v) glycerol in microtitre plates to identify the best 
variant strains, all samples were included in triplicates. The cell growth study for 
the characterisation of the variant strains is shown in Figure 5.8. Variant strains 
were also grown in MSM with 0.59 % (w/v) gluconate to check if the variant 
strains could still grow like the WT. 
 
 
 
Figure 5.8 Characterisation of variant strains adapted in 0.50 % (w/v) glycerol from Round 4, 
Round 5 and Round 6 from adaptive evolution. Characterisation analysis was performed in 
microtitre plates with 150 µL of MSM with 0.50 %, 1.00 % and 2.00 % (w/v) glycerol. C. necator 
H16 (circles), v4C2 (triangles), v5A4 (diamonds), v6C6 (squares), v6F8 (crossed squares), and 
v6G7 (open squares) were grown in MSM with 0.59 % (w/v) gluconate (green lines), 0.50 % (w/v) 
glycerol (red lines), 1.00 % (w/v) glycerol (orange lines), and 2.00 % (w/v) glycerol (blue lines). 
Error bars are ± SEM of three independent determinations. Abbreviations: v, variant. 
 
From Figure 5.8 it was confirmed that the cell growth of the variant strains 
screened from the last three rounds of adaptive evolution was effectively 
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improved compared the cell growth of C. necator H16 WT in glycerol. On the 
other hand, it was observed as well that variant strains were also capable of 
growing in gluconate (green lines) as the WT strain, which showed a similar 
maximum OD595 compared to the samples grown in 0.50 % (w/v) glycerol (red 
lines) as they have the same carbon concentration. The three graphs depicted in 
Figure 5.8 showed that all variants grew with a similar growth rate in all different 
concentrations of glycerol, unless for the variant v4C2, which was isolated from 
the Round 4 of adaptive evolution. Hence, from this point onwards, only the 
variants from the Round 6 of adaptive evolution (v6C6, v6F8, and v6G7) were 
used for further investigations. 
 
 
5.4.3.3 Confirmation of improved glycerol-utilising phenotype 
 
To confirm that the improved phenotype was not transient adaptations but true 
mutations, the three variants from the Round 6 of adaptive evolution v6C6, v6F8, 
and v6G7 were subjected to five consecutive rounds of cultivation in either a 
complex media (NB) or synthetic medium (MSM with 1.00 % (w/v) gluconate) in 
the absence of glycerol. After the five consecutive rounds of cultivation in both 
media, the variant strains were transferred back to MSM with 0.50 % (w/v) 
glycerol to confirm if these were still capable of growing in glycerol with the 
same specific growth rate as observed before. The three variants maintained their 
growth rates at the same level when they were first isolated after 5 passages in NB 
or MSM supplemented with gluconate (data not shown); this indicated that the 
improved growth rate in glycerol was a result of a genetic mutation and not only 
physical adaptation during adaptive evolution. 
 
 
5.4.3.4 Cell growth studies of variants of C. necator H16 
 
Due to previous studies described in Section 5.4.3.3 demonstrated that there were 
true mutations in variants of the Round 6 of adaptive evolution, a cell growth 
study of one of the variants from Round 6 (v6C6) was performed in order to 
investigate its improvement in specific growth rate compared to C. necator H16 
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WT (Figure 5.9A). The specific growth rate of v6C6 grown in 0.50 % (w/v) 
glycerol was 8-fold faster than its parent strain C. necator H16 WT in the same 
concentration of glycerol, and it was 69 % the rate in gluconate. Due to the v6C6 
variant strain showed a faster specific growth rate compared to the WT, the 
variant strain was transformed with the plasmids pPj5’c.rbs-glpKH16, pPj5’c.rbs1-
glpKDH16, and pPj5’c.rbs2-glpKDH16 (Figure 5.9B). Nevertheless, no 
improvement in growth was observed for the v6C6 recombinant strains, on the 
contrary, the recombinant strains resulted in a reduction of specific growth rate of 
the variant strain as shown in Table 5.5, which was reduced from 0.20 h-1 to 0.14 
– 0.15 h-1. The specific growth rate of the recombinant strain v6C6_glpKH16 (0.21 
h-1) was very similar to the specific growth rate of v6C6 (0.20 h-1) but with a 
longer lag phase, which might have been due to an additional metabolic burden of 
protein expression.  
 
 
 
Figure 5.9 Cell growth curve of C. necator H16 WT, v6C6 and v6C6 recombinant strains 
harbouring glpKH16, and glpKDH16 plasmids in 0.50 % (w/v) glycerol. A) Growth curve of C. 
necator H16 in MSM with 0.59 % (w/v) gluconate (circle, green line), v6C6 in MSM with 0.50 % 
(w/v) glycerol (square, red line), and C. necator H16 in MSM with 0.50 % (w/v) glycerol (circle, 
red line). The inset shows the magnified cell growth curve of C. necator H16 in gluconate and 
v6C6 in glycerol. B) Growth curve of v6C6 in MSM with 0.50 % (w/v) glycerol (square, red line), 
v6C6_glpKH16 in MSM with 0.50 % (w/v) glycerol (open square, blue line), v6C6_rbs1.glpKDH16 
in MSM with 0.50 % (w/v) glycerol (triangle, dark pink line), and v6C6_rbs2.glpKDH16 in MSM 
with 0.50 % (w/v) glycerol (open triangle, light pink line). Error bars are ± SEM of three 
independent determinations. 
 
 
The comparison table showing the different specific growth rates of all the 
recombinant and variant strains developed in this work are shown in Table 5.5, 
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from which is noted that the v6C6 variant strain remained as the fastest growing 
glycerol-utilising strain obtained from these studies. 
 
Table 5.5 Specific growth rate of C. necator H16, v6C6 and recombinant strains in glycerol. 
Strain Carbon source Specific growth rate [h-1] 
H16_WT 0.59 % (w/v) gluconate 0.290 
H16_WT 0.50 % (w/v) glycerol 0.024 
H16_glpKH16 0.50 % (w/v) glycerol 0.120 
H16_glpKEc 0.50 % (w/v) glycerol 0.130 
H16_glpDH16 0.50 % (w/v) glycerol - 
H16_rbs1.glpKDH16 0.50 % (w/v) glycerol 0.130 
H16_rbs2.glpKDH16 0.50 % (w/v) glycerol 0.140 
v6C6 0.50 % (w/v) glycerol 0.200 
v6C6_ glpKH16 0.50 % (w/v) glycerol 0.210 
v6C6_ rbs1.glpKDH16 0.50 % (w/v) glycerol 0.140 
v6C6_ rbs2.glpKDH16 0.50 % (w/v) glycerol 0.150 
 
 
Apart from gluconate, fructose is another preferred carbon source for C. necator 
H16, where at 0.50 % (w/v) fructose, C. necator H16 has shown to have a specific 
growth rate of 0.28 h-1 (Fukui et al., 2014), similar to the specific growth rate with 
0.59 % (w/v) gluconate (0.29 h-1). The best engineered strain v6C6 has a specific 
growth rate of 0.20 h-1 when cells are grown in 0.50 % (w/v) glycerol, although 
the specific growth rate is lower than when C. necator H16 is grown in a preferred 
carbon source such as gluconate or fructose, the use of these carbohydrates is 
expensive, and hence, their application is not attractive for bioproduction. 
 
After identifying that cells of v6C6 showed a faster specific growth rate compared 
to the recombinant strains of C. necator H16 and recombinant strains of v6C6, a 
further adaptive evolution was performed on v6C6 using different concentrations 
of glycerol (0.25 %, 2.00 % and 5.00 % (w/v) glycerol), were 267 variants were 
screened, but this adaptive evolution experiment did not show variants with a 
further improvement in glycerol assimilation (data not shown). 
 
 
5.4.3.5 Mutations found in glpKv6c6 
 
As reviewed in Bloom et al. (2009), evolutionary engineering has revealed that a 
single amino acid mutation is capable of enhancing catalytic activity or stability of 
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a protein, and that adaptation can generally occur through pathways that consist of 
sequential beneficial mutations, as might have occurred for with the variants 
isolated from the last rounds of adaptive evolution, which after adaptive evolution 
improved glycerol utilisation significantly. 
 
The v6C6 variant strain was isolated from the Round 6 of adaptive evolution, and 
even though it was evident that C. necator H16 effectively went through 
beneficial true mutations after adaptive evolution –as reflected by its new 
phenotype characteristics with an enhancement of glycerol assimilation-, the 
precise number, location, and nature of the genetic mutation(s) in its genome is 
unknown. Nevertheless, the rational design studies demonstrated that glpKH16 
played an important role in the enhancement of glycerol assimilation. Thus, it was 
decided to sequence the glpK gene (gene locus H16_A2507) and its 500-bp 
upstream element in v6C6 to check for gene modifications in that targeted region. 
Even though the genome size of C. necator H16 is 7,416,678 bp, it was surprising 
that after DNA sequencing of the glpKH16 gene and its 500-bp upstream element, 
mutations were found within the glpKH16 gene (Figure 5.10).  
 
 
Figure 5.10 Chromatogram and DNA sequence of GlpK in C. necator H16 and variant strains. A 
single non-synomymous mutation was found after DNA sequencing of the glpK gene (in green) 
and its 500-bp upstream element (in blue) of v6C6, v6F8, and v6G7. The same W480S substitution 
was found in the three variants isolated from the Round 6 of adaptive evolution. 
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The mutation found within the glpKH16 gene was a non-synonymous mutation, 
where the amino acid position 480 was mutated from tryptophan to a serine 
(W480S substitution). Thus, after finding this substitution, the glpKH16 gene and 
its 500-bp upstream element of the other two variants isolated as well from the 
Round 6 of adaptive evolution -v6F8, and v6G7- were also analysed, and the same 
substitution was found. This could indicate that this modification was enriched 
during the different rounds of adaptive evolution and that this could be the 
mutation responsible for the enhancement of glycerol assimilation. 
 
 
5.4.3.6 Protein model of GlpKv6C6 
 
A protein model of GlpKH16 and GlpKv6C6 was created using GlpKEc (PDB 1BOT) 
as a template (Figure 5.11). From the protein model created, it could be observed 
that W480 is found on a coiled region that is away from the catalytic centre. Due 
to W480 is not found in any known glycerol-binding, ATP-binding or activation 
loop in GlpK (Yeh et al., 2004; Anderson et al., 2007), it is difficult to predict if 
the mutation could have altered its catalytic function, further investigations would 
be required to confirm the effects of this mutation found in the protein due to this 
substitution; it is also possible that other genetic mutations could be found in other 
regions of C. necator H16 variant strains which could also be related to the 
enhancement of glycerol assimilation, where also, further analysis must be 
performed to understand how mutations helped to improve glycerol utilisation. 
For instance, whole-genome sequencing of the variant strains could be performed, 
as this would help to identify other possible mutations in the genome that could be 
responsible for the enhancement of glycerol-utilising phenotype observed in the 
variant strains. 
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Figure 5.11 Protein models of C. necator H16 GlpKH16 (gene locus: H16_A2507). A) and B) 
GlpKH16 with Trp480 shown in dark blue. C) and D) GlpKv6C6 (GlpK W480S mutant) with Ser480 
shown in dark blue. 
 
 
On the other hand, a Conserved Domain Search (Marchlet-Bauer et al., 2004) in a 
multiple sequence alignments of GlpKH16 against related protein in a variety of 
organisms, revealed that W480 is a reasonable conserved region (Figure 5.12), 
hence, the impact of this mutation could be of significant importance for the 
enhancement of glycerol utilisation. 
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Figure 5.12 Conserved Domain Search (Marchlet-Bauer et al., 2004) of GlpKH16. The illustration shows the 
multiple sequence alignment of GlpKH16 and related proteins from a variety of organisms. Sequence 
alignment is shown using colour bits 3.5 for the amino acids, where red colour indicates highly conserved 
and blue colour less conserved. 
 
 
5.4.4 Chemical production in C. necator H16 WT and v6C6 using glycerol 
as a carbon source 
 
After investigating both strategies –rational design and evolutionary engineering- 
to engineer C. necator H16 for enhancement of glycerol utilisation, PHB was 
chosen as an example of a chemical that could be produced using glycerol as 
feedstock, since the strain is a natural PHB producer. The PHB productivity was 
analysed in C. necator H16 WT and the variant strain v6C6, which showed to be 
the best-engineered strain of C. necator H16 for utilising glycerol. Two different 
carbon sources were used for PHB quantitation, a preferred carbon source 
(gluconate), and glycerol. PHB quantitation was surveyed using a Nile red assay 
(Tyo et al., 2006). Nile red is a lipophilic stain that is widely used for PHB 
quantitation, and in order to use it for PHB quantitation, initially, a standard curve 
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of Nile red was performed in order to keep the fluorescence detection within the 
linear range (Figure 5.13). 
 
 
 
Figure 5.13 Standard curve of Nile red assay for PHB quantitation. Error bars are ± SEM of three 
independent determinations. 
 
 
From the standard curve shown in Figure 5.13, it was determined that the 
maximum optical density used for Nile red assays would be OD600 of 2.0. The 
analysis of PHB content using Nile red assay was performed by generating a cell 
growth curve of C. necator H16 and v6C6 in four different media: 1) MSM with 
0.59 % (w/v) gluconate and 0.10 % (w/v) NH4Cl (for nutrient-balanced nitrogen 
conditions), 2) MSM with 0.59 % (w/v) gluconate and 0.05 % (w/v) NH4Cl (for 
nitrogen-limiting conditions), 3) MSM with 0.50 % (w/v) glycerol and 0.10 % 
(w/v) NH4Cl (for nutrient-balanced nitrogen conditions), and 4) MSM with 0.50 
% (w/v) glycerol and 0.05 % (w/v) NH4Cl (for nitrogen-limiting conditions), 
where an aliquot of all samples was withdrawn from the cultures at the 
exponential, early stationary and late stationary growth face for PHB quantitation. 
As observed in Figure 5.14 for both strains and carbon sources, a higher 
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fluorescence was obtained when cells were grown in nitrogen-limiting media, 
which agrees with the fact that C. necator H16 produces more PHB under nutrient 
stress (reviewed in Lee, 1996). 
 
 
 
Figure 5.14 PHB production surveyed using Nile red fluorescence assay. PHB production was 
quantified in 0.59 % (w/v) gluconate and 0.50 % (w/v) glycerol under nutrient-balanced and 
nitrogen-limited conditions. Nutrient-balanced conditions: C. necator H16 WT (green solid bars), 
and v6C6 variant (blue solid bars) in 0.59 % (w/v) gluconate, C. necator H16 WT (red solid bars), 
and v6C6 variant (black solid bars) in 0.50 % (w/v) glycerol. Nitrogen-limited conditions: C. 
necator H16 WT (green stripe bars), and v6C6 variant (blue stripe bars) in 0.59 % (w/v) 
gluconate, C. necator H16 WT (red stripe bars), and v6C6 variant (black stripe bars) in 0.50 % 
(w/v) glycerol. Error bars are ± SEM of three independent determinations. 
 
 
From Figure 5.14 it could also be observed that under nitrogen-limiting 
conditions, C. necator H16 WT produced more PHB in gluconate than in glycerol 
in all growth phases analysed. Contrary to what was observed for v6C6, where 
more PHB was produced in glycerol than in gluconate. The maximum PHB 
production under nitrogen-limited conditions from glycerol was achieved at the 
early stationary phase for v6C6, the variant strain produced 19 % more PHB than 
C. necator H16 WT, what is more, this maximum PHB production was achieved 
in 28 h for v6C6 against the 168 h for the WT strain; this represents a more than 
6-fold improvement in the PHB volumetric productivity from glycerol for v6C6. 
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PHB production was also confirmed by staining the PHB granules from samples 
of C. necator H16 and v6C6 in gluconate and glycerol under nitrogen-limiting 
conditions withdrawn at the early stationary phase with Nile red; the PHB 
granules were visualised using fluorescence microscopy (Figure 5.15). 
 
 
 
Figure 5.15 Fluorescence microscopy of Nile red-stained PHB granules. C. necator H16 and 
v6C6 cells samples were grown in 0.59 % (w/v) gluconate and 0.50 % (w/v) glycerol under 
nitrogen-limiting conditions. Abbreviations: NL, nitrogen-limited conditions. 
 
 
5.4.5 Crude glycerol assimilation of recombinant and variant strains of C. 
necator H16 
 
After engineering, characterising and bioproducing PHB from engineered C. 
necator H16 strains using laboratory-grade glycerol (pure glycerol), the potential 
for industrial applications of the engineered strains was verified using crude 
glycerol obtained from a high-pressure fat splitting process. Comparative growth 
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studies of recombinant strains and v6C6 were performed using crude glycerol as 
feedstock. Initially, different concentrations of crude glycerol were used (1.00 %, 
2.00 %, and 4.00 % (v/v) of MSM with crude glycerol) (Figure 5.16A), where, as 
observed with pure glycerol studies, v6C6 showed higher specific growth rates 
and shorter lag phase compared to C. necator H16 WT (Table 5.6), v6C6 showed 
a specific growth rate of 0.220 h-1 compared to the specific growth rate of 0.048 h-
1 for C. necator H16 in 4.00 % (v/v) crude glycerol (i.e., 4.6-fold faster than the 
WT strain). After analysing the cell growth at different concentrations of glycerol, 
4.00 % (v/v) crude glycerol was chosen for studying the growth of C. necator 
H16 recombinant strains (Figure 5.16B). The results of the cell growth study in 
crude glycerol with recombinant strains of C. necator H16 and v6C6 showed 
higher specific growth rates and shorter lag phase compared to C. necator H16 
WT (Table 5.6) as observed in previous results with pure glycerol, although the 
v6C6 variant strain remained as the best-engineered strain in glycerol 
assimilation. 
 
Chapter 5. Rational design and Evolutionary engineering:  
Engineering Cupriavidus necator H16 to convert waste stream  
into useful chemicals by enhancing glycerol assimilation 
 
 218 
 
 
Figure 5.16 Cell growth of C. necator H16, v6C6 and recombinant strains in crude glycerol. A) 
Growth curve of C. necator H16 (circles), and v6C6 (squares) in MSM with 1.00 % (v/v) crude 
glycerol (red lines), MSM with 2.00 % (v/v) crude glycerol (blue lines), and MSM with 4.00 % 
(v/v) crude glycerol (orange lines). B) Growth curve of v6C6 (square, orange line) in MSM with 
4.00 % (v/v) crude glycerol, H16_glpKH16 (open square, green line), H16_rbs1.glpKDH16 (triangle, 
pink line) in MSM with 4.00 % (v/v) crude glycerol, and H16_rbs2.glpKDH16 (open triangle, grey 
line) in MSM with 4.00 % (v/v) crude glycerol. 
 
 
The comparison table showing the different specific growth rates of all the 
recombinant and variant strains grown in crude glycerol are shown in Table 5.6, 
where also it was noted that the v6C6 variant strain remained as the fastest 
growing crude glycerol-utilising strain obtained from these studies. The 
comparison on growth rates of the recombinant and v6C6 engineered strains was 
performed only in 4.00 % (v/v) crude glycerol, as this concentration provided a 
similar OD600 of » 8 when cells reached stationary phase to the OD600 of » 8 also 
when cells reached the same growth phase when cells were grown in MSM with 
0.59 % (w/v) gluconate or 0.50 % (w/v) glycerol. 
 
 
Table 5.6 Specific growth rate of C. necator H16, v6C6 and recombinant strains in crude glycerol. 
Strain Carbon source Specific growth rate [h-1] 
H16_WT 1.00 % (v/v) crude glycerol 0.023 
H16_WT 2.00 % (v/v) crude glycerol 0.031 
H16_WT 4.00 % (v/v) crude glycerol 0.048 
v6C6 1.00 % (v/v) crude glycerol 0.170 
v6C6 2.00 % (v/v) crude glycerol 0.220 
v6C6 4.00 % (v/v) crude glycerol 0.220 
H16_glpKH16 4.00 % (v/v) crude glycerol 0.096 
H16_rbs1.glpKDH16 4.00 % (v/v) crude glycerol 0.095 
H16_rbs2.glpKDH16 4.00 % (v/v) crude glycerol 0.098 
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5.5 Conclusion 
 
The plasmids described in this Chapter 5 were constructed using the synthetic 
biology toolbox with the inducible and constitutive systems described in Chapter 
2 for the expression of glycerol-related proteins in C. necator H16, which were 
successfully transformed and expressed into C. necator H16 by electroporation 
with the optimised protocol method described in Chapter 2. 
 
Both strategies –rational design (optimised and studied in Chapter 2) and 
evolutionary engineering (studied in Chapter 4)- used in this work were proven 
successful to unlock the glycerol utilisation ability of C. necator H16, where the 
best variant of C. necator H16 –v6C6- showed a significant cell growth 
improvement in glycerol utilisation with an 8-fold faster specific growth rate 
compared to the WT. The best glycerol-utilising variant v6C6 also showed at least 
a 6-fold higher PHB volumetric productivity from glycerol compared to the WT. 
Although further studies –such as whole-genome sequencing- should be 
performed in order to fully understand the glycerol-utilising phenotype of the 
variant strains, the already identified GlpKv6C6 represents an attractive candidate 
to be used for directed evolution to construct a better glycerol-utilising mutant 
strain. The variants isolated from evolutionary engineering strategy via adaptive 
evolution –v6C6, v6F8, and v6G7- are valuable starting points for developing a 
sustainable bioprocess that could use crude glycerol as feedstock for chemical 
production such as the biodegradable PHB bioplastics. 
 
The fact that the best-engineered strain was derived from evolutionary 
engineering via adaptive evolution, even though the key glycerol enzymes were 
known and targeted in rational design, reflects the potential of evolutionary 
engineering tools and the challenges that the rational design engineering can have 
due to biological complexities. 
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6 Concluding remarks and Future work 
 
 
6.1 Concluding remarks 
 
In Chapter 1, the need for expanding tools for chemical production using C. 
necator H16 as a cell factory, the current and potential bioproducts that can be 
synthesised in the strain, and the different carbon sources -including sustainable 
and cheap feedstock- were discussed. The compilation of the literature of C. 
necator H16 also contributed to understanding the natural metabolism of C. 
necator H16, and hence, the design of the experiments in this work was designed 
based on potential bioproducts that could be synthesised in engineered strains of 
C. necator H16. In order to use C. necator H16 as a cell factory, mainly two 
different strategies were reviewed: Rational design and Evolutionary engineering, 
which are the most common engineering tools used for chemical production in 
industry. 
 
The first tool required to engineer C. necator H16 based on a rational design 
engineering approach was the developing of a more straightforward tool to 
transform C. necator H16 cells, which was achieved by the optimisation of the 
transformation method by electroporation for C. necator H16 described in 
Chapter 2. Due to bacterial conjugation –an alternative of transformation in C. 
necator H16- is a different technique compared to electroporation (the method 
proposed in this work), the comparison among these two methods in terms of 
efficiency is difficult, although, the key advantage with the method proposed in 
this work lies mainly in that this is a shorter and simpler method for 
transformation of C. necator H16, which only takes 2 days to be accomplished, 
while bacterial conjugation requires 4 to 5 days to be accomplished. The 
maximum transformation efficiency obtained for C. necator H16 was 3.86 x 105 
cfu/µg DNA. Some parameters have been studied in this work have been 
investigated in previous publications (Table 6.1), although the combination of all 
the optimised parameters has not been published before. As observed in Table 
6.1, Solaiman et al. (2010) previously reported a transformation efficiency of 470 
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cfu/µg DNA using the pBHR1plasmid, which was also used in this study, this 
represents a 103-fold improvement in transformation efficiency for the 
electroporation method proposed in this work. 
 
Table 6.1 Transformation efficiency of C. necator H16 reported in literature. 
Plasmid  Cells Electroporation condition   
Name Size 
(kb) 
OD600 Buffer Voltage 
[kV cm-1] 
Transformation 
eff. [cfu//µg 
DNA] 
References 
pKT230 11.9 0.8 10 % (v/v) 
glycerol 
11.5 8.00 x 101 Park et al., 
195 
pBHR1 5.3 0.6 0.2 M sucrose 11.5 3.86 x 105 This work 
(Tee et al., 
2017) 
pBHR1 5.3 n.r. 0.3 M sucrose 25 4.70 x 102 Solaiman 
et al., 2010 
pKK-II 89-6 7.8 n.r. 0.3 M sucrose 25 1.20 x 102  Solaiman 
et al., 2010 
pBS29-P2-gfp 8.7 n.r. 0.3 M sucrose 25 4.04 x 103 Solaiman 
et al., 2010 
Abbreviations: n.r.: not reported. Adapted from Tee et al., 2017. 
 
After optimising the transformation method by electroporation for C. necator 
H16, the construction of a synthetic biology toolbox tailored for C. necator H16 
with two different promoters (PBAD and Pj5) was performed, where all the plasmids 
constructed were based on a broad host range plasmid vector (pBBR1MCS-1), as 
this is a C. necator H16-compatible vector. The plasmids were constructed for 
protein expression for metabolic engineering purposes.  
 
Then, in Chapter 3, the applicability of the synthetic biology toolbox was tried 
out for the expression of heterologous biotin operons in E. coli BW25113 DbioC 
and C. necator H16 for pimelate production. Although most of the plasmids 
constructed in this work using the synthetic biology toolbox –either with a 
constitutive or inducible gene expression- mediated successfully the expression of 
native and heterologous genes in C. necator H16, the unsuccessful expression of 
all the genes of the biotin operons in C. necator H16 (and in E. coli BW25113 
DbioC) could be attributed to proteolysis as a mechanism of defence of the strain 
to protect it from cellular toxicity, although other studies could be tested to 
corroborate the expression of all the genes of the extended biotin operons (such as 
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GeLC-MS/MS), as well as study further the inducible system by optimising the 
induction point and concentration. 
 
In Chapter 4, a second strategy to engineer C. necator H16 was studied: 
evolutionary engineering. A method of directed evolution via random 
mutagenesis was developed to introduce random mutations in the genome of C. 
necator H16. The optimised method was then applied to try to understand the 
unknown biotin biosynthesis pathway of C. necator H16 by selecting mutant 
strains that could grow in the presence of a biotin analogue. The results showed 
that the selected mutants after screening selection were not overproducing biotin 
as expected, this might be due to the best mutants obtained after two rounds of 
directed evolution via random mutagenesis still did not show a significantly 
higher fold in cell growth compared to the WT, and hence the biotin production 
between C. necator H16 and the mutants was relatively the same. Nevertheless, 
the development of the EMS random mutagenesis method for C. necator H16 is a 
potential engineering tool for the strain, as it can be used for engineering C. 
necator H16 for a wide variety of purposes, as directed evolution via random 
mutagenesis is becoming increasingly crucial for metabolic engineering of 
complex phenotypes. 
 
The study and optimisation of some of the engineering tools used in rational 
design and evolutionary engineering studied in previous chapters contributed to 
engineer C. necator H16 strains for chemical production (bioplastics) using waste 
stream (crude glycerol) as feedstock in Chapter 5, where both recombinant and 
evolved cells of C. necator H16 were generated with the aid of recombinant strain 
engineering and adaptive evolution for improvement of glycerol utilisation. The 
parallel use of both strategies demonstrated the potential of combinatorial 
approaches, where the rational design approach showed that the glpK gene was 
essential for improving glycerol utilisation, and the evolutionary engineering 
approach also corroborated that the GlpK protein was a key enzyme for glycerol 
assimilation; although by natural adaptive evolution, the C. necator H16 strain 
improved better glycerol utilisation than the recombinant strains; this reflects that 
cells are complex systems, and thus, rational design engineering sometimes can be 
limited by this factor. 
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C. necator H16 is a versatile strain that can grow and naturally produce PHB on 
gluconate, fructose, fatty acids, and plant oils, but it cannot metabolise glucose, 
xylose or arabinose, and it shows a very poor growth in glycerol, an abundant 
waste stream in the bioindustry. Hence, the expansion of the carbon substrate 
range is vital for wider applications. To date, engineered strains of C. necator H16 
have been reported to be able to grow in glucose either using strategies of 
recombinant strain engineering (Sichwart et al., 2011) or evolutionary engineering 
(Franz et al., 2012). The same has been reported for related species of C. necator 
to grow in glycerol; it has been reported previously that other wild-type strains 
apart from C. necator H16 (Fukui et al., 2014) -C. necator JMP134 (DSMZ 4058) 
and DSM 545- were able to grow and to accumulate PHB on glycerol (Mothes et 
al., 2007; Cavalheiro et al., 2009).  
 
In Table 6.2, a comparison of the specific growth rates on glycerol for C. necator 
is shown. Fukui et al., (2014) produced PHB from glycerol with recombinant 
strains of C. necator H16 harbouring glpKFEc genes, where the recombinant 
strains were able to grow on glycerol much faster than the wild-type strain, but the 
specific growth rates (0.15 h-1 on 0.50 % (w/v) glycerol) were lower compared to 
other preferred carbon sources such as fructose (0.28 h-1 on 0.50 % (w/v) 
fructose). Mothes et al. (2007), produced also PHB from crude glycerol in 
Paracoccus denitrificans and C. necator JMP134, both strains accumulated PHB 
from pure grade glycerol or crude glycerol, although PHB accumulation was 65 % 
of CDW for P. denitrificans, while a higher PHB accumulation of 70 % of CDW 
was obtained for C. necator JMP134. The specific growth rate of C. necator 
JMP134 in glycerol was 0.13 h-1, which is also lower to the specific growth rate 
observed on other preferred carbon sources such as gluconate (0.29 h-1 on 0.59 % 
(w/v) gluconate, reported in this thesis). Higher specific growth rates on glycerol 
and crude glycerol were obtained in this thesis work, where v6C6 showed a 
specific growth rate of 0.20 h-1 on 0.50 % (w/v) glycerol, and 0.22 h-1 on 4.00 % 
(v/v) crude glycerol.  
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Table 6.2 Specific growth rates on glycerol in related species of C. necator. 
Strain Specific growth rate [h-1] [Glycerol] Reference 
C. necator JMP134 0.13 n.r. Mothes et al., 2007 
C. necator H16 0.15 0.50 % (w/v) Fukui et al., 2014 
C. necator DSM 545 0.17 0.50 % (w/v) Cavalheiro et al., 
2009 
v6C6 0.20 0.5 % (w/v) This study 
Abbreviations: n.r.: not reported. 
 
One of the main contributions of this work, is that a higher specific growth rate 
was obtained in an engineered strain of C. necator H16 (v6C6), which translates 
to a shorter time of PHB production. Engineered strains of C. necator H16 can 
reach stationary phase is a shorter period of time (28 h) compared to other 
reported publications (e.g., 50 h in Fukui et al., 2014). Higher specific growth 
rates are preferred as they are advantageous with respect to reducing production 
costs. On the other hand, for the recombinant strain engineering strategy followed 
in this study, the contribution of the individual gene glpKH16, and glpKDH16 genes 
to the enhancement in glycerol assimilation ability by the C. necator H16 strain 
have not been investigated before.  
 
Although in this work, PHB production was performed at low-scale in flasks for 
research purposes, it is well known that high-cell density fed-batch cultivation is 
the strategy mainly used to obtain higher PHB yields (Mothes et al., 2007; 
Cavalheiro et al., 2009, and 2012). Fed-batch are usually performed in 2 L 
reactor, where cultivation conditions such as gas composition and aeration rate 
have been found to be important to achieve high specific growth rates and high 
cell densities. Cavalheiro et al. (2009) maintained high dissolved oxygen 
concentration (DOC) levels in order to avoid oxygen limited growth using 
glycerol as carbon source, they demonstrated that high aeration rates and an inlet 
air stream containing pure oxygen were key factor to achieve high cell densities of 
approximately 45-50 gDW/L.  
 
C. necator H16 remains as a good candidate to be used for PHB production as this 
strain has been extensively studied for almost 60 years (Schlegel et al., 1961a, b) 
and is the best studied bacterium producer of PHB. The complete published 
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genome sequence of the strain allows scientist to look at the genetic potential of 
the strain, moreover, C. necator H16 is not limited to the production of PHB, but 
it can produce a wider range of copolyesters derived from PHB such as P(3HB-
co-3HV). Among other milestones, C. necator H16 is capable of accumulating 
PHB to over 80% (w/w) of its cell dry weight (CDW) (reviewed in Reinecke et 
al., 2009), reinforcing this strain as a candidate for chemical production. In Table 
6.3, results obtained using different microorganisms and carbon sources are given, 
where it can be observed that related species of C. necator H16 always produced 
>60 % of P(3HB)/CDW. 
 
Table 6.3 P(3HB) production in different microorganisms and carbon substrates. 
Strain Carbon source P(3HB)/
CDW %  
Reference 
E. coli CGSC 4401 Whey 87 Ahn et al., 2001 
E. coli XL1-Blue (pSYL105) Glucose 65 Kahar et al., 2005 
E. coli XL1-Blue (pJRDTrcphaCABRe)  Glucose 80 Kahar et al., 2005 
Methylobacterium rhodesianum MB 126  Glycerol  50 Bormann et al., 1999 
A. lactus  Sucrose  50 Yamane et al., 1996 
C. necator DSM 545  Glycerol 62 Cavalheiro et al., 2009 
C. necator DSM 11348  Glucose and 
peptone 
78 Bormann et al., 1998 
C. necator NCIMB 11599 Glucose  76 Kim et al., 1994 
C. necator JMP 134 Glycerol 70 Mothes et al., 2007 
Adapted from Cavalheiro et al., 2009. 
 
In this PhD thesis, the results obtained from the development of an efficient 
method for C. necator H16 transformation, a synthetic biology toolbox tailored 
for C. necator H16, a EMS random mutagenesis method for C. necator H16, and 
adaptive evolution studies in C. necator H16, have contributed to the expansion of 
engineering tools for chemical production in C. necator H16, methods that can be 
used in the bioindustry to convert waste stream such as crude glycerol into useful 
chemicals. 
 
 
6.2 Future work  
 
There are further investigations that should be performed to improve and to fully 
understand the results obtained in this work, which could enrich further either the 
optimisation of the engineering tools developed in this work or their applications. 
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Some of the future work that could be performed is mentioned in the following 
bullet points: 
 
 
Chapter 2. Recombinant strain engineering: Development of a 
transformation method and a synthetic biology toolbox for metabolic 
engineering in Cupriavidus necator H16 
 
Ø The synthetic biology toolbox can be further extended by replacing the 
PBAD and Pj5 promoters with other promoters of variable strengths that 
could be useful for engineering C. necator H16 for biomanufacturing 
applications; also, other genetic elements for controlling gene expression 
could be included in the synthetic biology toolbox, such as the tested 
RBSs studied in Alagesan et al. (2018). This due to similar to using 
different promoters for increasing protein expression, the RBS has a 
significant impact in the protein synthesis. The use of RBS with variable 
strengths could help to improve the levels of protein synthesis. 
 
 
Chapter 3. Metabolic engineering: Applicability of the synthetic biology 
toolbox by the expression of heterologous extended biotin operons in 
Cupriavidus necator H16 
 
Ø The inducible system of the synthetic biology toolbox constructed for C. 
necator H16 was applied for the expression of heterologous biotin operons 
in C. necator H16, were the genes occupying the first position of the 
operons were not visible in the SDS-PAGE. Thus, one of the first point 
calls of re-investigation would be to optimise the expression of the biotin 
operons. One way to explore this could be by 1) performing a dose-
dependent induction of PBAD promoter, using different L-arabinose 
concentrations to tune the expression of the biotin operons in E. coli and in 
C. necator H16, or 2) use a different inducible promoter such as the 
anhydrotetracycline-inducible Ptet promoter, which is also widely used to 
tune the expression of gene clusters in C. necator H16 (Johnson et al., 
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2018), or the tunable L-rhamnose inducible system which has been proven 
to be suitable for heterologous protein expression in C. necator H16, 
where variations in the induction time can be studied for the expression of 
toxic proteins, which could be the case of the extended biotin operons 
(Sydow et al., 2017). 
Ø Also, the study of the function of single genes of the extended biotin 
operons could be performed to check for BioC-like function. 
 
 
Chapter 4. Directed evolution: Development of directed evolution via random 
mutagenesis tool for Cupriavidus necator H16 to understand its biotin 
biosynthesis pathway 
 
Ø For the applicability of the EMS random mutagenesis method for C. 
necator H16, C. necator H16 cells were randomly mutagenised with the 
EMS chemical mutagen using a biotin analogue (TVA) as selection 
pressure to identify mutants that were able to grow in the presence of the 
biotin analogue, these mutants were expected to overproduce biotin in 
order to survive in the presence of TVA. Nevertheless, after biotin 
quantitation of the mutants isolated, the biotin production in C. necator 
H16 WT and mutant strains was somewhat the same. Thus, if in further 
experiments a mutant with a higher fold (e.g. 10-fold higher) in cell 
growth performance in the presence of TVA is obtained, and still the 
biotin content between the new isolated mutant strains and the WT is the 
same, one option to investigate could be to use a different biotin analogue 
as selection pressure such as azelaic acid. 
 
 
Chapter 5. Rational design and Evolutionary engineering: Engineering 
Cupriavidus necator H16 to convert waste stream into useful chemicals by 
enhancing glycerol assimilation 
 
Ø The evolutionary engineering approach provided exciting results which 
require further investigations, some of the future work that could be 
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performed in order to understand better the impact of the mutations 
generated during adaptive evolution could be: 
o Whole-genome sequencing of variant strains v6C6, v6F8, and 
v6G7, as this would help to identify other possible mutations in the 
genome that could be responsible for the enhancement of the 
glycerol-utilising phenotype observed in the variant strains, and to 
characterise variant strains fully. 
o Plasmid-based protein expression of GlpKv6C6 (GlpK W480S 
mutant) into C. necator H16 to check if the expression of this 
protein in the WT could improve glycerol assimilation with the 
same –or better- growth performance (i.e., a shorter lag phase than 
when GlpKH16 is overexpressed) as it does in v6C6. 
o The GlpKv6C6 (GlpK W480S mutant) also provides an interesting 
candidate to be used for directed evolution, which could generate a 
better glycerol-utilising mutant. 
References 
 231 
7 REFERENCES 
 
 
Aboulnaga E, Zou H, Selmer T, and Xian M. (2018) Development of a plasmid-
based, tunable, tolC-derived expression system for application in 
Cupriavidus necator H16. Journal of Biotechnology, 274: 15-27.  
 
Ahn WS, Park SJ, Lee SY. (2001) Production of poly(3-hydroxybutyrate) from 
whey by cell recycle fed-batch culture of recombinant Escherichia coli. 
Biotechnol Lett, 23: 235–40.  
 
Ahrens W, and Schlegel HG. (1972) Carbon-dioxide requiring mutants 
of Hydrogenomonas eutropha strain H16. Growth and CO2-fixation. Archiv 
Fur Mikrobiologie, 85(2): 142–152.  	
	
Alagesan S, Hanko EKR, Malys N, Ehsaan M, Winzer K, and Minton NP. (2018) 
Functional Genetic Elements for Controlling Gene Expression in 
Cupriavidus necator H16. App Environ Microbiol, 84(19): 1-8.	
 
Albuquerque MGE, Eiroa M, Torres C, Nunes BR, Reis MAM. (2007) Strategies 
for the development of a side stream process for polyhydroxyalkanoate 
(PHA) production from sugar cane molasses. Journal of Biotechnology, 
130(4): 411-421. 
 
Allaman I, Belanger M, and Magistretti P. (2015) Methylglyoxal, the dark side of 
glycolysis. Front Neurosci, 9: 23. 
 
Anderson MJ, DeLabarre B, Raghunathan A, Palsson BO, Brunger  AT, and 
Quake SR. (2007) Crystal structure of a hyperactive Escherichia coli 
glycerol kinase mutant Gly230 --> Asp obtained using microfluidic 
crystallization devices. Biochemistry, 46: 19. 
 
Andreeßen B, Lange AB, Robenek H, and Steinbüchel A. (2009) Conversion of 
glycerol to poly(3-hydroxypropionate) in recombinant Escherichia coli. 
Appl Environ Microbiol, 76: 622–626. 
 
Ashby RD, Solaiman DKY, Strahan GD, Zhu C, Tappel RC, and Nomura CT. 
(2012) Glycerine and levulinic acid: Renewable co-substrates for the 
fermentative synthesis of short-chain poly(hydroxyalkanoate) biopolymers. 
Bioresource Technology, 118: 272–80.  
 
Asif S, Mohsin H, Tanvir R, and Rehman Y. (2017) Revisiting the Mechanisms 
Involved in Calcium Chloride Induced Bacterial Transformation. Front. 
Microbiol. [online]. 8(2169) [Viewed on 15 March 2019]. Available from: 
doi: 10.3389/fmicb.2017.02169. 
 
References 
 232 
Atsumi S, Higashide W, and Liao JC. (2009) Direct photosynthetic recycling of 
carbon dioxide to isobutyraldehyde. Nature Biotechnology, 27(12): 1177–
U142. 
 
Attwood PV, and Wallace JC. (2002) Chemical and catalytic mechanisms of 
carboxyl transfer reactions in biotin-dependent enzymes. Acc Chem Res, 35, 
113-120.   
 
Bachmann H, Starrenburg MJ, Molenaar D, van Hylckama Vlieg JE, and 
Kleerebezem M. (2012) Microbial domestication signatures of Lactococcus 
lactis can be reproduced by experimental evolution. Genome Res, 22: 115–
124.  
 
Barker DF, Campbell AM. (1980) Use of bio-lac fusion strains to study regulation 
of biotin biosynthesis in Escherichia coli. J Bacteriol, 143: 789–800. 
 
Barrick J, Yu D, Yoon S, Jeong H, Oh T, Schneider D, Lenski R, and Kim J. 
(2009) Genome evolution and adaptation in a long-term experiment with 
Escherichia coli. Nature, 461: 1243–1247.   
 
Berkovitch F, Nicolet Y, Wan JT, Jarrett JT, and Drennan CL. (2004) Crystal 
structure of biotin synthase, an S-adenosylmethionine-dependent radical 
enzyme. Science, 303(5654): 76-79.  
 
Bhat T, Khan A, and Parveen S. (2005) Comparative analysis of meiotic 
abnormalities induced by gamma rays, EMS and MMS in Vicia faba L. J. 
Ind. Bot. Soc. 84: 45-48.  
 
Bi C, Su P, Mueller J, Yeh YC, Chhabra SR, Beller HR, Singer S, and Hillson N. 
(2013) Development of a broad-host synthetic biology toolbox for Ralstonia 
eutropha and its application to engineering hydrocarbon biofuel production. 
Microbial Cell Factories, 12: 107. 
 
Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, and 
Schwede T. (2014) SWISS-MODEL: modelling protein tertiary and 
quaternary structure using evolutionary information. Nucleic Acids 
Research [online], 42: W252-258. [Viewed 15 March 2019]. Available 
from: doi:10.1093/nar/gku340. 
 
Bloom J, Arnold F. (2009) In the Light of Directed Evolution: Pathways of 
Adaptive Protein Evolution. In: National Academy of Sciences. Ed. 
National Academies Press, USA. p. 256-269. 
 
Bormann EJ, Leibner M, Roth M, Beer B, and Metzner K. (1998) Production of 
polyhydroxybutyrate by Ralstonia eutropha from protein hydrolysates. Appl 
Microbiol Biotechnol, 50: 604–607.   
 
Bormann EJ, and Roth M. (1999) Production of polyhydroxybutyrate by 
Methylobacterium rhodesianum and Ralstonia eutropha in media containing 
glycerol and casein hydrolysates. Biotechnol Lett, 21: 1059–63.  
References 
 233 
 
Bower S, Perkins JB, Pero J. (1996b) Biotin biosynthesis in Bacillus subtilis. 
United States Patent 6,768,180. 
 
Bower S, Perkins JB, Yocum RR, Howitt CL, Rahaim P, and Pero J. (1996a) 
Cloning, sequencing, and characterization of the Bacillus subtilis biotin 
biosynthetic operon. J. Bacteriol, 178: 4122–4130.  
 
Bower S, Perkins JB, Yocum RR, and Pero JG. (2001) Biotin biosynthesis in 
Bacillus subtilis. United States Patent 6,303,377 B1. 
 
Bowien B, and Kusian B. (2002) Genetics and control of CO2 assimilation in the 
chemoautotroph Ralstonia eutropha. Archives of Microbiology, 178(2): 85–
93.   
 
Brigham CJ, Budde CF, Holder JW, Zeng Q, Mahan AE, Rha C, and Sinskey A. 
(2010) Elucidation of beta-Oxidation Pathways in Ralstonia eutropha H16 
by Examination of Global Gene Expression. Journal of Bacteriology, 
192(20): 5454-64. 
 
Brigham C, Zhila N, Shishatskaya E, Volova T, and Sinskey A. (2012) Chapter 
17: Manipulation of Ralstonia eutropha Carbon Storage Pathways to 
Produce Useful Bio-Based products. In: Wang X. Ed Reprogramming 
Microbial Metabolic Pathways, Subcellular Biochemistry, p. 343-366. 
 
Byrom D. (1987) Polymer synthesis by microorganisms - technology and 
economics. Trends in Biotechnology, 5(9): 246-50. 
 
Byrom D. (1992) Production of poly-beta-hydroxybutyrate -poly-beta-
hydroxyvalerate copolymers. Fems Microbiology Letters, 103(2-4): 247-
250. 
 
Cakar ZP, Alkim C, Turanli B, Tokman N, Akman S, Sarıkaya M, Tamerler C, 
Benbadis L, and François JM. (2009) Isolation of cobalt hyper-resistant 
mutants of Saccharomyces cerevisiae by in vivo evolutionary engineering 
approach. J Biotechnol, 143(2): 130-138. 
 
Cakar ZP, Seker UOS, Tamerler C, Sonderegger M, and Sauer U. (2005) 
Evolutionary engineering of multi-stress resistant Saccharomyces 
cerevisiae. FEMS Yeast Res, 5: 569–578.  
 
Cakar ZP, Turanli-Yildiz B, Alkim C, and Yilmaz U. (2011) Evolutionary 
engineering of Saccharomyces cerevisiae for improved industrially 
important properties. FEMS Yeast, 12: 171–182.  
 
Cameron DC, Altaras NE, Hoffman ML, and Shaw AJ. (1998) 
Metabolic engineering of propanediol pathways. Biotechnology Progress, 
14(1): 116–25.   
 
References 
 234 
Cartman S, Combe J, Foste A, and Kennedy J. (2018) Materials and methods for 
directing carbon flux and increased production of carbon based chemicals. 
United States Patent Application 20180023104. 
 
Cavalheiro J, Almeaida M, Grandfils C, Da Fonseca M. (2009) Poly(3-
hydroxybutyrate) production by Cupriavidus necator using waste glycerol. 
Process Biochemistry, 44(5): 509–515. 
 
Cavalheiro J, Raposo RS, de Almeida MC, Cesário MT, Sevrin C, Grandfils C, 
and Da Fonseca MMR. (2012) Effect of cultivation parameters on the 
production of poly(3-hydroxybutyrate-co-4-hydroxybutyrate) and poly(3-
hydroxybutyrate-4-hydroxybutyrate-3-hydroxyvalerate) by Cupriavidus 
necator using waste glycerol. Bioresource Technology, 111: 391-397. 
 
Choi JC, Shin HD, Lee YH. (2003) Modulation of 3-hydroxyvalerate molar 
fraction in poly(3-hydroxybutyrate-3-hydroxyvalerate) using Ralstonia 
eutropha transformant co-amplifying phbC and NADPH generation-related 
zwf genes. Enzyme and Microbial Technology, 32(1):178-185. 
 
Choi WJ, Hartono MR, Chan WH, Yeo SS. (2011) Ethanol production from 
biodiesel-derived crude glycerol by newly isolated Kluyvera cryocrescens. 
App Microbiol Biotechnol, 89: 1255–1264. 
 
Chu S. (2009) Carbon capture and sequestration. Science, 325(5948): 1599.    
 
Cobb R, Chao R, and Zhao H. (2013) Directed Evolution: Past, Present and 
Future. AIChE Journal, 59(5): 1432-1440. 
 
Connor M, Cann AF, and Liao J. (2010) 3-Methyl-1-butanol production in 
Escherichia coli: random mutagenesis and two-phase fermentation. App 
Microbiol Biotechnol, 86: 1155-1164. 
 
Conrad TM, Frazier M, Joyce AR, Cho BK, Knight EM, Lewis NE, Landick R, 
Palsson B. (2010) RNA polymerase mutants found through adaptive 
evolution reprogram Escherichia coli for optimal growth in minimal media. 
Proc Natl Acad Sci USA, 107: 20500–20505.  
 
Crameri A, Dawes G, Rodriguez E Jr, Silver S, Stemmer WPC. (1997) Molecular 
evolution of an arsenate detoxification pathway by DNA shuffling. Nat 
Biotechnol, 15: 436–438. 
 
Cronan J. (2001) The biotinyl domain of Escherichia coli acetyl-CoA 
carboxylase. Evidence that the "thumb" structure is essential and that the 
domain functions as a dimer. J Biol Chem, 276: 37355–37364.  
 
Cronan J. (2014) Biotin and Lipoic Acid: Synthesis, Attachment, and Regulation. 
EcoSal Plus [online], 6(1): 2324. [Viewed on 15 March 2019]. Available 
from: doi:10.1128/ecosalplus.ESP-0001-2012. 
 
References 
 235 
Cronan J, and Lin S. (2011) Synthesis of the α,ω-dicarboxylic acid precursor of 
biotin by the canonical fatty acid biosynthetic pathway. Current Opinion in 
Chemical Biology, 15(3): 407-413. 
 
Cronan J, and Reed KE. (2000) Biotinylation of proteins in vivo: a useful 
posttranslational modification for protein analysis. Methods Enzymol, 326: 
440-458. 
 
Cupples C, and Miller J. (1989) A set of lacZ mutations in Escherichia coli that 
allow rapid detection of each of the six base substitutions. Proc. Natl. Acad. 
Sci. USA, 86: 5345-5349. 
 
Cymbalyuk E, Chernomordik L, Broude N, and Chizmadzhev Y. (1988) Electro-
stimulated transformation of E. coli cells pretreated by EDTA solution. 
FEBS LETTERS, 234(1): 203-207. 
 
Dalby PA. (2011) Strategy and success for the directed evolution of enzymes. 
Curr Opin Struct Biol, 21: 473–480.  
 
Datsenko K A, and Wanner BL. (2000) One-step inactivation of chromosomal 
genes in Escherichia coli K-12 using PCR products. Proceedings of the 
National Academy of Sciences, 97(12), 6640-6645.  
 
Delamarre SC, and Batt CA. (2006) Comparative study of promoters for the 
production of polyhydroxyalkanoates in recombinant strains of Wautersia 
eutropha. Appl. Microbiol. Biotechnol., 71: 668–679.  
 
Delli-Bovi T, Spalding M, and Prigge S. (2010) Overexpression of biotin synthase 
and biotin ligase is required for efficient generation of sulfur-35 labeled 
biotin in E. coli. BMC Biotechnology, 10(73): 1-11. 
 
Dennis D, McCoy M, Stangl A, Valentin HE, Wu Z. (1998) Formation of poly(3-
hydroxybutyrate-co-3-hydroxyhexanoate) by PHA synthase from Ralstonia 
eutropha. Journal of Biotechnology, 64(2-3): 177-186. 
 
DeTitta GT, Edmonds JW, Stallings W, and Donohue J. (1976) Molecular 
structure of biotin. Results of two independent crystal structure 
investigations. J Am Chem Soc, 98: 1920-1926. 
 
Dobson R, Gray V, and Rumbold K. (2012) Microbial utilization of crude 
glycerol for the production of value-added products. J Ind Microbiol 
Biotechnol, 39: 217–226. 
 
Dower WJ, Miller JF, and Ragsdale CW. (1988) High efficiency transformation 
of E. coli by high voltage electroporation. Nucleic Acids Res., 16(13): 6127. 
 
Dragosits M, and Mattanovich D. (2013) Adaptive laboratory evolution – 
principles and applications in biotechnology. Microbial Cell Factories, 12: 
64. 
 
References 
 236 
Drake JW. (1991) A constant rate of spontaneous mutation in DNA-based 
microbes. Proc Natl Acad Sci USA, 88: 7160–7164.   
 
Drummond ML, Cundari TR, and Wilson AK. (2012) Protein-based carbon 
capture: progress and potential. Greenhouse Gases-Science and Technology, 
2(4): 223–238.   
 
Du GC, Chen J, Yu J, and Lun SY.(2001) Feeding strategy of propionic acid for 
production of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) with Ralstonia 
eutropha. Biochemical Engineering Journal, 8(2): 103–110.  
 
Du J, Shao Z, Zhao H. (2011) Engineering microbial factories for synthesis of 
value-added products. J Ind Microbiol Biotechnol, 38: 873– 890.   
 
Ducat DC, Way JC, and Silver PA. (2011) Engineering cyanobacteria to generate 
high-value products. Trends in Biotechnology, 29(2): 95–103.   
 
Durnin G, Clomburg J, Yeate Z, Alvarez PJJ, Zygourakis K, Campbell P, 
Gonzalez R. (2009) Understanding and Harnessing the Microaerobic 
Metabolism of Glycerol in Escherichia coli. Biotechnology and 
Bioengineering, 103(1): 148-161. 
 
Eisenberg M. (1975) Mode of Action of a-Dehydrobiotin, a Biotin Analogue. J. 
Bacteriol. 123(1): 248-254. 
 
Ewering C, Heuser F, Benoelken JK, Braemer CO, Steinbüchel A. (2006) 
Metabolic engineering of strains of Ralstonia eutropha and Pseudomonas 
putida for biotechnological production of 2-methylcitric acid. Metabolic 
Engineering, 8(6): 587-602. 
 
Ezeji TC, Qureshi N, and Blaschek HP. (2007) Bioproduction of butanol from 
biomass: from genes to bioreactors. Current Opinion in Biotechnology, 
18(3): 220–227.   
 
Finkenwirth F, Kirsch F, and Eitinger T. (2014) A versatile Escherichia coli strain 
for identification of biotin transporters and for biotin quantification. 
Bioengineered, 5(2): 129-132. 
 
Franz A, Rehner R, Kienle A and Grammel H. (2012) Rapid selection of glucose- 
utilizing variants of the polyhydroxyalkanoate producer Ralstonia eutropha 
H16 by incubation with high substrate levels. Letters in Applied 
Microbiology, 54(1): 45–51.   
 
Foster P. (1991) In Vivo Mutagenesis. Methods Enzymol, 204: 114-125. 
 
Friedrich B, Hogrefe C, and Schlegel HG. (1981) Naturally occurring genetic 
transfer of hydrogen-oxidizing ability between strains of Alcaligenes 
eutrophus. J. Bacteriol., 147: 198–205.  
 
References 
 237 
Fukui T, Abe H, and Doi Y. (2002) Engineering of Ralstonia eutropha for 
Production of Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) from 
Fructose and Solid-State Properties of the Copolymer. Biomacromolecules, 
3: 618-624. 
 
Fukui T, Mukoyama M, Orita I, and Nakamura S. (2014) Enhancement of 
glycerol utilization ability of Ralstonia eutropha H16 for production of 
polyhydroxyalkanoates. App Microbiol and Biotechnol, 98(17): 7559-68.  
 
Gai CS, Lu J, Brigham CJ, Bernardi AC, and Sinskey AJ. (2014) Insights into 
bacterial CO2 metabolism revealed by the characterization of four 
carbonic anhydrases in Ralstonia eutropha H16. AMB Express, 4(1): 2.   
 
Gloeckler R, Ohsawa I, Speck D, Ledoux C, Bernard S, Zinsius M, Villeval D, 
Kisou T, Kamogawa K, and Lemoine Y. (1990) Cloning and 
characterization of the Bacillus sphaericus genes controlling the 
bioconversion of pimelate into dethiobiotin. Gene, 87 (1): 63-70.  
 
Goh E-B, Baidoo EEK, Keasling JD, Beller HR. (2012) Engineering of Bacterial 
Methyl Ketone Synthesis for Biofuels. Applied and Environmental 
Microbiology, 78(1): 70-80. 
 
Goldberg MW, and Sternbach L. (1949) United States Patent 2,489,237. 
 
Gonzalez A, and Bell G. (2013) Evolutionary rescue and adaptation to abrupt 
environmental change depends upon the history stress. Philos Trans R Soc 
Lond B Biol Sci, 368(1610): 20120079. 
 
González-Pajuelo M, Andrade JC, and Vasconcelos I. (2004) Production of 1,3-
propanediol by Clostridium butyricum VPI 3266 using a synthetic medium 
and raw glycerol. J Ind Microbiol Biotechnol, 31: 442–446. 
 
González-Villanueva Miriam, Tee KL, Staniland P, Staniland J, Savil I, and 
Wong TS. (2018) Unlocking glycerol utilization in Cupriavidus necator 
H16 for bioplastic synthesis (submitted). 
 
Grabherr R, Nilsson E, Striedner G, and Bayer K. (2002) Stabilizing plasmid copy 
number to improve recombinant protein production. Biotechnol Bioeng, 77: 
142–147.  
 
Greene E, Codomo C, Taylor N, Henikoff JG, Till BJ, Reynolds SH, Enns LC, 
Burtner C, Johnson JE, Odden AR, Comai L, and Henikoff S. (2003) 
Spectrum of chemically induced mutations from a large-scale reverse-
genetic screen in Arabidopsis. Genetics 164(2): 731–740.   
 
Grothe E, Moo-Young M, Chisti Y. (1999) Fermentation optimization for the 
production of poly(beta-hydroxybutyric acid) microbial thermoplastic. 
Enzyme and Microbial Technology, 25(1-2): 132-141. 
 
References 
 238 
Grover LW, Holden HM, and St Maurice M. (2012) The enzymes of biotin 
dependent CO2 metabolism: What structures reveal about their reaction 
mechanisms. Protein Sci., 21(11): 1597-1619. 
 
Gruber S, Hagen J, Schwab H and Koefinger P. (2014) Versatile and stable 
vectors for efficient gene expression in Ralstonia eutropha H16. Journal of 
Biotechnology, 186: 74–82.  
 
Grzesiuk E, Janion C. (1993) Some aspects of EMS-induced mutagenesis in 
Escherichia coli. Mutation Research, 297: 313-321. 
 
Guan Y, Zhu Q, Huang D, Zhao S, Jan Lo L, and Peng J. (2015) An equation to 
estimate the difference between theoretically predicted and SDS PAGE-
displayed molecular weights for an acidic peptide. Scientific Reports. 
Nature Publishing Group, 5(1): 13370.  
 
Hall B. (1998) Adaptive mutagenesis: a process that generates almost exclusively 
beneficial mutations. Genetica, 102/103: 109-125. 
 
Hall BG, Acar H, Nandipati A, and Barlow M. (2013) Growth rates made easy. 
Molecular Biology and Evolution, 31(1): 232-238. 
 
Hanahan D. (1983). Studies on transformation of Escherichia coli with plasmids. 
J. Mol. Biol. 166: 557–580.  
 
Hanka L, and Martin DG. (1942) Antibiotic a-methyldethiobiotin, a-methylbioti, 
and their esters. United States Patent Office 3,658,837. 
 
Hatti-Kaul R, Tornvall U, Gustafsson L, and Borjesson P. (2007) Industrial 
biotechnology for the production of bio-based chemicals - a cradle-to-grave 
perspective. Trends in Biotechnology, 25(3): 119–24.   
 
He Q, McNutt J, and Yang J. (2017) Utilization of the residual glycerol from 
biodiesel production for renewable energy generation. Renewable & 
Sustainable Energy Reviews, 71: 63-76. 
 
Hong A, Cheng K, Peng F, Zhou S, Sun Y, Lui C, and Lui D. (2009) Strain 
isolation and optimization of process parameters for bioconversion of 
glycerol to lactic acid. J Chem Technol Biotechnol, 84: 1576–1581. 
 
Hoshino T, Akimufi F, and Masaaki Y. (1999) Process for the production of d-
Biotin. United States Patent 5,922,581. 
 
Hua Q, Joyce AR, Palsson B, Fong SS. (2007) Metabolic characterization of 
Escherichia coli strains adapted to growth on lactate. Appl Environ 
Microbiol, 73: 4639–4647.  
 
Ibarra R, Edwards J, Palsson B. (2002) Escherichia coli K-12 undergoes adaptive 
evolution to achieve in silico predicted optimal growth. Nature, 420: 186–
189.  
References 
 239 
 
Ifuku O, Haze S, Kishimoto J, Koga N, Yanagi M, and Fukushima S. (1993) 
Sequencing Analysis of Mutation Points in the Biotin Operon of Biotin-
overproducing Escherichia coli Mutants. Bioscience, Biotechnology, and 
Biochemistry, 57(5): 760-765.  
 
Ifuku O, Miyaoka H, Koga N, Kishimoto J, Haze S, Wachi Y, and Kajiwara M. 
(1994) Origin of carbon atoms of biotin. 13C-NMR studies on biotin 
biosynthesis in Escherichia coli. Eur. J. Biochem., 220: 585–591.  
 
Ishizaki A, Tanaka K, and Taga N. (2001) Microbial production of poly-D-3- 
  hydroxybutyrate from CO2. Applied Microbiology and Biotechnology, 
57(1–2): 6-12.    
 
Izumi Y, Fukuda H, Tani Y, and Ogata K. (1977) Action of 5-(2-thienyl)valeric 
acid as a biotin antagonist. Biochemia et Biophysica Acta, 499: 315-317. 
 
Izumi Y, Fukuda H, Tani Y, and Ogata K. (1978) The Mode of Action of 5-(2-
Thienyl)-valeric Acid on Biotin Biosynthesis. Agric. Biol. Chem., 42(3): 
579-584. 
 
Jajesniak P, Omar-Ali HEM and Wong TS. (2014) Carbon dioxide capture and 
utilization using biological systems: Opportunities and challenges. Journal 
of Bioprocessing and Biotechniques, 4(3).   
 
Jitrapakdee S, and Wallace JC. (2003) The biotin enzyme family: conserved 
structural motifs and domain rearrangements. Curr Protein Pept Sci, 4: 217-
229.   
 
Johnson AO, Gonzalez Villanueva M, Wong TS. (2015) Engineering Cupriavidus 
necator for chemical production. In: Industrial Processes and 
Nanotechnology. 10. Studium Press LLC, USA. p. 255-292. 
 
Johnson AO, Gonzalez Villanueva M, Tee KL, and Wong TS. (2018) An 
engineered constitutive promoter set with broad activity range for 
Cupriavidus necator H16. ACS Synth [online]. [Viewed 15 March 2019]. 
Available from: doi: 10.1021/acssynbio.8b00136. 
 
Johnson DT, and Taconi KA. (2007) The glycerin glut: Options for the value-
added conversion of crude glycerol resulting from biodiesel production. 
Environ. Progress, 26 (4): 338-348.  
 
Jun S, Moon C, Kang C, Kong S, Snag B, and Um Y. (2010) Microbial fed-batch 
production of 1,3-propanediol production using raw glycerol with 
suspended and immobilized Klebsiella pneumoniae. Appl Biochem 
Biotechnol, 161: 491–501.  
 
Jung Y-M, Lee Y-H. (2000) Utilization of oxidative pressure for enhanced 
production of poly-β-hydroxybutyrate and poly(3-hydroxybutyrate-3-
References 
 240 
hydroxyvalerate) in Ralstonia eutropha. Journal of Bioscience and 
Bioengineering, 90(3): 266-270. 
 
Kahar P, Agus J, Kikkawa Y, Taguchi K, Doi Y, and Tsuge T (2005). Effective 
production and kinetic characterization of ultra-high-molecular-weight 
poly[(R)-3-hydroxy-butyrate] in recombinant Escherichia coli. Polym 
Degrad Stabil, 87(1): 161–169.  
 
Kahar P, Tsuge T, Taguchi K, Doi Y. (2004) High yield production of 
polyhydroxyalkanoates from soybean oil by Ralstonia eutropha and its 
recombinant strain. Polymer Degradation and Stability, 83(1): 79-86. 
 
Kanzaki N, Kawamoto T, Matsui J, Nakahama K, Ifuku O. (2001) Microorganism 
resistant to threonine analogue and production of biotin. United States 
Patent 6,284,500. 
 
Kessler B, Witholt B. (2001) Factors involved in the regulatory network of 
polyhydroxyalkanoate metabolism. Journal of Biotechnology, 86(2): 97-
104. 
 
Khalil AS, and Collins JJ. (2010) Synthetic biology: Applications come of age. 
Nature Reviews Genetics, 11(5): 367–79.   
 
Kim BS, Lee SC, Lee SY, Chang HN, Chang YK, and Woo SI. (1994) Production 
of poly(3-hydroxybutyric acid) by fed-batch culture of Alcaligenes 
eutrophus with glucose-concentration control. Biotechnology and 
Bioengineering, 43(9): 892–8.  
 
Kim HY, Park JS, Shin HD, and Lee YH. (1995) Isolation of glucose utilizing 
mutant of Alcaligenes eutrophus, its substrate selectivity, and accumulation 
of poly-beta-hydroxybutyrate. Journal of Microbiology, 33(1): 51–8.  
 
Kim Y., Schumaker K, and Zhu J. (2005) EMS mutagenesis of Arabidopsis. In: 
Methods in Molecular Biology. 323. Humana Press, Inc., USA. p. 101 – 
103. 
 
Kiyasu T, Nagahashi Y, and Hoshino T. (2001) Cloning and characterization of 
biotin biosynthetic genes of Kurthia sp. Gene, 265, (1-2): 103-113.  
 
Knowles JR. (1989) The mechanism of biotin-dependent enzymes. Annu Rev 
Biochem, 58: 195-221.   
 
Koga N, Kishimoto J, Haze S, Ifuku O. (1996) Analysis of the bioH gene of 
Escherichia coli and its effect on biotin productivity. J Ferment. Bioeng, 81: 
482–487. 
 
Kovach ME, Phillips RW, Elzer PH. (1994) pBBR1MCS: a broad-host range 
cloning vector. BioTechniques; 16: 800–801.  
 
References 
 241 
Kovalchuk I, Kovalchuk O, and Hohn B. (2000) Genome-wide variation of the 
somatic mutation frequency in transgenic plants. EMBO J. 19: 4431–4438. 
 
Koutinas AA, Wang R, Webb C. (2007) The biochemurgist—bio- conversion of 
agricultural raw materials for chemical production. Biofuels Bioprod Bioref, 
1: 24–38.  
 
Kram K, and Finkei S. (2014) Culture volume and vessel affect long-term 
survival, mutation frequency, and oxidative stress of E. coli. Appl Environ 
Microbiol, 80(15): 1732-1738. 
 
Krieg D. (1963) Ethyl methanesulfonate-induced reversion of bacteriophage T4rII 
mutants. Genetics 48: 561–580.    
Kumar A, Singh S. (2013) Directed evolution: tailoring biocatalysts for industrial 
applications. Critical reviews in biotechnology, 33(4): 365–78. 
 
Kurosawa K, Radek A, Plassmeier J, and Sinskey A. (2015) Improved glycerol 
utilization by a triacylglycerol- producing Rhodococcus opacus strain for 
renewable fuels. Biotechnology and Biofuels, 8: 31. 
 
Kusian B, Sultemeyer D, and Bowien B. (2002) Carbonic anhydrase is essential 
for growth of Ralstonia eutropha at ambient CO2 concentrations. Journal of 
Bacteriology, 184(18): 5018–26.   
 
Lane MD, Rominger KL, Young DL, and Lynen F. (1964) The enzymatic 
synthesis of holotranscarboxylase from apotranscarboxylase and (+)-biotin. 
J Biol Chem, 239: 2865-287.   
 
Lee IY, Kim GJ, Shin YC, Chang HN, Park YH. (1995) Production of poly(beta-
hydroxybutyrate-co-beta-hydroxyvalerate) by 2-stage fed-batch 
fermentation of Alcaligenes eutrophus. Journal of Microbiology and 
Biotechnology, 5(5): 292-296. 
 
Lee SY. (1996) Plastic bacteria? Progress and prospects for polyhydroxyalkanoate 
production in bacteria. Trends in Biotechnology, 14(11): 431-438. 
 
Lee TS, Krupa RA, Zhang F, Hajimorad M, Holtz WJ, Prasad N, Lee SK, 
Keasling JD. (2011) BglBrick vectors and datasheets: A synthetic biology 
platform for gene expression. J Biol Eng., 20(5): 12. 
 
Lemoine Y, Wach A, and Jeltsch JM. (1996) To be free or not: the fate of 
pimelate in Bacillus sphaericus and in Escherichia coli. Mol. Microbiol, 19: 
645-647.  
 
Lenz R, and Marchessault R. (2005) Bacterial Polyesters: Biosynthesis, 
Biodegradable Plastics and Biotechnology. American Chemical Society, 
6(1): 1-8. 
 
References 
 242 
Li C, Lesnik KL, and Liu H. (2013) Microbial Conversion of Waste Glycerol 
from Biodiesel Production into Value-Added Products. Energies, 6: 4739-
4768. 
 
Li H, and Liao JC. (2015) A synthetic anhydrotetracycline-controllable gene 
expression system in Ralstonia eutropha H16. ACS Synthetic Biology, 4(2): 
101–6. 
 
Li H, Opgenorth PH, Wernick DG, Rogers S, Wu T-Y, Higashide W, et al. (2012) 
Integrated Electromicrobial Conversion of CO2 to Higher Alcohols. Science, 
335(6076): 1596. 
 
Lin S, and Cronan J. (2011) Closing in on complete pathways of biotin 
biosynthesis. Molecular BioSystems, 7(6): 1811-1821.  
 
Lin S, and Cronan J. (2012) The BioC O-methyltransferase catalyzes methyl 
esterification of malonyl-acyl carrier protein, an essential step in biotin 
synthesis. J Biol Chem, 287: 37010–37020.  
 
Lin S, Hanson R, and Cronan J. (2010) Biotin synthesis begins by hijacking the 
fatty acid synthetic pathway. Nature Chemical Biology, 6 (9): 682-688.  
 
Linde M, Galbe M, and Zacchi G. (2008) Bioethanol production from non-starch 
carbohydrate residues in process streams from a dry-mill ethanol plant. 
Bioresource Technology, 99 (14): 6505–11.   
 
Lindlbauer AK, Marx H, and Sauer M. (2017) 3-Hydroxypropionaldehyde 
production from crude glycerol by Lactobacillus diolivorans with enhanced 
glycerol uptake. Biotechnol Biofuels, 10: 295. 
 
Liu ZL, Slininger PJ, Gorsich SW. (2005) Enhanced biotransformation of 
 furfural and hydroxymethylfurfural by newly developed ethanologenic 
yeast strains. Appl Biochem Biotechnol, 5: 451–460.   
 
Loo CY, Lee WH, Tsuge T, Doi Y, Sudesh K. (2005) Biosynthesis and 
characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) from 
palm oil products in a Wautersia eutropha mutant. Biotechnology Letters, 
27(18): 1405-1410. 
 
Loo CY, Sudesh K. (2007) Polyhydroxyalkanoates: Bio-based microbial plastics 
and their properties. Malaysian Polymer Journal, 2(2): 31-57. 
 
Loveless A. (1959) Mutation of bacteria at high levels of survival by ethyl 
methane sulphonate. Nature, 5: 1780-1782. 
 
Lu J, Brigham CJ, Gai CS, Sinskey AJ. (2012) Studies on the production of 
branched-chain alcohols in engineered Ralstonia eutropha. Applied 
Microbiology and Biotechnology, 96(1): 283-297. 
 
References 
 243 
Lu P, Vogel C, Wang R, Yao X, Marcotte EM. (2007) Absolute protein 
expression profiling estimates the relative contributions of transcriptional 
and translational regulation. Nat Biotechnol, 25: 117–124.  
 
Lundby A, and Olsen JV. (2011) GeLCMS for in-depth protein characterization 
and advanced analysis of proteomes. Methods Mol Biol, 753: 143-155. 
 
Lüte S, Pohlmann A, Zaychilkov E, Schwartz E, Becher JR, Heumann H, and 
Friedrich B. (2012) Autotrophic Production of Stable-Isotope-Labeled 
Arginine in Ralstonia eutropha Strain H16. Appl Environ Microbiol., 
78(22): 7884-7890. 
 
Madden LA, Anderson AJ, Asrar J, Berger P, and Garrett P. (2000) Production 
and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-4- 
hydroxybutyrate) synthesized by Ralstonia eutropha in fed-batch cultures. 
Polymer, 41(10): 3499–3505.  
 
Manandhar M, and Cronan J. (2017) Pimelic acid, the first precursor of the 
Bacillus subtilis biotin synthesis pathway, exists as the free acid and is 
assembled by fatty acid synthesis. Molecular Microbiology, 104(4): 595-
607. 
 
Mann S, Carillon S, Breyne O, and Marquet A. (2002) Total Synthesis of 
Amiclenomycin, an Inhibitor of Biotin Biosynthesis. Chem. Eur., 8(2): 439-
450. 
 
Marangoni C, Furigo A, and Aragao G. (2001) The influence of substrate source 
on the growth of Ralstonia eutropha, aiming at the production of 
polyhydroxyalkanoate. Braz. J. Chem. Eng., 18(2): 1678. 
 
Marchler-Bauer A, and Bryant SH. (2004) CD-Search: protein domain 
annotations on the fly. Nucleic Acids Research, 32. 
 
Min YN, Yan F, Liu FZ, Coto C, and Waldroup PW. (2011) Glycerine—a new 
energy source for poultry. Int J Poult Sci, 9:1–4. 
 
Moon C, Ahn J, Kim S, Sang B, and Um Y. (2010) Effect of biodiesel- derived 
raw glycerol on 1,3-propanediol production by different microorganisms. 
Appl Biochem Biotechnol, 161: 502–510. 
 
Moser BR. (2011) Biodiesel Production, Properties, and Feedstocks. In Biofuels; 
Tomes, D., Lakshmanan, P., Songstad, D., Eds.; Springer: New York, NY, 
USA; pp. 285–347. 
 
Mothes G, Schnorpfeil C, and Ackermann JU. (2007) Production of PHB from 
crude glycerol. Eng. Life Sci., 5: 475-479. 
 
Mozumder SI, De Wever H, Volcke EIP, and García-González L. (2014) A robust 
fed-batch feeding strategy independent of the carbon source for optimal 
polyhydroxybutyrate production. Process Biochemistry 49(3): 365-373.	
References 
 244 
 
Mu Y, Teng H, Zhang DJ, Wang W, and Xiu ZL. (2006) Microbial production of 
1,3-propanediol by Klebsiella pneumoniae using crude glycerol from 
biodiesel preparations. Biotechnol Lett, 28: 1755–1759. 
 
Müller J, MacEachran D, Burd H, Sathitsuksanch N, Bi C, Yeh Y, Lee TS, 
Hillson NJ, Chhabra SR, Singer SW, and Beller HR. (2013) Engineering of 
Ralstonia eutropha H16 for Autotrophic and Heterotrophic Production of 
Methyl Ketones. Appl Environ Microbiol, 79(14): 4433-4439. 
 
Nannemann D, Birmingham W, Scism R, and Bachmann B. (2001) Assessing 
directed evolution methods for the generation of biosynthetic enzymes with 
potential in drug biosynthesis. Future Med Chem, 3(7): 809-819. 
 
Nielsen J. (1998) Metabolic engineering: techniques for analysis of targets for 
genetic manipulations. Biotechnol Bioeng, 58: 125–132.   
 
Oh B, Seo J, Choi MH, and Kim CH. (2008) Optimization of culture conditions 
for 1,3-propanediol production from crude glycerol by Klebsiella 
pneumoniae using response surface methodology. Biotechnol Bioprocess 
Eng, 13: 666–670. 
 
Oh B, Seo J, Heo S, Hong W, Luo L, Joe M, Park D, and Kim C. (2011) Efficient 
production of ethanol from crude glycerol by a Klebsiella pneumoniae 
mutant strain. Bioresour Technol, 102: 3918–3922. 
 
Ohsugi M, Inoue Y. (1981) Formation of pimelic acid and azelaic acids, biotin 
intermediates, derived from Oleic acid by Micrococcus sp. Agric. Biol. 
Chem, 45(10): 2355-2356.  
 
Okamoto H, Miyagawa A, Shiota T, Tamura Y, and Endo T. (2014) 
Intramolecular disulfide bond of Tim22 protein maintains integrity of the 
TIM22 complex in the mitochondrial inner membrane. The Journal of 
biological chemistry. American Society for Biochemistry and Molecular 
Biology, 289(8): 4827–38.  
 
Oleoline. (2018) Glycerine Market Report June 2018 [online]. The Independent 
Oleo reporter [Viewed 15 March 2019]. Available from: 
http://www.hbint.com/datas/media/590204fd077a6e381ef1a252/sample-
quarterly-glycerine.pdf 
 
Otsuka A, and Abelson J. (1978) The regulatory region of the biotin operon in 
Escheriehia coli. Nature, 276 (5689): 689-694. 
 
Overhage J, Steinbüchel A, and Priefert H. (2002) Biotransformation of Eugenol 
to Ferulic Acid by a Recombinant Strain of Ralstonia eutropha H16. Appl 
Environ Microbiol, 68(9): 4315-4321.  
 
Park JM, Kim TY, Lee SY. (2011) Genome-scale reconstruction and in silico 
analysis of the Ralstonia eutropha H16 for polyhydroxyalkanoate synthesis, 
References 
 245 
lithoautotrophic growth, and 2-methyl citric acid production. BMC Systems 
Biology, 5(101). 
 
Park HC, Lim KJ, Park JS, Lee YH, and Huh TL. (1995) High frequency 
tranformation of Alcaligenes eutrophus producing poly-β-hydroxybutyric 
acid by electroporation. Biotechnol. Tech., 9: 31- 34.  
 
Paulo da Silva G, Mack M, and Contiero J. (2009) Glycerol: A promising and 
abundant carbon source for industrial microbiology. Biotechnology 
Advances, 27: 30-39. 
 
Perkins JB, Bower S, Howitt CL, Yocum RR, and Pero J. (1996) Identification 
and characterization of transcripts from the biotin biosynthetic operon of 
Bacillus subtilis. J. Bacteriol, 178: 6361–6365.  
 
Perkins DN, Pappin DJ, Creasy DM, and Cottrell JS. (1999) Probability-based 
protein identification by searching sequence databases using mass 
spectrometry data. ELECTROPHORESIS: An International Journal, 20(18): 
3551-3567. 
 
Pohlmann A, Fricke WF, Reinecke F, Kusian B, Liesegang H, Cramm R Eitinger 
T, Ewering C, Pötter M, Schwartz E, Strittmatter A, Voß I, Gottschalk G, 
Steinbüchel A, Friedrich B, and Bowien B. (2006) Genome sequence of the 
bioplastic-producing “Knallgas” bacterium Ralstonia eutropha H16. Nature 
Biotechnology, 24(10): 1257–62.   
 
Polyak SW, Abell AD, Wilce MC, Zhang, L, and Booker GW. (2012) Structure, 
function and selective inhibition of bacterial acetyl-CoA carboxylase. Appl. 
Microbiol. Biotechnol., 93(3): 983−992.  
 
Porcar M. (2010) Beyond directed evolution: Darwinian selection as a tool for 
synthetic biology. Sis Synth Biol, 4: 1-6. 
 
Posada JA, Cardona CA. (2010) Design and analysis of fuel ethanol production 
from raw glycerol. Energy, 35: 5286–5293. 
 
Pries A, Steinbüchel A, and Schlegel HG. (1990) Lactose-utilizing and galactose- 
utilizing strains of poly(hydroxyalkanoic acid)-accumulating Alcaligenes 
eutrophus and Pseudomonas saccharophila obtained by recombinant-DNA 
technology. Applied Microbiology and Biotechnology, 33(4): 410–7.   
 
Raberg M, Peplinski K, Heiss S, Ehrenreich A, Voigt B, Doering C, Bömeke M, 
Hecker M, and Steinbüchel A. (2011) Proteomic and transcriptomic 
elucidation of the mutant Ralstonia eutropha G(+)1 with regard to glucose 
utilization. Applied and Environmental Microbiology, 77(6): 2058–70.   
 
Rausch KD, Belyea RL. (2006) The future of coproducts from corn processing. 
Appl Biochem Biotechnol, 128: 47–86.  
 
References 
 246 
Rehm BHA. (2010) Bacterial polymers: biosynthesis, modifications and 
applications. Nature Reviews Microbiology, 8(8): 578-92. 
 
Reinecke F and Steinbüchel A. (2009) Ralstonia eutropha strain H16 as model 
organism for PHA metabolism and for biotechnological production of 
technically interesting biopolymers. Journal of Molecular Microbiology and 
Biotechnology, 16(1–2): 91–108.   
 
Riedel SL, Bader J, Brigham CJ, Budde CF, Yusof ZAM, Rha C, and Sinskey A. 
(2012) Production of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) by 
Ralstonia eutropha in high cell density palm oil fermentations. 
Biotechnology and Bioengineering; 109(1): 74-83. 
 
Rodionov D, Dubchak I, Arkin A, Alm E, and Gelfand M. (2004) Reconstruction 
of regulatory and metabolic pathways in metal-reducing δ-
proteobacteria.Genome Biology, 5: R90. 
 
Rodionov D, Mironov A, and Gelfand M. (2002) Conservation of the Biotin 
Regulon and the BirA Regulatory Signal in Eubacteria and Archaea. 
Genome Research, 12: 1507-1516. 
 
Rymowicz W, Rywijska A, and Goldkowski W. (2008) Simultaneous production 
of citric acid and erythritol from crude glycerol by Yarrowia lipolytica. 
Chem Pap 62: 239–246. 
 
Sakurai N, Imai Y, Masuda M, Komatsubara S, and Tosa T. (1993) Construction 
of a Biotin-Overproducing Strain of Serratia marcescens. Appl Environ 
Microbiol, 59: 2857-2863. 
 
Sakurai N, Imai Y, and Komatsubara S. (1995) Instability of the mutated biotin 
operon plasmid in a biotin-producing mutant of Serratia marcescens. 
Journal of Biotechnology, 43(1): 11-19.  
 
Sakurai N, Imai Y, Masuda M, Komatsubara S, Tosa T. (1994) Improvement of a 
d-biotin-hyperproducing recombinant strain of Serratia marcescens. J 
Biotechnol, 36: 63–73. 
 
Sambrook J, and Russel D. (2011) Molecular Cloning: A Laboratory Manual, 
third ed. Cold Spring Harbor Laboratory Press, Cold Spring, NY.  
 
Sanyal I, Lee S, and Flint DH. (1994) Biosynthesis of pimeloyl-CoA, a  biotin 
precursor in Escherichia coli, follows a modified fatty acid synthesis 
 pathway. 13C-Labeling studies. J. Am. Chem. Soc, 116: 2637–2638. 
 
Sato S, Fujiki T, and Matsumoto K. (2013) Construction of a stable plasmid 
vector for industrial production of poly(3-hydroxybutyrate-co-3-
hydroxyhexanoate) by a recombinant Cupriavidus necator H16 strain. J. 
Biosc. Bioeng, 116(6): 677-681. 
 
References 
 247 
Schlegel HG, Gottschalk G, and Von Bartha R. (1961a) Formation and utilization 
of poly-[beta]-hydroxybutyric acid by Knallgas bacteria 
(Hydrogenomonas). Nature, 191(4787): 463–465.  
 
Schlegel HG, and Gottscha G. (1965) Verwertung von glucose durch eine mutante 
von hydrogenomonas H16. Biochemische Zeitschrift, 341(3): 249–259.   
 
Schlegel HG, Kaltwasser H, and Gottschalk G. (1961b) Ein Submersverfahren zur 
Kultur wasserstoffoxydierender Bakterien: Wachstumsphysiologische 
Untersuchungen. Archiv für Mikrobiologie, 38(3): 209–222.  
 
Schlegel HG, Lafferty R, Krauss I. (1970) Isolation of mutants not accumulating 
poly-beta-hydroxybutyric acid. Archiv Fur Mikrobiologie; 71(3): 283-294. 
 
Schrag DP. (2007) Preparing to capture carbon. Science, 315(5813): 812–3.   
 
Schwartz E, Henne A, Cramm R, Eitinger T, Friedrich B, and Gottschalk G. 
(2003) Complete nucleotide sequence of pHG1: A Ralstonia eutropha H16 
megaplasmid encoding key enzymes of H2-based lithoautotrophy and 
anaerobiosis. Journal of Molecular Biology, 332(2): 369–383.  
 
Sega G. (1984) A review of the genetic effects of ethyl methanesulfonate. 
Mutation Research, 134: 113-142. 
 
Sen M, Yılmaz U, Baysal A, Akman S, Cakar ZP. (2011) In vivo evolutionary 
engineering of a boron-resistant bacterium: Bacillus boroniphilus. Antonie 
Van Leeuwenhoek, 99: 825–835.  
 
Shahnawaz K, and Samiullah K. (2014) Ethyl methanesulphonate (EMS), A 
Potent Chemical Mutagen: A Review. International Journal of Scientific 
Research, 3(10): 488-490. 
 
Shang LG, Jiang M, and Chang HN. (2003) Poly(3-hydroxybutyrate)synthesis in 
fed-batch culture of Ralstonia eutropha with phosphate limitation under 
different glucose concentrations. Biotechnology Letters, 25(17): 1415–1419.  
 
Shi C, and Alrich C. (2012) Design and Synthesis of Potential Mechanism-Based 
Inhibitors of the Aminotransferase BioA Involved in Biotin Biosynthesis. J. 
Org. Chem., 77: 6051-6058.  
 
Shimizu R, Chou K, Orita I, Suzuki Y, Nakamura S, and Fukui T. (2013) 
Detection of phase-dependent transcriptomic changes and Rubisco-mediated 
CO2 fixation into poly (3-hydroxybutyrate) under heterotrophic condition in 
Ralstonia eutropha H16 based on RNA-seq and gene deletion analyses. 
BMC Microbiology, 13: 169. 
 
Sichwart S, Hetzler S, Broeker D, and Steinbüchel A. (2011) Extension of the 
substrate utilization range of Ralstonia eutropha strain H16 by metabolic 
engineering to include mannose and glucose. Applied and Environmental 
Microbiology, 77(4): 1325–34.  	
References 
 248 
	
Sydow A, Pannek A, Krieg T, Huth I, Guillouet SE, and Holtmann D. (2017) 
Expanding the genetic tool box for Cupriavidus necator by a stabilized L- 
rhamnose inducible plasmid system. J Biotechnol, 263: 1-10. 
	
 
 
Sniegowski P, Gerrish P, Lenski R. (1997) Evolution of high mutation rates 
in experimental populations of E. coli. Nature, 387: 703–705.   
 
Solaiman D, Swingle BM, and Ashby R. (2010) A new shuttle vector for gene 
expression in biopolymer-producing Ralstonia eutropha. J Microbiol M, 82: 
120-123. 
 
Sonderegger M, and Sauer U. (2003) Evolutionary Engineering of Saccharomyces 
cerevisiae for Anaerobic Growth on Xylose. Appl. Environ. Micriobiol, 
69(4): 1990-1998. 
 
Soucaille P. (2002) Metabolic pathway engineering for the production of 1,3- 
propanediol from glucose. Abstracts of Papers American Chemical Society, 
224(1– 2): 129-BIOT. 
 
Srinivasan S, Barnard GC, Gerngross TU. (2003) Production of recombinant 
proteins using multiple-copy gene integration in high-cell-density 
fermentations of Ralstonia eutropha. Biotechnol. Bioeng., 84: 114–120.  
 
Steinbüchel A, Lutke-Eversloh T. (2003) Metabolic engineering and pathway 
construction for biotechnological production of relevant 
polyhydroxyalkanoates in microorganisms. Biochemical Engineering 
Journal, 16(2): 81-96. 
 
Stok JE, and De Voss JJ. (2000) Expression, purification, and characterization of 
BioI: a carbon–carbon bond cleaving cytochrome P450 involved in biotin 
biosynthesis in Bacillus subtilis. Arch Biochem Biophys, 384: 351-360. 
 
Streit WR, and Entcheva P. (2003) Biotin in microbes, the genes involved in its 
biosynthesis,	 its biochemical role and perspectives for biotechnological 
production. Appl Microbiol Biotechnol, 61: 21-31.  
 
Sullivan JT, Brown SD, Yocum RR, and Ronson CW. (2001) The bio operon on 
the acquired symbiosis island of Mesorhizobium sp. strain R7A includes a 
novel gene involved in pimeloyl-CoA synthesis. Microbiology, 147: 1315–
1322.  
 
Taga N, Tanaka K, and Ishizaki A. (1997) Effects of rheological change by 
addition of carboxymethylcellulose in culture media of an air-lift fermentor 
on poly-D-3-hydroxybutyric acid productivity in autotrophic culture of 
hydrogen- oxidizing Bacterium, Alcaligenes eutrophus. Biotechnology and 
Bioengineering, 53(5): 529–33.  
 
References 
 249 
Taketo, A. (1974) Sensitivity of Escherichia coli to viral nucleic acid. J. Biochem. 
75: 895–904. 
 
Tanadchangsaeng N, and Yu J. (2012) Microbial Synthesis of 
Polyhydroxybutyrate From Glycerol: Gluconeogenesis, Molecular Weight 
and Material Properties of Biopolyester, Biotechnology and Bioengineering, 
109(11): 2808-18. 
 
Tcherkez GGB, Farquhar GD, and Andrews TJ. (2006) Despite slow catalysis and 
confused substrate specificity, all ribulose bisphosphate carboxylases may 
be nearly perfectly optimized. Proceedings of the National Academy of 
Sciences of the United States of America, 103(19): 7246–51.   
 
Tee KL, and Wong TS. (2013) Polishing the craft of genetic diversity creation in 
directed evolution. Biotechnology Advances, 31: 1707-1721. 
 
Tee KL, and Wong TS. (2014) Directed evolution: A powerful algorithm for 
advancing synthetic biology. In: Singh, V., Ed. Advanced Synthetic Biology. 
4. USA: Studium Press LLC, 465–97.  
 
Tizei P, Csibra E, Torres L, and Pinheiro V. (2016) Selection platforms for 
directed evolution in synthetic biology. Biochem Soc Trans, 44(4): 1165–
1175. 
 
Tobin MB, Gustafsson C, Huisman GW. (2000) Directed evolution: the ‘rational’ 
basis for ‘irrational’ design. Curr Opin Struct Biol, 10: 421–427.  
 
Todd P, Brouwer J, and Glickman B. (1981) Influence of DNA-repair deficiencies 
on MMS and EMS induced mutagenesis in Escherichia coli K-12. Mutation 
Research, 82: 239-250. 
 
Truniger V, and Boss W. (1993) Glycerol uptake in Escherichia coli is sensitive 
to membrane lipid composition. Res. Micriobiol, 144: 565-574. 
 
Tyo KE, Zhou H, and Stephanopoulos GN. (2006) High-throughput screen for 
poly-3-hydroxybutyrate in Escherichia coli and Synechocystis sp. strain 
PCC6803. Appl Environ Microbiol, 72(5): 3412-3417. 
 
U.S. Energy Information Administration: Washington, DC, USA. (2013) Monthly 
Biodiesel Production Report.   
 
Van Arsdell SW, Perkins JB, Yocum RR, Luan L, Howitt CL, Chatterjee NP, and 
Pero JG. (2005) Removing a bottleneck in the Bacillus subtilis biotin 
pathway: BioA utilizes lysine rather than S- adenosylmethionine as the 
amino donor in the KAPA-to-DAPA reaction. Biotechnology and 
Bioengineering, 91(1): 75-83.  
 
Volodina E, Raberg M, and Steinbüchel A. (2016) Engineering the heterotrophic 
carbon sources utilization range of Ralstonia eutropha H16 for applications 
in biotechnology. Critical Reviews in Biotechnology, 36(6): 978-991. 
References 
 250 
 
Voss I, and Steinbüchel A. (2006) Application of a KDPG-aldolase gene-
dependent addiction system for enhanced production of cyanophycin in 
Ralstonia eutropha strain H16. Metabolic Engineering, 8: 66-78. 
 
Washburn MP, Wolters D, and Yates III JR. (2001) Large-scale analysis of the 
yeast proteome by multidimensional protein identification technology. 
Nature biotechnology, 19(3): 242. 
 
Wensink P, Finnegan D, Donelson J, and Hogness D. (1974) A system for 
mapping DNA sequences in the chromosomes of Drosophila melanogaster. 
Cell 3: 315–325.  
 
Wilde E. (1962) Untersuchungen über Wachstum und Speicherstoff synthese von 
Hydrogenomonas. Archiv für Mikrobiologie, 43(2): 109–137.  
 
Wilms B, Hauck A, Reuss M, Syldatk C, Mattes R, Siemann M, Altenbuchner J. 
(2001) High cell density fermentation for production of L-N-carbamoylase 
using an expression system based on the Escherichia coli rhaBAD 
promoter. Biotechnol Bioeng, 73: 95–103.  
 
Witthoff S, Schmitz K, Niedenführ S, Nöh K, Noack S, Bott M, Marienhagen J. 
(2015). Metabolic engineering of Corynebacterium glutamicum for 
methanol metabolism. Appl Environ Microbiol, 81: 2215–2225.  
 
Wu CF, Valdes JJ, Rao G, Bentley WE. (2001). Enhancement of 
organophosphorus hydrolase yield in Escherichia coli using multiple gene 
fusions. Biotechnol Bioeng, 75: 100–103.  
 
Wu G, Yan Q, Jones A, Tang Y, Fong SS, and Koffas, MAG. (2016) Metabolic 
Burden: Cornerstones in Synthetic Biology and Metabolic Engineering 
Applications. Trends in Biotechnology, 34(8): 652-664. 
 
Yadav D, Tanveer A, Malviya N, and Yadav S. (2018) Overview and Principles 
of Bioengineering: The Drivers of Omics Technologies. In: Omics 
Technologies and Bio-Engineering. 1. Academic Press, p. 3-23. 
 
Yamada H, Osakai M, and Tani Y. (1983) Biotin Overproduction by Biotin 
Analog-resistant Mutants of Bacillus sphaericus. Agric. Biol. Chem., 47(5): 
1011-1016. 
 
Yamane T, Fukunaga M, and Lee YW (1996). Increased P(3HB) productivity by 
high-cell-density-fed-batch culture of Alcaligenes latus, a growth-associated 
P(3HB) producer. Biotechnol Bioeng, 50: 197–202.  
 
Yang F, Hanna MA, and Sun R. (2012) Value-added uses for crude glycerol— a 
byproduct of biodiesel production. Biotechnol Biofuels, 5: 13. 
 
Yeh JI, Charrier V, Paulo J, Hou L, Darbon E, Claiborne A, Deutscher J. (2004) 
Structures of enterococcal glycerol kinase in the absence and presence of 
References 
 251 
glycerol: correlation of conformation to substrate binding and a mechanism 
of activation by phosphorylation. Biochemistry, 43(2): 362-373 
 
Yu J. (2014) Bio-based products from solar energy and carbon dioxide. Trends in 
Biotechnology, 32(1): 5-10. 
 
Zambrano MM, Siegele DA, Almirón M, Tormo A, and Kolter R. (1993) 
Microbial competition: Escherichia coli mutants that take over stationary 
phase cultures. Science, 259: 1757-1760. 
 
Zha W, Rubin-Pitel S, Shao Z, and Huimin Z. (2009) Improving cellular malonyl-
CoA level in Escherichia coli via metabolic engineering. Metabolic 
Engineering, 11(3): 192-198. 
 
Zhang WW, Yang MM, Li Hx, and Wang D. (2011) Construction of recombinant 
Bacillus subtilis strains for efficient pimelic acid synthesis. Electronic 
Journal of Biotechnology. ISSN: 0717-3458.  
 
Zhao H. (2007) Directed evolution of novel protein functions. Biotechnol Bioeng, 
98: 313–317.  
 
Zhu C, Nomura CT, Perrotta JA, Stipanovic AJ, and Nakas JP. (2010) Production 
and Characterization of Poly-3-hydroxybutyrate From Biodiesel-Glycerol 
by Burkholderia cepacia ATCC 17759. Biotechnol. Prog., 26(2): 424-430. 
Appendices 
 252 
APPENDICES 
 
Appendix 1: List of reagents 
List of Reagents Catalogue #; Manufacturer details 
Antibiotics  
Chloramphenicol  Cat#: CLA01; FORMEDIUM, Norfolk, UK 
Kanamycin Cat#: A1493,0025; AppliChem, Cheshire, UK 
Gentamicin Cat#: A1492,0005; AppliChem, Cheshire, UK 
Media components 
Agar granulated Cat#: AGR03; FORMEDIUM, Norfolk, UK 
Ammonium chloride (NH4Cl) Cat#: A9434-500; Sigma-Aldrich, Dorset, UK 
Ammonium iron(III) citrate 
(Fe(III)NH4-Citrate) 
Cat#: 09713-50; Fluka, Bremen, Germany 
Beef extract Cat#: B4888-50G; Sigma-Aldrich, Dorset, UK 
Calcium chloride (CaCl2 • 2H2O) Cat#: 437055N; VWR, Leicestershire, UK 
Coomassie blue Cat#: A1092.0025; AppliChem, Cheshire, UK 
Crude glycerol (sweet water) Obtained from a high-pressure fat splitting 
process as industrial waste kindly provided by 
Croda Europe Ltd (batch 8/1/18), Hull, UK 
Glycerol, BioReagent Cat#: G2025-500; Sigma-Aldrich, Dorset, UK 
Magnesium sulphate (MgSO4 • 7H2O) Cat#: 437044k; VWR, Leicestershire, UK 
Peptone Cat#: PEP03; FORMEDIUM, Norfolk, UK 
Potassium phosphate monobasic 
(KH2PO4) 
Cat#: P979; Sigma-Aldrich, Dorset, UK 
Sodium chloride (NaCl) Cat#: NAC02; FORMEDIUM, Norfolk, UK 
Sodium gluconate (NaGlu) Cat#: A3712.0250; AppliChem, Cheshire, UK 
Sodium phosphate dibasic (Na2HPO4 • 
7H2O) 
Cat#: 71505; Sigma-Aldrich, Dorset, UK 
Trace elements solution SL6 
    ZnSO4 • 7H2O 
     
    MnCl2 • 4H2O 
    H3BO3 
    CoCl2 • 6H2O 
    CuCl2 • 2H2O 
    NiCl2 • 6H2O 
    Na2MoO2 • 2H2O 
 
Cat#: Z/1550/53; Fisher Chemical, 
Loughborough, UK  
Cat#: 36526; Alfa aesar, Lancashire, UK 
Cat#: 327130010; Acros, Leicestershire, UK 
Cat#: C8661; Sigma-Aldrich, Dorset, UK 
Cat#: C3279-100; Sigma-Aldrich, Dorset, UK 
Cat#: N6136-100; Sigma-Aldrich, Dorset, UK 
Cat#: 331058-5; Sigma-Aldrich, Dorset, UK 
Tryptone Cat#: TRP02; FORMEDIUM, Norfolk, UK 
Yeast extract Cat#: YEA03, FORMEDIUM, Norfolk, UK 
Miscellaneous 
Acetic acid Cat#: 20104.334; VWR, Leicestershire, UK 
Acrylamide Bis-Acrylaminde  Cat#: 20-2100-10; Severn Biotech Ltd., 
Worcestershire, UK 
Agarose Cat#: 50004; Lonza, Slough, UK 
Ammonium persulphate (APS) Cat#: A2941.0500; AppliChem, Cheshire, UK 
Boric acid Cat#: 327130010; VWR, Leicestershire, UK 
Bromophenol blue Cat#: 32641; Alfa Aesar, Lancashire, UK 
Coomassie brilliant blue staining dye Cat#: A1092.0025; AppliChem, Cheshire, UK 
DNA ladder 1 kb Quick-Load ® [50 
µG/ML] 
Cat#: N0468S; New England BioLabs, Herts, UK 
EDTA DISODIUM Cat#: EDTA500; FORMEDIUM, Norfolk, UK 
Ethanol, BioUltra Cat#: 51976-500ML-F; Sigma-Aldrich, Dorset, 
UK 
Ethidium bromide Cat#: HC001596; MERCK, Darmstadt, Germany 
Gel Loading Dye Blue (6x) Cat#: B707 S; New England Biolabs, Herts, UK 
Glycerol Cat#: 444485B; VWR, Leicestershire, UK 
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L-(+)-Arabinose Cat#: SC-221794B; ChemCruz, Heidelberg, 
Germany 
Lysozyme  Cat #: 89833; Thermo Scientific, Loughborough, 
UK 
Methanol Cat#: 10598240; Fisher Chemical, 
Loughborough, UK 
Nile Red Cat#: N3013-100; Sigma-Aldrich, Dorset, UK 
Potassium phosphate dibasic (K2HPO4) Cat#: A2945,1000; AppliChem, Chesire, UK 
PageRuler Broad Range Unstained 
Protein Ladder 
Cat#: 26630; Thermo Fisher Scientific, 
Loughborough, UK 
Sodium dodecyl sulphate (SDS) Cat#: 444464T; VWR, Leicestershire, UK 
Sodium hydroxide (NaOH) Cat#: A6829-0500; AppliChem, Cheshire, UK 
Sodium thiosulphate (Na2S2O3) Cat#: A17629; Alfa Aesar, Lancashire, UK 
Sucrose Cat#: 84100-250; Sigma-Aldrich, Dorset, UK 
Synthetic genes (DV and DD) GenScript; Piscataway, USA 
Tetramethylethylenediamine (TEMED) Cat#: A1148,0100; AppliChem, Cheshire, UK 
Tris Molecular Biology grade Cat#: BP152-1; Fisher Chemical, Loughborough, 
UK 
T4 DNA ligase [400,000 U/ml] Cat#: M0202S; New England BioLabs, Herts, UK 
T4 DNA ligase 10x Buffer with 10 mM 
ATP 
Cat#: B0202S; New England BioLabs, Herts, UK  
5-(2-thienyl)-pentanoic acid (TVA) Cat#: L13122; Alfa Aesar, Lancashire, UK 
b-mercaptoethanol Cat#: A1108,0100; Applichem, Damstadt, 
Germany 
Restriction enzymes  
AvrII [5,000 U/ ml] Cat#: R0174S; New England BioLabs, Herts, UK  
DpnI [20,000 U/ml] Cat#: R0176S; New England BioLabs, Herts, UK  
NdeI [20,000 U/ml] Cat#: R0111S; New England BioLabs, Herts, UK  
PstI-HF [20,000 U/mL] Cat#: R3140S; New England BioLabs, Herts, UK 
SacI-HF [20,000 U/mL] Cat#: R3156S; New England BioLabs, Herts, UK  
XhoI [20,000 U/ml] Cat#: R0146S; New England BioLabs, Herts, UK  
10x CutSmart Buffer Cat#: B7204S; New England BioLabs, Herts, UK  
PCR reagents  
dNTPs (10 mM) Cat#: N0447S; New England BioLabs, Herts, UK  
Primers Eurofins Genomics; Ebersberg, Germany 
Pfu Turbo DNA Polymerase [2.5 U/µl] Cat#: 600250-52; Agilent, Cheshire, UK  
10x Cloned Pfu Reaction Buffer Cat#: 600153-82; Agilent, Cheshire, UK 
Pfu Ultra HF DNA Polymerase [2.5 
U/µl] 
Cat#: 600380-51; Agilent, Cheshire, UK 
10x Pfu Ultra HF Reaction Buffer Cat#: 600380-52; Agilent, Cheshire, UK 
Q5 HF DNA Polymerase [2.0 U//µl] Cat#: M0491S; New England BioLabs, Herts, UK 
5x Q5 Reaction Buffer Cat#: B9027S; New England BioLabs, Herts, UK 
5x Q5 High GC Enhancer Cat#: M0491S; New England BioLabs, Herts, UK 
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Appendix 2: List of kits 
 
Experiment Catalogue #; Manufacturer details 
Biotin quantitation Cat#: F30751; FluoReporter Biotin Quantitation 
Assay Kit, Molecular Probes, Paisley, UK 
HiFi DNA Assembly Cloning Cat#: E5520S; NEBuilder® HiFi DNA 
Assembly Cloning Kit, New England Biolabs 
Ltd, Hitchin, UK 
Isolation of plasmid DNA Cat#: D6942-01; E.Z.N.A.® Plasmid Mini Kit I, 
Omega Bio-Tek, Norcross, USA  
Gel and PCR purification Cat#: 740609.250; NucleoSpin® Gel and PCR 
Clean-up Macherey-Nagel, Düren, Germany  
Genomic DNA extraction Cat#: D3350-01; E.Z.N.A.® Bacterial DNA 
Kit, Omega Bio-Tek, Norcross, USA  
 
 
 
Appendix 3: List of equipment 
 
Experiment Details 
Bacterial cultivation For 37 ºC à ES-20 shaker-incubator; Grant 
Instruments, Shepreth, UK  
For 30 ºC à MaxQTM 4450 benchtop orbital 
shaker; Thermo Fisher Scientific, 
Loughborough, UK  
Bacterial incubation For 30º C and 37 ºC à INCU-Line Incubator; 
VWR, Leicestershire, UK 
Bacterial Optical Density (OD600)  
– Large cuvettes 
BioPhotometer Plus UV/Vis photometer; 
Eppendorf, Stevenage, UK  
Bacterial Optical Density (OD595, OD600) 
– Microtitre plates  
Chapter 4 à MultiskanTM FC microplate 
photometer; Thermo Fisher Scientific, 
Loughborough, UK 
Chapter 5 à SpectraMax M2e microplate 
reader, Molecular Devices, Winnersh, UK 
Microscopy RX30F Brunel Microscope Ltd, Chippenham, 
UK 
Bacterial transformation For heat shock à Eppendorf Thermomixer C; 
Eppendorf, Stevenage, UK 
Centrifugation Microcentrifuge accuSpin Micro 17; Fisher 
Scientific, Loughborough, UK 
DNA concentration VersaWave Spectrophotometer; Expedeon, 
Cambridge, UK 
Electrophoresis  Mini-Sub Cell GT Systems; Bio-Rad, 
Hertfordshire, UK 
Electroporation Electroporator àEppendorf Eporator; 
Eppendorf, Stevenage, UK 
Electroporation cuvettes à Eppendorf 1 mm 
and 2 mm; Eppendorf, Stevenage, UK 
Fluorescence Chapter 4 à Fluoroskan Ascent, Thermo 
Scientific; Loughborough, UK 
Chapter 5 à SpectraMax M2e microplate 
reader; Molecular Devices, Wokingham, UK  
Gel documentation system Genosmart2, VWR, Leicestershire, UK 
PCR Eppendorf Mastercycler; Eppendorf, Stevenage, 
UK 
pH  pH meter Jenway 3510; Jenway, Staffs, UK 
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Appendix 4: List of software 
 
Experiment Details 
Analysis of data and creation of graphs GraphPad Prism 7 Software, La Jolla, CA, USA  
DNA and protein data analysis SnapGene, GSL Biotech. Chicago, USA 
Protein graphics PyMOL Molecular Graphics System, Version 
2.0 Schrödinger, LLC  
Protein modelling  SWISS-MODEL (Biasini et al., 2014) 
 
 
 
Appendix 5: Media preparation 
 
Media Preparation 
2x YT Per 1 L 
16 g Tryptone 
10 g Yeast extract 
5 g NaCl 
Sterilise by autoclaving 
  
TYE Agar plate Per 1 L 
10 g Tryptone 
5 g Yeast extract 
8 g NaCl 
15 g Agar 
Sterilise by autoclaving 
  
NB Per 1 L 
5 g Peptone 
1 g Beef extract 
2 g Yeast extract 
5 g NaCl 
15 g agar (if required) 
Sterilise by autoclaving 
  
M9 salts Prepare M9 salts 5x stock per 1 L 
 30.0 g Na2HPO4 • 7H2O 
 15.0 g KH2PO4 
 2.5 g NaCl 
 5.0 g NH4Cl 
 Sterilise by autoclaving 
  
 Prepare stocks of the following components: 
 0.01 M CaCl2 • 2H2O 
 1.00 M MgSO4 • 7H2O 
 20 % (w/v) Glucose 
 1 mg/mL Thiamine (sterilize with 0.2 µm filter) 
 40 mg/mL Casamino acids 
 4 x 10-6 M Biotin (sterilize with 0.2 µm filter) 
 Sterilise by autoclaving the previous components separately unless 
specified otherwise 
  
 Prepare M9 supplemented with: 
 1x M9 salts 
 1 x 10-4 M CaCl2 • 2H2O 
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 1 x 10-3 M MgSO4 • 7H2O 
 0.2 % (w/v) Glucose 
 1 x 10-3 mg/mL Thiamine 
 0.04 mg/mL Casamino acids 
 2 x 10-9 M Biotin 
 (Biotin-free media was prepared as well) 
  
MSM Per 1 L 
6.74 g Na2HPO4 • 7H2O 
1.50 g KH2PO4 
1.00 g NH4Cl (Use 0.50 g for NL condition) 
0.20 g MgSO4 • 7H2O (Take 400 µL from a 0.5 g/mL stock) 
20.00 mg CaCl2 • 2H2O (Take 80 µL from a 0.25 g/mL stock) 
1.20 mg Fe(III)NH4-Citrate (Take 4.8 µL from a 0.25 g/mL stock) 
10 g Sodium gluconate (A different carbon source can be used in 
MSM medium) 
0.10 mL SL6 (Trace elements solution SL6 must be prepared 
separately and sterilised by 0.2 µm filter. Add to MSM after it has 
been autoclaved) 
 Sterilise by autoclaving 
  
 Prepare SL6 stock per 1 L: 
     10 mg ZnSO4 • 7H2O (Take 40 µL from a 0.25 g/mL stock) 
    3 mg MnCl2 • 4H2O (Take 12 µL from a 0.25 g/mL stock) 
    30 mg H3BO3 (Measure 30 mg. Not very soluble in water) 
    20 mg CoCl2 • 6H2O (Take 80 µL from a 0.25 g/mL stock) 
    1 mg CuCl2 • 2H2O (Take 4 µL from a 0.25 g/mL stock) 
    2 mg NiCl2 • 6H2O (Take 8 µL from a 0.25 g/mL stock) 
    3 mg Na2MoO2 • 2H2O (Take 12 µL from a 0.25 g/mL stock) 
Sterilised by 0.2 µm filter 
 
 
Appendix 6: List of miscellaneous 
 
List of miscellaneous Catalogue #; Manufacturer details 
Filter Unit 0.2 µm Cat #: 10462200; GE Healthcare Life 
Sciences WhatmanTM, Buckinghamshire, UK 
Filter paper Circles 595 Cat #: 10311612; Whatman GmbH, Dassel, 
Germany 
Gene sequencing Eurofins Genomics sequencing was used to 
check quality of plasmids, and for DNA 
sequencing of glpK of C. necator H16 WT 
and glpK of C. necator H16 variants; Eurofins 
Genomics UK, Wolverhampton, UK. 
Microscope slides 0.8 -1.0 mm Cat #: B57011/2; Thermo Scientific, 
Loughborough, UK 
Microscope cover glasses Cat #: MNJ-350-020H; Thermo Scientific, 
Loughborough, UK 
 
Appendices 
 257 
Appendix 7: Synthetic bioDV1-4 and bioDD1-5 extended biotin operons 
 
Optimised codon sequence of the designed bioDV1-4 and bioDD1-5 extended 
biotin operons synthesised by GenScript. Genes are marked with colours 
according to diagrams, and restriction sites are in italics and underlined. 
 
 
Synthetic bioDV1-4 extended biotin operon: 
 
 
 
 
CATATGAAGACCGTGCACGAGGGTACCTTCCTGTTTCCGGCGACCCACCCGCTGTTTGC
GGACCACTTTGAAGGTGCGCCGGTGGTTCCGGGCAGCCTGCTGCTGCGTGCGTTTGTG
GAGGAAGCGGGTACCGTTTGGCCGGATTTTGCGACCCAGGGTGCGACCGGCTTCCGTT
TTCGTCGTTTCGTTACCCCGGGCCGTCACCCGTTTCGTATGGAGCGTACCGACCTGAC
CGTGCGTTGCACCCTGATGGATGCGCAAGGTGGCATCCTGGTTCGTGGTGACCTGACC
ACCGCGGACGCGACCGGTGATGCGGGTACCGACAACGATCGTACCGGTGCGGATGGT
GAAGCGGCGCTGCACACCAGCCCGCGTGGCACCACCGCGTAATGAACTAGTGAATTCA
AAAGATCTTTTAAGAAGGAGATATACAAATGACCCTGCACCAGAAGGATGGTGACGA
TTACGCGGGTGGCACCCGTCGTCCGACCGCGGTGGCGCACGCGCAACATGACATTGC
GCCGGGCGTGGTTCTGATTCTGGGTGGCAGCAGCACCCTGGGTCTGGCGGCGGGTCGT
GCGCTGCTGGCGGCGGGTCACCCGGTTGCGCTGACCACCCGTAACGCGGAGGGTACC
GGTCGTATCCTGGCGGCGCTGGCGCCGGGTGAAGCGGGCATTCCGGACGGTGGCACC
GATTTCAGCGGCAACCGTCCGGACCTGTTTAGCAACCGTCCGGATCTGAGCAACGGTG
GCGCGGACCGTTGCCGTGTGTGCCGTCACACCGGTCACGCGCCGTATGCGGTGCTGCC
GGTTGAGAGCGCGGAAAGCCTGCCGGACCGTTGCGCGGATGCGCTGGGTACCCCGCC
GCGTCACATGCTGGATTTCATGCATGGCCGTTTTGAAACCCTGGTGGCGGCGGCGCAT
GTTCATGACATCGACCGTTGGGCGATCGACGATATTGCGCTGCGTGCGCGTTGCCTGC
GTGCGGTTAGCCGTGCGATGCTGGCGGAACGTGCGGGTCGTTGCGTGTTCGTTAGCAG
CACCGCGGCGGCGATGGCGGCGCACGGTCAAGGTTACTATGCTGCGGCGAAAGCGGC
GGGTGAAGCGCTGTACCGTAGCGCGGGTCTGGAACTGGCGAGCCGTGGCGTGACCAC
CTGTAGCCTGCGTCTGGGTTGGGTTGATGCGGGTCGTGGCGCGGATTTTATCCGTGGT
AACGATGCGCCGTATCGTGATGGTACCGCGCACGCGGTTCCGACCCCGCACACCGCG
ACCCAACTGGCGGATGGTGTTCCGACCGGCCGTCTGGTGACCGTTGACGAGGTGGTTG
GTACCCTGATGTTCCTGCTGAGCGGTGCGGCGACCAGCCTGAACGCGACCCACATTAC
CCTGGACGGTGGCTTTACCGCGGGTAAACCGCGTGCGGGTACCCCGCGTACCGGTAG
CGGCACCCGTCGTACCGGTTAATGAGAGCTCGAATTCAAAAGATCTTTTAAGAAGGAG
ATATACAAATGCCGGAAACCCCGGCGTTCGATACCGTGCGTGCGATCGTTGCGGACA
TTTTTGAAGTTGCGCCGGAGACCCTGACCCCGGCGACCCGTCTGTTCGAAGATCTGCC
GTGCGAGAGCATCGACCTGCTGGAGATTGGTGCGGGCCTGAACCGTCGTTGCCGTATC
CCGGTTGACGATGACGCGGCGTTTCTGCGTAGCCTGCGTATTCACCTGATGGAGGCGG
AACGTGAGCGTCGTGATGCGACCCAACACCTGGCGAGCGTGTACCCGCACCTGACCG
CGCGTCGTGTGGCGAGCATCGTTGAGGCGCTGCGTGCGCCGGCGAGCCCGCCGGTTCT
GACCCTGGCGGACATTACCGCGTATGTGGATCACGTTCGTAACGACGTGCAACGTACC
GGTGAGGTTTAATGAATCGATGAATTCAAAAGATCTTTTAAGAAGGAGATATACAAAT
GAACGATAGCGCGCACCACCAGCGTACCCAAGACGCGACCGGTAACCGTATGCGTGT
GGTTATCAGCGGTATGGATTGCGTGACCCCGCTGGGTGATGATGCGAGCCTGGCGGC
GCACCTGCACCACGGTACCCCGCCGTTCATGCCGGCGCCGGTGCTGCCGGGTGCGGC
GTGGTGCCCGGTTAACGCGTTTGATCCGGCGCAGGCGACCGACCACTGGCGTCACCGT
CGTTACCTGAGCCGTGGTGGCCTGTTTGCGCTGGCGAGCGCGCTGGGTGCGGCGCGTG
ATGCGGGTTGGGGCGCGAGCGCGCCGGATGGTGCGGCGCTGGTGACCGCGCACGGCC
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CGAACCTGGACATTACCAGCGATTTTCCGCACTGCCACTGCGACGTTAGCGGTACCGG
TGATACCCAAGGTGATGCGCCGAGCCCGTGCGCGACCAGCACCCATGGTGGCCCGAC
CGCGGCGCACGGTGTGAACGGCATGAACGGTGTTGATGGTCCGGATGAAGCGCGTCA
TGGTCTGAGCCGTGACACCGCGGGTCTGGATCATCCGGGTCTGGATGCGCTGTGGCTG
CTGCGTTGGCTGCCGAACACCGCGGCGAGCGCGATTGCGCAGCGTCTGGGTATTCAC
GGTGAAGGCCTGGTGGTTGGTACCGCGTGCGCGGCGGGTCTGCAAGCGCTGGGCGAA
GCGTATCGTCGTGTGCGTCATGGTCTGGCGCCGACCGTTCTGGCGGCGGGTGGCGATA
GCCGTCTGAGCGCGGGTGGTATGCTGGGTTATGCGCGTGCGGATGCGCTGTGGCACA
GCAACGCGCGTCCGGCGAGCCACGCGGAGGCGCTGCGTGCGATGCGTCCGTTTGATG
CGGCGCATGGTGGCTTTGTGCCGGGTGAAGGTGGCGCGGCGTTCGTTCTGGAGACCG
AAGCGGCGGCGTGCGCGCGTGGTGCGACCATCCACGGCGAGATTCTGGGTTTTGGCG
CGACCCTGGATGGCGCGAGCCTGACCGCGCCGGATGCGACCGCGCACCATGCGGAAT
GCGCGGTGCGTAAAGCGCTGGATGATGCGGGTTTCACCCCGGGTGACATTGCGTGGG
TTGCGGCGCACGGTACCAGCACCCCGCGTGGCGATGCGGCGGAGGCGCTGCTGCTGC
AACGTGTGTTTACCGATGCGGGTCACCGTCCGGCGGTTACCGCGCTGAAAAGCTGGA
CCGGTCACCTGGCGAGCGCGTGCGGTCTGGCGGAATGCGCGCTGATGCTGCGTGCGG
CGCGTTGCGGTGTGCTGCCGAGCATTCGTAACCTGGATACCCCGTGCAGCCCGGCGGC
GGAGGGTCTGGACCTGGTTCGTGAACCGCGTCCGTTCCCGCAGGGTCCGGGTCTGATC
CAAAGCTTCGGTTTTGGTGGCCAGAACGCGGCGCTGATTGTGATGCCGGCGGTTACCC
GTGCGGGCCAATAATGAGGATCCCTCGAGGATCGCATGC 
 
 
Synthetic bioDD1-5 extended biotin operon: 
 
 
CATATGAGCGAGAAGAACATGCCGGAAAAAACCGTGAGCGAACGTGATGGTGAAAGC
AGCGATGCGCCGCGTGATACCGCGATGAGCGGCGCGCAGAAGCACAGCGCGGAGAA
GATGGGTCGTAAAAGCAGCGCGGCGGTTCCGGCGGCGCGTAGCGCGAGCGTTTTCTG
CTGCTTTCCGGCGGATGATCCGGTGTATGCGGAGCACTTTCCGGGTGCGCCGTGCGTT
CCGGGCAGCCTGCTGATGCAGGCGTTTATCCGTGCGGCGGAACAAATGACCGGTCCG
GCGCCGGATGCGGGCCAGTGGACCTTCACCGGTGTGCGTTTCCGTAAATTTGTTCCGC
CGGGTACCCACGTGTGCACCGTTAGCGCGGTGACCGATGGTAGCGGCAGCGCGTATC
GTTGCACCCTGCTGGTTGATGGTGTGGCGGCGGTTACCGGTACCATTCAATGCGCGTA
ATGAACTAGTGAATTCAAAAGATCTTTTAAGAAGGAGATATACAAATGCGTCTGAGCC
ATACCCGTGGCTGCGTGCTGGTTGCGGGTGGCGGTAGCGCGCTGGGTACCGCGAGCG
CGACCCTGCTGGCGCGTGCGGGCGTGCCGCTGTGCCTGACCGCGGGTAGCGCGGAAG
CGGCGGCGCGTATTCACAACGCGTTCAGCGCGGCGCACCTGAGCTGCCCGCCGGTGC
TGATCGTTCGTATGGAGGACACCACCCGTGCGGATGCGCTGCCGGAACAAGCGGCGG
CGGCGGCGGGCATGCCGGCGGCGTACCTGCTGGACCTGATGCACACCGATCATGAGA
GCCTGCTGGCGAGCGCGAGCCCGGACACCATCAGCGCGTATATTGAAGCGAACATTA
CCTGGCGTGCGCGTCTGGTGCGTGCGGTTAGCCGTCACATGCTGCACCGTCGTTGCGG
CCGTATGGTGTTCGTTAGCAGCACCGCGGCGGCGCTGCCGGCGGCGGGTCAGGGTCT
GTACGCGGCGGCGAAGCTGGCGGCGGAGGCGCTGTATCGTAGCACCGGTACCGAACT
GGCGGCGCGTGGTATTACCACCTGCAGCCTGCGTCTGGGTTATGTTGCGGCGGGTCGT
GGTGCGCGTTATCTGAAACAACACCCGGACCTGCTGCAGCGTATCCCGCTGCAACGTG
CGGTGGATGTTCATGAAGCGGCGGGCGCGCTGGCGTTTCTGCTGAGCGATGGTGCGG
CGGCGATTAACGCGACCGCGATCACCATGGATGGCGGTCTGACCGCGTGCAAGTAAT
GAGAGCTCGAATTCAAAAGATCTTTTAAGAAGGAGATATACAAATGACCCAACAAAC
CGCGCCGTGCGCGGTGACCGAGCGTGTTATCGGTATCATTGCGGAAGTGCTGGACATC
CCGCCGCACACCATTACCCCGGAGACCCGTGTTCTGCGTGACCTGGAGACCGAGAGC
ATCGACCTGCTGGAGTTCGGTGTGGGCCTGAACGCGGCGTTTGGCATTCCGGTGGCGG
ACGATACCGTTTTCCTGACCAGCCTGCGTGTTCACCTGGAGGAAGCGCGTCATGCGGA
TGCGGACCCGTACAAGATGATGGCGGGTCGTTATCCGCACCTGAGCTGCGATCGTGTG
GCGTGCATCCTGCGTACCCTGGACGATGGCCCGGTGCTGAGCGTTCAGGACATTGCGG
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ATTACGTTCTGCACGCGCTGCGTGCGGGTCAACACGAGAAAGCGCCGAGCCACGCGG
GCTAATGAATCGATGAATTCAAAAGATCTTTTAAGAAGGAGATATACAAATGCAGGCG
GAGCGTCGTGTGGTTATTACCGGTGCGGGTGCGGTTACCCCGCTGGGTCACACCCCGC
AGGATATTCGTCAAAGCGTGCTGACCGGTCGTACCGTTTTCGAACCGACCAGCGTGCC
GGCGGGTTATGCGCAGGCGCCGGCGCAATTTGATGCGGACGATGCGCTGCGTGGTTG
GCGTCACCGTCGTTATCTGAACCGTGGCGCGGCGATGGCGGTGCATGCGGCGCGTCA
GGCGGCGGGTGCGGCGGGTTTCGCGGCGGGCCTGCCGGGTTACTGCGGTATCTTTGCG
GGCAGCGGTCCGCACCTGGACATGGATAGCGACTATGCGCAGCCGCAACACCTGCCG
CAACGTCACGATACCCTGTGCGCGCTGTGGATGCTGCGTTACCTGCCGAACACCGCGG
CGAGCGCGATCAGCCAACTGCTGGGTGCGCGTGGCGAGAGCCTGGTTACCGGTACCG
CGTGCGCGGCGAGCCTGCAAGCGGTGGGTGAAGCGTTCCGTCGTATTCGTCATGGTGT
GCTGCCGGTTGCGCTGGCGGGTGGCGGTGACAGCCGTCTGAGCTACGGCGGTCTGCT
GGCGTATGCGAAAGCGGGTGCGCTGGCGCCGTGCAGCGAGGATACCCATGCGGCGGC
GGCGGCGGCGTGCCGTCCGTTCGACACCGGTCGTCAGGGTTTTGCGGCGGGTGAAGG
CGCGGCGTTCTTTGTTCTGGAAAGCCTGGATCACGCGCAAAAACGTGGTGCGGTGCCG
CTGGCGGAAGTTTGCGGTTATGGTTGCAGCATGGATGGTCATGCGATGACCGCGCCGC
ACCCGCAGGGTATGCATGCGGAGCAAGCGGTGCGTACCGCGCTGCATGAAGCGGGTG
CGGGTCCGGCGGATGTGACCGCGGTTTGCGCGCATGGTACCGGTACCCGTCGTAACG
ACACCGCGGAGAGCGTTATGCTGACCCGTCTGTTTGCGCCGACCGGTCATCGTCCGCC
GGTGCTGGCGCTGAAGAGCTGGACCGGTCACTGCGCGAGCGCGTGCGGTGCGGTTGA
ACTGGCGGTTCTGCTGGCGTGCGCGCGTCATGGCTTCCTGCCGCCGGTTCGTAACCTG
CAGACCCCGCTGTGCGATAGCCTGAGCTTTGTGCGTCGTATTCACCCGTGCACCGCGG
CGGAGCTGTATGCGGCGGGTCGTCCGGAAAAACTGAGCGCGCTGACCCTGCTGCAGA
GCTTCGGCTTTGGCGGTCAAAACGCGGCGCTGGCGGTTCGTCCGTTCCGTGCGAGCAC
CGCGGCGGCGATCCAAGACGATAACATTCCGGCGTAATGAGTCGACGAATTCAAAAG
ATCTTTTAAGAAGGAGATATACAAATGAAGCACAAAAACACCATCACCCTGCGTTGC
AACGCGGCGCCGGCGCCGGAGACCCTGCACACCCCGGCGACCGCGCTGTTTGTGGTT
CCGGCGGCTGTGAGCGCGGTTTGCGGCAGCAGCATTCGTGGTACCGTGCGTGGTGGC
GGTCACAGCGGCGAGCCGTGGTTCATGACCGAAGCGCTGGCGCAGTTTGCGGCGCTG
CACACCCGTTGGCTGTGCGGTTTCAGCTGCCACGCGTTTCTGCTGAGCGTGCGTCGTA
TGCCGCACATCCGTCTGAGCGCGGCGGACCTGCCGGCGGGTGCGACCGCGCCGGTTC
ACGCGCTGCTGACCAGCCGTACCGGTAGCGATAGCCGTCACGCGTTTGAGTACACCGT
GCAGATGCAACTGGGCGCGCGTACCGTTCAGGGCATTCTGCTGACCGGTACCCTGCCG
TACGACGGTCGTTTCAGCGCGGATCGTCTGCAAAAGCGTTATCGTGAACTGTTTGCGT
GGCTGACCCGTCACTAATGAGGATCCCTCGAGGATCAAGCTT 
 
 
